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Outline 
Biotechnology has come a long way. Micro-organisms and enzymes have been used for 
thousands of years for preparing beer, cheese and even medicines. Though no fundamental 
understanding was present during those times, biotechnology was an everyday aspect of 
human life. With the advent of genetic engineering, new possibilities arose to steer the strength 
of this technology to create new kinds of molecules, enzymes or to optimize the micro-
organisms used. Step by step, the knowledge was expanded and the possibilities increased 
alongside.  
Thanks to a growing environmental awareness, alternatives for petrochemical derived 
molecules such as fuels, plastics or surfactants were researched starting from the capabilities 
of biotechnology for their production. In the case of fuels, biodiesel and biogasoline are both 
accepted renewable alternatives for their petrochemical rivals. Bioplastics such as polylactic 
acid and polyhydroxyalkanoates are used in both disposable and non-disposable applications 
such as wrapping material or medical implants. For the surfactants, several interesting 
molecule classes have been discovered, but their commercialization is hampered by high costs 
and a low molecule diversity combined with a minimal understanding of the wild type producers. 
The most promising class of these green surfactants, called biosurfactants, are the glycolipids. 
These molecules are composed out of a carbohydrate hydrophilic group attached to a lipidic 
hydrophobic group. Several types of them are already in use by industry. One of these are the 
sophorolipids, already applied in cosmetics and healthcare industry. The main producer of 
these sophorolipids is Starmerella bombicola, a yeast which in nature is associated with 
bumblebees. The molecules produced by this yeast are a mixture of different congeners. 
Though a mixture, certain structural similarities are conserved such as the preferred fatty acid 
tail. Attempts have been made during recent years to modify this yeast to steer the sophorolipid 
production towards a more uniform product. 
Another successful class of glycolipids are the rhamnolipids. These molecules have interesting 
applications in for example pharmaceuticals, cosmetics and bioremediation. They are 
produced by bacteria belonging to the Pseudomonas and Burkholderia genera. Several 
species of these genera are known pathogens of humans, such as Pseudomonas aeruginosa 
and Burkholderia pseudomallei. Some of these species are capable of producing rhamnolipids 
in high amounts, making them an interesting candidates for further production purposes. Still, 
the pathogenic nature of several of the producers implies special measures to ensure 
employee safety during the production process and can have an impact on their applicability 
in certain industries. Attempts have been made to produce rhamnolipids in non-pathogenic 
bacteria such as Escherichia coli and Pseudomonas putida, but the overall production remains 
low. 
The initial goal of this PhD was to engineer Starmerella bombicola to enable the production of 
rhamnolipids and from there on creating a production platform for other glycolipids as well. The 
benefits of this are multiple. First of all, S. bombicola is a non-pathogenic yeast. This already 
makes the production process less complex compared to the wild type producers of 
rhamnolipids. Furthermore, S. bombicola is resistant towards high levels of (bio)surfactants. 
Genetic engineering is possible and has led to several new sophorolipid producing strains 
already used in large scale production experiments. To produce rhamnolipids with S. 
bombicola, several aspects of their production need to be addressed. First of all, there is a 
  
 
need for suitable precursors in the yeast cell. One of these precursors, the β-hydroxy fatty 
acids, are present though not accessible for the biosynthetic enzymes involved in rhamnolipid 
synthesis. The other precursor, activated rhamnose, is not present at all. Feeding all of these 
components is possible, but wouldn’t make the production process economically interesting 
due to their high cost. Engineering S. bombicola for the production of these precursors was 
chosen to counteract these problems. 
During the PhD, several obstacles became apparent when engineering S. bombicola. Though 
molecular tools for genetic engineering and screening purposes were present, other question 
remained. For fast and efficient engineering, plasmids are an indispensable tool. S. bombicola 
does not have a native plasmid so designing one was necessary. During Chapter II, an attempt 
has been made to create a functional, and preferably stable, plasmid for this yeast. After 
engineering and screening, pathways or genes are often integrated in the genome to ensure 
that the resulting production strains are stable. For efficient genetic engineering, multiple genes 
should be introduced during one single event. This was necessary as well for rhamnolipid 
engineering since up to 14 genes are required for the simplest molecule. Still, turning S. 
bombicola in a production platform for glycolipids in general also requires understanding where 
the synthesis happens inside the cell. This allows for more efficient targeting of biosynthetic 
enzymes when creating new glycolipid production strains. 
Besides the more fundamental problems of creating a production platform, more practical 
hurdles have to be taken as well. As glycolipids are composed out of a carbohydrate and a 
lipid moiety, being able to modify both groups is a necessity. During the PhD, understanding 
both carbohydrate and lipid modifications was improved using the sophorolipid biosynthesis 
as a starting point. In Chapter III, new kinds of sophorolipids were created by changing the first 
step in their production pathway. Though several obstacles remain for large scale production, 
is was proven that even small modifications can have a significant impact on the structure of 
the molecules produced. In Chapter IV, carbohydrate engineering and strain optimisation 
resulted in strains producing glucolipids and cellobiose lipids. Though producer strains for both 
molecules already existed, the original engineered strains showed low productivity. 
Redesigning the molecular work and starting from strains with a higher overall fitness provided 
the necessary means for further enhancing production. 
The final chapter focusses on the initial goal of producing rhamnolipids with S. bombicola. The 
engineering strategy was split up in three smaller subjects, one for the activated rhamnose, 
another for production of the hydrophobic moiety and a final one for coupling both into the final 
rhamnolipid molecule. For each subject, a suitable proof-of-concept was chosen to validate 
each part. At the end, no rhamnolipid molecules were produced, but some small successes 
were achieved while trying. 
As a whole, this PhD points towards the applicability of S. bombicola as a production platform 
for different kinds of glycolipids. Several problems involving their production were investigated 
and solved. Albeit the final goal of rhamnolipids was not achieved, new knowledge on the 
production of other kinds of glycolipids might provide the necessary tools in the future to 
achieve this.  
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Surfactants, the major constituents of soap, are known since ancient times. The earliest 
evidence of soap-making dates back to the Babylonians 2800 years BC. The word soap is 
derived from the Latin word sapo, first mentioned by Pliny the Elder in his Historia Naturalis1. 
Throughout history, more applications, molecule types and resources were discovered and by 
2014, the global surfactant market generated a revenue of 33 billion dollars, accounting for 
over 13 million tonnes. This market is expected to rise annually with 2.5 %2. The major interest 
in surfactants originates from their interesting properties. Their amphiphilic structure, 
combining both hydrophilic and lipophilic domains, allows them to interact with a broad variety 
of products and molecules. Surfactants locate themselves at the surface or interface between 
two phases like air and water or oil and water. They lower the surface tension of both phases, 
resulting in better contact between them. Besides lowering surface tension, surfactants are 
known for the formation of so-called micelles, structures made by the surfactant molecules 
when present above a certain concentration (critical micelle concentration or CMC). These 
micelles can have different forms and structures, depending on the structure and the 
concentration of the surfactant molecule. This is why they are extensively used in for example 
cleaning applications, food production, health care and many others. Most of these surfactants 
are obtained by chemical processes from petrochemical and/or oleochemical resources like 
earth oil or palm oil. They are divided in four main classes, describing the hydrophilic head 
group: ionics (either cationic or anionic), nonionics and amphoterics (containing both cationic 
and anionic parts).  
During recent years, a shift towards more environmentally friendly surfactants is observed, 
caused by a growing awareness of both consumers and companies for the adverse effects 
that surfactants can have on the environment. For example, the majority of surfactants are 
produced from non-renewable petrochemical resources. Several companies have invested in 
producing surfactants based on renewable resources like glucose or oleochemicals. Examples 
of these ecological surfactants are alkyl polyglycosides (APGs), fatty acid methyl esters 
(FAMEs) and methyl sulphonates. These biobased molecules are often called biosurfactants 
while their production isn’t in anyway more environmentally friendly than their classic petroleum 
derived cousins. Surfactants also have an impact on the environment after they have been 
used. Most surfactants are very resistant towards degradation which can lead towards 
accumulation of the surfactant in the environment. Furthermore, they have been proven to be 
toxic towards several marine organisms3–5. It has to be noted that a recent life cycle analysis 
of biosurfactants shows that their burden on the environment still can be significant. This is 
mostly due to the usage of first-generation renewable resources. Production of materials such 
as vegetable oils and glucose requires a massive amount of water and is in direct competition 
with food and feed production. Using second-generation materials such as agricultural waste 
streams will certainly lower the environmental impact6. 
Chemical production of glycosides was first reported by Emil Fischer in 18937. Two main 
production processes can be identified for chemical glycosylations. The first one is acid-
catalysed and can be seen as oligomerisation equilibria reactions. The Fischer synthesis uses 
a glucose donor such as starch and fatty alcohols to produce alkyl polyglucosides using an 
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acid catalyst and temperatures of approximately 110 °C. Though the carbohydrate moiety 
tends to polymerise during the production process, adjusting the ratio of the glucose donor and 
the fatty alcohol provides good control on the degree of polymerisation. The second production 
strategy are stereoselective substitutions on activated carbohydrates8. An example of such a 
production process is the Koenigs-Knorr reaction9,10. In this type of reaction, a glycosyl halide 
is condensed with a fatty alcohol producing alkyl glycosides. Though both production strategies 
have their own benefits and drawbacks, in general the production of alkyl polyglycosides by 
direct condensation reactions is a cost-effective way to generate chemical biosurfactants. If 
however a more pure compound is needed, the more exhaustive stereoselective substitutions 
can be used. This however implies more elaborate production schemes using expensive 
substrates and/or special catalysts, adding to the overall higher cost of molecules produced 
this way. 
True biosurfactants, surfactants produced by prokaryotic and eukaryotic micro-organisms, are 
a worthy green alternative for the classic petrochemical surfactants. Because of their 
interesting properties like low ecotoxicity11, easy biodegradability5, mild production conditions 
and high effectiveness in various conditions12,13, biosurfactants have numerous potential 
applications in a wide variety of industrial sectors like agriculture, pharmacy and medicine14. 
Biosurfactants can be divided in two main groups, the low and high molecular weight classes. 
Major examples of the former are fatty acids, phospholipids, lipopeptides and glycolipids. 
These amphiphilic molecules lower the surface tension between two phases, whereas the high 
molecular weight biosurfactants are often polyphilic and are rather stabilizers of emulsions, 
without significantly lowering the surface tension. The high molecular weight group are 
therefore also called bioemulsifiers and comprise, for example, polysaccharides, 
lipopolysaccharides and lipoproteins15. An overview of the different classes of biosurfactants 
as well as some producing organisms can be found in Table 1.1. 
Table 1.1: Overview of common biosurfactant classes with their producing organism and reported yields. 
Yields are given in the same order as the producing organisms when more than one is listed. Nd = Not 
determined 
Class Biosurfactant Producing organism Titers (g/L) 
Glycolipids Sophorolipids Starmerella bombicola, Rhodotorula bogoriensis, 
Candida batistae 
>30016; 1.2617; 
618 
 Rhamnolipids Pseudomonas aeruginosa, Burkholderia 
thailandensis 
>10019; 1.4720 
 Mannosylerythritol lipids Ustilago maydis, Pseudozyma aphidis 2721, 7522 
 Trehalose lipids Rhodococcus erythropolis 4023 
 Cellobiose lipids Ustilago maydis, Pseudozyma flocculosa 1.721; 1524 
 Rubiwettin RG1 Serratia rubidaea Nd25 
 Xylolipid Pichia caribbica 7.4826 
Lipopeptides Surfactin Bacillus subtilis 6.4527 
 Serrawettin Serratia marcescens Nd28 
 Lichenysin Bacillus licheniformis 0.02529 
 Daptomycin Streptococcus roseosporus 0.81230 
 Gramicidins Bacillus brevis 0.22031 
Lipids Oligomeric fatty acids Serratia rubidaea, P. aeruginosa Nd25, 0.59832 
 Spiculisporic acid Penicillium spiculisporum 11033 
Polymeric 
surfactants 
Emulsan Acinetobacter calcoaceticus 0.09734 
Liposan Yarrowia lipolytica 835 
Alasan Acinetobacter radioresistens 2.236 
Biodispersan A. calcoaceticus 1237 
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The natural role of biosurfactants is still heavily debated. A generalization of their role is difficult 
due to their structural diversity and appearance in different ecological niches38. Their surface 
tension lowering capacities can enhance the availability of hydrophobic substrates for the 
organism and thus promote growth on these substrates. The biological activity of some 
biosurfactants might serve as a defence mechanism in ecological competition. It has been 
suggested that the production of sophorolipids provides an advantage to S. bombicola in niche 
protection as an extracellular carbon storage mechanism, while also having a mild 
antimicrobial effect39. Another natural role assigned to biosurfactants is the regulation of biofilm 
formation. Cell-bound surfactants can form an interface between a surface and the cell for 
easier attachment or other organisms can be inhibited in their biofilm formation. An extreme 
example of niche formation is the pathogenicity of Pseudomonas aeruginosa. This bacteria is 
dependent on the production of rhamnolipids for efficient colonization of their host organism40. 
Some biosurfactants have been shown to bind heavy metals, reducing their cell toxicity.  
For the industrial production of biosurfactants, some obstacles still remain. Only a few are 
currently produced on an industrial scale and are commercially available, namely rhamnolipids, 
sophorolipids, mannosylerythritol lipids and surfactin. Sophorolipids and rhamnolipids are 
produced by companies like MG Intobio Co Ltd and Jeneil Biotech Inc (Table 1.2). These 
biosurfactants are already in use in cosmetics and cleaning products and future applications 
involving pharmaceuticals and bioremediation are nearby. Often issues like low yields 
combined with high purification costs, resulting in overall high costs, hamper market 
penetration and limited structural variation hinders further integration in existing application 
domains or the development of new ones (see Table 1.1 and Table 1.3).  
Table 1.2: Overview of several companies producing biosurfactants41. 
Company Biosurfactants Applications 
TeeGene Biotech Rhamnolipids, Lipopeptides Pharmaceuticals, cosmetics, antimicrobials 
AGAE Technologies Rhamnolipids Pharmaceuticals, bioremediation, EOR 
Jeneil Biosurfactant Co. LLC Rhamnolipids Cleaning products, EOR 
Rhamnolipid Companies, Inc. Rhamnolipids Agriculture, EOR, pharmaceuticals 
Fraunhofer IGB Cellobiose lipids, MELs Cleaning products, pharmaceuticals 
Cognis Care Chemicals Alkyl polyglucosides Household cleaners, agrochemicals 
Saraya CO. Ltd Sophorolipids Cleaning and hygiene products 
Ecover Belgium Sophorolipids Cleaning products, cosmetics, bioremediation 
Groupe Soliance Sophorolipids Cosmetics 
MG Intobio Co. Ltd. Sophorolipids Cosmetics, personal hygiene 
Synthezyme LLC Sophorolipids Cleaning products, cosmetics 
Allied Carbon Solutions Ltd. Sophorolipids Agricultural products 
Henkel Sophorolipids, Rhamnolipids Glass cleaning, cosmetics 
Lion Corporation Methyl ester sulfonates Cleansing products 
Kaneka Co. Sophorolipids Cosmetics and toiletry products 
Evonik  Sophorolipids Household cleaners 
 
To counter these problems, a lot of effort has been put into engineering the production process 
using either cheap waste streams42 or optimizing the fermentation parameters and product 
recovery43. With the rise of biotechnological engineering, new ways for improving the 
production of biosurfactants became available. Both the engineering of wild type producers 
and the development of heterologous production systems are viable approaches towards 
increased yields and enlarged molecular diversity. 
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Table 1.3: Prices for different kinds of (bio)surfactants for bulk orders. Prices are in $/kg unless otherwise 
stated. (Source: www.zauba.com). 
Surfactant Price per kg (bulk price) 
Triton® X-100 $16.00 
Sodium Stearate $2.09 
Cocamidopropyl Betaine $1.92 
Decyl Glucoside 55% $3.29 
Sodium Lauryl Sulfoacetate $26.45 
Sodium Laureth Sulfate 27% $1.47 
Sodium Dodecyl Sulphate $1.28 
Cetyl Trimethyl Ammonium Bromide $9.66 
First generation biosurfactants  
APG $1.60 
Methyl ester sulfonates $0.95 
Fatty acid methyl esters $0.75 
Second generation biosurfactants  
Di-rhamnolipid solid 97% $270.27 
R90L (90% pure rhamnolipid mixture) $100 for 1 liter 
Sophorolipids $34.26 
Surfactin $39.89 
Mannosylerythritol lipid $252.12 
 
In the following sections the industrially available rhamnolipids, sophorolipids and 
mannosylerythritol lipids will be discussed, as well as cellobiose lipids and lipopeptides, which 
are also considered of industrial and economical relevance. These glycolipids and lipopeptides 
are both low-molecular weight biosurfactants. 
 
 
Rhamnolipids, perhaps the most studied glycolipids to date, are composed of one or two L-
rhamnose molecules coupled to a mono- or dimer of β-hydroxy fatty acids44 (Figure 1.1). The 
production of rhamnolipids depends on two pathways delivering the necessary intermediate 
molecules. The first one produces dTDP-L-rhamnose by the rmlABCD operon. The enzymes 
coded by the genes of this operon convert glucose-1-phosphate to the activated rhamnose 
that serves as a donor for the hydrophilic part of the rhamnolipids. The hydrophobic part is 
synthesized by dimerization of β-hydroxy fatty acids coupled to an acyl carrier protein, 
originating from the fatty acid synthesis which will be discussed later on. Two of these 
molecules are coupled by rhamnosyltransferase A (RhlA) to form 3-(3-
hydroxyalkanoyloxy)alkanoic acids (HAA). Rhamnosyltransferase B (RhlB) will then transfer 
the rhamnose from dTDP-L-rhamnose to the HAA to form a monorhamnolipid. 
Rhamnosyltransferase C (RhlC) can use this monorhamnolipid to create dirhamnolipids44. 
Besides the rhamnolipids, HAA molecules can be detected outside the cell as well. Initially it 
was thought that they originated from degradation of the secreted rhamnolipids, but addition 
of deuterium-labelled rhamnolipids did not result in labelling of the free HAAs. Their existence 
might be explained by the fact that rhamnosyltransferases have a higher specificity towards 
longer HAAs with chain lengths of 10 or 12 carbon atoms while the secreted ones are mainly 
8 or 10 carbon atoms long32.   
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Figure 1.1: Structure of a rhamnolipid with two rhamnose moieties and two β-hydroxydecanoic acids. 
Rhamnolipids are produced by several species from the Pseudomonas45 and Burkholderia46 
genera with Pseudomonas aeruginosa being the top producer with titers over 100 g/L. They 
have the capability to reduce the surface tension of water from 72 mN/m to 24 mN/m47, which 
is better than sodium dodecyl sulfate (SDS)48 or cetrimonium bromide (CTAB)49, two common 
chemical surfactants. Depending on the type of rhamnolipid tested, either a pure compound or 
a mixture, their critical micelle concentration varies between 10 and 234 mg/L. During 
degradation studies, it was found that compared to CTAB, SDS and Triton X-100 the 
rhamnolipids showed nearly full degradation in a timespan of several days4. Rhamnolipids are 
hence extensively tested for their properties in bioremediation of contaminated soils. They tend 
to form complexes with metal ions like cadmium, lead, nickel and mercury50. In the case of 
cadmium, up to 71.9 % is removed from kaolin, a typical soil component51. In view of their 
biodegradability, it is stated that rhamnolipids are stable enough to sequester metal cations, 
but unstable enough to not form a threat to the ecosystem. Solubilization followed by microbial 
degradation of complex hydrocarbons like diesel fuel52, pentachlorophenol53 or phenanthrene54 
is elevated when using rhamnolipids either as sole surfactant or in a mixture with other 
(bio)surfactants. Besides remediation they can also be used for microbial enhanced oil 
recovery (MEOR). Conventional oil extraction techniques only remove 30-45 % of the original 
oil in place. Using the excellent emulsification properties of rhamnolipids combined with their 
biodegradability make them interesting alternatives for chemical surfactants. MEOR can be 
applied ex situ by injecting culture broth or surfactant solutions or in situ by introducing the 
producing organism together with sufficient substrates. It has to be noted that oil fields contain 
high levels of H2S, an inhibitory molecule for both growth of P. aeruginosa and production of 
rhamnolipids. By co-culturing sulphide-removing strains like Pseudomonas stutzeri, in situ 
MEOR remains possible55. 
Rhamnolipids are commercialized by a couple of companies like Jeneil Biotech Inc. and Agea 
Technologies. Unfortunately, the higher price compared to chemical surfactants (Table 1.3) 
combined with the pathogenicity of P. aeruginosa and less than optimal uniformity of the 
product still hampers further market penetration.  
A part of this PhD (Chapter 5) focuses on the production of rhamnolipids and engineering of 
its biosynthesis. Since all the necessary building blocks for these rhamnolipids are derived 
from the central metabolism of the bacterial cell, a more detailed discussion is presented in the 
following sections. In a first part the synthesis of the hydrophobic part of the rhamnolipid is 
discussed (I.2.2), in a second one the biosynthesis of the hydrophilic part (I.2.3) and in a third 
part their coupling (I.2.4). Further on the regulation of the pathway is explained (I.2.5), and 
finally some engineering possibilities are discussed (I.2.6). 
Chapter I   Literature Review 
 
   
 
6 
 
 
Producing fatty acids is one of the key elements any prokaryotic and eukaryotic organism has 
to accomplish to be able to grow, maintain its membrane structures or modify biomolecules 
like oligosaccharides or proteins. In most eukaryotes, except plants, all the reactions are 
performed by the type I fatty acid synthase system (FAS I)56. This system is a big polyfunctional 
multizyme consisting of all necessary domains to synthesize fatty acids starting from acetyl-
CoA. The bacterial type II system (FAS II) is a dissociated system with each catalytic step 
being carried out by a different enzyme. Even though the structure of both systems varies 
extremely, four steps can be identified that are shared between them: (1) a condensation, (2) 
a reduction, (3) a dehydration and a (4) final reduction. Another similarity of both systems is 
that they perform a cyclic reaction, using the product of one cycle as a substrate for the next 
until the desired fatty acid is produced. These steps as well as the enzymes responsible will 
be discussed below. A scheme of the cyclic reaction mechanism of the pathway can be found 
in Figure 1.2. 
 
Figure 1.2: Fatty acid synthesis in prokaryotic organisms. Initiation of the synthesis starts at the right hand 
side while elongation of the acyl chain is shown at the left side. (1): Acetyl Carboxylase (ACCase), (2): 
Malonyl-CoA:ACP Transacylase (FabD), (3): β-Ketoacyl-ACP Synthase III (FabH), (4) & (8): β-Ketoacyl-ACP 
Reductase (FabG), (5): β-Hydroxyacyl-ACP Dehydratase (FabZ) and β-Hydroxydecanoyl-ACP Dehydratase 
(FabA), (6) & (10): Enoyl-ACP Reductase I (FabI), II (FabK) and III (FabL), (7): β-Ketoacyl Synthase I (FabB) 
and II (FabF), (9): β-Hydroxyacyl-ACP Dehydratase (FabZ) and β-Hydroxydecanoyl-ACP Dehydratase (FabA). 
n = [0, 7]. When the fatty acid has reached its final length, a thioesterase will hydrolyse the bond between 
the ACP and the fatty acid. In P. aeruginosa, step 3 is catalysed by FabY instead of FabH. 
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  Acyl Carrier Protein 
A central factor of the FAS II system is the acyl carrier protein (ACP), a small 10 kDa protein 
consisting of 78 amino acids. The ACP carries the growing acyl chain during the different 
catalytic steps. In P. aeruginosa, the ACP is encoded by acpP57 and lies within the cluster of 
fatty acid biosynthetic genes. Similar genomic configurations can be found in other species 
like Escherichia coli58, Vibrio harveyi59 or Bacillus subtilis60. It has been proven that three 
different ACPs are present in P. aeruginosa. One of these is for example necessary for the 
production of N-butyrylhomoserine lactone molecules, essential for quorum-sensing61. The 
sequence and structure of the ACP is highly conserved between these and other species with 
identities over 80% being common. To be able to carry the growing acyl chain, the ACP needs 
to be converted from its inactive apo-ACP state to the active holo-ACP (Figure 1.3). This 
activation is done by a 4'-phosphopantetheinyl transferase, an enzyme transferring a 
pantetheine 4'-phosphate from Coenzyme A to a serine residue contained in the DSLD 
consensus amino acid sequence62. The intermediates in the synthesis are coupled to the 
terminal thiol group of the pantetheine by a thioester bound.  
 
Figure 1.3: Schematic representation of ACP activation by the 4'-phosphopantetheinyl transferase (PPTase) 
During synthesis, the growing acyl chain is buried within the hydrophobic core of the ACP 
between helix II and III63. It has been proposed that hiding the cargo protects the thioester 
bound or acts as a ruler to control the size of the fatty acids. It has been noted in E. coli that 
an ACP carrying an acyl chain has a smaller diameter compared to a non-acylated variant and 
is more resilient towards denaturation64. This stabilizing effect has been found to be 
proportional to the length of the acyl chain up to chain lengths of eight carbon atoms65. During 
docking of the ACP with one of the reaction partners, the acyl chain inside the ACP is 
transferred by a chain-flipping mechanism66. The exact way how this flipping mechanism is 
triggered is still to be discovered. Even though the ACP interacts with a wide variety of reaction 
partners, no clear binding sequence has been detected67,68. Still, structural research has shown 
that electrostatic interactions exist between the ACP and its reaction partner. Along helix II of 
the ACP, several electronegative residues can be detected that interact with electropositive 
residues in the ACP-binding sites of the reaction partners. Depending on the reaction partner, 
specific amino acid residues are responsible for interaction69.  
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 Acetyl-CoA carboxylase (Acc) 
The first step in the synthesis of fatty acids is the generation of the essential precursor molecule 
malonyl-CoA (step 1 in Figure 1.2). This is governed by the biotin-dependent enzyme Acetyl-
CoA carboxylase. In E. coli, Acc is composed out of four different subunits70 which are 
carboxyltransferase α71, carboxyltransferase β71, biotin carboxyl carrier protein (BCCP) and 
biotin carboxylase72. Two half-reactions can be identified, the carboxylation of biotin by the 
biotin carboxylase using ATP and bicarbonate and the transfer of this carboxyl group onto 
acetyl-CoA to produce malonyl-CoA73,74. The biotin used in this process needs to be covalently 
bound to the BCCP. It has been shown that overproducing these subunits in E. coli can elevate 
the production of fatty acids by enlarging the pool of malonyl-CoA inside the cell70. Therefore, 
it has been suggested that Acc is a key regulatory enzyme of the fatty acid biosynthesis.  
 Malonyl-CoA:ACP transacylase (FabD) 
In order to be available for fatty acid synthesis, the malonyl-CoA precursor needs to be 
transferred to the ACP (step 2 in Figure 1.2). This is done by malonyl-CoA:ACP transacylase, 
also known as FabD or MCAT using a ping-pong kinetic mechanism. The transfer of the 
malonyl-group is mediated by an intermediate malonyl-enzyme complex. In this state, the 
malonyl-group is covalently bound to a highly reactive serine residue75. This serine residue is 
part of a highly conserved pentapeptide GHSLG, strongly resembling the serine-dependent 
acyl hydrolases motif GXSXG76. It is worth mentioning that in a typical serine hydrolase, the 
intermediate acyl-enzyme is not stable and hydrolyses quickly in the presence of water. FabD 
however efficiently stabilizes this bond in a watery environment77.  
 β-Ketoacyl-ACP Synthase III (FabH, FabY) 
The first condensation reaction involves malonyl-ACP and acetyl-CoA (step 3 in Figure 1.2). 
This reaction is catalysed by FabH in E. coli78. Like FabD, FabH uses a ping-pong kinetic 
mechanism with an acetyl-enzyme intermediate79. The substrate specificity of FabH in E. coli 
is strictly limited to short chains like acetyl and propionyl-CoA while the other condensation 
enzymes discussed below easily utilize chain lengths differing from four to 16 carbon atoms. 
Another remarkable aspect is that FabH prefers CoA thioesters instead of ACP-bound acyl 
chains78,80. Since FabH initiates the cyclic fatty acid production, it is an important regulator of 
the pathway. Long-chain acyl-ACPs are the most efficient inhibitors of FabH. Decreasing the 
concentration of these molecules resulted in an increase of short-chain acyl-ACP types80–82. 
Strains overexpressing thioesterases, enzymes capable of degrading long-chain acyl-ACPs 
into a fatty acid and a holo-ACP, show constitutive production of fatty acids under otherwise 
limiting conditions83,84.  
Most bacteria only have one copy of the fabH gene in their genome. Noteworthy exceptions 
are B. subtilis85 and P. aeruginosa86. In B. subtilis, the two FabH homologs are involved in the 
production of branched-chain fatty acids using iso- and anteiso-branched-chain acyl-CoA 
substrates. Expression in E. coli of these enzymes resulted in the production of a branched-
chain, odd-chain fatty acid85. In P. aeruginosa, the story becomes even more complicated. 
Three potential genes have been identified as FabH while none of these actually are involved 
in initiating the fatty acid biosynthesis. Analysis of one of these fabH homologs, PA3286 or 
FabH3, showed that it was involved in shunting products, more specifically octanoyl-CoA, from 
the β-oxidation into the FASII pathway87. Potentially, this is done to conserve energy since 
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many different molecules are derived from the next few intermediates in the FAS II pathway. 
One of them is for example 3-hydroxydecanoyl-ACP, used in rhamnolipid and 
polyhydroxyalkanoate synthesis86. Most likely, the real initiator of the biosynthesis is FabY, 
another β-ketoacyl synthases distinct from FabH. Deletion of this gene resulted in slower 
growth while complementation with the E. coli FabH restored the wild type phenotype88. 
 β-Ketoacyl-ACP reductase (FabG) 
The next step (steps 4 and 8 in Figure 1.2) in the production of fatty acids is the reduction of 
the generated β-ketoacyl-ACP. This is done by FabG using NADPH in the process. This 
enzyme was discovered thanks to its high sequence identity to several acetoacetyl-CoA 
reductases58. Yet, it belongs to the short-chain dehydrogenase/reductase (SDR) family of 
enzymes, so correct annotation can be problematic. Up until now, only one isozyme has been 
detected that is capable of reducing the β-keto group.  In E. coli and other bacteria, fabG is an 
essential gene making it an interesting target for antimicrobial drug development89. However, 
up until now, no inhibitors have been discovered. 
In P. aeruginosa, a second β-ketoacyl-ACP reductase is present, also discovered based on its 
high sequence identity90. It has been hypothesized that the product of this rhlG gene uncouples 
the rhamnolipid production from the fatty acid synthesis. Recent data however states that RhlG 
doesn’t have the required ACP docking site near its active centre and in vitro assays show that 
it’s activity is 2000-fold lower than the one of FabG91. It has been theorized that RhlG has 
evolved into a single substrate enzyme requiring different enzymes and reaction partners than 
the regular FAS II system present in P. aeruginosa.  
 β-Hydroxyacyl-ACP-dehydratase (FabZ) and β-Hydroxydecanoyl-
ACP-dehydratase (FabA) 
Dehydration of the β-hydroxyacyl-ACPs is achieved by two different dehydratases (steps 5 
and 9 in Figure 1.2). FabZ can only catalyse the dehydration while FabA can dehydrate and 
isomerize the double bond in the acyl chain, a necessary step for the production of unsaturated 
fatty acids. FabA has a very high substrate specificity towards β-hydroxy-decanoate ACPs92, 
but it can accept shorter hydroxyl-acyl-ACPs as well93. It has been found that FabA stays 
inactive throughout the biggest part of the unsaturated fatty acid synthesis93 due to its structure; 
the active site lays at the end of a 0.6 nm straight hydrophobic tunnel. Hence, the bend tails of 
the cis unsaturated fatty acids are not able to enter this tube effectively excluding them from 
further catalytic steps by FabA94. Another peculiar property of this enzyme is that the reactions 
are freely reversible. This means that a part of the cis-enoyl-ACPs is converted back to trans-
enoyl-molecules and further processed to saturated fatty acids. Because of this 
interconvertability, only a part of the products are the cis-enoyl-ACPs95. Ratios range from 
equal81,96 to 75:22:397 for respectively β-hydroxy, trans-2 and cis-3 products. In P. aeruginosa, 
fabA is clustered together with fabB in one operon98. FabB encodes an β-ketoacyl synthase, 
essential to the first step in the further elongation of the fatty acid intermediates. Specific 
interplay between FabA and FabB is needed for the efficient production of unsaturated fatty 
acids. FabB effectively pulls the reaction in favour of the unsaturated fatty acids, thereby 
competing with FabA for the cis-enoyl-ACPs. This in part explains that strains lacking FabB 
cannot produce unsaturated fatty acids. Overexpression of both fabA and fabB results in 
strains with higher ratios of unsaturated fatty acids99. 
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FabZ is the dehydratase that is active in the further processing of unsaturated fatty acid 
intermediates and is more active than FabA on longer hydroxyl-acyl-ACPs. It has been 
suggested that variations in the FabA:FabZ-ratio are in fact one of the regulatory actions 
controlling the balance between saturated and unsaturated fatty acids93. The catalytic 
reactions of this enzyme are as easily reversible as the ones catalyzed by FabA. Kinetic 
characterization of Plasmodium falciparum FabZ clearly shows that the product of the reaction 
is again a good substrate for the reverse reaction. Though it has to be noted that these 
experiments were conducted with CoA-coupled molecules instead of ACP-coupled ones100, 
similar results were reported for other species as well101. Structural analysis of E. coli FabA 
and P. aeruginosa FabZ revealed that both enzymes are nearly imposable. Both enzymes 
have the necessary key residues to perform dehydration and isomerization, but only FabA is 
capable of performing this reaction. A more close analysis revealed that in FabZ, the active 
site tunnel has a slightly different conformation effectively shielding the trans-enoyl-ACP from 
isomerization102. Nevertheless, it has to be noted that dividing FabZ and FabA in different 
classes is difficult due to the high structural similarities. Enterococcus faecalis utilizes for 
example a FabZ enzyme capable of replacing FabA in E. coli103. In Streptococcus pneumoniae 
even a third mechanism has been identified104. In this organism, the point where saturated and 
unsaturated synthesis separate lays behind the dehydration step. FabM is responsible for 
converting trans-2-decenoyl-ACP tocis-3-decenoyl-ACP. 
 Enoyl-ACP reductase I (FabI), II (FabK) and III (FabL) 
Understanding the mechanism on how antibiotics like triclosan influence microbial metabolic 
steps has led to the characterization of enoyl-ACP reductases. In the special case of 
diazaborines, a single point mutation in the allele encoding FabI caused resisitence105. FabI is 
one of few enzymes that can reduce the trans-enoyl-ACP molecules to the corresponding acyl-
ACPs, utilizing NAD(P)H as a cofactor for electron donation (steps 6 and 10 in Figure 1.2). 
Depending on which cofactor is used, the resistance of FabI towards antibiotics or overall 
stability can be altered. When using NADPH, an increase can be seen in antibiotic resistance, 
but the enzyme becomes less stable. It has been hypothesized that this is due the difference 
in charges between NADH and NADPH resulting in conformational changes. FabI also acts as 
an important control point for fatty acid biosynthesis since it’s easily inhibited by palmitoyl-CoA, 
a molecule present when sufficient fatty acids are available96,106.  
Besides FabI, a few other enzymes exist that are able to reduce the enoyl-ACP intermediates. 
In species like Enterococcus faecalis and Pseudomonas aeruginosa, other classes of 
reductases can be detected107,108. FabL, specific to Bacillus subtilis was discovered by 
identification of the characteristic active site dyad tyrosine-X6-lysine109 also present in E. coli 
FabI. Reductases FabI and FabL are both members of the Short Chain 
Dehydrogenase/Reductase superfamily, sharing several properties even though sequence 
homology is rather low110. Shared properties are for example folding of the enzymes, presence 
of a Rossman fold for cofactor binding, the already mentioned conserved active site and size 
of the enzymes. Besides the already mentioned SDR-family members, two enoyl-reductases 
have been found that differ significantly even though catalysing the same reactions. These are 
FabK and FabV. In Streptococcus pneumoniae, the flavoprotein FabK is the only reductase 
present111. Interestingly, FabK has been shown to utilize only NADH, even in absence of its 
substrate. It is suggested that besides its role in fatty acid synthesis, it is also involved in 
oxygen-dependent anaerobic energy metabolism. FabV was initially found in Vibrio cholera 
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and proved to be essential for triclosan resistance108,112. Similar to FabK, it has a high 
preference for NADH over NADPH. It has been hypothesized that the high structural diversity 
of enoyl-reductases, compared to the other fatty acid synthesis reactions, is due to the 
existence of compounds inhibiting one or several enoyl-reductases107,113,114 and their 
involvement in other metabolic processes than the production of fatty acids. 
 β-Ketoacyl-ACP Synthase I (FabB) and II (FabF) 
Elongation of the fatty acid is performed by FabB and FabF (step 7 in Figure 1.2). FabB was 
discovered first in temperature sensitive mutants115. Though both enzymes are capable of 
condensing malonyl-ACP with the growing acyl chain and have a similar structure, they play 
different roles in the central metabolism of the cell. Deletion mutants of fabB are viable when 
supplemented with an exogenous source of unsaturated fatty acids. This proves the role of 
FabB in elongating the cis-3-decanoyl-ACP produced by FabA116. In vitro studies showed that 
FabF can also utilize the products of FabA. FabB is also known for its capacity to begin fatty 
acid synthesis by using a side reaction of malonyl-ACP decarboxylase in the absence of acetyl-
ACP117. In vitro studies showed that both FabF and FabB can utilize a wide range of acetyl 
and ACP coupled fatty acids with a length up to 22 carbon atoms. Temperature adaptation in 
E. coli is controlled by FabF. At lower temperatures, FabF is far more capable than FabB to 
elongate palmitoleic (C16:1) molecules to cis-vaccenic acid (C18:1), a common membrane 
fatty acid in cold-adapted E. coli. Regarding antibiotic resistance, both enzymes are 
susceptible to cerulenin which forms an covalent bond with the active site cysteine118. 
 
Rhamnose is a deoxy sugar commonly found in plants and bacteria. It is an essential 
component of the bacterial cell wall and can be found in the O-antigen part of the 
lipopolysaccharides of several microorganisms like Salmonella enterica119 and in the 
rhamnolipids produced by P. aeruginosa. The bacterial system uses deoxy-thymidine-
diphosphate-L-rhamnose as rhamnose source for rhamnolipid production. Production of this 
activated sugar starts from glucose-1-phosphate and by means of four catalytic steps it is 
converted to dTDP-L-rhamnose120,121 (Figure 1.4). The enzymes show high sequence 
similarities between different species making it easy to generalize conclusions122,123.  
The first step in the conversion is carried out by a glucose-1-phosphate thymidylyltransferase 
called RmlA. In S. enterica124, it catalyses a reversible group transfer using dTTP or UTP to 
create respectively dTDP- or UDP-D-glucose. During the reaction, the phosphate group of 
glucose-1-phosphate performs a nucleophilic substitution on the α-phosphate of dTTP. By this 
reaction, pyrophosphate is released and the stereochemistry of this phosphate is inversed125. 
RmlA is regulated by both allosterical and competitive inhibition by dTDP-L-rhamnose126. 
dTDP-L-rhamnose binds in the active site required for the production of dTDP-D-glucose. Due 
to its different structure, dTDP-L-rhamnose is protected from the pyrophosphorylase activity of 
RmlA125. 
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Figure 1.4: Production of dTDP-L-rhamnose starting from glucose-1-phosphate. First, 
thymidylyltransferase RmlA couples a thymidine group to the glucose-1-phosphate, creating dTDP-D-
glucose. The next step is a dehydration by RmlB, followed by epimerization of the dTDP-4-keto-6-deoxy-D-
glucose intermediate by RmlC. The final reduction step is carried out by RmlD resulting in dTDP-L-
rhamnose. 
RmlB catalyses the dehydration of dTDP-D-glucose to dTDP-4-keto-6-deoxy-D-glucose. It 
consists out of two domains, one for binding the cofactor NAD+ and one binding the sugar-
nucleotide. The first step in the mechanism is transferring the hydrogen from C4 from the 
glucose moiety to the NAD+. This results in the dTDP-4-ketoglucose intermediate. Secondly, 
an essential glutamate residue removes a proton from C5. In the next step, a water molecule 
is removed creating the 4-keto-5,6-glucosene intermediate. This is followed by a hydride 
transfer from the NADH and inversion of the configuration of the glucose ring at the C6 position. 
Finally, a glutamate residue protonates the C5 position127,128. 
Epimerization of the dTDP-4-keto-6-deoxy-D-glucose is governed by RmlC. The configuration 
at positions C3 and C5 is inverted and the final product of this step is dTDP-4-keto-6-deoxy-
D-mannose. The structure of RmlC does not resemble other known epimerases, suggesting it 
constitutes a different class129. 
The final step is the reduction of the C4 keto group by RmlD using NAD(P)H as the reducing 
cofactor. This step requires efficient catalysis as the intermediate keto-product shows 
enhanced reactivity. One essential element is Mg2+, required for correct dimerization of RmlD. 
Sequence analysis has shown that RmlD might be part of the single domain 
reductase/epimerase/dehydrogenase (RED) protein superfamily130. Both a Rossman fold as 
several conserved catalytic residues have been identified.  
 
Coupling of β-hydroxyacyl-ACPs and dTDP-L-rhamnose is catalysed by the 
rhamnosyltransferases RhlA, RhlB and RhlC (Figure 1.5). In P. aeruginosa, transferases RhlA 
and RhlB are organized in the rhlAB operon131. In Burkholderia species, two identical gene 
clusters can be identified with all three transferases included20,46. It has been suggested that 
grouping rhlC together with rhlA and rhlB ensures equal stoichiometric ratios, thereby shifting 
the production to mainly di-rhamnolipids in the Burkholderia species.  
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The first rhamnosyltransferase RhlA doesn’t transfer rhamnose as it name suggests, but 
instead it couples β-hydroxyacyl-ACPs to form β-D-(β-D-hydroxyalkanoyloxy)alkanoic acids 
(HAAs). Though mostly dimers are produced, the occasional trimer is also possible. In P. 
aeruginosa PA14, its most preferred substrate is β-hydroxydecanoyl-ACP132. When comparing 
substrates differing in only two carbon atoms in length like β-hydroxyoctanoyl-ACP and β-
hydroxydodecanoyl-ACP, activities dropped to 9.8 % and 4.7 % respectively. This in part 
already explains the overall abundance of β-hydroxydecanoate in the in vivo produced 
rhamnolipids133. In Burkholderia glumae, the affinity of RhlA is highest for β-
hydroxytetradecanoyl-ACP since the most abundant hydroxyl fatty acid of its rhamnolipids 
produced contains 14 carbon atoms134. The N-terminus of the transferase contains a putative 
signal peptide for potential targeting towards the membrane131. 
 
Figure 1.5: Final steps in the production of rhamnolipids. The first rhamnosyltransferase RhlA couples two 
β-hydroxy-decanoic acids to form a dimer of these molecules. The second transferase RhlB couples the 
first rhamnose moiety to form a monorhamnolipid. The second rhamnose necessary for dirhamnolipids is 
coupled by RhlC. 
The second rhamnosyltransfere RhlB is essential for the production of mono-rhamnolipids131. 
In the process it uses the earlier produced HAA-molecules and dTDP-L-rhamnose. Sequence 
analysis has shown that the transferase contains two large hydrophobic regions, potentially 
transmembrane helices, suggesting that the transferase is membrane bound or at least 
associated. The final step in the biosynthesis is the addition of a second rhamnose moiety on 
the already produced mono-rhamnolipids by RhlC consuming again one dTDP-L-rhamnose as 
precursor135. Like RhlB, RhlC possesses a large hydrophobic region again suggesting its 
location inside the cell near the membranes. Interestingly, in P. aeruginosa, in the same operon 
upstream of the gene coding for RhlC lies PA1131. Though it has not been characterized yet, 
in silico structural analysis has shown that it belongs to the major facilitator superfamily of 
transporters. A similar genomic organization exists in B. thailandensis where up- and 
downstream of rhlC several genes potentially coding for transporters have been found20. 
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Production of secondary metabolites is often regulated by direct and indirect factors. In the 
case of rhamnolipids produced by P. aeruginosa, quorum sensing (QS) is an important part of 
the regulatory network controlling the biosynthesis of these molecules136,137 (Figure 1.6). 
Quorum sensing can be explained as a way to sense population density by the local 
concentration of certain signal molecules. Various attempts have been made to understand 
and interfere with these regulatory mechanisms to uncouple production from the various 
factors influencing this system.  
In P. aeruginosa, two major QS systems are operational138: las and rhl. Both systems produce 
a specific kind of QS molecule with a shared core structure. This core structure is a homoserine 
lactone (HSL), which is further processed in respectively N-3-oxo-dodecanoyl HSL by LasI and 
N-butanoyl HSL for RhlI. Both systems belong to the so-called LuxR-LuxI family regulators139 
and in both systems, the synthase of these molecules as well as the receptor protein of the 
mechanism are located in the same operon. The current understanding of the QS regulation 
is that the las operon acts as a global integrator of several signal cascades. Expression of the 
las operon is often followed by expression of the rhl operon.  
Expression of the rhl operon results in the production of N-butanoyl HSL by RhlI, which in turn 
will activate RhlR. After activation, RhlR will bind on the rhlAB operon and express the first two 
transferases of the rhamnolipid biosynthesis. The role of RhlR is however subtler than just 
initiate expression of the rhlAB operon. When no N-butanoyl HSL is present, RhlR still binds 
to the promotor of the rhlAB operon, but effectively inhibits transcription140. Though it appears 
that the expression of the las operon regulates the expression of the rhl operon, experiments 
show that the expression of the latter operon is not necessarily a case of population density 
and that the rhl operon can also be expressed prior to the las operon. In mutant strains lacking 
the las operon, rhamnolipid production is still detectable, but productivity is often reduced. It 
has been found that the different regulatory systems can circumvent each other in case of a 
deficiency141.  
A third quorum sensing system is built around 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas 
quinolone signal PQS). Production of this molecules is initiated by the pqsABCD operon and 
finalized by pqsH producing PQS. PQS will bind after a certain minimum level is reached to its 
receptor PqsR (also known as MvfR), which is expressed under control of LasR. The PQS-
PqsR complex will further activate the pqsABCD operon resulting in elevated production of 
these molecules as well in elevated expression of PqsE, an enzyme elevating the activity if 
RhlR, again resulting in (higher) expression of the rhlAB operon. 
Other regulators have a direct influence on the rhlAB operon as well. AlgR, a regulator involved 
in several pathways like alginate production142, has a direct role in the expression of the rhlAB 
operon by binding the promotor143 and inhibiting its activity. Deletion of this regulator shows an 
increased rhamnolipid production in biofilms compared to the wild type PAO1 strain144. 
Unfortunately, no differences could be observed when the knock-out strains were grown in 
liquid medium. Simple overexpression of AlgR did not guarantee rhlAB operon inhibition since 
AlgR requires activation by phosphorylation.  
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Figure 1.6: Part of the regulation controlling the production of rhamnolipids in P. aeruginosa44.  
Regulators like PtxR, RsaL, RsmA, DksA and several sigma factors like RpoN and 
RpoS138,145,146 also influence the expression levels of the rhlAB operon. This is either by 
activating or inhibiting expression of either the rhlAB operon or its regulatory network. This 
explains why even without activation of the las system, production of rhamnolipids can occur. 
 
Great potential for obtaining more rhamnolipids lies in uncoupling their production from its 
complex regulatory system. This should ensure a stable and continuous production of the 
rhamnolipids. Another strategy for enhancing rhamnolipid production proved to be the 
introduction of the Vitreoscilla hemoglobin gene vgb in P. aeruginosa. Production for the 
engineered strain was higher than for the wild type NRRL B-771 strain147. This might be 
correlated to the higher oxygen uptake and availability, which enhances cell density and hence 
production. It has to be noted that more significant improvements were reported in the same 
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article by process engineering than by engineering of the strains themselves, resulting in yields 
being improved from 969 mg/L to 7543 mg/L. Though this increase in product titers is 
significant, it is still lower than the titers achieved by the wild type P. aeruginosa PAO1, the top 
producing strain. 
Since the substrates used by RhlA are β-hydroxyacyl-ACPs, engineering the fatty acid 
synthesis to enlarge this pool of molecules has been proven successful as well. When 
inactivating either FabA or FabI, increased productivity by respectively 55 % and 36 % could 
be detected132. 
Production of rhamnolipids results in a mixture of both mono- and dirhamnolipids. By knocking-
out rhlC, encoding a rhamnosyltransferase, only monorhamnolipids are produced without a big 
loss in production titers135. It has to be noted that in the research paper concentrations are 
expressed as milligrams of rhamnose per milliliter of broth. Since the wild type rhamnolipids 
are a mixture of mono- and dirhamnolipids, a direct comparison is difficult. Still, the strain 
lacking the second rhamnosyltransferase produces 120 ± 21 mg of rhamnose while the wild 
type producer PAO1 reaches 150 ± 15 mg per milliliter. 
Engineering of species other than P. aeruginosa has been reported as well. Using this strategy, 
the opportunistic pathogenic nature of P. aeruginosa, which is a serious burden both for the 
production and application, can be circumvented. Usually, the P. aeruginosa rhlAB operon is 
expressed in a strain that is resistant towards high biosurfactant concentrations148. Using 
several Pseudomonas putida strains like KT2440148, KT2442149 and KCTC1067150, titers 
ranging from 0.6 g/L149 to 7 g/L150 were obtained. The lower production compared to P. 
aeruginosa might be explained by insufficient production of the dTDP-L-rhamnose precursor, 
a necessary substrate for the rhamnosyltransferases150.  
Other production hosts were evaluated as well, such as Escherichia coli strains W2190151 and 
BL21152. When using the same strategy as for P. putida, maximum production titers of 0.18 g/L 
were obtained. Again, it is suggested that the flux through the dTDP-L-rhamnose synthesis 
pathway is too low to guarantee higher production titers151. By introducing the rhlAB operon 
from P. aeruginosa PAO1 in Burkholderia kururiensis KP23, a 6-fold increase from 0.78 g/L to 
5.67 g/L was detected153. 
 
 
Sophorolipids (Figure 1.7), another well studied type of glycolipids, are produced by certain 
yeasts, most of them belonging to the Starmerella clade, like Starmerella bombicola154, 
Wickerhamiella domercqiae155 and Candida batistae18. In S. bombicola, the molecules are 
constituted out of a sophorose molecule (2-O-β-D-glucopyranosyl-D-glucopyranose) linked to 
a terminal or subterminal hydroxylated fatty acid with a chain length of 18 or 16 carbon atoms. 
These can undergo further modifications like acetylation by a specific acetyltransferase at 
position 6’ and 6” and lactonisation between the free carboxylic end and the C4” of the 
sophorose unit by an extracellular lactone esterase39,156,157.  
Chapter I   Literature Review 
 
   
 
17 
 
 
Figure 1.7: General structure of acidic (left) and lactonic (right) sophorolipids produced by S. bombicola. 
The fatty acid tail is made from oleic acid. Further acetylations are possible at R1 and R2. 
Like all biosurfactants, sophorolipids lower the surface tension of water. Depending on the 
sophorolipids tested, most values average around 35 mN/m after addition to water12.  The 
critical micelle concentration varies, depending on the type of sophorolipid and its uniformity, 
between 35 and 200 mg/L158. Interestingly, these molecules tend to maintain their properties 
in a wide range of salt concentrations, pH and temperatures. Still, at pH values above 7.5, 
hydrolysis of the ester bonds occurs. Similar to the rhamnolipids, sophorolipids are promising 
for soil remediation since they efficiently enhance microbial degradation of complex 
hydrocarbons159,160 while being easily biodegradable themselves161. Other more specialized 
applications exist in cosmetics162, medicine163, pharmacy164,165 and nano-industry166–169. 
Besides acting as a final product, sophorolipids can be used as a substrate as well, for the 
production of hydroxy fatty acids16, glucolipids16, sophorose170 and novel chemically derived 
surfactants171. Sophorolipids are already used in several products like dish-washer and laundry 
products from companies like Ecover and Saraya. S. bombicola, known for the efficient 
production of sophorolipids up to 400 g/L154, is the best studied producer so far. 
 
The production of sophorolipids is associated with the stationary phase and expression of the 
necessary enzymes can be detected when the yeast is transitioning from the exponential to 
the stationary phase172. The real trigger is still undefined, but several options have been 
proposed such as low C/N-ratio156, phosphate limitation173 and a low pH174. As is typical for 
secondary metabolites in fungi and yeast, in S. bombicola all the genes necessary for 
sophorolipid production, except the lactone esterase, are located inside a gene cluster situated 
on chromosome 2.  
The first step in the biosynthesis of sophorolipids (Figure 1.8) by S. bombicola is the terminal 
or subterminal hydroxylation of a fatty acid by the cytochrome P450 monooxygenase enzyme 
CYP52M1. This class of enzymes is further discussed in I.3.3. Strains knocked-out in this P450 
are incapable of producing sophorolipids39 confirming its role. Next at play is UGTA1 that 
glucosylates the hydroxy fatty acid175. The main glucose donor for UGTA1 is UDP-glucose 
though small residual activity can be detected for UDP-galactose and UDP-glucuronic acid. 
When looking at hydroxy fatty acid preference, the highest activity is seen with 17-hydroxy-
oleic acid. Terminally hydroxylated palmitic acid shows only 20 % of the activity compared to 
17-hydroxy-oleic acid176. Sequence analysis of UGTA1 revealed that it belongs to the GT-B 
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type superfamily of glycosyltransferases. The second glucosyltransferase UGTB1 adds a 
second glucose moiety to the glucolipid produced by the first transferase. It shows the same 
preference for the glucose donor as UGTA1, but is more promiscuous when it comes to the 
glucolipid being glucosylated. When using alkyl glucosides as acceptor, still 83 % activity was 
detected for decylglucoside compared to the natural 17-O-glucopyranosyloctadecenoic acid 
substrate. It has become evident that the UDP-glucose dependent soluble 
glucosyltransferases UGTA1 and UGTB1 add the two glucose units in a stepwise manner to 
form a non-acetylated acidic sophorolipid.  
The acetyltransferase is another soluble enzyme from the pathway. As a member of the 
maltose-O-acetyltransferase (MAT) and galactoside-O-acetyltransferase (GAT) subfamilies, it 
transfers an acetyl group from acetyl-CoA to the 6th carbon atom of the sugar moiety177. 
Transport of the sophorolipids to the extracellular environment is attributed to a specific 
transporter. The protein contains twelve transmembrane helices and two nucleotide binding 
sites39 necessary for ATP-binding. Knocking out the transporter results in production levels 
lower than 10% of those of the wild type. These sophorolipids might be exported by another 
transporter-like protein or by diffusion through the plasma membrane of the yeast. It has to be 
noted that knocking-out the acetyltransferase also resulted in lowered production. It might be 
that the main substrate for the transporter are di-acetylated sophorolipids, the most abundant 
type found in the natural culture broth.  
The final step in the production is the optional extracellular lactonisation of the sophorolipids 
by condensing the carboxyl group of the fatty acid to the 4” position of the sophorose. As 
mentioned before, the gene coding for the lactone esterase is not situated inside the 
sophorolipid cluster, but approximately 2.5 megabases upstream of the cluster on 
chromosome 2. The occurrence of lactonic sophorolipids pointed however towards the 
existence of such enzyme. Analysis of the exoproteome gathered in various growth phases 
identified four proteins showing lipid binding motifs157. One of them showed high similarities 
towards the Candida antarctica lipase A, a lipase with high specificity towards longer fatty acids 
and alcohols178. Further studies of this enzyme of S. bombicola confirmed its function as the 
missing sophorolipid lactone esterase. It has been hypothesized that the regulation of the 
lactone esterase is influenced by citrate concentrations174. 
Besides product titers, small variations in congener ratios exist among the different species 
producing sophorolipids. While in S. bombicola and Candida apicola the most abundant forms 
are the lactonic sophorolipids, Candida batistae and Candida NRRL Y-27208 mainly produce 
free acidic variants18,179. Another difference is the position of the hydroxyl group on the fatty 
acid. Again a clear distinction can be made between the different yeast species. S. bombicola 
and C. apicola mainly incorporate ω-1 hydroxy fatty acids while C. batistae and Candida NRRL 
Y-27208 prefer the terminal hydroxylated ones. Variations in acetylation pattern can also occur. 
S. bombicola, C. batistae and Candida NRRL Y-27208 mainly produce di-acetylated lactonic 
sophorolipids in comparison to C. apicola, which produces non-, mono- and di-acetylated 
lactonic sophorolipids. Interesting outsider is the basidiomycete Rhodotorula bogoriensis180. 
The molecules produced by this yeast are composed of a 22 carbon atom fatty acid tail with 
the sophorose group connected by a O-glycosidic to the 13th carbon atom181. Minor amounts 
of C24 sophorolipids can be found as well. Using hydrophobic substrates like meadowfoam or 
rapeseed oil, higher productivities can be achieved17. 
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As described above, the first step of the sophorolipid biosynthesis pathway is performed by a 
cytochrome P450 monooxygenase enzyme. Cytochrome P450 enzymes (P450s) have been 
studied for several decades because of their interesting biocatalytic properties like the 
capability to perform oxygenations, nitrations, reductions or even non-redox related 
reactions182. First described in the sixties as the carbon monoxide-binding pigment with a 
characteristic absorption at 450nm183–185 when reduced with carbon monoxide, they are now 
one of the biggest enzyme families found in all kingdoms of nature186. They are arranged in 
families and subfamilies based on sequence homology187,188. Most P450s rely on a reaction 
partner for donating the electrons to perform their catalytic reaction. Depending on the number 
and type of partners, up to ten different classes can be distinguished. 
In chapter 3, P450 enzymes are evaluated utilizing their interesting biocatalytic properties for 
the production of biosurfactants. These enzymes and their different classes are discussed in 
more detail below. 
 Structure and reaction mechanism 
Though P450s differ in their amino acid sequence, reaction partners used or type of reaction 
catalysed, most P450s have a common structural organization (Figure 1.9). In general, it can 
be stated that P450s are composed out of thirteen α-helices (A, B, B’, C-L) and five β-sheets 
(β1 – β5)189. As expected, a strong conservation can be seen around the central heme group, 
which includes α-helices E, I, J, K, L, B190 and the β-sheets. Small variations between the core 
helices D, E, I, L191 and the other helices (A, B, B’, F, G, H and a part of K) that are less 
conserved result in the wide variety of substrates that can be accommodated. In general, six 
substrate recognition/binding sequences can be detected lining the active site192.  
Binding of the heme group happens at a cysteine residue accommodated in a region called 
the Cys-pocket on the distal end of the helix L. It is locked inside a highly conserved consensus 
sequence FXXXXGXRXCXG. During the beginning of the catalytic reaction, the electrons from 
this cysteine residue are donated and believed to significantly contribute to the heterolytic 
cleavage of molecular oxygen. Other residues may interact with the heme group as well. 
Mutating these or similar residues can result in altered reduction potential193–195 or altered 
stability of the heme group196–198. On Helix I, a conserved motif with sequence (A/G)GX(E/D)T 
is found containing a highly conserved threonine residue, believed to be involved in 
catalysis199–201. Another essential motif is on the C-terminus of the K-helix. This EXXR-motif is 
well conserved and plays a role in formation of the tertiary structure of the P450 and in heme 
insertion.  
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Figure 1.8: Biosynthetic pathway of the sophorolipids produced by S. bombicola. (1): Cytochrome P450 
monooxygenase CYP52M1, (2): Glucosyltransferase UGTA1, (3): Glucosyltransferase UGTB1, (4): 
Acetyltransferase AT, (5): Multi-drug resistant ABC transporter MDR, (6): Lactone esterase LE 
 
Chapter I   Literature Review 
 
   
 
21 
 
 
Figure 1.9: General topology of a P450 enzyme. Helices are depicted by the green boxes carrying a letter. 
Dark coloured shapes with blue arrows are β-sheets202.  
During its catalytic cycle (Figure 1.10), the heme iron group of the P450 can occur in eight 
distinct states. At rest (1) the ferric enzyme is in its low-spin state with a distal water ligand. 
When a substrate enters the active site (2) this will displace the water molecule and induce a 
shift in the d-orbitals of the iron atom shifting it to a high spin state203,204. This high spin state 
benefits in most cases the reduction of the ferric Fe3+ enzyme to the ferrous Fe2+ state by (3) 
electrons donated from NAD(P)H or another suitable donor. The next step (4) is binding of 
molecular oxygen resulting in an ferric superoxo complex205,206. Following a second reduction 
and first protonation (5), respectively a peroxo-ferric and a hydroperoxo-ferric intermediate 
state are obtained207. Following the second protonation (6), the molecular oxygen is 
heterolytically cleaved and a water molecule is detached and a ferryl oxo porphyrin radical 
cation remains208. This radical withdraws (7) a hydrogen atom from the substrate inducing the 
rebound of the oxygen to oxidize the substrate. Finally (8), the product is released and the 
distal water ligand returns to stabilize the heme iron. A more in depth review was written by Ilia 
Denisov209.  
During the cycle, several abortive side reactions are possible resulting in a loss of electrons 
and generating radicals. These reactions are known as shunts. Three of them are reported. 
The autoxidation shunt releases a superoxide anion from the ferric superoxo intermediate, the 
peroxide shunt creates hydrogen peroxide from the hydroperoxo-ferric intermediate and the 
oxidase shunt produces a water molecule using an additional pair of electrons and 
protons210,211. 
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Figure 1.10: Catalytic cycle showing all the different intermediate compounds of the heme iron as well as 
all the different possible abortive side reactions209.  
 Class I 
The class I P450 systems are characterized by being composed out of three reaction partners 
(Figure 1.11). Even though they can be found in bacteria and mitochondria, this configuration 
is conserved. The first enzyme in the cascade is a FAD-containing reductase, which accepts 
the electrons from NAD(P)H. They are then transferred to the ferredoxin, which finally donates 
them to the P450. One small difference is that in bacteria all proteins are cytosolic while in the 
mitochondria both the reductase and the P450 are bound to the inner membrane212,213. 
The best studied bacterial example is CYP101A1 (P450cam) from P. putida catalysing the 5-
exo-hydroxylation of camphor to 5-hydroxycamphor. It utilizes putidaredoxin and putidadoxin 
to transfer electrons from NADH214. Putidaredoxin is an iron sulfur protein belonging to the 
[2Fe-2S] group215. During each turnover of the electrons, two binding events have to take place. 
These events are induced by conformational changes resulting from substrate and oxygen 
binding in P450cam214–216. Other types of ferredoxins can be used as well like [3Fe-4S], [4Fe-
4S]217 and combinations218. 
Eukaryotic systems have been found in mammals, insects and nematodes, but not in plants. 
Examples of human class I P450s are CYP11A1, CYP11B2 and CYP27B1219. These enzymes 
are active in steroid hormone or vitamin D production.  Up to date, only one type of ferredoxin 
has been reported, namely the [2Fe-2S] type. Interesting to mention is that interchanging 
ferredoxins or reductases can lead to suboptimal results. Switching the ferredoxins from 
CYP101A1 and CYP11A1 only results in a partial electron transfer214, while CYP2B4 is as 
efficient with the putidaredoxine as with its own reductase220. 
Chapter I   Literature Review 
 
   
 
23 
 
 Class II 
Class II enzyme systems are defined by having one or several electron transfer enzymes, 
either a cytochrome P450 reductase (CPR) or a cytochrome b5 reductase, and one P450, all 
attached to the membrane of the endoplasmatic reticulum (hence microsomal) (Figure 1.11). 
A noteworthy exception to this is CYP105A3 from Streptomyces carbophilus, which is 
completely soluble, but uses a separate soluble reductase containing the same domains as 
the eukaryotic systems221. Up to date it is the only bacterial class II system reported. The CPR 
is an essential electron transfer enzyme necessary in the microsomal I and II families of class 
II systems. While P450s of family I only interact with the CPR, the microsomal II family uses 
cytochrome b5 as an additional electron transfer partner and can use either a CPR or a 
cytochrome b5 reductase as an electron donor. Family III doesn’t use a CPR at all, but only a 
specific cytochrome b5 reductase222–224. In total three different types of P450 interactions can 
be distinguished for cytochrome b5. The first one is transferring both electrons needed for the 
P450 from cytochrome b5 reductase and the cofactor NADH225,226. The second interaction is 
the delivery of only the second electron to the P450. The third interaction is noncatalytic. 
Several P450s show enhanced properties due to allosteric stimulation of cytochrome b5227. In 
the case of CYP17A1, cytochrome b5 even has an influence on the type of reaction the P450 
catalyses. When no cytochrome b5 is present, CYP17A1 will perform as a hydroxylase of 
pregnenolone. The product from this reaction is a precursor for the glucocorticoids. When 
cytochrome b5 is present, CYP17A1 will also display 17,20-lyase activity, generating 
dehydroepiandrosterone, a precursor for the sex steroids228. Due to the high identity with 
bacterial flavodoxines and FAD-containing proteins, it has been suggested that the CPR is the 
result of a gene fusion229. 
The structure of the CPR consists out of five distinct domains. These are an N-terminal 
membrane anchor, an NADPH binding domain, a flavine adenine dinucleotide (FAD) binding 
domain, a flavine mononucleotide (FMN) binding domain and a linker domain in between the 
FAD and FMN domains. Binding of NADPH is initiated by electrostatic interactions between 
the positively charged binding site residues and the negatively charged phosphor-AMP from 
NADPH230. Next, the electrons are sequentially transferred to the FAD to form FADH2. Without 
interaction of the amino acid residues of the CPR, the electrons are then transferred to the 
FMN, creating an FMNH2. During the electron transfer, FADH2 can be completely oxidized 
while FMN2 forms a stable semiquinone intermediate. CPRs will always shuffle between a total 
of one to three electrons bound to their flavine domains231–235. Control over the amount of 
reducing elements inside the CPR is done by a second non-donating NADPH-binding site236. 
During the reduction of the CPR and its domains, the conformation of the enzyme changes 
from a compact to a more open form. The FMN-binding domain remains close to the 
membrane while the FAD-binding domain rises. This leads to a more exposed FMN-binding 
domain capable of interacting with the P450237.  
Well studied examples of the Class II system are the vertebrate families CYP1, CYP2 and 
CYP4. All of them are involved in fatty acid hydroxylation or epoxidation. Human CYP1A1 and 
CYP1B1 both act on arachidonic acid. The former performs mainly hydroxylations at the 
subterminal ω-1 position and epoxidations between carbon atoms 14 and 15238. The latter 
performs a wide selection of terminal and subterminal hydroxylations and epoxidations on 
arachidonic acid as well as several other substrates like 17β-estradiol239,240. The CYP2-family 
seems to show high affinity for fatty acids ranging from eight to 20 carbon atoms. CYP2E1 
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accepts mainly lauric, myristic, palmitic and stearic acids and hydroxylation is very strict 
towards the ω-1 position241,242. This high product specificity can be broadened by targeted 
mutations to include hydroxylations from ω-1 to ω-7 as well243. 
Another well studied group is the CYP52 family found in fungi and yeast. These P450s of 
microsomal family I act on alkanes, fatty acids and their derivatives. In Candida tropicalis seven 
CYP52 P450s have been identified244–246. Not all enzymes respond the same when alkanes, 
alcohols or fatty acids are present in the culture medium, but six out of seven have an aliphatic 
inducer and are present when glucose is available. All of these P450s might play a specific 
role to convert alkanes and fatty acids to α,ω-dicarboxylic acids. Selective engineering of the 
genes encoding these enzymes proved to be an interesting strategy for increasing production 
of these fatty acid derivatives247. In Candida maltosa up to nine different P450s of the CYP52 
family are found and were partially characterised248–250. They are induced by alkanes and fatty 
acids, explaining the alkane utilization as source for production of cellular lipids and 
dicarboxylic acids251. Also worth mentioning are Candida apicola252 and Starmerella 
bombicola253,254. Both yeasts produce sophorolipids which harbour a palmitic, stearic or oleic 
acid tail. In S. bombicola, CYP52M1 is responsible for the hydroxylation of these fatty acids. 
As the same type of fatty acids tails can be identified in the C. apicola mix255, it is not unlikely 
that a CYP52M1 homologue is present in C. apicola performing the same reactions in the 
sophorolipid biosynthesis. Comparing the C. apicola CYP52E1 and CYP52E2 enzymes with 
S. bombicola CYP52E3, high identities can be found as well254. 
 
Figure 1.11: Prokaryotic class I and eukaryotic class II of the microsomal I family.  
 
 Class III 
The class III systems highly resemble the ones from class I except that the second reaction 
partner is not an iron-sulfur protein, but a flavodoxin instead (Figure 1.12). In this way, it shares 
all the domains from class II like FAD and FMN, but in separate enzymes. A classic example 
of the class III enzymes is CYP176A1, a P450 from Citrobacter braaki, enabling this 
microorganism to grow on cineole256,257.  
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 Class IV 
Class IV systems are best characterized in thermophilic species like the archaea Sulfolobus 
solfataricus. They again highly resemble the class I bacterial system except that the reducing 
elements are not donated by NAD(P)H, but from a 2-oxo acid like pyruvate (Figure 1.12) by a 
2-oxoacid-ferredoxin oxidoreductase. CYP119 is the first P450 discovered to utilize such a 
non-NADPH-consuming flavoprotein258–260. It has to be noted that in the case of CYP119, the 
exact electron donor has not been discovered yet. Several other P450 have been discovered 
in thermophilic species, but it has to be said that more information about redox-partners and 
electron donors is scars.  
 
Figure 1.12: Class III and the oxo-acid utilizing class IV. OFOR = 2-oxoacid-ferredoxin oxidoreductase 
 Class V 
Class V is characterized by the fusion of the ferredoxin reaction partner to the P450 (Figure 
1.13). Only one member of this family has been characterized, but other candidates have been 
identified in other species. The enzyme MCCYP51FX from Methylococcus capsulatus is a 14α-
sterol demethylase261. Structural analysis revealed that the ferredoxin domain is linked to the 
P450 by an alanine linker to the C-terminus of the enzyme. A homologue has been discovered 
in Mycobacterium tuberculosis though this P450 is not a fusion product262,263. However, a [3Fe-
4S] ferredoxin gene is found next to the P450. Further research on the properties of the M. 
capsulatus system in comparison with the class I systems is ongoing. Potentially, by fusing 
both reaction partners, a more efficient electron transfer could be obtained. 
 Class VI 
Another class consisting out of fusion enzymes is class VI (Figure 1.13). Here, a flavodoxin 
domain is fused to the P450, strongly resembling the class III system. The first P450 of this 
class to be discovered was XplA, an enzyme from Rhodococcus rhodochrous264. Special 
interest goes to this enzyme since it can convert hexahydro-1,3,5-trinitro-1,3,5-triazine, an 
explosive compound with widespread contamination265. Using Rhodococcus species or 
organisms heterologously expressing XplA might be interesting for bioremediation 
purposes264,266. The reductase of this system is XplB266. Genetic analysis of other RDX-
degrading strains suggests that this property is the result of lateral gene transfers267 of the 
P450s involved. 
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Figure 1.13: Fusion P450s of class V and class VI 
 Class VII 
The class VII systems are fusion proteins containing a unique reductase domain with high 
homology to phthalate dioxygenase reductases of type I268, commonly referred to as PFOR269. 
The reductase is fused to the C-terminus of the P450 (Figure 1.14). The reductase domain is 
constituted out of three subdomains, namely an FMN-binding domain, an NADH-binding 
domain and a [2Fe-2S] ferredoxin domain270. Indeed, in P450 PFOR enzymes, the electrons 
are donated to the FMN instead to an FAD like in most P450 classes. After the hydride transfer, 
NAD+ is released from the NADH-binding domain. Small structural changes induced by the 
release control the transfer of the electrons to the [2Fe-2S]-domain. P450 Rhf, also known as 
CYP116B2, from Rhodococcus sp. NCIMB9784 was the first enzyme of this class to be 
discovered270,271. Other members have been identified as well in several Burkholderia 
species.272 Sequence analysis of the P450 domain revealed high similarities with the class I 
CYP116A1 from Rhodococcus erythropolis NI86/21, an enzyme involved in the degradation of 
thiocarbamate herbicides273. Recently, CYP116B1 from Cupriavidus metallidurans was found 
to be a class VII P450 as well, with similar thiocarbamate degrading properties274. 
 Class VIII 
Class VIII enzymes are again fusion proteins. The reductase domain however has high 
similarity to the eukaryotic diflavin reductases (for example the CPR enzyme from class II) 
(Figure 1.14). The first discovered and model enzyme for this class is fatty acid hydroxylase 
CYP102A1 (BM3) from Bacillus megaterium ATTC 13368275. CYP102A1 harbours all the 
necessary domains to perform its catalytic reactions. The reductase domain contains a FAD 
and FMN-binding domain as well as a NADPH-binding pocket. The electrons are transferred 
from the NADPH to FAD and sequentially FMN almost the same way as in the eukaryotic 
cytochrome P450 reductase. In the eukaryotic reductase, the electrons come from the double 
reduced FMN group creating a FMNH semiquinone, while in contrast, the electrons in BM3 are 
donated from the FMNH semiquinone276. Studies have shown that electron transfer through 
the reductase domain, dioxygen binding and substrate binding are all not rate-limiting. 
Depending on the substrate bound, electron transfer rate can vary277. This control is believed 
to be due to conformational changes in the flavoprotein induced by the fatty acids. It is believed 
that the transfer of electrons from FMNH semiquinone towards the heme group is rate-limiting, 
together with other factors like product release278. 
Other compounds have been studied besides the natural substrates of CYP102A1, other 
compounds have been studied as well with promising results for biocatalytic applications279–
281. The natural enzyme can deliver high region- and stereospecificity depending on the used 
substrate and conditions282–284. The high catalytic activity of BM3 combined with enlarged 
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substrate promiscuity under varying conditions also promises interesting opportunities for 
engineering the enzyme to produce high value molecules like novel potential drugs or for 
improving the understanding of drug intermediate toxicity. A first example of engineering BM3 
is the substitution of F87V for producing high purity (14S,15R) epoxyeicosatrienoic acid.  
In the wild type enzyme, the Phe87 residue acts as a steric gate, controlling substrate specificity 
due to its bulky side chain protruding in the active site channel. By switching between two 
states, either the final methyl group or its 14,15-olefin are positioned near the heme group. 
Replacement by valine effectively expands the active site allowing better positioning of the 
14,15-olefin285. It has to be noted that mutating Phe87 has a distinct effect on coupling 
efficiencies285,286 of other non-natural substrates of BM3. Another example is the production of 
piceatannol (3,5,3′,4′-tetrahydroxystilben), a hydroxylation product of resveratrol (3,4′,5-
trihydroxystilbene). It shows interesting antitumor properties in several cell lines since it is 
known as a protein kinase inhibitor working on several cellular targets287–289. It can be produced 
in the liver by CYP1A2, but a side product is formed. Wild type and mutant variants of 
CYP102A1 all produce a single product, piceannatol. Activities higher than for the wild type 
BM3 enzyme and CYP1A2 were found for several mutated BM3 enzymes290. 
All enzymes of the CYP102A family are known as fatty acid hydroxylases. All of them perform 
subterminal ω-1, ω-2 and ω-3 hydroxylations of medium and long chain fatty acids like lauric, 
myristic and palmitic acid291–293. In Fusarium oxysporum, a similar self-sufficient P450 called 
CYP505A1 or P450foxy has been found294,295. In contrast to CYP102A1, P450foxy appears to be 
membrane bound or at least associated. 
 
Figure 1.14: Self-sufficient P450s of class VII and class VIII 
 Class IX 
The class IX system is occupied by a single family of P450 enzymes, CYP55A. It is the only 
P450 family known in eukaryotes that is completely soluble (Figure 1.15). All enzymes of this 
class are known as nitric oxide reductases (P450nor). They can be found in both the cytosol 
and the mitochondria. They are necessary for clearing nitrogen oxide when dioxygen is limited 
by reducing it to nitrous oxide296,297, thereby preventing nitrogen oxide inhibition of the 
mitochondria.  The first enzyme discovered of this class was P450nor or CYP55A1 from F. 
oxysporum298. Upon binding of an electron donor, in the case of CYP55A1 the pyridine 
nucleotide NADH, a global conformational change enables efficient transfer of two electrons 
and one proton towards the heme group by a channel connecting the NADH binding site and 
the heme group299. Further analysis of fungi and yeast like Cylindrocarpon tonkinense300, 
Aspergillus oryzae301 or Trichosporon cutaneum302 provided more isozymes of cytochrome 
P450nor. Depending on the species, either NADH, NADPH or both can be used by their P450. 
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 Class X 
The class X enzymes can be called atypical since they don’t depend on an external electron 
source for their reactions. Instead they use an intramolecular transfer system and don’t require 
molecular oxygen. Their substrates are acyl hydroperoxides and by rearranging the bonds new 
products are generated (Figure 1.15). All members originate from the CYP74 family and are 
only detected in plant chloroplasts303,304, fungi305 and some bacteria306. The class members can 
be divided in three subfamilies, allene oxide synthase (AOS) CYP74A, hydroperoxide lyase 
(HPL) CYP74B and CYP74C and finally divinyl ether synthase (DES) CYP74D.  
 
Figure 1.15: Class IX and class X P450 systems. 
As mentioned, the catalytic mechanism of these P450s differs from traditional ones. An 
overview of all three reactions can be found in Figure 1.16. For AOS, the mechanism was 
elucidated using 13(S)-hydroperoxide linolenic acid (HPOT)307. The peroxide bond located at 
C13 is evenly broken by using a transition phase leaving an oxygen radical on the substrate 
and binding the leaving hydroxyl group in the heme iron. In a next step, the oxygen radical 
interacts with the nearby C12 methyl-group creating the epoxide. The radical is stabilized in 
this stage since the conjugated double bonds nearby delocalize it. In the final step, a proton 
from C12 is extracted and transferred to the heme group of the P450. This reacts with the 
hydroxyl group and is lost as water. The C12 methyl group rearranges to finally form the allene 
oxide 13-hydroperoxy-octadecatrienoic. This product can then be further processed either by 
enzymatic and non-enzymatic ways. The allene oxide can be used as a precursor for 
jasmonate formation by conversion to 12-oxo phytodienoic acid, catalysed by allene oxide 
cyclase (AOC). It has been hypothesized that due to the instable nature of the allene oxide, 
AOS and AOC are linked308. Non-enzymatic reactions include the conversion of the allene 
oxide in α- or γ-ketols. Though most AOS enzymes are specific towards this substrate, the 
AOS from barley is capable of accepting 9-hydroperoxides as well while others are only 
specific for 9-hydroperoxies. 
The HPL mechanism is very similar to that of AOS (Figure 1.16) with specificities towards one 
or several kinds of hydroperoxides. The peroxide group is again evenly split with the hydroxyl 
group associating with the heme iron and leaving an oxygen radical on the substrate. This 
radical will transform into the epoxide by interacting with the adjacent methyl group. Next is the 
cleavage of the C:C bond of the oxirane ring followed by a nucleophilic attack by water on the 
remaining carbocation. The resulting hemiacetal degrades spontaneously in the corresponding 
aldehydes and aldoacids309. 
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The final DES mechanism (Figure 1.16) corresponds to that of divinyl ether synthase. It again 
uses an epoxide intermediate which will undergo cleavage at the C:C bond. Next follows a 
proton abstraction from the nearby methyl group resulting in the ether group being flanked by 
double bonds. 
 
Figure 1.16: Different reactions catalysed by the class X P450 enzymes with 13-hydroperoxy linoleic acid 
as a substrate. The products can be further converted by enzymatic or spontaneous reactions. 
 
Development of an efficient transformation and selection system made engineering of S. 
bombicola possible310–312. For the moment, three different selection markers are used, namely 
the ura3 auxotrophic marker and antibiotic resistance genes for hygromycine and 
nourseothricin. Due to the fact that no plasmid is available, all modifications are done by 
homologous recombination in the yeast genome. 
Several knock-out and overexpression strains were created for the production of modified 
sophorolipids. One example involves the acetyltransferase, necessary for acetylation of the 
sophorose group. A knock-out strain of this gene produces purely unacetylated177 as well as 
bolaamphiphilic sophorolipids313. The latter ones are molecules consisting of two non-
acetylated sophorose hydrophilic groups with the newly introduced one coupled to the 
carboxylic group of the fatty acid (Figure 1.17). 
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Figure 1.17: Example of a bolaamphiphilic sophorolipid with an oleic acid linker between both sophorose 
groups. 
Another engineering example is that of the lactone esterase, the enzyme catalysing 
lactonisation of the sophorolipids. Knock-out strains are capable of producing the acidic form 
in concentrations comparable to the wild-type strains157. Overexpression of the lactone 
esterase results in producing lactonic sophorolipids at enriched ratios compared to the wild 
type profile.  
Production of medium-chain sophorolipids is challenging as the required special substrates 
such as primary alcohols and diols are readily metabolized in β-oxidation. Knocking out the 
multifunctional enzyme type 2 (MFE-2), catalysing the second and third step of the β-oxidation, 
enhances the production of sophorolipids with shorter chain lengths up to 3 times compared 
to the wild-type strain314. Still, the dependence on special substrates instead of vegetable oil 
greatly affects the production cost. Another example of using the MFE-2 deletion strain is the 
production of 20-hydroxyeicosatetraenoic acid by S. bombicola315. Although the natural 
substrates for CYP52M1 are stearic and especially oleic acid, the double bonds of arachidonic 
acid effectively shorter the total chain length making it possible for CYP52M1 to hydroxylate 
the ω and ω-1 carbon atoms. Another way of engineering the hydrophobic tail involves the 
aox1 gene which encodes and aldehyde oxidase. Knock-out strains of this gene produce 
sophorolipids with an alkyl chain instead of the traditional fatty acid tail when grown on primary 
alcohols316. 
Other successful engineering resulted in the production of biosurfactants differing from the 
traditional sophorolipid structures. A successful knock-out involves ugtB1, the gene 
responsible for the addition of a second molecule of glucose in the sophorolipid biosynthesis. 
After a prolonged fermentation, final concentrations of 3.9 g/L were obtained of both acetylated 
and non-acetylated glucolipids317,318. Introduction of the codon optimized ugt1 gene from U. 
maydis in this knock-out strain was used for the heterologous production of cellobiose lipids in 
S. bombicola318. Even though 70 % of the obtained molecules are glucolipids, a diverse 
population of cellobiose lipids was observed as well. Most of these cellobiose lipids are new-
to-nature, consist of a C18 hydroxy fatty acid tail and have no acylations of the cellobiose group. 
Also no lactonisation is observed. Still, optimization is required because of the glucolipid 
contamination and the less than optimal product concentrations that often remain below 1 g/L.  
A final engineering example involves bioplastics. Several microorganisms like P. aeruginosa 
are known to produce polyhydroxyalkanoates (PHA), a type of bioplastic polymer build up from 
β-hydroxy fatty acids. Polymerization of the fatty acids is done by poly(3-hydroxyalkanoate) 
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synthases using acyl-CoA as a substrate. In the past, production of these molecules was 
proven to be successful in other yeast species like Sacchoromyces cerevisiae319, Pichia 
pastoris320 and Yarrowia lipolytica321.  
Introduction of the codon-optimized P. resinovorans phaC1 gene coupled to a peroxisomal 
targeting sequence resulted in production of PHA molecules in S. bombicola. Depending on 
the substrates used, yields up to 2.2 % wt/dwt could be obtained318. These engineering 
examples show that it is possible to obtain very specific types of molecules with S. bombicola. 
 
 
Cellobiose lipids (CBLs) are produced by several fungi like Ustilago maydis and Pseudozyma 
flocculosa. They are composed of cellobiose (4-O-β-D-glucopyranosyl-D-glucopyranose) 
attached to a hydroxylated palmitic acid. Further modifications to this molecule such as 
acetylations, acylations and hydroxylations are possible322–325 (Figure 1.18). The enzymes 
necessary for production of cellobiose lipids in U. maydis and P. flocculosa are grouped inside 
a gene cluster326,327. When comparing both clusters, it becomes clear that though they are 
used for the same kind of molecules, their overall organization and size differs. 
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Figure 1.18: General structure of cellobiose lipids produced by U. maydis. 
The synthesis of CBLs is initiated by CYP1, a cytochrome P450 enzyme necessary for terminal 
hydroxylation of palmitic acid328. A second hydroxyl group is introduced by CYP2 at the ω-1 
position, but it was observed that the second hydroxylation is not necessary for further 
synthesis of the CBLs.  The cellobiose moiety is coupled to the 15,16-dihydroxy palmitic acid 
by UGT1 in U. maydis or FGT1 in P. flocculosa. The lack of a second glucosyltransferase in 
the cluster points to the capability of sequential glucosylation by one transferase in both 
organisms.  
Further modifications are carried out by acetyl/acyl transferases and hydroxylases326. The acyl 
transferase couples a β-hydroxy fatty acid with six or eight carbon atoms to the cellobiose 
group at position 2”. These acylation reactions are carried out by UAT1 and FAT1. Prior to this 
acylation, a β-hydroxylation is carried out by UHD1 and FHD1. Both enzymes belong to the 
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short-chain dehydrogenase-reductases (SDR) and contain several conserved motifs like 
TGXXGXX and HxAs for cofactor binding329. The short-chain fatty acids which are coupled by 
the acyltransferases might be specifically produced by FAS2, a part of the fatty acid synthesis 
complex present in both organisms. Besides the acylations, acetylations by UAT2, FAT2 and 
Fat3 can be performed respectively on positions 5’, 5’ and 3”. A final modification is performed 
by Ahd1 in U. maydis. Here, an α-hydroxy group is introduced on the palmitic acid chain. In P. 
flocculosa, such an enzyme hasn’t been discovered: it might be that the precursors for the 
pathway are β-hydroxy-palmitic acids originating from the de novo synthesis of fatty acids. 
In U. maydis, the CBL production is initiated under nitrogen starvation. Regulation is governed 
by Rua1, a transcription factor interacting with the cluster genes and located herein330. 
Overexpression of this regulator promoted biosurfactant production already in the exponential 
growth phase. In P. flocullosa N-limited induction nor a cluster-embedded regulator were 
reported24. It has been hypothesized that flocculosin is produced more as an energy overflow 
compound when the cells stop growing. This theory is supported by the ability of the fungus to 
catabolize its own glycolipids331 in energy deprived situations. 
 
It has to be said that U. maydis produces two classes of glycolipids, cellobiose lipids and 
mannosylerythritol lipids (MELs, see I.5), with titers of total glycolipids up to 30 g/L with varying 
ratios of MEL’s and cellobiose lipids21. Deletion of either the mannosyltransferase emt1 or the 
cytochrome P450 monooxygenase cyp1 genes results in total blockage of respectively the 
MELs or CBLs biosynthesis, allowing recovery of one type of glycolipid.  
Other engineering possibilities have been reported besides deletion of either cyp1 or emt1, 
both involved in respectively cellobiose lipid and mannosylerythritol lipid production. Deletion 
mutants of the cyp2, ahd1, uat1 and uhd1 genes in U. maydis produce altered cellobiose 
lipids327. These genes are respectively responsible for the ω-1 hydroxylation (cyp2) and α-
hydroxylation (ahd1) of the fatty acid tail, the acylation and acetylation of the cellobiose group 
(uat1) and the hydroxylation of the short-chain fatty acid coupled to the cellobiose group (uhd1). 
Unfortunately, no data are available on the cellobiose lipids titers of these knock-out strains. 
 
Mannosylerythritol lipids (MELs) are interesting compounds consisting of a 4-O-β-D-
mannopyranosyl-meso-erythritol with various acyl- and acetylation patterns, depending on the 
production organism and substrates used (Figure 1.19). Depending on the acetylation degree, 
MELs are divided into four groups. MEL A corresponds to di-acetylated variants, MEL B and 
C refer to mono-acetylated at C6 and C4 respectively, and finally MEL D are non-acetylated 
molecules332. Caution has to be made since some types of MELs differ from these four groups. 
For example the MELs from Pseudozyma tsukubaensis contain a 1-O-β-D-mannopyranosyl-
meso-erythritol carbohydrate structure333. Though not a MEL, the fungus Pseudozyma 
parantarctica produces a similar molecule with a mannitol instead of erythritol group334. The 
titers of these molecules can easily reach 100 g/L or more335.  
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Their properties are equivalent to other glycolipids like rhamnolipids and sophorolipids in terms 
of lowering surface tension and critical micelle concentration. Special interest goes out to these 
molecules because of their self-assembling properties336, potential pharmaceutical 
applications337 and their usage in cosmetics338. The Japanese companies Toyobo and Kanebo 
Cosmetics commercialize MEL’s. 
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Figure 1.19: Main structure of mannosylerythritol lipids.  
Biosynthesis in U. maydis starts with EMT1, which couples a mannose, donated by GDP-
mannose, to the terminal C4 hydroxyl group of erythritol. In the next step, MAC1 and MAC2 
add acyl groups to the mannose C2 and C3. Until now, it is not known which transferase works 
on which position. Structural analysis of the MELs however points out that C2 is mostly 
acylated with short chains (C2 – C8) while C3 harbours longer chains (C10- C18). A final 
modification is done by MAT1, transferring acetyl groups from acetyl-CoA to C4 and C5 of the 
mannose group328. Export of the MELs is governed by MMF1, a major facilitator type of 
transporter. Deletion of its coding sequence results in complete abolishment of production. 
As mentioned in section I.4.2, some engineering is done to optimize production in U. maydis. 
Deletion of emt1, the gene encoding the erythritol/mannose transferase, abolished production 
while overexpression did not lead to higher production. The deletion of MAT1, the 
acetyltransferase responsible for both acetylation reactions, proved that it is possible to 
produce non acetylated MEL’s without severely influencing the production capacity328.  
 
Several species belonging to the Aspergillus, Bacillus and Pseudomonas genera are capable 
of synthesizing lipopeptides. These molecules are characterized by an oligopeptide, either 
linear or circular, coupled to a fatty acid. The oligopeptide varies both in number and types of 
amino acids339 (Figure 1.20). Unusual or non-proteiogenic amino acids are incorporated as 
well. For example, in surfactin, synthesized by Bacillus subtilis, two D-leucine molecules are 
present340. In the case of surfactin, titers of 6.45 g/L are possible27.  
 
Lipopeptides have drawn attention because of their potential as antimicrobial agents341. The 
minimum inhibitory concentration (MIC) of daptomycin for example towards species like 
Enterococcus faecalis ranges from 2 to 4 mg/L342. It has been used successfully in clinical trials 
for S. aureus bacteremia and right-sided endocarditis343. 
Chapter I   Literature Review 
 
   
 
34 
 
 
Figure 1.20: Structures of daptomycin and surfactin, two circular lipopeptides. 
The hydrophilic oligopeptide structure of lipopeptides is synthesized by a non-ribosomal 
peptide synthetase (NRPS). This is a single enzyme in many fungi yet a multizyme complex in 
bacteria. Both types of NRPS can be further divided in modules consisting of several domains 
(Figure 1.21). Each module is responsible for the incorporation of at least one amino acid and 
contain the necessary domains for the elongation and modification of the peptidyl chain. 
Several modules can be grouped together in a subunit, a monomer being part of the multizyme 
complex coded by a single gene.  
 
 
Figure 1.21: Simplified structure of a NRPS containing multiple subunits. Different domains can be present 
inside a single module. PCP = peptide carrier protein; At = adenylation domain required for amino acid 
thioesterification; Co = condensation domain required for amide bond formation of the growing peptide 
chain from the previous module with the amino acid group of the current module; Cy = Condensation and 
cyclization of serine, threonine or cysteine can be performed by certain condensation modules.; E = 
epimerization into D-amino acids.  
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The first module of the NRPS is called an initiation module, the following are extending 
modules and the final one is a releasing module. Termination can be performed by a 
thioesterase, which is mostly present at the end of the releasing module (type I) or can form 
an independent subunit (type II). These thioesterases also cyclize the peptide chain prior to 
release. Release of a linear fragment is catalysed by a reducing domain resulting in a terminal 
aldehyde or alcohol function. Further processing of the peptides by glycosylation or acylation 
is done by separate enzymes, which are often associated with the NRPS and are commonly 
situated near or inside the operons or gene clusters of the NRPS. 
 
Significant effort has been put into engineering of the hydrophilic oligopeptide structure. In a 
first engineering strategy subunits of the NRPS are exchanged. In the case of daptomycin, a 
lipopeptide produced by Streptomyces roseosporus, replacing the final subunit DptD by 
introducing the genes encoding lptD and cdaPS3 from Streptomyces fradiae and 
Streptomyces coelicolor results in compounds differing in the last two amino acid of the peptide 
core344. A second option is to exchange or delete modules345 or domains within these 
modules346. This leads to peptide cores differing in number and types of amino acids. By 
targeting the genes responsible for modification of the amino acids347, even greater diversity 
can be created. Again in the case of daptomycin, a library of molecules differing in MICs 
against several kinds of microorganisms was derived using such combinatorial biosynthesis348.  
 
Besides by changing the size and amino acid sequence of the oligopeptide core, structural 
diversity has also been achieved by “decorating” reactions like halogenation, glycosylation and 
sulfation. Though these modifications not necessarily enhance antimicrobial activity, they 
enhance aqueous solubility and hydrolytic stability. Attempts to modify the fatty acid tail have 
been successful for the lipopeptides from Streptomyces coelicolor where a shorter tail was 
introduced349, as well as for daptomycin derivative CB-183,315 where a longer, unsaturated 
branched fatty acid was coupled to the peptide ring350. A more comprehensive review on 
lipopeptide engineering was written by Winn et al351. 
 
A couple of examples exist where engineering of the production strain leads to significant 
higher production levels. Random mutagenesis strategies resulted in mutant strains with 
production capacities up to twelve times higher compared to the original wild-type producers 
(change from 33 mg/L to 391 mg/L)352. Genome shuffling was used for enhancing the surfactin 
production in Bacillus amyloliquefaciens. The recombinant strains are capable of producing up 
to 10 times more compared to the wild-type (maximum surfactin concentration was 350.1 mg/L) 
due to higher expressions levels of the genes involved353. More targeted methods like 
overexpression of certain genes or ribosome engineering are possible as well. In the case of 
Streptomyces roseosporus, three target genes where identified by in silico modeling. Two of 
them, dptI and dptJ govern modifications of amino acids, while the third one is involved in 
glucose catabolism. Co-overexpression resulted in a production increase of 43.2 %354. An 
example of ribosome engineering can again be found for Streptomyces roseosporus. When 
using streptomycin, an aminoglycoside protein synthesis inhibitor, resistant mutants showed a 
2.2-fold increase in production of daptomycin from approximately 55 mg/L to 120 mg/L355. The 
higher productivity arises from a single mutation in the rpsL gene. Though the mode of action 
is still not fully understood, it might be due to higher protein synthesis during the late growth 
phase affecting the regulation and expression of the NRPS genes. Similar observation were 
made for Streptomyces albus356, Streptomyces avermitilis357 and Saccharopolyspora 
erythraea357,358. 
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It is clear that a lot of research has already been dedicated to unravelling and understanding 
the biosynthetic pathways involving the production of biosurfactants. Though the 
commercialization of certain molecules was mainly due to process optimization, an era of tailor-
made biosurfactants seems near. Nevertheless, several big obstacles remain that prevent 
further expansion of the molecular diversity and further optimisation of the production strains, 
and thereby usage in many industries and applications.  
When looking at the economics of biosurfactants, it is impossible to ignore that their overall 
cost is significantly higher than that of the chemical derived detergents. Even biosurfactants 
produced through chemical means, but from renewable resources are considerably cheaper 
than microbial produced biosurfactants. High end applications are not hampered by this 
problem, but for example 'bulk applications' like household detergents are. As mentioned 
before, the cost aspect is mostly governed by yield and downstream processing expenses. 
Methods like resin or carbon adsorption, solvent extraction or precipitation already offer ways 
to attain high purity without extreme financial investments.  
Still, lowering the overall cost of these remarkable molecules points towards the creation of 
robust, easy to cultivate, hyperproducing strains resulting in preferentially high product 
uniformity. In the case of S. bombicola, this was clearly achieved for certain types of molecules. 
Titers up to 140 g/L were recently reported for 99 % pure lactonic and 100 % acidic 
sophorolipids174. Unfortunately though, this is often not the case. Often yields remain south of 
the 30 g/L mark and products are composed out of many different congeners. To counter these 
problems, a more fundamental understanding is necessary of biosurfactant biosynthesis and 
its regulation.  
Indeed, the regulatory networks controlling the production still need to be unravelled in most 
cases. For example, in the case of P. aeruginosa, the regulatory systems governing 
rhamnolipid production were extensively explored, but no clear advance of deregulation could 
be noted. In the case of S. bombicola even greater uncertainties remain since no true regulator 
has been found to date. The only example where engineering the regulation was successful 
was reported for U. maydis known for cellobiose lipid production. A simple overexpression of 
the cluster regulator Rua1 resulted in enhanced production even when using media that were 
not optimized for production. Regulation can also be circumvented by using well studied 
platform organisms like E. coli for heterologous production. However, this can result in losing 
the benefit of the wild type producer resistance towards these molecules leading to lower yields. 
A compromise would be using naturally robust strains to synthesize molecules similar to the 
ones they already produce. An example of this strategy is the heterologous production of 
cellobiose lipids in S. bombicola. It has to be mentioned though that the productivity of these 
molecules is low so further metabolic optimization and investigation is certainly required. Still, 
harbouring the capacity of efficient producers for the production of similar molecules might be 
a valid strategy for further cost reduction.  
A second focus for strain engineering lies on the genes governing the biosynthesis of 
precursors or biosurfactants themselves. When looking again at glycolipids, variation in 
hydrophobic or hydrophilic moieties remain limited to a few carbohydrates and fatty acids. 
Understanding and/or engineering the specific enzymes offer interesting possibilities to 
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address either uniformity problems and the demand for tailor-made molecules. In the case of 
sophorolipids, this resulted in strains producing only lactonic or acidic sophorolipids, as 
mentioned above. For several classes of glycolipids, a P450 is necessary for activation of fatty 
acids. The engineering of P450s to alter their substrate specificity and product formation can 
already be a big step forward in the modification of glycolipids like sophorolipids and cellobiose 
lipids. Still it has to be noted that the specificity of the enzymes downstream of the P450 has 
to be compatible with the engineered P450. In the case of UGTA1 of S. bombicola, no other 
substrate than UDP-glucose can be used for glycosylation of the hydroxy fatty acid. Protein 
engineering can alter the specificities towards other kinds of activated sugars or broaden the 
range of accepted hydroxy fatty acids. On the other hand, interesting enzymes for 
heterologous expression can be identified using for example glycan array data, a screening 
method to investigate protein-carbohydrate interactions359. 
Molecular diversification can also be obtained by utilizing the promiscuity of the biosynthetic 
enzymes. New kinds of molecules have been synthesized using non-conventional substrates 
like alcohols and ketones, but the cost of the substrates counteracts the need for cheaper 
production. Recently, novel kinds of sophorolipids have been produced using petroselinic acid 
as a substrate360. This fatty acid is an isomer of oleic acid, the natural preferred substrate of 
CYP52M1. Though similar in structure, the double bond is closer towards the carboxylic group 
of the fatty acid moiety. This small difference in molecular structure resulted in different 
physico-chemical properties like lowered CMC compared to the molecules with an oleic acid 
as their hydrophobic group.  
Finally, chemical or biocatalytic derivatization of molecules can be used to obtain new kinds of 
glycolipids with the possibility of new functional groups added to their structure. Recently, 
several examples have been reported where chemical derivatization of sophorolipids resulted 
in novel molecules with interesting properties361–363. For rhamnolipids364 and mannosylerythritol 
lipids365 similar strategies exist. 
To conclude, it is evident that biosurfactant production is maturing, yet several obstacles 
remain, structural diversification being the major one. The creation of platform organisms like 
S. bombicola is contributing to attain cheap, eco-friendly molecules and the platform will prove 
a valuable tool in the next few years. In this thesis, attempts are made to better understand S. 
bombicola on a fundamental level and to combine improved knowledge with more production 
oriented engineering strategies to broaden S. bombicola’s product palette.  
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Ever since the 1970s when the first genetic engineered organisms were created new 
techniques have been developed to ensure faster, more targeted engineering for a wide array 
of purposes. A major step forward in yeast engineering was the development of a hybrid 
plasmid for usage in E. coli and in S. cerevisiae in 1978366. Meanwhile, plasmid systems have 
been developed for other yeasts as well. Such plasmids can for example help screening for 
efficient enzymes or be used to determine optimal promotor strength and to balance pathways. 
Using a plasmid also solves potential location effects when integrating in the genome. Further, 
since no steps like linearization of the integration cassette are required and no incorporation 
of the DNA in the genome is necessary, engineering times can be shortened significantly. 
S. bombicola, a yeast known for its efficient sophorolipid synthesis, is the subject of extensive 
research aiming at the development of a platform organism for the production of novel kinds 
of biosurfactants318. A transformation and selection procedure310 and targeted genome 
engineering methods have been established, and these methods have been successfully used 
for the deletion and insertion of genes. Unfortunately, though, a plasmid system for this 
industrially interesting yeast has not been described. Yet, further expansion of the molecular 
toolkit of S. bombicola with such a plasmid system is essential for speeding up screening and 
engineering. Hence, in this thesis the development of an episomal vector which can be stably 
maintained in S. bombicola was aimed at.  
A functional plasmid requires several types of sequences for maintenance and correct 
expression of the plasmids and its genes. One of those essential sequences is the origin of 
replication, called autonomous replicating sequence (ARS) in yeast. These sequences allow 
efficient replication of chromosomes in every eukaryotic cell and have been used successfully 
to maintain plasmid based systems in yeasts. Most of them are AT-rich and they often contain 
a preserved motif highly specific for each species367. These features can be used to scan 
chromosomes for unknown replication origins, a strategy also followed here. Other strategies 
investigated are the use of heterologous ARS sequences and the screening of genomic 
libraries. 
Once a plasmid system is developed and plasmid based screening efforts have enabled the 
determination of the most beneficial combination of genes, promotors and terminators, the final 
combined (heterologous) pathway(s) needs to be introduced in the genome to ensure stability 
of the resulting strain and because no constant selection pressure would be needed. Hence, 
it has to be determined which is the largest size of recombination cassette that can be used. 
The larger this size, the more genes one can introduce in one single transformation. The size 
of the cassette to be introduced is strongly correlated with the transformation efficiency, which 
thus needs to be addressed as well. To explore the opportunities in S. bombicola, constructs 
with increasing size were evaluated, and in a final experiment the entire sophorolipid 
biosynthetic cluster was transformed in S. bombicola and integrated at a second location in 
the genome.  
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Another tool, which was missing for S. bombicola until recently368, is a robust reporter system 
enabling the investigation of promotor, terminator and integration sites, but also external stimuli 
like medium components, temperature, oxygen levels, etc and the location of biosynthetic 
enzymes. The latter enables to direct engineered proteins towards specific organelles or to 
cluster a biosynthetic pathway for more efficient production of interesting molecules. The most 
famous reporter protein is green fluorescent protein (GFP)369. This protein, originating from a 
jellyfish, has been used for in vivo localization of proteins, screening promotor libraries or 
pathway assemblies, and as a biological sensor. Besides the traditional green variant, other 
emission spectra have been developed as well, ranging from violet to infrared. This allows the 
simultaneous use of several reporter proteins in one cell, enabling the study of colocalisation 
and interactions of different proteins or creating libraries of different regulatory elements like 
promotors and terminators. An expansion of the reporter set suited for S. bombicola is 
described in this chapter: two new fluorescent proteins were evaluated, fused to the 
sophorolipid biosynthetic genes. 
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Wild type Starmerella bombicola ATCC22214 and a derived ura3 auxotrophic PT strain311 were 
used. Prior to transformation, the yeast cells are cultured in liquid YPD medium composed out 
of 2 % (w/v) glucose (Cargill; USA), 1 % (w/v) yeast extract (Brenntag; Belgium) and 2 % (w/v)  
bactopepton (Becton, Dickinson and Company; USA). Selection of ura3 positive transformants 
is done on synthetic drop-out (SD) medium lacking uracil. The medium is composed out of 
Yeast Nitrogen Base without amino acids 0.67 % (w/v) (Sigma-Aldrich; USA), 2 % (w/v) 
glucose, 2 % (w/v) Agar Noble (Becton, Dickinson and Company; USA) and 0.77 % (w/v) 
Single Dropout Complete Supplement Mixture without uracil (MP Biomedicals; USA). 
Evaluation of mutant strains for their capacity to produce sophorolipids was done on medium 
described by Lang et al370. The cultures were supplemented with 35 g/L rapeseed oil. 
Cultivation occurred at 30 °C at 200 rpm unless otherwise stated. 
Standard cloning procedures were carried out in Escherichia coli Dh5α unless otherwise stated. 
E. coli was cultured in Luria Bertani medium constituted out of 1 % (w/v) trypton (Biokar; 
Belgium), 0.5 % (w/v) yeast extract, 1 % (w/v) NaCl (Brenntag; Belgium) and if necessary 15 
g/L A4 agar (Biokar; Belgium) for plates. Ampicillin (Sigma-Aldrich; USA) was added at a final 
concentration of 100 mg/L. Incubation of E. coli happened at 37 °C and 200 rpm unless stated 
otherwise. 
 
 General techniques 
Primers, plasmids and final strains were designed using the Clone Manager Basic Version 9 
software suite from Sci-ED Software. Primers were ordered at Integrated DNA Technologies 
(USA) and diluted upon arrival to a 10 mM stock solution. Working solutions are derived from 
these by a 100x dilution to 10 µM. All plasmids and cassettes were confirmed by sequencing at 
LGC Genomics (Germany). Bacterial plasmid DNA was isolated with the innuPREP Plasmid 
Mini Kit (Analytik Jena AG). Purification of linear DNA fragments was performed with 
the innuPREP PCRpure Kit (Analytik Jena AG). All PCR fragments were analysed for their 
presence and length by agarose gel electrophorese (1 % agarose in 40 mM Tris, 20 mM acetic 
acid, 1 mM EDTA). A 2-Log DNA Ladder is used as a reference for fragment length. The 
electrophoresis is run at 120 V for 25 minutes.  
Transformation of S. bombicola was done following the protocol of Van Bogaert et al.310. Unless 
otherwise stated, cells were incubated on the previously described SD medium. 
Transformation of E. coli was performed as described by Sambrook and Russel371. Colony 
PCR on both yeast and E. coli were performed with TAQ polymerase (New England Biolabs; 
USA). 
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 Isolation of genomic DNA from S. bombicola 
Small scale (1~10 µg) 
Isolation of small amounts of genomic DNA was performed on 5 mL cultures incubated 
overnight at 30°C in YPD. From these cultures, 2 mL were spun down and washed with 1 mL 
mQ water. The cell pellet was dissolved in 540 µL SCE buffer made out of 1 M sorbitol (Sigma-
Aldrich; USA), 0.1 M sodium acetate (Sigma-Aldrich; USA) and 60 mM EDTA (Sigma-Aldrich; 
USA) at pH 7. To lyse the cell wall, 200 U of yeast lytic enzyme (MP Biomedicals; USA) was 
added. After incubation at 37 °C for 90 minutes, cells were centrifuged for 5 minutes at 14.000 
rpm and 200 µL fresh SCE buffer and 20 µL of RNAse A (Sigma-Aldrich; USA) were added. 
After a two-minute incubation at room temperature, the protocol was switched to the GenElute 
Bacterial Genomic DNA kit (Sigma-Aldrich; USA) and the kit protocol was followed from step 
5 onward. 
Large scale (>10µg) 
Large scale isolation commences with inoculating the desired strain in 50 mL of YPD. A fully 
stationary culture produces 100 µL of packed cell volume per mL used. For every 100 µL of 
packed cells 200 µL of TEAS, a buffer made out of 50 mM Tris-HCl (Sigma-Aldrich; USA), 1 
mM ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich; USA), 0.1 M lithium acetate 
(Sigma-Aldrich; USA) and 1% sodium dodecyl sulphate (Sigma-Aldrich; USA) at pH 7.4 is used 
for resuspension of the pellet. An equal volume compared to the TEAS of glass beads is added, 
as well as a double volume compared to the TEAS of PCI (Phenol:Chloroform:Isoamyl alcohol 
25:24:1 saturated with 10 mM Tris, pH 8.0, 1 mM EDTA) (Sigma-Aldrich; USA). Cells are lysed 
by using the FastPrep®-24 Instrument (MP Biomedicals; USA) for 20 seconds at 4 m/s. After 
centrifugation for 10 minutes at 13.000 rpm the upper aqueous layer is collected and 1 mL of 
absolute molecular grade ethanol (VWR; Belgium) is added. After 5 minutes at -80 °C the 
mixture is centrifuged at 13.000 rpm at 4 °C and the pellet is recovered. The pellet is 
suspended in 200 µL TE-buffer (50 mM Tris-HCl, pH 7.4; 1 mM EDTA) and RNAse A is added. 
The whole is incubated at room temperature for 10 minutes and 500 µL of absolute ethanol is 
added followed by an incubation of 5 minutes at -80 °C. After centrifugation at 4 °C and 13.000 
rpm the pellet is washed with 75 % ethanol:dH2O followed by a final centrifugation step at 
13.000 rpm and 4 °C. The pellet air dried and suspended in 100 µL of TE buffer. If necessary, 
the pellet is washed several times to obtain higher purities of the isolated genomic DNA. 
 
 Development of an ARS screening vector for S. bombicola and S. 
cerevisiae 
Creation of the screening vector 
As a start the pJET vector from the Thermo Scientific CloneJET PCR Cloning Kit was used. 
The pJET vector is not a yeast shuttle vector and hence it does not contain a yeast origin of 
replication. To keep the screening vector as small as possible, the decision was made to 
remove the endonuclease Eco47RI since it has no function further down the experiment. 
Primers P728_pJETinternFOR and P729_pJETinternRev result in a vector backbone of 2013 
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bp. The ura3 marker was picked up from S. bombicola genomic DNA as well as the terminator 
of cabom03g11120. This terminator was chosen to minimize possible recombination effect at 
the ura3 locus when the original terminator of the ura3 gene would be used. Its functionality 
was proven during other experiments. The ura3 marker and its promotor were amplified with 
primers P551_ura3endrev and P731_pUraUratRegpJETRev resulting in a fragment of 1188 
bp. The terminator was amplified using primers P730_pUraUratRegpJETFor and 
P550_cabom03g11120downfor (336 bp). The entire vector was assembled using In-Fusion 
HD Cloning Kit and is called BS_EC_0073 (Figure 2.1). The vector is linearized by either using 
the primers P1316_tUraRev and P729_pJETinternRev (3577 bp) or by restriction digest with 
BamHI depending on the strategy used for creation of the genomic library. 
 
Figure 2.1: Overview of the constructed vector used for ARS screening.  
Development of different episomal vectors 
Several autonomously replicating sequences and potential candidates were chosen to be 
screened in the screening vector. In Table 2.1 gives an overview of the sequences that were 
ligated in the by PCR screening vector by Gibson Assembly (Table 2.2). Sequences of these 
inserts can be found in the appendices. The Cen4 and 2micron sequences were amplified from 
plasmids suited for use in S. cerevisiae (www.euroscarf.de). The K. lactis NRRL Y-1140 ARS 
was ordered as a gBlock from Integrated DNA Technology and the Repeatchrom1 and 
Intergenicchrom1 were amplified from genomic DNA of S. bombicola ATCC22214. The gBlock 
of the K. lactis ARS was ligated directly in the screening vector thanks to the integrated overlap 
regions. The final plasmids are named BS_EC_0085 for the K. lactis ARS, BS_EC_0142 and 
BS_EC_0144 for respectively the S. cerevisiae CEN4 and 2µ sequences and finally 
BS_EC_0236 and BS_EC_0263 for the S. bombicola in silico discovered sequences. 
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Table 2.1: Sequences used for ARS screening in S. bombicola and/or S. cerevisiae 
Sequence name Length (bp) Forward Primer Reverse Primer 
CEN4 854 P1074_Cen4GibFor P1075_Cen4GibRev 
2micron 1162 P1076_2muGibFor P1077_2muGibRev 
KLARS 452 / / 
Repeatchrom1 1000 P1542b_Repeat760000GibFor P1543_Repeat760000GibRev 
Intergenicchrom1 3001 P1679_776779Kchrom1gibpJETFor P1680_776779Kchrom1gibpJETRev 
 
Table 2.2: Primers used for the ligation of candidate ARS sequences in the screening plasmid. When 
overhanging primers were used, a dash represents the start of the binding region of the primer. 
Primer name Primer sequence  
P728_pJETinternFOR CCAATTGCTTTCCAGTCGGGAAACC 
P729_pJETinternRev ATAATTCGGCTGCAGGGGCGGCCTC 
P551_ura3endrev TCATCTTGACTGAACTTTTCTCAGATA 
P731_pUraUratRegpJETRev CTGGAAAGCAATTGG-AAAACAGCCCGCTCTGCTGG 
P730_pUraUratRegpJETFor CTGCAGCCGAATTAT-GGATCCCGATAAACAGCTGACTCCGAGAATATGC 
P550_cabom03g11120downfor GTTCAGTCAAGATGAGCGTTATCGACCTGAATCAGTT 
P1316_tUraRev CCGATAAACAGCTGACTCCGAGAATATGC 
P1679_776779Kchrom1gibpJETFor GAGGCCGCCCCTGCAGCCGAATTAT-
AACAATTAACAGATTCAAAGTCGTGACAT 
P1680_776779Kchrom1gibpJETRev ATTCTCGGAGTCAGCTGTTTATCGG-TCCTCAGAAGATTATTTGCAAGGCTA 
P1542b_Repeat760000GibFor ATCACGAGGCCGCCCCTGCAGCCGAATTAT-TAACACGTGCAGATAACATGTC 
P1543_Repeat760000GibRev TGCATATTCTCGGAGTCAGCTGTTTATCGG-TAATCCAGGCACAGGTTACT 
P1074_Cen4GibFor GCGTATCACGAGGCCGCCCCTGCAGCCGAATTATG-
CGCTGGGCCATTCTCATGAA 
P1075_Cen4GibRev GCGGCTGCATATTCTCGGAGTCAGCTGTTTATCGG-
ACTCTAAGAGGTGATACTTATTTACTG 
P1076_2muGibFor GCGTATCACGAGGCCGCCCCTGCAGCCGAATTATG-
AACGAAGCATCTGTGCTTCATTTTG 
P1077_2muGibRev GCGGCTGCATATTCTCGGAGTCAGCTGTTTATCGG-
ACGCATTTAAGCATAAACACGCACTA 
 
Creation and screening of a genomic DNA library 
Isolated genomic DNA was partially digested for creation of an ARS screening library. The 
vector BS_EC_0073 was digested with BamHI and the genome with Sau3AI. The genomic 
fragments are purified by gel extraction using the Analytik Jena (Germany) InnuPREP Gel 
Extraction Kit to obtain certain length classes. The linearized vector is treated with Antarctic 
phosphatase (NEB) to remove the 5’ phosphate to minimize self-ligation. After ligation with T4 
ligase (NEB) of the vector and the genomic fragments, a second digest with BamHI was 
performed to remove any self-ligated vector. The ligation mixture was then transformed in E. 
coli and the cells were incubated overnight with ampicillin. The day after, the library was 
isolated and transformed in S. bombicola PT36. After incubation on SD medium for 5 days, the 
colonies are screened for potential plasmid possession. 
In another strategy the vector was linearized by PCR with primers P1316_tUraRev and 
P729_pJETinternRev (3577 bp) to ensure that self-ligation is minimized due to the lack of the 
5’ and 3’ phosphate groups. The genomic DNA was digested by the blunt cutting enzyme PvuII. 
Ligation and transformation were identical to the above described method. 
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 Construction of enlarged cassettes for homologous recombination 
Construction of the enlarged integration cassettes 
The previous constructed plasmid BS_EC_0360 for recombination at the cyp52m1 locus was 
used for constructing the enlarged recombination cassettes (Figure 2.2). The plasmid contains 
a pGEMT vector backbone for cloning in E. coli and homologous regions for incorporation in 
the genome of S. bombicola. The 5’ homologous region encompasses 1000 base pairs (bp) 
upstream of the start codon of cyp102a7, the gene present inside the plasmid. Downstream of 
the locus are the ura3 marker gene with its promotor and terminator followed by the 3’ 
homologues region also encompassing 1000 bp. 
Starting from this plasmid, the integration cassette was subsequently enlarged by inserting 
random pieces of E. coli LMG12566 genomic fragments in the cyp102a7 coding sequence. In 
total three different cassettes were created by inserting pieces of 2050 bp, 3021 bp and 4082 
bp. All inserts were picked up by high fidelity PCR from genomic DNA of E. coli MG1655 using 
the forward primer P271_insertTestFor combined with P272_Rev2KB, P498_Rev3kb and 
P618_Rev4kb (see Table 2.3). Linearization of the plasmid prior to insertion of the E. coli DNA 
fragments was performed by restriction digest with AfIII and ClaI (NEB; USA). The vector 
backbone and insert were ligated using the In-Fusion HD Cloning Kit (Takara; Japan). The 
final integration cassette was amplified from these vectors with the Phusion High Fidelity DNA 
Polymerase (NEB; USA) and primers P847_Cm2ExCasLongFor and P887_Cm2ExCasRev.  
 
Figure 2.2: Overview of the plasmid BS_EC_0360 used for recombination at the cyp52m1 locus. 
The integration of the cassettes was checked by PCR at the 5’ and 3’ region of the cyp52m1 
locus by respectively primers P954_Cm2checkFor and P272_Rev2KB (2465 bp) and primers 
P953_ura3outendfor and P952_A21TotRev (1172 bp). Whole genome extraction followed by 
PCR was used to validate that the entire expression cassette was integrated. Primers used 
were P954_Cm2checkFor and P952_A21TotRev resulting in fragments of 7604 bp, 9654 bp, 
10625 bp and 11868 bp for the different sizes. During efficiency testing, primers 
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P2025_CYP1021A7insertcheckFor and P2026_CYP102A7insertcheckRev were used instead. 
This resulted in a PCR-product with specific length for each cassette (482 bp, 2404 bp, 3375 
bp and 4436 bp). 
Construction of the sophorolipid cluster knock-in cassette 
Construction of the cassette for a knock-in of the sophorolipid biosynthetic cluster at the ura3 
locus started from the available plasmid BS_EC_0251 designed for recombination at the ura3 
locus. The backbone of the vector was amplified with primers P647_FOR_vector 
pGAPD_ura3_ura3locus and P824_ura3cdsrev (4781 bp). The benefit of the ura3 marker 
upstream of the inserted cluster is that this configuration enables using the double terminator 
of the ugtb1 gene and thereby saving space on the plasmid (Figure 2.3). The entire 
sophorolipid cluster was amplified from genomic DNA of S. bombicola ATCC22214 with 
primers P1040_ClusterGibURA3For and P1041_ClusterGibURA3rev (11057bp). Both PCRs 
were carried out with Primestar GXL DNA Polymerase (Takara; Japan). The fragments were 
ligated by Gibson Assembly372. The final cassette was amplified from this plasmid using 
primers P49_FOR_URA3upextNheI and P1013_GAPDAT_FusionF (14121 bp) with the 
previous mentioned high fidelity polymerase. Transformants were checked for integration at 
the ura3 locus with primers P33_FOR_checkcassIN and P72_REV_ADHdown for the 5’ region 
(2728 bp) and P843_A21knockhygroCasFor and P35_REV_checkcassIN_DOWN for the 3’ 
region (3187bp). To ensure that the entire cluster was integrated, a final PCR was performed 
on the correct mutant strains with P33_FOR_checkcassIN and 
P35_REV_checkcassIN_DOWN (14329 bp). A similar PCR was done at the level of the 
original sophorolipid cluster location with primers P469_FOR_GOF7_ADH and 
P64_REV_cassPHAC1 (12712 bp). 
Table 2.3: Primers used for the construction of the CYP102A7 base cassette and subsequent enlarged 
cassettes. Restriction sites are marked by an underline. When overhanging primers were used, a dash 
represents the start of the binding region of the primer. 
Primer name Primer sequence  
P33_FOR_checkcassIN CCATACTCAAGCGCGAACAC 
P35_REV_checkcassIN_DOWN GAGCTCAAGACGCGTTTACTCAATGC 
P49_FOR_URA3upextNheI CGCTAGCC-ATGCTGAAGACAGCACCGCTGCTATC 
P64_REV_cassPHAC1  GGTGTCGACTCGCCAAATTC 
P72_REV_ADHdown TTGCAACTGTGCCCTCCATC 
P271_insertTestFor TCCGGATAAGCTTAA-GCGTGGTCGTTAGGCATTCC 
P272_Rev2KB GCCAAAGCCTTATCG-CCAGCCGGATACACTTCCAG 
P469_FOR_GOF7_ADH  TCACGCACTCAAACTTACAA 
P498_Rev3kb GCCAAAGCCTTATCG-CGTCGTCCATGCTTTCAG 
P618_Rev4kb GCCAAAGCCTTATCG-GCGGTACCAATCTCCAGTCC 
P647_FOR_vector_pGAPD_ura3_ura3locus CTGCAGTTTTAAAAATTTGCAGCTCTATAG 
P824_ura3cdsrev TCATCTTGACTGAACTTTTCTCAGATA 
P843_A21knockhygroCasFor GAGTCGGGCGTTATTTCTCC 
P847_Cm2ExCasLongFor CGTTGTCAAGTCCTAAGGTAT 
P887_Cm2ExCasRev AAGCGTGAAGCTCCTCTGACAATC 
P952_A21TotRev GCTCTTGTTCGGTACTCTTATT 
P953_ura3outendfor TAAAGAAACGAAGGGCCCAGCAGTC 
P954_Cm2checkFor TCATAGCGAGTTTCTTTGCATGTG 
P1013_GAPDAT_FusionF GCCTCGTCAACCATCTTATC 
P1040_ClusterGibURA3For GGGCTGGAATGCATATCTGAGAAAAGTTCAGTCAAGATGA-
TTCTGCTCTCAACACCGAGT 
P1041_ClusterGibURA3rev AACTAAATTACTATAGAGCTGCAAAT-
TTTTAAAACTGCAGTTAAGAAAACCGCACAACC 
P2025_CYP1021A7insertcheckFor CTTGTTGACCGGATCATCG 
P2026_CYP102A7insertcheckRev AATGCCTCGGCATCTTCTC 
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Figure 2.3: Genomic organization of the ura3 locus and surrounding sequences before (A) and after (B) 
knock-in of the sophorolipid gene cluster.  
 Constructs for the localization of the sophorolipid biosynthetic 
enzymes 
Construction of the CYP52M1-FP plasmids 
The starting plasmid for the construction of the different fusion construct is derived from 
plasmid BS_EC_0081. The vector was linearized with P69_FOR_RegulUP and 
P1439_BMRLinkerRev (8228 bp) and Primestar GXL High Fidelity polymerase. The inserts 
are the coding sequences of gfpco10genes368, bfpcostatgenes and rfpcostatgenes (see 
Appendix B). The sequences of the blue and red fluorescent proteins are synthetic constructs. 
The BFPcoStatgenes (BFP) (Genbank AAB16959.1) and RFPcoStatgenes (RFP) (Swiss-Prot 
Q9U6Y8.1) coding sequences were back translated from protein sequences using the codon 
usage of S. bombicola during stationary phase (see Appendix A). This phase was chosen since 
expression of cyp52m1 and the other genes of the cluster only occurs in this phase. The back 
translated coding sequences were finally ordered as a gBlock at Integrated DNA Technologies. 
DNA sequences can be found in the appendices. The coding sequences of the fluorescent 
proteins were amplified (Table 2.4) and subsequently assembled by Gibson Assembly at the 
C-terminus of CYP52M1. The linker used between CYP52M1 and the fluorescent proteins 
belongs to CYP102A1 and was already present on the starting plasmid BS_EC_0081. The 
final plasmids are BS_EC_0218_pGEMT_CYP52M1GFP, 
BS_EC_0219_pGEMT_CYP52M1BFP and BS_EC_0216_pGEMT_CYP52M1RFP. 
Amplification of the different fluorescent constructs was done with primers 
P847_Cm2ExCasLongFor and P887_Cm2ExCasRev. Screening of the S. bombicola mutants 
was performed by colony PCR with primers P954_Cm2checkFor and P1439_BMRlinkerRev 
(2716 bp) for the 5’ region and with primers P953_ura3outendfor and P952_A21TotRev (1172 
bp) for the 3’ region.  
Construction of the CYP52M1-GFP and UGTA1-RFP fusion plasmids 
Assembly of plasmids where RFP is fused to the first glucosyltransferase UGTA1 was done 
by using the previous constructed BS_EC_0218 plasmid (see III.2.2.2) as a vector backbone 
donor and integrating the new 5’ homologues region for integration at both the cyp52m1 locus 
and the ugta1 locus together with the rfp coding sequence fused to the ugta1 sequence. To 
test whether there is an effect on transferase activity by the RFP, both N- and C-terminally 
fused constructs are made for UGTA1.  All pieces were assembled in one Gibson assembly. 
The final plasmid is called BS_EC_0353 (5’ ugta1-rfp 3’) and BS_EC_0354 (5’ rfp-ugta1 3’). 
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Table 2.4: Primers used for the construction of the localization plasmids When overhanging primers were 
used, a dash represents the start of the binding region of the primer. 
Primer name Primer sequence 
P52_REV_upCYP ATATGTACTTTTCAATATGATAAACGGAGAAATAACG 
P69_FOR_RegulUP GTTTCTTAGCCTCCCATGGAAG 
P722_BM3CPRLinkerInfFor AAAATTCCGCTTGGCGGTATTCCTTCACC 
P952_A21TotRev GCTCTTGTTCGGTACTCTTATT 
P953_ura3outendfor TAAAGAAACGAAGGGCCCAGCAGTC 
P954_Cm2checkFor TCATAGCGAGTTTCTTTGCATGTG 
P1014_URA3_Cb_gen_FOR GTTGAACCATGATGGCAGTGTTCG 
P1394_URA3RevGib GAACACTGCCATCATGGTTCAACTTCTGCTCTCAACACCGA
GTGTAGTTCTTGGTTT 
P1439_BMRlinkerRev GTTTTCTGCCTTTTTGCGTAC 
P1529_BFPGibCYP52M1For GCTAAAAAAGTACGCAAAAAGGCAGAAAAC-
TCGAAAGGAGAGGAGCTGTTCACTGG 
P1530_BFPGibCYP52M1Rev GAACGTTTCTTCCATGGGAGGCTAAGAAAC-
TTATTTGTACAGCTCGTCCA 
P1531_RFPGibCYP52M1For GCTAAAAAAGTACGCAAAAAGGCAGAAAAC-
AGGTCTTCCAAGAACGTTATCAAGGAATT 
P1532_RFPGibCYP52M1Rev GAACGTTTCTTCCATGGGAGGCTAAGAAAC-
CTAGAGGAAGAGGTGGTGAC 
P1533_GFPGibCYP52M1For GTCTGCTAAAAAAGTACGCAAAAAGGCAGAAAAC-
TCGAAAGGAGAGGAGCTGTTCACTGG 
P1534_GFPGibCYP52M1Rev GAACGTTTCTTCCATGGGAGGCTAAGAAAC-
TTATTTGTACAGCTCGTCCA 
P1535_UGTARFP_CYP52M1GFP_BBRev TATGGGAGAGCTCCCAACGCGTTGGATG 
P1536_UGTARFP_CYP52M1GFP_BBFor TATATGGCCTGAAAGAGGCAAGC 
P1537_UGTARFP_CYP52M1GFP_5homGibFor TGCATCCAACGCGTTGGGAGCTCTCCCATA-
GACTCCTAGAAAAGAAATTGAC 
P1538_UGTARFP_CYP52M1GFP_5homGibRev CACCTCTTCCTCTAGAATC-GTACGATCAAATCAGA 
P1539_UGTARFP_CYP52M1GFP_RFPGibFor TTTGATCGTACGATT-CTAGAGGAAGAGGTGGTGAC 
P1540_UGTARFP_CYP52M1GFP_RFPGibRev TTAGCGGTGAGTTCT-AGGTCTTCCAAGAACGTTAT 
P1541_UGTARFP_CYP52M1GFP_UGTAGibRev GTTCTTGGAAGACCT-AGAACTCACCGCTAAGGC 
P1542_UGTARFP_CYP52M1GFP_UGTAGibFor GCTTGCGGCTTGCCTCTTTCAGGCCATATA-
ATGCCCGTTTTGAGTCTGGTA 
P2184_RFPGibPromFor GCTTGCGGCTTGCCTCTTTCAGGCCATATA-
ATGAGGTCTTCCAAGAACG 
P2185_RFPGibUGTARev GACTCAAAACGGGCAT-GAGGAAGAGGTGGTGACG 
P2186_UGTA1GibRFPFor CACCACCTCTTCCTC-ATGCCCGTTTTGAGTCTG 
P2187_UGTA1GibTermRev CTCTTCCCTGATCTGATTTGATCGTACGATTCTAA-
GAACTCACCGCTAA 
 
 
 Follow up of growth and glucose consumption 
Biomass formation was followed by measuring the optical density at 600 nm using the 
FLUOstar OPTIMA fluorometer (BMG LABTECH GmbH, Germany). Samples were diluted in 
0.9 % NaCl in dH2O solution if necessary. Follow up of the glucose concentration was done 
with the 2700 Select Biochemistry Analyzer (YSI inc.; USA). Samples were diluted in a range 
between 0.1 g/L and 7.5 g/L to ensure correct measurement.  
 Analysis of sophorolipid production 
Sophorolipid production was followed by sampling every two days. The samples were 
extracted by adding three volumes of ethanol to the culture broth. After shaking vigorously, the 
samples were spun down at 14.000 g for 5 minutes. The supernatant was analysed by HPLC. 
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The HPLC system used is an Agilent (USA) Varian Prostar HPLC system with Evaporative 
Light Scattering Detection (Grace; USA) at 40°C. The column used is a Chromolith® 
Performance RP-18 endcapped 100-4.6 HPLC from Merck KGaA (Germany). The column is 
kept at 30 °C during the analysis. A gradient of two eluents, 0.5 % acetic acid (Sigma-Aldrich; 
USA) aqueous and 100 % acetonitrile (Sigma-Aldrich; USA), is used to separate the different 
molecules. The analysis starts at 95 % acetic acid aqueous and changes over a period of 40 
minutes to 100 % acetonitrile. This condition is kept for 10 minutes to flush the column. 
Afterwards, the eluent composition is switched back to 95 % acetic acid aqueous in a 5-minute 
period. The flow rate was 1 mL/minute during the entire analysis. Quantification of 
sophorolipids was done using a calibration curve of purified acidic and lactonic sophorolipids. 
If necessary, total sophorolipid extraction and purification was performed followed by 
gravimetrical determination of the obtained sophorolipids. 
Liquid chromatography mass spectroscopy (LC-MS) analysis was performed with an Intertek 
ASG (Manchester, UK) with a Micromass Quattro Ultima LIMS 1107 (Waters). The detection 
range was set at m/z 200 to 800 and the negative ion mode was applied. The same column 
and LC conditions as for the HPLC analysis were used.  
UPLC-ELSD was done on an Acquity UPLC H-Class CM with an Acquity UPLC ELS detector 
(Waters). The column used is an Acquity UPLC® CSHTM C18 1.7 µm, 2.1x50 mm. The 
temperature of the drift tube, nebulizer and column is set at 50, 12 and 30 °C respectively. The 
same gradient conditions were applied as for the HPLC method, only differing in the time 
required to obtain 100 % acetonitrile (6.72 minutes). The flow rate used was 0.6 mL/minute. 
Total time of analysis is 10.12 minutes. 
Analysis by thin layer chromatography (TLC) is based on the method developed by Asmer at 
al156. The samples were spotted in volumes of 2 µL on VWR TLC silica gel 60 F254 25 
aluminium sheets. The eluens used is chloroform:methanol:water in a 65:15:2 ratio. The TLC 
plate was air dried and sprayed with a 10% H2SO4 solution and developed by applying heat. 
 
Imaging of the fluorescent S. bombicola strains was done using a Nikon A1+ with a Plan Apo 
VC 60x oil DIC N2 filled objective. Excitation wavelengths of 405.3 nm, 488.0 nm and 561.7 
nm for respectively blue, green and red fluorescent protein were used. Emission was observed 
at 450 nm, 525 nm and 595 nm. Imaging was done with a Nikon Galvano scanner with a DU4 
detector.  
 
 qPCR sample preparation  
Cells were harvested at the time point of interest and centrifuged for 5 minutes at 14.000 g. 
The supernatant was removed and the remaining cell pellet flash frozen in liquid nitrogen. RNA 
isolation was performed with the RNeasy Mini Kit (Qiagen; Netherlands). The harvested cells 
were mechanically crushed using liquid nitrogen and a spatula. When the cell pellet was 
sufficiently disrupted, 350 µL of RTL buffer was added and the cell suspension was further 
disrupted by a syringe and MICROLANCE 21 G2 green needle. The lysate was then 
centrifuged for 5 minutes at 14.000 g and the supernatant further processed by adding 1 
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volume of 70 %. This mixture was applied to the RNeasy Mini Spin Column. The column was 
centrifuged for 15 seconds at 15.000 rpm and the flow through was discarded. DNase digest 
on column was performed by adding 350 µL RW1 buffer to the column and centrifuging for 10 
seconds at 10.000 rpm. The DNase incubation mix was prepared by adding 10 µL DNase 
stock solution (QIAGEN RNase-Free DNase 1500 Kunitz dissolved in 550 µL mQ) to 70 µL 
RDD buffer. The resulting 80 µL mix was added to the column and incubated for 15 minutes 
at room temperature. Before centrifugation for 15 seconds at 15.000 rpm, 350 µL RW1 buffer 
was added to the column. The resulting flow through was discarded. Two washing steps were 
performed with 500 µL RPE buffer. Elution of the DNA was performed with RNase free water. 
cDNA synthesis was performed with the Superscript III First-Strand synthesis kit (Invitrogen; 
USA) with oligo(dT)20 primers. Concentrations and quality of the RNA and cDNA were 
measured by the Nanodrop (Thermo Scientific; USA). 
 qPCR analysis 
qPCR analysis was performed in 72-well plates. For each strain, three housekeeping genes 
and the genes involved in sophorolipid production were selected (Table 2.5) and three 
technical replicates were taken for each strain. The SensiMix™ SYBR® & Fluorescein kit was 
used in all qPCR analyses. The reaction mixture was composed out of 1 µL forward and 
reverse primer (10 µM), 9 µL of mQ, 10 µL of Sensimix 2x which contains SYBR Green for 
detection. The amount of cDNA added to each sample was 1 µL. cDNA concentrations were 
normalised before addition. The reactions were performed in the Rotor-Gene 3000 (Corbett 
Life Science) using Rotor Discs (Qiagen). The qPCR was performed with one initial hold for 
10 minutes at 95 °C followed by 45 cycles of 25 seconds at 95 °C, 60 s at 58 °C and 20 seconds 
at 72 °C. After the PCR, a melting curve was generated by increasing the temperature to 95 °C 
to assess the PCR specificity, potential contamination and primer dimers. Data analysis was 
performed with the qBase Plus software package developed by Biogazelle. 
Table 2.5: Primers used for the qPCR analysis of the wild type and double cluster S. bombicola. HSK3_MPP 
= Mitochondrial processing peptidase subunit; HSK11_SDH = Saccharopine dehydrogenase; 
HSK17_G6PDH = Glucose-6-phosphate dehydrogenase. 
Primer name Primer sequence  
P421_FOR_HSK3_MPP ATGAGCTTCTCGACCTCTTA 
P422_REV_HSK3_MPP AAATGAACCAGGTCGTCAAT 
P437_FOR_HSK11_SDH TTGAAGGCTAATGCTGACTC 
P438_REV_HSK11_SDH GTCTTGGCATCAGAGAACAT 
P449_FOR_HSK17_G6PDH TCAAATTGCCCGTAATGAGT 
P450_REV_HSK17_G6PDH CAATCCCGGGAATTTGGTAT 
P457_FOR_GOF1_CYP52M1 CAATCCTGGCAACCAAATTC 
P458_REV_GOF1_CYP52M1 CGAGACTGTTTCCATCCATT 
P459_FOR_GOF2_UGTA1 AGCAGCCATCAACTATGAAG 
P460_REV_GOF2_UGTA1 CTTTGACGCCCAATATACCA 
P463_FOR_GOF4_AT CTGCGACTCATCCTATTAGC 
P464_REV_GOF4_AT AATTGTTGAGCCATCTCCAA 
P465_FOR_GOF5_MDR TGTATGGAGTGAGGAAGGTT 
P466_REV_GOF5_MDR GTACTTGAGGTCGAGTAGGA 
P467_FOR_GOF6_LIP CTTGTCGAGCAGTATGTTGA 
P468_REV_GOF6_LIP TCATGAAGAAGACCCGGATA 
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 Protein extraction for MRM 
The S. bombicola wild type (WT) and double cluster strains were both cultivated on the Lang 
medium until sophorolipid production was detected (72 hours). Proteins were extracted from 
cell pellets derived from 2 mL of culture using the Thermo Scientific TM Mem-PERTM 
Eukaryotic Membrane Protein Extraction Reagent kit. The hydrophobic and hydrophilic 
proteins were kept together. Next, proteins were precipitated with trichloroacetic acid (Sigma-
Aldrich; USA) and washed with acetone. Eventually pellets were solubilized in 2 M urea 
(Sigma-Aldrich; USA) in 50 mM ammonium bicarbonate. 50 μg of protein solutions were spiked 
with 200 ng BSA (MS grade protein standard), reduced and alkylated, and digested with 0.5 
μg trypsin. Digested samples were dried and dissolved in 100 μl 0.1% formic acid in water for 
LC-MRM analysis (5 μL injection). 
  LC-MRM Analysis 
The digested samples were first separated by RP-LC on a U3000- RSLC system (Thermo). 
The sample was loaded onto an Acclaim PepMap100 pre-concentration column (L × ID 2 cm 
× 100 μm, C18, 5 μm, 100 Å) at a flow rate of 5 μl/min, and flushed for 5 min with 0.1% 
HCOOH/2% ACN. The sample was then separated on a Thermo Acclaim PepMap100 
analytical column (L×ID 15 cm×75 μm; C18; 3 μm, 100 Å) at a flowrate of 300 nl/min, with 
mobile phases 0.1 % HCOOH in water (solvent A) and 0.1 % HCOOH in ACN (solvent B). 
Peptides were separated with a 30 min gradient, going from 2 to 40 % solvent B, and eluting 
peptides were sprayed directly in a 4000 QTRAP mass spectrometer (AB Sciex, Framingham, 
MA) with a NanoSpray II ESI source (AB Sciex), using a PicoTip Emitter (uncoated SilicaTipTM 
10 ± 1 μm). The ion spray voltage was set at 3.5 kV, curtain gas at 10 (arbitrary units), 
nebulizing gas at 5, and interface heater temperature at 60 °C. 
Target peptides (two for each protein; Table 2.6) were measured in multiple reaction monitoring 
(MRM) acquisition mode, with the Q1/Q3 resolution set at low and with a maximum total cycle 
time of 3 s. The double charged peptide was selected as precursor (Q1), and for each 
precursor three fragment ions were selected from the y-ions (Q3). The MRM data was imported 
in Skyline v2.5373 The total area under curve (AUC) of each target peptide was calculated, and 
normalized to the spiked BSA standard. 
Table 2.6: Sequences of the target peptides used during the MRM experiments. 
Protein Target peptide 1 Target peptide 2 
UGTB1 AIPEQYDALQTALK EVLATPSYHEK 
MDR GLTAASILNEAIDR NNTPGALTSILAK 
AT EFNTIASESR TVVGGVPAR 
UGTA1 TGLPTVEQIK LPDDVVVPENAR 
CYP52M1 FNDFGLGAR LAPVLPLNFR 
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Extra-chromosomal entities can be found both in prokaryotes and eukaryotes. Among these, 
plasmids are the most studied and used in biotechnological applications. Engineering of strains 
is facilitated and sped-up by these plasmids and hence they are essential tools in the state-of-
the-art engineering strategies nowadays commonly used. Unfortunately, S. bombicola does 
not harbour a plasmid system like for example the Saccharomycetaceae, a shortcoming aimed 
to be solved in this PhD. Development of a plasmid system can be done by identifying 
sequences that are able to autonomously initiate replication inside the cell. Several strategies 
include in silico analysis of the genome, using heterologous replicating sequences from other 
organisms with known functionality or screening genomic libraries of S. bombicola. 
 Heterologous ARS screening  
As described by Liachko374, the ARS sequence located at position 781040–781491 on 
chromosome F of Kluyveromyces lactis NRRL Y-1140 can be used as a relatively stable ARS 
(also called panARS) for several budding yeasts like S. cerevisiae and P. pastoris. The 
screening vector BS_EC_0073 containing the S. bombicola ura3 selection marker under 
control of its native promotor (II.2.3.1) was used to assess the possibility of using this sequence 
for plasmid replication in S. bombicola. As a control, the same plasmid was transformed in an 
ura3 negative strain of S. cerevisiae. After 10 to 12 days colonies appeared on the selection 
plates for S. bombicola, but after screening by PCR these colonies turned out to have 
integrated the ura3 marker in their genome, allowing them to grow. This was in sharp contrast 
to the S. cerevisiae mutants that appeared after 3 days. From these the plasmid was easily 
recovered and transformed in E. coli. Analysis by sequencing confirmed that no other 
replicating sequence was present in vector BS_EC_0085 (BS_EC_0073 with the K. lactis 
panARS) than the K. lactis panARS, further proving activity in S. cerevisiae. Similar results 
were observed for the 2µ and CEN4 sequences: illegitimate or non-homologues integration 
occurred in S. bombicola, while stable plasmid replication was confirmed in S. cerevisiae. 
Similar results were described by Roelants et al. for the CEN4 sequence368. 
 Genomic libraries for ARS screening 
As it became clear from the results of the heterologous ARS screening that S. bombicola is 
unable to recognize such ARS sequences, it was decided to scan its own genome. Several 
libraries were constructed from genomic material of S. bombicola using different restriction 
enzymes as described in II.2.3.1. Vector BS_EC_0073 contains a BamHI restriction site which 
can be used to ligate genomic DNA partially digested with Sau3AI. Both enzymes create 
compatible sticky end DNA sequences to enable the efficient creation of a library. Another 
enzyme tested is PvuII, a blunt cutting enzyme. After transformation of the genome library 
vectors, several colonies appeared on the selective plates. All were capable of growing on 
minimal selection medium, yet plasmid recovery in E. coli failed. Most likely, the strains 
integrated the ura3 marker in their genome again. No useful ARS sequence for S. bombicola 
was found by following this strategy. 
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 In silico search for potential ARS sequences 
In silico searching for ARS sequences when no real knowledge is available of the organism of 
interest is similar to finding a needle in an Earth sized haystack. Yet, by using tools developed 
for or observations made in other organisms, interesting regions were searched for. We used 
for example GC-skew375, AT-content, DNA curvature376, motif searching, blasting known ARS 
sequences or any combination of the above. To limit the search space, only chromosome 1 of 
S. bombicola was used. 
Using these methods, a region was detected on chromosome 1 that exhibits interesting 
properties. Position 777464 and the surrounding base pairs showed very high AT content, high 
bendability and curvature of the DNA strand. All these elements are known to be present in 
ARS sequences in S. cerevisiae. Unfortunately, after being tested in the screening vector 
(II.2.3.1 Table 2.1 Repeatchrom), no stable plasmid was maintained in S. bombicola. 
Another in silico strategy used was screening for a potential centromere sequence. These 
sequences are often situated in regions where low to no active genes are present. When 
looking at RNA data, these regions also have lower expression levels due to their compact 
DNA structure. Such a region was detected for chromosome 1 of S. bombicola, but again after 
testing in the screening vector only mutants that had incorporated the vector were discovered 
(II.2.3.1 Table 2.1 Intergenicchrom). 
Even though all efforts to develop a plasmid system for S. bombicola failed, it was decided to 
determine the maximum size of integrative cassettes for S. bombicola anyway, as this remains 
interesting for engineering purposes regardless of the plasmid system.  
 
Different integrative cassettes for recombination at the cyp52m1 locus were created as 
described in II.2.3.2. This resulted in four different expression cassettes with lengths of 7604 
bp, 9654 bp, 10625 bp and 11686 bp. The gene present on the smallest integration cassette 
codes for CYP102A7, an enzyme proven not to be harmful for S. bombicola when being 
expressed (see Chapter III). The larger integration cassettes were created by inserting a 
random DNA sequence originating from E. coli MG1655 in the coding sequence of cyp102a7. 
When transforming the different linear fragments, an equimolar mixture of the different 
cassettes was used to ensure equal transformation conditions for all the sizes tested. The 
mixture was transformed 5-fold into a fresh batch of competent S. bombicola cells. The 
resulting plates were incubated for one week. In total 176 colonies appeared on the selective 
plates. On average, 35.2 ± 8.58 colonies were counted per transformation. By colony PCR, all 
colonies were tested to determine the exact cassette being incorporated by amplifying over 
the E. coli insert (Table 2.7). This resulted in a PCR-product with specific length for each 
cassette (482 bp, 2404 bp, 3375 bp, 4436 bp). As depicted in Table 2.7, no significant 
differences in the number of obtained colonies was observed for the different cassette lengths. 
Even for the relatively short cassette of 7.6 kb, only 9 colonies carried the correct cassette. 
This is in sharp contrast with the 148 colonies which appeared on the selective plates, but 
showed a band of approximately 900 base pairs in the PCRs. These colonies appeared 
simultaneously with the correct mutants. Scanning the genome of the wild type S. bombicola 
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resulted in no additional binding sites for both primers, so this 900 bp band could not be 
explained. However, control PCR on wild type S. bombicola did produce a similar PCR 
fragment. This is not expected since the primers used for the screening are specific towards 
the cyp102a7 coding sequence in the integration cassette, which is absent in the genome of 
wild type S. bombicola. 
Overall, 15.9% of the mutants had successfully integrated one of the four different expression 
cassettes. Each transformation was performed with 3 µL of equimolar composition and a total 
amount of 520 ng per transformation. This translate to roughly 4.9 x 107 molecules of DNA per 
transformation or in total 2.5 x 108 molecules used. Comparing these values to the ones of Van 
Bogaert et al310, some interesting parallels can be seen. In their research, a total amount of 2.5 
µg was used during two transformations, equalling 1.1 x 109 DNA fragments. From all 
transformants, they selected 68 at random and screened them by colony PCR. In total, 12 
correct mutants were identified, which corresponds to 17.6 % of the total sample population, 
similar to the results obtained here. When considering the number of colonies per amount of 
DNA, the enlarged cassettes have 10 positive transformants per µg of DNA. In the research of 
Van Bogaert et al.377, similar values are obtained. This suggests that the incorporation of longer 
DNA fragments is as efficient as shorter ones and that transformation efficiency is not 
necessarily dependent on the size of the integrative cassette. Other parameters clearly also 
play a significant role in overall efficiency, which is low when for example compared to S. 
cerevisia where efficiency ratings up to 75% and higher have been reported378. Still, it is 
possible to construct large integrative DNA fragments for a specific genomic region and 
successfully integrate them.  
Table 2.7: Analysis of the colonies after transformation of the different integration cassettes. # = number 
  # integrating     
Repeat Total # 7.6 kb 9.6 kb 10.6 kb  11.6 kb  # without cassette 
1 43 6 2 1 0 34 
2 28 1 0 1 0 26 
3 44 1 3 1 1 38 
4 25 0 1 2 2 20 
5 36 1 1 2 2 30 
Total 176 9 7 7 5 148 
 
 Strain preparation and sophorolipid production analysis 
Overexpression of certain genes essential in the production of secondary metabolites has 
been proven to be a valuable technique for enhanced production174,379. These overexpression 
experiments are often restricted to certain bottleneck steps in the pathway and aim at 
generating higher fluxes. In the case of S. bombicola, a real bottleneck hasn’t been found in 
terms of sophorolipid biosynthesis. Therefore, it has been opted to double the cluster encoding 
the different enzymes to assess whether this leads to higher productivity, higher expression 
levels or altered regulation of sophorolipid biosynthesis. This also acts as a proof of concept 
for the integration length analysis since the cluster is already over 11000 bp in length. The 
cassette developed in this experiment has a total length of 14121 bp designed to integrate at 
the ura3 locus (Figure 2.3). Several differences with the experiment described in II.3.2 have to 
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be pointed out. First of all, the cassette is 2500 bp longer than the longest one tested for 
integration at the cyp52m1 locus in II.3.2. Another big difference is the genomic location for 
recombination. The ura3 locus is situated on chromosome 3 around the 226 kb mark while the 
original cluster location is only 40 kb from the telomere of chromosome 2. Furthermore, the 
cassettes tested for the different sizes mainly contained E. coli sequences: the only homology 
present except for the recombination regions are the ura3 promoter and terminator. In contrast, 
the double cluster integration cassette has an 11 kb long region homologues to the 
sophorolipid biosynthesis cluster since an extra copy of this cluster is being integrated without 
any modifications to it. 
After transformation of the double cluster integration cassette, three colonies appeared on the 
selective plates. No additional transformations were done with the double cluster integration 
cassette. The colonies were screened for incorporation of the biosynthetic cluster at the ura3 
locus by colony PCR. As a control, a wild type S. bombicola was used (Figure 2.4). The wild 
type, which has only the ura3 gene at the ura3 locus, shows a band of 2944 bp while the cluster 
mutants clearly have a larger fragment at that position, representing the correct integration of 
the cassette. A similar PCR was conducted at the original cluster location to investigate 
potential genomic alterations. As can be seen for this position, the mutant strains show an 
identical result as the wild type. Though no sequencing has been done on the mutant strains, 
at first sight no difference is visible besides the integration of an extra copy of the sophorolipid 
cluster.  
 
Figure 2.4: Result of the colony PCR on a wild type S. bombicola and the three mutants with a double SL 
biosynthetic cluster. On the left, the results for the ura3 locus are visible while on the right those for the 
original SL cluster position are visualized. 
Next, a production experiment was conducted to test the new strains for their production 
capabilities (as described in II.2.1). All three mutants and a wild type were inoculated in duplo 
and sampled during the exponential and stationary phase to assess if the sophorolipid 
synthesis benefits from the doubled cluster on a different location. Since it is no longer situated 
at the end of chromosome 2, chromatin-level regulation380 of the cluster might be reduced or 
even abolished, resulting in exponential production of sophorolipids. To reduce product variety, 
the strains were grown on oleic acid. This way, only one fatty acid type will be available for 
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CYP52M1 to hydroxylate instead of several different types when using vegetable oils like 
rapeseed oil. Analysis on HPLC-ELSD made it clear that there is no difference in sophorolipid 
mixture composition for the wild type S. bombicola and the double cluster mutants 
Unfortunately, there was big variety in production levels between the different replicates, which 
made a second production trial necessary.  
The wild type and double cluster mutant 1 were inoculated in four-fold and oleic acid was used 
as a substrate. In Figure 2.5, follow-up of the production can be seen until 5 days after 
inoculation. Some small differences are visible at the beginning of the stationary phase (Figure 
2.6).  
 
Figure 2.5: Production of sophorolipids by the wild type S. bombicola and the double cluster strain. For 
each strain four replicates were taken. The error bars represent standard deviation. 
 
Figure 2.6: Production of sophorolipids during the exponential and early stationary phase for both wild 
type S. bombicola and the new double cluster mutant. For each strain four replicates were taken. The error 
bars represent standard deviation. 
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Statistical analysis of the HPLC chromatogram surface values indicated that this difference is 
significant (p < 0.05), yet after the 2nd day the difference is not significant anymore. It seems 
that the double cluster initiates production earlier or faster than the wild type, but the benefit of 
this earlier production is lost quickly as the rise in sophorolipid concentration is very similar 
between the wild type and double cluster mutant. If the extra cluster has an effect on production, 
it seems that this is only marginal. To see if the additional copies of the genes results in higher 
transcriptome or proteome levels, a follow-up experiment was performed for qPCR and MRM 
analysis. 
 Comparison of gene expression and protein levels between the wild 
type and double cluster strain by qPCR and MRM experiments 
Transcriptome and proteome analyses were conducted to verify if the minor differences in 
production reflect minor differences in gene expression or protein level. This way the effect of 
the extra integrated cluster could be measured more directly. The samples were prepared as 
described in II.2.6.  
The results from the qPCR experiment can be found in Figure 2.7 and those for the MRM 
experiment in Figure 2.8. Curiously, both experiments result in opposing data for some of the 
genes. In the qPCR experiment, the wild type S. bombicola has significantly higher relative 
amounts of mRNA for the acetyltransferase and the sophorolipid transporter. For cyp52m1 and 
ugta1, no significant differences were detected. When looking to the protein level, the double 
cluster strain shows higher values for both the acetyltransferase and UGTA1, yet not for the 
transporter. This is an interesting observation since the samples for both experiments were 
taken at the same time.   
Though no clear explanation is available, it might be that one of the methods used is not 
suitable yet for analysis of their respective omics domain. The extraction of both RNA and 
proteins relies on the efficient lysis of the yeast cells and subsequent purification of the RNA 
or proteins. For RNA extraction, small contaminations of ribonucleases or genomic DNA can 
lead to skewed results, either higher or lower. The results of the MRM experiment rely on the 
digestion of the proteins by trypsin. Though the sample is spiked with BSA to enable 
normalisation for the differences in digestion, experimental variability resulting in uneven 
protein amounts cannot be ruled out completely. Therefore, it is necessary to further 
investigate and compare the power of both analytical methods. Several strains validated in 
production trails that can be used for further validation of these techniques are already 
available at the lab. Examples are the lactone esterase overexpression strain or the ugtb1 
knock-out strain. 
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Figure 2.7: qPCR data for the cluster genes. For both the wild type and double cluster strain, the Calibrated 
Normalized Relative Quantities (CNRQ) values are calculated and plotted. AT = acetyltransferase, MDR = 
multi-drug resistant (MDR) ABC transporter involved in sophorolipid export, UGTA1 = glucosyltransferase 
A1 involved in sophorolipid synthesis. 
 
Figure 2.8: MRM data for the sophorolipid biosynthetic enzymes in both the wild type S. bombicola and 
double cluster strain. Full peptide sequences can be found in II.2.6.4 Table 2.6. AT = acetyltransferase, MDR 
= multi-drug resistant ABC transporter involved in sophorolipid export, UGTA1 = glucosyltransferase A1 
involved in sophorolipid synthesis, UGTB1 = glucosyltransferase B1 involved in sophorolipid synthesis. 
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Strains expressing GFP have been developed for S. bombicola for some time368. They allowed 
the screening of promotors to investigate their strength and regulation. However, expanding 
the number of fluorescent proteins available is interesting when several targets need to be 
examined at the same time. This can for example be in a study of bidirectional promotors or 
for the localization of enzymes involved in a certain biosynthetic pathway. 
In the case of the sophorolipid biosynthetic enzymes, some information is available on their 
location inside the cell. The P450 enzyme CYP52M1, catalysing the first step in the pathway, 
contains a transmembrane helix at its N-terminus. This is typical for class II P450 enzymes 
and necessary for anchoring them to the membrane of the endoplasmatic reticulum where 
their reaction partner resides. This sounds logical, since the substrate for the first transferase 
UGTA1 are hydroxylated fatty acids, hydrophobic compounds residing in the lipid bilayer of the 
membranes. Though somewhat more hydrophilic, the glucolipids used as a substrate by 
UGTB1 are still relatively hydrophobic and thereby potentially associated with the membranes 
as well. Still, in silico analysis done by Saerens et al.381 for both transferases did not result in 
the discovery of signal peptides or significant hydrophobic surface regions. 
As the localization of the enzymes of the sophorolipid pathway till now was only based on in 
silico analyses, it was decided to set up in vivo localisation experiments for these important 
partners in glycolipid production. Indeed, knowing the true location of activity for these 
enzymes is crucial in the further development of S. bombicola as a platform production host 
for tailor-made glycolipids or other interesting compounds. 
 CYP52M1 localization by fluorescent protein fusion. 
As a first test, CYP52M1 was coupled to the already available GFPco10genes368 and to the 
new blue fluorescent protein (BFP) and red fluorescent protein (RFP) (described in II.3.4.1). 
The chimeric enzymes consisted of the P450 coding sequence linked by the natural linker from 
CYP102A1 and the fluorescent protein of interest. Since the N-terminus of CYP52M1 is 
anchored in the membrane of the ER, only C-terminal constructs were developed.  
After transformation of the different expression cassettes and screening of the mutants, 
microscopy and growth and production trials were conducted to localize the enzyme inside the 
cell and to evaluate the influence of coupling an extra domain to the CYP52M1 on its function 
or activity. A production experiment was conducted with the three different fluorescent strains 
in comparison with the wild type S. bombicola.  
In terms of glucose consumption there is no clear difference to be detected between the 
fluorescent strains and the wild type yeast (Figure 2.9). For sophorolipid production, some 
differences can be seen between the wild type and the different fusion strains (Figure 2.10), 
yet the enzyme activity of CYP52M1 is at least not hindered by the presence of an extra domain 
at its C-terminus and its native localisation is most likely conserved. From the data it is appears 
that the GFP and RFP strains produce more than the wild type S. bombicola while the BFP 
produces similar levels of sophorolipids, but statistical analysis did not show a significant 
difference. Most likely this is due to the small sample size (the strains were only tested in duplo) 
resulting in low power of the analysis. A production trial with a higher number of replicates is 
needed to verify if the observed differences are indeed significant. Still, it can be concluded 
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that the addition of an extra domain to CYP52M1 did not result in severely impaired production. 
These results open the possibility of coupling other domains to CYP52M1 in order to 
investigate for example increasing productivity. 
 
Figure 2.9: Glucose consumption of the wild type yeast and the fluorescent strains.  
 
Figure 2.10: Sophorolipid production of the wild type yeast and the fluorescent strains 6 days after 
inoculation. 
A striking visual observation is the strong colour change in the CYP52M1-RFP mutant in 
comparison with the other two constructs. As can be seen in Figure 2.11, this culture has a 
distinctive red colour. This can be explained by potentially higher emission strength of the RFP 
since all mutants have the same promotor controlling the fusion construct382.  
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Figure 2.11: Visual difference between the CYP52M1-BFP, CYP52M1-GFP and CYP52M1-RFP strain 
Using confocal microscopy, the location of the fluorescent chimeric proteins was visualized. 
The small size of S. bombicola, approximately 4 µm, limited detailed information about 
organelles or other structures, but as can clearly be seen in Figure 2.12, localization of the 
P450 is possible. The dark dot represents the nucleus. For each construct, a bright area near 
the nucleus can be seen. This corresponds to the endoplasmatic reticulum, which is often 
associated with the nucleus or at least near it383. Class II P450s like CYP52M1 are anchored 
to its membrane. These images clearly prove the localization of the P450 on these membrane 
structures instead of a more homogenous distribution throughout the cell. They also prove that 
the fluorescent proteins can be used for localization purposes in S. bombicola. From the three 
fluorescent proteins tested, RFP showed the highest signal when studied by a confocal 
microscope. As already mentioned, this might be due to the higher efficiency of the protein in 
regard to conversion of excitation energy to emitted light compared to the other fluorescent 
proteins tested382. 
 
Figure 2.12: Confocal fluorescent microscopy images of the three fluorescent CYP52M1 constructs. 
 Localisation of Ugta1-RFP and CYP52M1-GFP  
A next step in the localisation of the sophorolipid enzymes is the coupling of a fluorescent 
protein to the first glucosyltransferase UGTA1. Though it has been noted that the UGTA1 is 
present in the soluble cell lysate fractions of S. bombicola175, its exact location in the cell is still 
unknown. To counter any potential effects on expression or enzyme activity, both C- and N-
terminal fused constructs were generated. Both UGTA1-RFP fusion enzymes were introduced 
together with the CYP52M1-GFP chimeric construct in S. bombicola to investigate potential 
colocalisation of these enzymes (Figure 2.13). 
Chapter II  Improving the molecular toolkit of S. bombicola 
   
 
64 
 
 
Figure 2.13: Visual representation of the two different expression cassettes for UGTA1 and CYP52M1 
localization. A.) C-terminal UGTA1-RFP fusion enzyme. B.) N-terminal UGTA1-RFP fusion enzyme. 
When the cultures were visually inspected, a clear difference was seen between the wild type 
yeast and the fusion constructs (Figure 2.14). Striking is the pink colour of the C-terminally 
fused RFP compared to the N-terminal RFP construct. While the C-terminal construct shows 
a strong pink colour compared to the wild type, the pink colour is only marginal for the N-
terminal strain. Another difference between the two fusion constructs is the presence of a 
brown precipitate in the pink C-terminal mutant culture, probably caused by sedimenting 
sophorolipids. In order to assess the impact of two fusion enzymes on the sophorolipid pathway, 
a production trial was conducted.  
 
Figure 2.14: Visual observation of RFP-fusion constructs expression. From left to right wild type S. 
bombicola, C-terminal UGTA1-RFP and N-terminal RFP-UGTA1. Both fluorescent strains also had 
CYP52M1-GFP expressed. 
As can be clearly seen in Figure 2.15, the two different fluorescent strains clearly produce 
different amounts of sophorolipids. While the C-terminally coupled RFP has a productivity 
better than the wild type S. bombicola (p = 0.01982), the N-terminal RFP strain showed no 
production at all. Between the wild type and the C-terminal RFP mutant, no difference in 
sophorolipid composition could be observed. This proves that both the GFP and RFP do not 
interfere in the production of sophorolipids when simultaneously coupled to CYP52M1 and the 
C-terminus of UGTA1, respectively. 
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Figure 2.15: Relative production of sophorolipids for the wild type S. bombicola, the C-terminal RFP and 
the N-terminal RFP mutants. 
While inspecting the different strains using a confocal microscope, the difference in 
fluorescence becomes very clear (Figure 2.16). In the C-terminal fused RFP strain, both the 
red and green fluorescent chimeric proteins are easily detected while for the N-terminal one 
only marginal detection of both is possible. When combining both green and red channels of 
the image, the resulting yellow colour suggests a colocalisation of the proteins.  
When looking at the N-terminal RFP fusion construct it exhibits lower fluorescence values 
compared to the CYP52M1-GFP while the brightness of the RFP is higher than GFP (as could 
be seen for the CYP52M1-FP constructs both visually and in the imaging data). Extreme 
contrast adjustments show that there is expression, but this remains just above noise levels 
for most cells in the sample. As a control, a wild type S. bombicola was imaged as well with 
both green and red channels adjusted to the same levels as the N-terminal RFP image. No 
real fluorescence could be detected, confirming the observed fluorescence for the N-terminal 
construct being the result of protein expression. 
Using the C-terminally coupled UGTA1-RFP strain, three samples were taken and imaged in 
both green and red fluorescence channels. Next, the resulting data was analysed using JACoP, 
a colocalisation plugin for ImageJ. In each analysis, the green channel was taken as channel 
1 and the red channel as channel 2. Threshold determination was done automatically by the 
software to determine areas of interest and background. In Table 2.8 an overview of the 
resulting parameters can be found. Calculated colocalisation values are given both with and 
without using these threshold values.  
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Figure 2.16: Fluorescence images of the different strains tested. Column one is the brigthfield image with 
overlay of the green (CYP52M1-GFP) and red (UGTA1-RFP) channels. Both colour channels are also 
given. The strains tested by confocal microscopy were the wild type S. bombicola and both UGTA1-RFP 
strains with the co-expressed CYP52M1-GFP. 
The Pearson’s correlation coefficient (PCC) calculates the covariance in pixel intensity of both 
channels on a pixel-by-pixel basis. Since it uses a mean pixel value calculated for both 
channels, which is subtracted from the recorded pixel value, this method is independent of 
background interference as well as dynamic range of the recorded values384. A value of 1 
means perfect colocalisation, 0 means no colocalisation and -1 anti-localization. The Manders 
overlap coefficient (MOC) is similar to the Pearson’s coefficient, but does not subtract a mean 
pixel value, this way preventing a negative value to be calculated troubling interpretation of the 
data. This results in values between 0 and 1, corresponding to no overlap and 100 % 
colocalisation. However, the MOC is highly sensitive towards co-occurrence of high value 
pixels while low value results or combinations of high and low values are of less importance. 
Also offsets in the data can heavily influence the calculated values385. A third coefficient is Li’s 
colocalisation coefficient. It is based on the PCC, but instead of calculating covariance it counts 
the occurrence of pixels with both values above or below the mean image value. This has the 
downside that small differences above the mean have an equal weight in the calculation 
compared to strong signals, favouring pixel pairs with intensities near the mean intensity of 
each fluorophore used. The correlation scale runs from -0.5 for negative correlations to +0.5 
for positive correlations. 
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Table 2.8: Calculated colocalisation values for the C-terminally fused UGTA1-RFP samples. 
Parameter Sample 1 Sample 2 Sample 3 
Pearson’s coefficient 0.838 0.908 0.907 
Manders coefficient 1 Tr 0.768 0.895 0.899 
Manders coefficient 2 Tr 0.8 0.815 0.781 
Li’s coefficient 0.428 0.451 0.446 
 
When looking at the specific values of the correlation coefficients, it becomes clear that there 
is high correlation between the location of the CYP52M1-GFP and UGTA1-RFP. Comparing 
this with Figure 2.16 B, one can conclude with certainty that the P450 and glucosyltransferase 
are located in the same region of the yeast cell. This is presumably the membrane of the 
endoplasmatic reticulum since this is where the P450 is anchored to. Saerens et al.175 reported 
that UGTA1 shows a high homology with enzymes of the GT1 family of glycosyltransferases. 
Most transferases of that family are bound to the membrane structures like the endoplasmatic 
reticulum or Golgi apparatus386. However, for UGTA1 no membrane anchors could be detected 
and cell lysate experiments without the insoluble membrane fraction seemed to prove their 
presence in the cell lysate381. Still, if the proteins would be completely soluble, one would 
expect to see fluorescence in the entire cell and not strictly associated with CYP52M1. 
Moreover, if some kind of hydrophobic region would be present to let the transferase associate 
with the membranes one still would expect to see fluorescence near the plasma membrane 
and other membrane structures.  
A possible explanation for the fact that the enzymes are colocalised despite the fact that 
UGTA1 is not targeted to the ER (no signal present) might be P450-transferase interaction. In 
the case of class II P450s, interaction with the CPR enzyme is guided by electrostatical 
interactions on the protein surface of both enzymes. Something similar might be the case for 
the interaction between CYP52M1 and UGTA1. The technique used in this research does not 
allow to see how close the two enzymes are located, but techniques like Förster resonance 
energy transfer (FRET) could help to see if they are closely associated or not. Protein 
modelling might help as well to identify the responsible interacting regions and amino acid 
residues.  
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Relying on homologues integration for engineering can be a bottleneck when considering 
state-of-the-art engineering techniques. A plasmid would hence be a welcome addition to the 
molecular toolbox of S. bombicola. Unfortunately, no stable plasmid could be obtained using 
both in silico and in vivo strategies. Screening for potential ARS sequences in the genome of 
S. bombicola was unsuccessful and using heterologous ARS sequences from S. cerevisiae 
and K. lactis also did not result in a stable plasmid system. Interestingly, colonies were 
detected, but these all resulted from integration of the ura3 marker somewhere in the genome 
of S. bombicola.  
During the experiments, it became clear that the efficient recombination of the marker in the 
genome of S. bombicola is a major problem. Two causes arise when looking at the sequence 
of the ARS screening plasmid. One possibility is the ura3 promotor. The promotor might be 
used as a guide for integration near or in the empty ura3 locus in the genome of S. bombicola 
PT36 since only the coding sequence is missing. This problem can be eliminated by using non-
homologues sequences like the ura3 promotor off S. cerevisiae. Since in the experiments with 
the panARS the ura3 promotor and marker of S. bombicola were active in S. cerevisiae, the 
other way around might be possible as well. This could greatly reduce the risk of targeting and 
integration in the genome of the marker in screening experiments. The remaining risk can be 
partially attributed to the genomic fragments inserted in the screening vector. These 
sequences can also be used for targeting the vector towards certain regions and facilitate 
recombination in or near non-essential sequences. Developing systems that don’t use S. 
bombicola genomic sequences like an orthologous system involving mitochondrial DNA can 
cure this last problem. Though these strategies don’t elevate the chances of finding a working 
S. bombicola ARS sequence, they will reduce the risk of genome integration. 
When stable expression over longer periods of time is wanted, genomic integration is still the 
best strategy. Integration of complex cassettes in S. bombicola was often constrained due to 
uncertainties about the maximum length these cassettes can have. As could be seen from the 
results presented, very large constructs can be made and successfully integrated. In the case 
of the double cluster strain, five genes and a marker were introduced successfully and 
relatively easy. This opens the doors to more intensive engineering as large pathways can be 
introduced in one single transformation step. Indeed, there is no limit concerning the length of 
the final construct up to 14.000 base pairs.  
The first real example of using a large expression cassette was the creation of the double 
cluster strain. A significant difference in sophorolipid production was found during the early 
stages of production when compared to the wild type S. bombicola, but this initial difference 
did not result in higher yields or productivity. Furthermore, follow-up qPCR and MRM 
experiments showed an inconsistency between the results from both techniques, which needs 
to be further investigated. An interesting observation in the workflow of the qPCR are the 
housekeeping genes that are taken along for normalisation between the different biological 
and technical replicates. In the case of the performed MRM experiments, no equivalent 
normalisation factor is used. Instead, BSA spiking is applied for differences in trypsin digest, 
but variability already present before this step is not taken into account. For qPCR, a set of 
housekeeping genes has been tested by Roelants et al.368 A similar list could be composed for 
the MRM experiments387,388 to enable more robust strain comparisons in future research. 
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Besides validation of both techniques, development of a strain lacking the sophorolipid gene 
cluster at its original location would be interesting for comparison. This way, introduction of the 
cluster at the ura3 locus can be evaluated without the influence of the original one. A cluster 
negative strain can also be used for engineering the production of other glycolipids in S. 
bombicola since the sophorolipid biosynthetic enzymes can then not interfere in the synthesis 
anymore. 
Finally, it was shown that coupling enzymes from the sophorolipid gene cluster to fluorescent 
proteins does not influence their biosynthetic activity. Though no “functional” domains where 
coupled to the P450 or transferase, they remained their original function in the production of 
sophorolipids. Furthermore, two new fluorescent proteins are available for S. bombicola during 
this research, offering the possibility of studying bidirectional promotors, protein 
(co)localisation or other cellular processes. The in vivo confirmation of the targeting of the P450 
to the ER membrane and the finding that the UGTA1 and P450 are co-localized are the first 
results obtained by using multiple fluorescent proteins in one S. bombicola strain. Coupling to 
other enzymes like the second glucosyltransferase, the acetyltransferase or even the lactone 
esterase will enable to investigate their localisation and their role in the production of 
sophorolipids. This knowledge is crucial in the further development of S. bombicola as a 
platform production host for tailor-made glycolipids or other interesting compounds. 
Furthermore, the fluorescent chimera allow the rapid screening of promotors coupled to real 
production. 
Another interesting possibility of these proteins could be identification and characterisation of 
localisation signals. Peroxisomal targeting is described by Roelants et al.318 using the signal 
peptide present at the C-terminus of the peroxisomal multifunctional enzyme type 2314. Other 
signal peptides like nuclear, membrane, Golgi or mitochondrial localisation signals are still 
unknown or untested. For certain applications these sequences might be necessary, for 
example when integrating the 2µ plasmid maintenance proteins that need to be located inside 
the nucleus.  
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Starmerella bombicola is a yeast known for its efficient production of sophorolipids, a kind of 
glycolipid biosurfactant389. The first step in the sophorolipid biosynthesis involves hydroxylation 
of a fatty acid by a cytochrome P45039. Cytochrome P450 enzymes are hemeproteins known 
for their capacity to use molecular oxygen to be incorporated in a wide variety of substrates. 
Besides oxygenation reactions, other less common reactions like nitration occur as well390.  
In the sophorolipid biosynthesis, hydroxylation of the fatty acids is carried out by CYP52M1 
and it largely determines the length of the fatty acids introduced315. The enzyme has a high 
specificity towards fatty acids like stearic acid (C18:0) and oleic acid (C18:1), less towards 
shorter and longer fatty acids like palmitic (16:0) or myristic (14:0) acid. In combination with 
the specificity of the first glucosyltransferase UGTA1, this results in mainly C16:0, C18:0 and 
C18:1 fatty acid tails being incorporated. Therefore, most production processes are conducted 
with hydrophobic substrates like vegetable oils or longer fatty acids. Though the incorporation 
of these longer fatty acids is very efficient, it is also a burden when further molecular 
diversification of the sophorolipid molecules is desired. It is feasible to incorporate shorter alkyl 
chains by chemical or biocatalytical ways363, in vivo production is still limited. 
Growth trials with shorter fatty acids resulted mainly in long-chained sophorolipids and some 
smaller amounts of medium-chained ones. This is due to the elongation of the shorter fatty 
acids by elongase enzymes of the endoplasmatic reticulum. Shorter fatty acids can also be 
degraded in the β-oxidation pathway and those building blocks will serve as a substrate for de 
novo synthesis of fatty acids391. However when using specialized substrates like alcohols or 
ketones, short- and medium-chained sophorolipids can be obtained392,393. The main problems 
are still the high cost of for example ketones and the relatively low amounts of novel 
sophorolipids being produced. Engineering of S. bombicola by knocking-out the β-oxidation314 
or enzymes involved in long-chain alcohol oxidation394 already improve the production of these 
novel new-to-nature molecules using cheaper substrates, but the traditional sophorolipids still 
remain a part of the mixture since de novo fatty acid synthesis is still occurring with subsequent 
incorporation of these fatty acids in the sophorolipids.  
All in all, the major factors hindering the production of new-to-nature molecules are de novo 
sophorolipid synthesis, high substrates costs and less than optimal production. To circumvent 
this problem of elongation, degradation and de novo incorporation, one may try to express 
P450s with interesting substrate specificities, for example CYP52A4249, CYP102A7293, 
P450foxy295 or CYP1395. CYP52A4, CYP102A7 and P450foxy have a high activity towards 
myristic acid (C14:0) and CYP1 presumably towards palmitic acid (C16:0). All these P450s 
perform hydroxylations near the terminal or the terminal carbon atom of the fatty acid tail.  
As already mentioned, natural P450s exhibit a wide range of potential reactions, substrates 
used and products formed. Still, research has focused on engineering specific P450 enzymes 
for studying for example drug metabolism. One such enzyme that has been studied extensively 
is CYP102A1 from Bacillus megaterium275 also known as BM3. To date it is the most active 
P450 described in nature mostly due to the fact it does not depend on a separate reaction 
partner like most other P450 enzymes.  
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Structural analysis as well as mutagenic research on the enzyme proved that it is possible to 
shift substrate specificity and product formation when specific amino acid residues are 
altered396–398. Another technique used to widen the reaction horizon of CYP102A1 is so-called 
domain shuffling between the different CYP102A family members or mutants of CYP102A1 
itself. The resulting synthetic chimeric P450s often have novel properties not directly linked to 
the parental enzymes399,400. To explore the full potential of other P450s, synthetic chimeric 
constructs have been constructed401. 
In this chapter, the creation of S. bombicola strains capable of producing sophorolipid mixtures 
not yet described by heterologous expression of wild type and engineered P450 enzymes and 
moreover enhancing this production by creation of chimeric P450s is described. 
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Starmerella bombicola ATCC22214 is the wild type strain used during the experiments. The 
derived PT36 strain, a ura3 auxotrophic mutant, was used to engineer all the mutants 
described in this research. Transformation and growth trials were performed as described in 
II.2.1. As a hydrophobic substrate, rape seed oil was used at 37.5 g/L or another suitable 
hydrocarbon like ethyl palmitate, palmitic acid, myristic acid, ethyl myristate, lauric acid or ethyl 
myristate at concentrations of 5 g/L in Erlenmeyer experiments unless otherwise stated. All the 
different substrates were acquired from Sigma-Aldrich (USA) 
Experiments in bioreactors were routinely carried out using the Biostat® B 3 L vessels 
(Sartorius BBI-systems; Germany) with 1.5 liter working volume. At inoculation, 1 liter of Lang-
medium370 was inoculated with 200 mL of a late exponential culture from an Erlenmeyer flask. 
The medium has an initial pH of 5.8 and is allowed to drop spontaneously to pH 3.5 and is kept 
at this pH by using a 5 M NaOH solution. Due to the acidification of the culture broth by the 
yeast itself, no acid has to be added. The reaction vessel is kept at 30 °C and stirred at 600 
rpm. Aeration is kept at 1 L/min and closely monitored. Daily sampling of glucose 
concentrations and optical density is performed as stated in II.2.4.1. When the glucose 
concentration drops below 30 g/L, a precalculated volume from a 60 % glucose stock solution 
is added to the fermentor until a final concentration of 100 g/L. Larger fermentations were 
carried out in the 30 L B. Braun Biotech International C20-3 (Germany). Aeration and stirrer 
rates can be found in Table 3.8 Recuperation of the sophorolipids from the fermentation broth 
was done by using two techniques depending on the strain used. Isolation from highly 
productive strains was done by placing the culture broth overnight at 60 °C. This results in a 
precipitation of the sophorolipids produced. Recovery of sophorolipids from low productive 
strains was done by extraction with ethyl acetate.  
 
  General techniques 
High fidelity PCRs are performed with PrimeSTAR HS DNA Polymerase (Takara) when 
fragments are shorter than 3000 base pairs. Longer fragments are amplified with PrimeSTAR 
GXL DNA Polymerase (Takara). For colony PCR, TAQ-polymerase (New England Biolabs) is 
used. Genomic DNA was isolated using the Sigma Genomic DNA isolation kit. 
Primers, plasmids and final strains were designed using the Clone Manager Basic Version 9 
software suite from Sci-ED Software. Primers were ordered at Integrated DNA Technologies 
and diluted upon arrival to a 10 mM stock solution. Working solutions are derived from these 
by a 100x dilution to 10 µmol. Sequencing of plasmids and intermediate constructs was 
performed by LGC Genomics (Germany). 
Transformation of S. bombicola was done following the protocol of Van Bogaert et al.310. Unless 
otherwise stated, cells were incubated on the previously described SD-medium. 
Transformation of E. coli was performed as described by Sambrook and Russel371. 
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 Vector construction 
All the different plasmids constructed in this chapter are targeted towards the cyp52m1 locus 
(Figure 3.). The P450s of interest are ligated between the cyp52m1 promotor and terminator. 
Selection is performed by the ura3 marker, which is situated downstream of the P450 coding 
sequence. In Table 3.1, an overview is given, which P450s were tested during this research. 
 
Figure 3.1: Overview of the plasmid used for knock-in strategies at the cyp52m1 locus. 
Table 3.1: P450 enzymes tested at the cyp52m1 locus for the production of medium-chained sophorolipids. 
P450 name Organism Coding sequence length  Preferred substrate(s) 
CYP52A4 Candida maltosa 1617 bp Lauric acid 
CYP52M1 Starmerella bombicola 1617 bp Oleic acid 
CYP1 Ustilago maydis 2007 bp Presumed palmitic acid 
CYP102A1 Bacillus megaterium 3150 bp Myristic acid 
CYP102A7 Bacillus licheniformis 3225 bp Myristic acid 
P450Foxy Fusarium oxysporum 3201 bp Lauric acid 
 
Wild type CYP102A1, CYP102A7 and P450Foxy enzymes 
Plasmid BS_EC_0360 was used for constructing the novel knock-in cassettes. The plasmid 
was constructed by using a pGEMT backbone for cloning in E. coli and contains homologues 
regions for incorporation in the genome of S. bombicola at the cyp52m1 locus. The 5’ 
homologous region encompasses 1000 base pairs upstream of the start codon of cyp52m1. 
Downstream of the locus are the ura3 marker gene with its promotor and terminator followed 
by the 3’ homologous region. The plasmids were constructed by linearizing the previous 
mentioned cyp52m1 locus plasmid by high fidelity PCR (8228 bp). This results in a scarless 
vector backbone suitable for assembly cloning of the coding sequences of the to be tested 
P450s. 
The coding sequence of CYP102A1 (3150 bp) and CYP102A7 (3225 bp) were amplified from 
genomic material from Bacillus megaterium ATCC14581 and Bacillus licheniformis LMG12363 
respectively with the primers provided in Table 3.2. A similar strategy was used for creation of 
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the P450Foxy from F. oxysporum JCM11502. The coding sequence of P450Foxy was obtained 
by RNA isolation from a stationary cell culture using the QIAGEN RNeasy kit to avoid introns. 
After reverse transcription, amplification of the cDNA resulted in the expected PCR product 
(3201 bp). Ligation in the vector backbone was done by Gibson assembly for all sequences. 
Screening of the correct E. coli mutants by colony PCR is done with primers 
P843_A21knockhygroCasFor and P79_REV_tCYP_extBamHI. The resulting plasmids are 
called BS_EC_0358, BS_EC_0360 and BS_EC_0362 for respectively CYP102A1, CYP102A7 
and P450Foxy.After sequencing, the correct expression cassettes were amplified with primers 
P847_Cm2ExCasLongFor and P947_Cm2ExCasRev and transformed in S. bombicola PT36. 
Screening of the correct mutant yeasts happens with primer P954_Cm2CheckFor combined 
with P1231_BM3F87Arev, P243_CYP102A7checkrev, and P242_FoxyP450checkrev for 
respectively CYP102A1 (1335 bp), CYP102A7 (1545 bp) and P450Foxy (1642 bp) for the 5’-
region. For the 3’ region, only one primer pair is needed for screening all mutant strains; 
P953_URA3outendFor and P952_A21totRev (1172 bp). 
Mutant CYP102A1F87A, CYP102A7F88A and P450FoxyF88A enzymes 
A previously acquired CYP102A1F87A plasmid was used as a template for amplification of the 
CYP102A1F87A insert. The plasmids described in III.2.2.2 for CYP102A7 and P450Foxy 
expression were used for mutagenesis of the phenylalanine at position 87-88 by Sanchis site 
saturation mutagenesis with primers P2086_CYP102A7mutF88ASanFor and 
P2089_FoxyP450F88AsanFor. As reverse primer their respective Gibson reverse primers 
were used for generation of the megaprimer. The resulting plasmids are BS_EC_0359, 
BS_EC_0361 and BS_EC_0363 for CYP102A1F87A, CYP102A7F88A and P450FoxyF88A. 
The same primers described in the previous section were used for screening correct yeast 
mutants.  
Table 3.2: Primers used for the construction of wild type and mutated P450 expression plasmids. When 
overhanging primers were used, a dash represents the start of the binding region of the primer. For Sanchis 
primers the altered codon is marked in bold. 
Primer name Primer sequence  
P52_REV_upCYP ATATGTACTTTTCAATATGATAAACGGAGAAATAACG 
P69_FOR_RegulUP GTTTCTTAGCCTCCCATGGAAG 
P79_REV_tCYP_extBamHI CAGGATCCGTCGGTTAAACGCACTCCTTC 
P395_UmCYP1InfFor TGAAAAGTACATATGGTACC-ATGTCGCTCAAAGTGCAG 
P396_UmCYP1InfRev AACGCTAGCTTGGCG-TTATCTAGTGCCTTCCTTGCAAC 
P843_A21knockhygroCasFor GAGTCGGGCGTTATTTCTCC 
P847_Cm2ExCasLongFor  CGTTGTCAAGTCCTAAGGTAT 
P887_Cm2ExCasRev AAGCGTGAAGCTCCTCTGACAATC 
P954_Cm2CheckFor TCATAGCGAGTTTCTTTGCATGTG 
P679_UmCYP1checkRev TGAGCTAAGTCCACCCTGAG 
P953_URA3outendFor TAAAGAAACGAAGGGCCCAGCAGTC 
P952_A21totRev GCTCTTGTTCGGTACTCTTATT 
P1231_BM3F87Arev  GCGTCCAGCTTGTAGCTAACCCGTCTCCTGC 
P2086_CYP102A7mutF88ASanFo
r 
CGAGTTCAGCGGAGACGGGCTCGCAACAAGCTGGACGGAAGAACCCAATTGG 
P2089_FoxyP450F88AsanFor GAGGGTGTTCACGATGGCCTCGCAACAGCATTCGAGGATGAGCCCAATTG 
P2090_FoxyP450GibFor GTTATTTCTCCGTTTATCATATTGAAAAGTACATAT-ATGGCTGAATCTGTCCCTA 
P2091_FoxyP450GibRev GAACGTTTCTTCCATGGGAGGCTAAGAAAC-CTAATCGAAAACATCAGTAGCA 
P2092_CYP102A7GibFor GTTATTTCTCCGTTTATCATATTGAAAAGTACATAT-
ATGAACAAGTTAGATGGAATTCCAATC 
P2093_CYP102A7GibRev GAACGTTTCTTCCATGGGAGGCTAAGAAAC-TTACGTTCTTGCAATGCAGTC 
P2094_CYP102A1GibFor GTTATTTCTCCGTTTATCATATTGAAAAGTACATAT-
ATGACAATTAAAGAAATGCCTCAG 
P2095_CYP102A1GibRev GAACGTTTCTTCCATGGGAGGCTAAGAAAC-TTACCCAGCCCACACGTC 
Chapter III  Engineering of the P450 pool of S. bombicola 
  
 
78 
 
Ustilago maydis CYP1 
The wild type coding sequence of cyp1 from U. maydis 521402 was ordered from GeneArt. No 
codon optimisation was performed since the codon usage was similar to the codon usage of 
S. bombicola during the stationary phase. The sequence was amplified with primers 
P395_UmCYP1InfFor and P396_UmCYP1InfRev (2041 bp). The previous mentioned 
pGEMT_CYP102A7 plasmid was used as a vector backbone (7514 bp). Ligation was 
performed by the In-Fusion HD Cloning kit. This resulted in plasmid BS_EC_0058. After 
sequencing, the expression cassette was amplified from the plasmid with primers 
P847_Cm2ExCasLongFor and P947_Cm2ExCasRev (6512 bp). After transformation in S. 
bombicola PT36 and selection on SD-medium, the transformants were screened for correct 
integration of the cassette by yeast colony PCR using primers P954_Cm2CheckFor and 
P679_UmCYP1checkRev for the 5’-region and P953_URA3outendFor and P952_A21totRev 
for the 3’ region. The 5’ region fragment has a length of 1116 bp and the 3’ region fragment of 
1172 bp.  
CYP1, CYP52M1 and CYP52A4 chimeric constructs 
The earlier constructed plasmid BS_EC_0058 was used as a vector backbone to insert the 
Bacillus megaterium BM3 reductase. The vector backbone was amplified with primers 
P788_UmCYP1scarlessBMRInfRev and P69_FOR_RegulUP (8558 bp) (Table 3.3). This 
resulted in plasmid BS_EC_0091. The other plasmids are derived from the latter by 
amplification of the vector backbone (including the BM3 linker) with primers 
P1439_BMRlinkerRev and P69_FOR_RegulUP (8618 bp). The reductase of B. megaterium 
ATCC14581 was amplified from genomic material with primers P722_BM3CPRLinkerInfFor 
and P723_BM3CPRLinkerInfRev (1794 bp) and ligated using the In-Fusion HD Cloning Kit. 
The S. bombicola CPR was amplified from genomic DNA with primers 
P1440_SbombicolaCPRGibCYP52M1For and P1441_SbombicolaCPRGibCYP52M1Rev 
(1992 bp) and was assembled in the vector backbone using Gibson assembly. The expression 
cassettes were amplified with primers P847_Cm2ExCasLongFor and P887_Cm2ExCasRev 
(respectively 7310 bp, 7583 bp and 7691 bp). 
Chimeric enzymes were also constructed for CYP52M1 and CYP52A4. The coding sequence 
of cyp52m1 was amplified from genomic S. bombicola DNA with primers 
P834_Cyp52M1GibFor and P829_Cyp52M1BMRGibRev (1674 bp). The template of 
CYP52A4 was a plasmid kindly shared by Zimmer et al249 named Cm2_correct_pl4. Primers 
P789_Cyp52A4scralessInfFor and P790_Cyp52A4scarlessBMRInfRev (1644 bp) were used 
for amplification of the sequence. CYP52M1 was combined with the reductase part of BM3 
(BMR) or the S. bombicola CPR while CYP52A4 was only coupled to BMR.  
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Validation of CYP1BMR chimeric construct 
Validation of the function of the reductase domain of B. megaterium ATCC14581 was done by 
introducing several mutations in the domains of the reductase. Part of the reductase was 
ordered as a gBlock from IDT (Leuven, Belgium) since PCR-based site-directed mutagenesis 
was impossible to achieve. The sequence can be found in Appendix C. For the mutation in the 
FMN domain, primers P1645_BMRmutgBlockMidGibFor and 
P1642_BMRmutbbGibgBlockRev were used for the vector backbone (9657 bp) with plasmid 
BS_EC_0091 as a template (Table 3.3). The mutated sequence was amplified from the gBlock 
with primers P1644_BMRmutblockGibgBlockFor and P1646_BMRmutgBlockMidGibRev (761 
bp). A similar strategy was followed for the mutation in the NADPH binding domain with primers 
P1642_BMRmutbbGibgBlockRev and P1645_BMRmutgBlockMidGibFor for vector the 
backbone with BS_EC_0091 (9766 bp) as a template and primers 
P1643_BMRmutblockGibgBlockRev and P1645_BMRmutgBlockMidGibFor for the mutated 
sequence (645 bp). Finally, the double mutation construct was created with primers 
P1641_BMRmutbbGibgBlockFor and P1642_BMRmutbbGibgBlockRev for linearization of the 
vector BS_EC_0091 (9043 bp) and primer pair P1643_BMRmutblockGibgBlockRev and 
P1644_BMRmutblockGibgBlockFor for the sequence carrying the double mutation (1372 bp).  
All vectors were assembled by Gibson assembly. Transformation in S. bombicola PT36 and 
screening of the mutants is identical as described in II.2.2. 
Table 3.3: Primers used for construction of the various chimeric constructs and for the validation cassettes 
of the CYP1BMR construct. Binding and non-binding parts of the primers are separated by a dash. 
Primer name Primer sequence  
P52_REV_upCYP ATATGTACTTTTCAATATGATAAACGGAGAAATAACG 
P69_FOR_RegulUP GTTTCTTAGCCTCCCATGGAAG 
P722_BM3CPRLinkerInfFor AAAATTCCGCTTGGCGGTATTCCTTCACC 
P723_BM3CPRLinkerInfRev GGGAGGCTAAGAAAC-TTACCCAGCCCACACGTCT 
P788_UmCYP1scarlessBMRInfRev GCCAAGCGGAATTTTTC-TAGTGCCTTCCTTGCAACATCGAAGGG 
P789_Cyp52A4scarlessInfFor TTGAAAAGTACATAT-ATGTCGGTTTCCTTTGTTCAC 
P790_Cyp52A4scarlessBMRInfRev GCCAAGCGGAATTTT-GTACATTTGGATATTGGCACCATC 
P829_Cyp52M1BMRGibRev AGGTGAAGGAATACCGCCAAGCGGAATTTT-
AGAAAACCGCACAACCACACCGGGAGGAG 
P834_Cyp52M1GibFor TCTCCGTTTATCATATTGAAAAGTACATAT-
ATGTTAATCAAAGACATTATTCTAACTCCAATGAG 
P847_Cm2ExCasLongFor CGTTGTCAAGTCCTAAGGTAT 
P887_Cm2ExCasRev AAGCGTGAAGCTCCTCTGACAATC 
P1439_BMRlinkerRev GTTTTCTGCCTTTTTGCGTAC 
P1440_SbombicolaCPRGibCYP52M1For GCTAAAAAAGTACGCAAAAAGGCAGAAAAC-
GCCGATATTAATTTTATCGCT 
P1441_SbombicolaCPRGibCYP52M1Rev GAACGTTTCTTCCATGGGAGGCTAAGAAAC-CTACCAAACGTCCTCTTG 
P1641_BMRmutbbGibgBlockFor CGGAGACGGAAGCCAAATGGCACCTGCCGTTGAAGCAACG 
P1642_BMRmutbbGibgBlockRev CAAATACGGAGTAGCGAACGCCTTTTACTTCATCAGCA 
P1643_BMRmutblockGibgBlockRev CGTTGCTTCAACGGCAGGTGCCATTTGGCTTCCGTCTCCG 
P1644_BMRmutblockGibgBlockFor TGCTGATGAAGTAAAAGGCGTTCGCTACTCCGTATTTG 
P1645_BMRmutgBlockMidGibFor GCAAAACGTTTAACAATGCTTGAACTGCTTGAAAAATACC 
P1646_BMRmutgBlockMidGibRev CCGGGTATTTTTCAAGCAGTTCAAGCATTGTTAAACGTTTTGCC 
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Substrate specificity screening of CYP1BMR 
For testing the substrate specificity of the chimeric CYP1BMR, the V60 vector system for S. 
cerevisiae W(R) was used for overexpression. The three parts of the V60 vector are obtained 
using the following primers (Table 3.4); P613_pYeDP60_Gibson_Piece1_Rev and 
P1032_V60Piece1For (4752 bp) for V60Piece1 and P614_pYeDP60_Gibson_Piece2_For and 
P1033_V60Piece2Rev (4498 bp) for V60Piece2. The primers used to obtain the coding 
sequence of the CYP1BMR are P2005_CYP1BMR_V60GibFor and 
P2006_CYP1BMR_V60GibRev (3857 bp). Final assembly of the plasmid was performed in 
vivo in Saccharomyces cerevisiae WT 630. For identification of the positive colonies in S. 
cerevisiae W(R) by colony PCR, the primers P274_V60insertRev and P273_V60insertFor 
were used (4094 bp). 
Table 3.4: Primers used for construction of the V60 substrate screening plasmid. Binding and non-binding 
regions are separated by a dash. 
Primer name Primer sequence  
P273_V60InsertFor TGCATGTGCTCTGTATGTA 
p274_V60InsertRev TTTAGCGTAAAGGATGGG 
P613_pYeDP60_Gibson_Piece1_Rev TTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAAC 
P614_pYeDP60_Gibson_Piece2_For TTCCGCGCACATTTCCCCGAAAAGTGCCACCTGACGTCTAAGAAAC 
P1032_V60Piece1For GATCTCCCATGTCTCTACTGGTGGTGGTGCTTCTTT 
P1033_V60Piece2Rev TAATTTAGTGTGTGTATTTGTGTTTGCGTGTCTA 
P2005_CYP1BMR_V60GibFor CACGCAAACACAAATACACACACTAAATTA-ATGTCGCTCAAAGTGCAG 
P2006_CYP1BMR_V60GibRev GCACCACCACCAGTAGAGACATGGGAGATC-TTACCCAGCCCACACGTC 
 
 
The specificity with respect to fatty acids of the membrane-bound cytochrome P450 enzymes 
can be assayed by adding the substrate of interest to isolated microsomes. The S. cerevisiae 
W(R) strain is used in order to overexpress the cytochrome P450 enzyme of interest. S. 
cerevisiae does not contain endogenous hydroxylation activity to fatty acids. Furthermore, the 
S. cerevisiae cytochrome P450 reductase is overexpressed after induction with galactose. The 
following method is used for a culture containing a total of 5x109 cells/mL. All components 
should be scaled up corresponding to culture size. For isolation of the microsomes, the protocol 
of Pompon et al.403 was followed. To determine the protein concentration of obtained samples 
the Pierce™ BCA Protein Assay Kit of Thermo Scientific™ (product number #23225) is used. 
Protein concentrations are determined and reported with reference to standards of the 
common protein bovine serum albumin (BSA).  
 
 Checking for the presence of microsomes 
When the microsomes are isolated, one needs to check if the microsomes are present in the 
isolated protein mixture. This is done by a protocol where cytochrome c is reduced by the 
present cytochrome P450 reductase enzymes. This is accompanied by a colour change that 
can be observed at 550 nm. The stock solutions are made using distilled water. The 
composition of the reaction mixture can be found in Table 3.5. NADP+ is added last to the 
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reaction mixture, since this component allows for the start of the reaction. The regeneration of 
NADPH is based on an enzymatic reaction. The glucose-6-phosphate dehydrogenase, present 
in the reaction mixture, will convert the oxidized NADP+ back into NADPH in the presence of 
glucose-6-phosphate. NADPH then serves as an electron donor for the CPR. All components 
are acquired from Sigma-Aldrich (USA) unless otherwise stated. 
Table 3.5: Composition of the reaction mixture to check for the presence of microsomes 
Components Volume (µL) 
Protein (10 mg/mL) 100 
K2HPO4 (2M; pH 7.4) 125 
MgCl2 (1 M) 3.3 
Glucose-6-phosphate (60 mM) 55 
Glucose-6-phosphate dehydrogenase (100 U/mL) 4 
NADP+ (100 mM) 13 
Cytochrome c (9 mg/mL) 100 
mQ 599.7 
Total volume 1000 
 
 Cytochrome P450 activity protocol 
To analyse the activity of the cytochrome P450, added to different substrates, the following 
reaction mixture is used. The stock solutions are prepared with distilled water, except for the 
fatty acids. For these, stock solutions are made in 100 % dimethylsulfoxide (DMSO). The 
composition of the reaction mixture for 1 substrate is given in Table 3.6. In order to start the 
reaction NADP+ is added last. Everything is incubated at 30 °C and 120 rpm for 3 hours. After 
incubation the reaction is stopped by adding 0.5 mL 0.8 % (vol/vol) H2SO4. The formed 
products are extracted with ethyl acetate. This was done by adding 440 µL ethyl acetate and 
10 µL acetic acid to the reaction mixture with subsequent vigorous mixing. After 5 minutes, the 
mixture is centrifuged at full speed for 5 minutes. After centrifugation, the top layer is collected 
for further analysis. 
Table 3.6: Composition of the reaction mixture to screen for cytochrome P450 activity. 
Components Volume (µL) 
Protein (10 mg/mL) 100 
K2HPO4 (2M; pH 7.4) 125 
MgCl2 (1 M) 6.6 
Glucose-6-phosphate (60 mM) 110 
Glucose-6-phosphate dehydrogenase (100 U/mL) 8 
NADP+ (100 mM) 26 
Substrate (100 mM) 2 
mQ 622.4 
Total volume 1000 
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Table 3.6
 
Determination of glucose, optical density and sophorolipid production were performed as 
described in II.2.4. The products of the CYP1BMR and S. bombicola self-sufficient P450 
enzyme tests were analysed with a scan range from 100 to 400 m/z by LC-MS. 
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As mentioned before, the physico-chemical and biological properties of surfactants are partially 
influenced by their hydrophilic-lipophilic balance (HLB). In the case of sophorolipids, the HLB 
value can be modified by changing the fatty acid tail to either shorter or longer congeners. In 
the past, sophorolipids differing from the wild type mixture have been made using atypical 
substrates like alcohols, ketones or related substrates392,393,404. Still, wild type sophorolipids 
often contaminate the product mixture leading to lowered uniformity. As can be seen in Figure 
3.1, a simple substrate such as ethyl palmitate will be elongated to oleic and stearic acid or 
degraded in the β-oxidation and used for de novo fatty acid synthesis. Another interesting 
observation is the double signal for the lactonic C16 sophorolipids. Oleic and stearic acid are 
preferably hydroxylated at the ω-1 position, while palmitic acid is more equally hydroxylated at 
the ω and ω-1 positions. Since palmitic acid is shorter than both oleic and stearic acid, the 
terminal carbon atom might be better positioned for hydroxylation resulting in a mixture of ω 
and ω-1 products. 
 
Figure 3.1: HPLC-ELSD chromatogram of a growth trial of wild type S. bombicola with ethyl palmitate as a 
hydrophobic substrate.  
Still, S. bombicola is capable of utilizing shorter fatty acids with differing hydroxylation patterns 
as a substrate for glucosylation by UGTA1. However, a big drawback is the low uniformity 
caused by the promiscuity of the enzymes involved. As Figure 3.1 clearly depicts, a mixture of 
different C16 and C18 hydroxy fatty acids are incorporated in the sophorolipids rather than just 
one single congener. An interesting way to increase sophorolipid fatty acid uniformity would 
be to use P450s that are rather limited in their substrate while still converting enough to ensure 
adequate production of these molecules. In the following research, an attempt has been done 
to create new-to-nature sophorolipids with shorter fatty acid tails. 
 
 Expression of natural self-sufficient P450s in S. bombicola 
Expression of self-sufficient P450s is an interesting strategy to alter the substrates available 
for the glucosyltransferases without risking incompatibility issues between the P450 and the 
cytochrome P450 reductase (CPR) of S. bombicola. In total three class VIII enzymes were 
expressed successfully in S. bombicola by integration at the cyp52m1 locus and using the 
cyp52m1 promotor for expression (see III.2.2.2). These were CYP102A1 from Bacillus 
megaterium, CYP102A7 from Bacillus licheniformis and CYP505A1 (also known as P450Foxy). 
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Though the substrate specificities differ slightly between them, it is fair to say that fatty acids 
ranging from lauric acid (C12:0) up to docosahexaenoic acid (C22:6) can be hydroxylated or 
oxidized.  
However, sophorolipid synthesis tests with strains carrying CYP102A7 or P450Foxy using 
myristic acid as a hydrophobic substrate (5 g/L added 2 days after inoculation) resulted in no 
novel sophorolipid molecules being produced in detectable amounts. No adverse effects of the 
P450s could be detected in comparison with the wild type ATCC 22214 strain for parameters 
like growth rate or glucose consumption. 
In order to verify enzyme activity in the S. bombicola cells, test with cell lysates from 4 days 
old cultures were conducted. Tested substrates were myristic acid (C14:0), oleic acid (C18:1), 
eicosapentaenoic acid (C20:5) and docosahexaenoic acid (C22:6) for CYP102A7 and lauric 
(C12:0), myristic acid (C14:0) and oleic acid (C18:1) for CYP505A1. Product formation was 
evaluated by HPLC and LC-MS (Figure 3.2 and Figure 3.3).  
 
All evaluated substrates were clearly converted to hydroxylated compounds; proving the 
correct and active expression of the self-sufficient CYP1072A7 and P450Foxy genes in S. 
bombicola. In the case of CYP102A7, C14 and C18:1 are converted to hydroxylated products, 
which elute at 22.5 and 26.8 minutes respectively. For the polyunsaturated substrates more 
complex products combining several hydroxylations and epoxidations of the double bond are 
observed. The signal at 37.5 minutes originates from cell-own free fatty acids. For P450Foxy, 
similar results are obtained for lauric and myristic acid. Both are converted to their respective 
hydroxy fatty acid and elute at 18.5 and 22.7 minutes for respectively hydroxy lauric acid and 
hydroxy myristic acid. No activity could be detected for oleic acid, which was unsuspected 
since according to Nakayama et al.295 the relative activity of P450Foxy towards oleic acid is still 
50 % compared to the activity towards lauric acid. It has to be noted that characterisation of 
P450Foxy by Nakayma et al.295 was done in vitro on purified enzyme while the results discussed 
here are for raw cell lysates. 
 
 
Figure 3.2: HPLC chromatograms of the CYP102A7 activity towards several fatty acids (A): myristic acid, 
(B): oleic acid, (C): eicosapentaenoic acid and (D): docosahexaenoic acid). The major hydroxylation or 
Chapter III  Engineering of the P450 pool of S. bombicola 
  
 
85 
 
epoxidation product is annotated for each substrate tested. The signal at 37.5 minutes represents the cell 
own oleic acid molecules from de novo fatty acid biosynthesis. 
 
Figure 3.3: HPLC chromatograms of the enzyme assays using the P450Foxy mutant strains. (A): lauric acid, 
(B): myristic acid and (C): oleic acid. The major product formed is annotated. The molecule eluting after 
37.5 minutes is oleic acid. 
To conclude, both P450s were successfully expressed and able to hydroxylate the fatty acids 
in vivo. Yet, no incorporation of the hydroxylated compounds in sophorolipids was observed. 
This could on the one hand be attributed to the non-compatible region- and/or stereo-specificity 
of the hydroxylation. It is for instance not clear if the first glucosyltransferase can handle 
hydroxylated fatty acids different from the ω or ω-1 hydroxylated ones; CYP102A7 has a 
preference towards the ω-2 carbon atom, but side reactions towards the adjacent atoms are 
possible. The ratio of hydroxylation between the ω-1, ω-2 and ω-3 positions differs between 
different fatty acids, but in general the majority of hydroxylations occurs on the ω-2 carbon 
atom. This is consistent with other members of the CYP102A family. For myristic acid, both 
CYP102A2 and CYP102A3 also have higher activity towards the ω-2 or even ω-3 position and 
less for ω-1291,405. CYP102A5 also prefers ω-2 when incubated with palmitic and linoleic acid292. 
This stands in contrast with CYP102A1, which has a higher preference for the ω-1 carbon atom 
when the same substrates are compared. In the case of P450Foxy no ratios have been 
determined. In general no values are given for terminal hydroxylation, suggesting that this 
reaction is very uncommon for these enzymes. Still, ω-1 incorporation is indeed possible for 
C18 fatty acids since they occur in wild type sophorolipids, but it is not clear if this is also 
feasible for C12 and C14 fatty acids.  
Furthermore, the unclear R/S configuration of both P450s might also be of importance; for the 
native sophorolipids, only the S-configured hydroxylated fatty acid is glucosylated by the first 
glucosyltransferase377. High sequence identity on the protein level with CYP102A1, a known 
R-hydroxylating P450, points towards a similar product being formed by both P450s. When 
looking at the ω-1 and ω-2 carbon atoms from several hydroxy fatty acids, the percentage of 
R-configured hydroxy groups ranges between 93 and 98%. At the ω-3 position this ratio drops 
to values between 74 and 87 %406. Though some of the hydroxy fatty acids have the correct 
stereospecificity, no production of sophorolipids on myristic acid could be observed.  
Chapter III  Engineering of the P450 pool of S. bombicola 
  
 
86 
 
 Screening of alanine mutants of CYP102A1, CYP102A7 and CYP505A1 
Shifting the P450s hydroxylating at the terminal position might be an interesting strategy to 
avoid possible problems with wrong regio- and stereospecificity. The wild type CYP102A1 is 
not only capable of accepting fatty acids, but also alcohols, alkenes and more bulky molecules 
like aromates407. Engineering of CYP102A1 has been done in several examples resulting in a 
broader substrate acceptability408–410. This is mostly done by rational design or directed 
evolution, but in general it comes down to a widening of the substrate channel inside the 
enzyme. Applications in drug metabolism research where big molecules need to access the 
enzyme for further oxidization are examples of this398.  
One amino acid residue stands out in all the mutagenesis experiments and this is the 
phenylalanine at position 87 of the wild type enzyme. According to several studies285,411–413, 
this residue interacts with the hydrophobic tail of the fatty acids, resulting in a slight bend in the 
carbon atom chain of the substrate. Consequently, it is believed that the ω-1, ω-2 and ω-3 
carbon atoms are more favourable positioned towards the heme iron and therefore are more 
easily oxidized than the terminal carbon atom. Phenylalanine 87 also plays a potential role in 
the stereoselectivity by blocking certain C-H bonds on the chain that might be used for S-
hydroxylation. Mutating this residue to an alanine results in a shift of the hydroxylation position 
towards the terminal carbon atom for C12 and C14 fatty acids411. Molecular dynamics (MD) 
simulations and quantum-mechanical/molecular mechanics (QM/MM) calculations seem to 
support these findings413. It has to be noted that several reports don’t support these findings 
concerning the fatty acid hydroxylation products414,415 of these alanine mutants. As mentioned 
before, the wild type CYP102A1 has a high preference for the ω-1 position for myristic, lauric 
and capric acid. In vitro tests with both the entire enzyme and only the heme domain for the 
F87A mutants showed a shift towards the ω-4, ω-5 and ω-6 positions. Substitution with other 
residues like isoleucine have been reported as well to influence the regiospecificity of 
CYP102A1416. 
 
Figure 3.4: Alignment of the first amino acid residues of CYP102A1, CYP102A7 and CYP505A1 (P450Foxy). 
The phenylalanine at position 87 is indicated by the black arrow. 
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In this work a total of three alanine mutants at position 87 were made. Sequence alignment of 
CYP102A7 and P450Foxy with CYP102A1 revealed that the same phenylalanine residue is 
present at position 88 for P450Foxy and 89 for CYP102A7. It has to be noted that historically 
the threonine at position 2 for CYP102A1 has been chosen as the starting residue of the protein 
sequence resulting in a slightly different numbering for the phenylalanine. In Figure 3.8, the 
first 118-119 residues of the three enzymes are aligned. As can be seen clearly, the 
phenylalanine is situated in a conserved DGLFT motif. This holds true for other members of 
the CYP102A family as well.406 For CYP102A7 and P450Foxy, this residue will be given the 
number 88 according to the alignment. 
Creation of the alanine mutants was done starting from the wild type enzymes using site-
directed mutagenesis417. Both wild type and mutated constructs were transformed in S. 
bombicola PT36 and correct transformants were selected. A first growth trial was done using 
ethyl myristate as a substrate. This substrate was chosen since it is liquid at room temperature, 
facilitating its admission, and because all three enzymes have a fairly high preference towards 
myristic acid, but the latter one is solid even at 30°C resulting in low substrate availability in 
the medium. Usage of methyl and ethyl esters of fatty acids has been proven successfully for 
production of sophorolipids418 and generally resulting in high product titers. 
At the end of the trail, LC-MS analysis was performed to detect the medium chain sophorolipids. 
Surprisingly, only longer congeners corresponding to C16 and C18 sophorolipids were found 
only in low amounts (Figure 3.5). Several explanations can be found for this phenomenon. 
First of all, the mutation does not have an effect on the kind of hydroxy fatty acid being 
produced. The mutant P450 shows the same activity as the wild type enzyme without the 
F87/88A mutation, C14:0 hydroxy fatty acids are still being produced in subterminal R-
enantiomeric form, but can’t be glucosylated by UGTA1. Secondly, the correct (S)-13-OH-
C14:0 and 14-OH-C14:0 products are being formed, but UGTA1 is not or less active towards 
the C14 length. Though unlikely, the preference of UGTA1 drops significantly when shorter 
chains are presented in in vitro studies175. Thirdly, using the ethyl ester of myristic acid might 
be a problem. When using ethyl palmitate, this substrate is easily converted to palmitic acid in 
the culture medium. This is possibly done by a lipase. However, when using ethyl myristate, 
no hydrolysis of the ester bond could be seen. 
 
Figure 3.5: Sophorolipids produced by CYP102A1 on ethyl palmitate. M/z values of 679, 705 and 707 
correspond to C16:0, C18:1 and C18:0 di-acetylated acidic sophorolipids. M/z values of 661, 687 and 689 
correspond to C16:0, C18:1 and C18:0 di-acetylated lactonic sophorolipids 
Therefore, a new trial was conducted using myristic acid. Again, no clear production could be 
seen for the shorter chain sophorolipids. A third growth trial was performed, this time using 
ethyl palmitate. This trail showed clear production of sophorolipids. The LC-MS spectra show 
the presence of C16:0 mono-acetylated, di-acetylated, lactonic di-acetylated, C16:1 lactonic 
di-acetylated and minor amounts of C18:1 di-acetylated acidic and lactonic sophorolipids 
(Figure 3.6). UPLC-ELSD analysis revealed that production was very low, but the wild type 
enzymes produced more than their corresponding F88A mutant. It has to be noted that acetate 
Chapter III  Engineering of the P450 pool of S. bombicola 
  
 
88 
 
adducts of sophorolipids are rare during LC-MS analysis, but they do occur occasionally. 
Though the reason for their occurrence is unknown, they can be resolved by applying higher 
voltages for the MS or by running the samples again independently from the first run. The 
conclusion why these are lactonic di-acetylated sophorolipids is based on the several 
arguments419. First of all, the elution times correspond with the lactonic sophorolipids. Secondly, 
when the molecular mass of acetate is subtracted from the measured mass they correspond 
to lactonic sophorolipids. Thirdly, adducts with other molecules might occur as well, but seem 
unlikely. For example, acetonitrile adducts are only measured in positive mode. In the case 
they do appear in negative mode, a molecular mass of 720 Dalton would be expected for di-
acetylated C16 sophorolipids (680 + 41 – 1 = 720).  
 
Figure 3.6: LC-MS spectrum of the broth of the S. bombicola CYP102A7 strain after 217 h with ethyl 
palmitate as the hydrophobic substrate  
 Enzyme tests for the F87A mutants 
Though in vivo experiments showed lower productivity of the F87/88A mutants, it might still be 
that the mutants produce other kinds of products compared to the wild type enzymes, but that 
these molecules can’t be incorporated by glucosyltransferases UGTA1 and UGTB1 into 
sophorolipids. Since the aim is to produce medium-chain sophorolipids, this lowered 
productivity of glycolipids might mask efficient production of other molecules. As explained in 
III.3.1.1, tests on crude cell lysate already showed high activity of the self-sufficient P450s 
towards several fatty acids.  
All the F87A mutants were grown until three days in the stationary phase. As substrates, the 
fatty acids lauric, myristic and palmitic acid were chosen since all the P450s tested show high 
activity towards these molecules. The different cell lysates and molecules were incubated at 
30 °C and sampled after three hours. LC-MS analysis of the different lysates clearly shows the 
lower activity of the F87A mutants compared to their respective wild type counterparts. In 
Figure 3.7, a comparison can be seen for CYP102A7 and its mutant variant incubated with 
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myristic acid. The wild type enzyme clearly produced more hydroxylated myristic acid (m/z 243) 
than the alanine mutant. Other products originating from the cell own fatty acids are visible as 
well. For example, hydroxylated oleic acid elutes at 30.5 minutes (m/z 297). Again the cell 
lysates originating from the CYP102A7 strain were the most potent for converting fatty acids 
to their corresponding hydroxylated congeners.  
 
Figure 3.7: LC-MS analysis of an essay with cell lysate from S. bombicola A.) CYP102A7 and B.) CYP102A7 
F88A. The substrate used was myristic acid (m/z 227). Hydroxylated myristic acid is visible at 24 minutes 
(m/z 243). 
 Hydroxylation of quercetin and resveratrol 
The self-sufficient P450 CYP102A1 and its derived mutants is an oxidizer of many different 
molecules, among them quercetin420 and resveratrol290. Several of the mutants mentioned are 
mutated at the F87 position as well. Though only tested for CYP102A1 in literature, the other 
two mutant P450s created in this work were tested as well together with their wild type 
enzymes to assess the possibility of in vivo hydroxylation of quercetin and resveratrol in parallel.  
The wild type S. bombicola and the strains containing the wild type and mutated self-sufficient 
P450s were inoculated in production medium with both molecules added at the beginning of 
the stationary phase in 1 g/L quantities. After several hours, the cultures with quercetin started 
producing a very distinctive smell. Though the origin and composition is unknown, it is 
speculated that it might be a degradation product of quercetin. After several days, it became 
clear that the wild type S. bombicola was producing sophorolipids for both substrates tested. 
TLC and HPLC analysis of the different mutant strains showed that no detectable amounts of 
modified of resveratrol or quercetin occurred compared to the wild type S. bombicola.  
Possibly both substrate accessibility/solubility and transport are the reason for this. Both 
resveratrol and quercetin have low solubility in water and tend to aggregate in small particles, 
further lowering the availability of these molecules. 
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 Introduction 
Most P450 enzymes need an extra reaction partner for delivering the electrons necessary for 
catalysing their specific reaction (see I.3.3 for a more detailed overview). For class II enzymes, 
this is done by cytochrome P450 reductase (CPR), a membrane bound protein capable of 
accepting electrons from NAD(P)H and transporting them towards the P450. In mammalian 
liver tissue, the ratio between the P450 population and CPR roughly is 20:1421. When looking 
at S. bombicola, no clear answer is available on the ratio P450:CPR. However, using RNA 
sequencing data available at the research group, an estimation can be made. During the 
stationary phase with oil addition, normalized reads per million (RPKM) values of all P450s 
amounts to 4153.96 while that of the CPR is 326.10 resulting in a ratio of 12.74:1 (Table 3.7). 
This value is only an estimation since final protein expression levels depend on RNA stability, 
RNA processing and protein stability. 
Table 3.7: Table representing all P450s and the CPR in S. bombicola and their RNA expression levels. The 
RPKM values are used to calculate an approximation of the P450:CPR ratio. 
Gene name Exponential Phase Stationary Phase with oil Stationary Phase without oil 
Cabom01g00060 (CYP52E4) 95.90 41.67 57.24 
Cabom01g04780 (CYP52N2) 42.87 43.83 38.64 
Cabom01g04790 (CYP52N3) 46.60 35.12 36.80 
Cabom01g10350 (CYP61A1) 936.28 845,62 727.69 
Cabom02g13890 (CYP52M1) 258.01 2391.91 3759.45 
Cabom03g00070 (CYP52E5) 153.26 47.90 61.88 
Cabom03g00110 (CYP52E6) 567.91 208.62 204.84 
Cabom03g01690 (CYP52E3) 99.67 93.82 163.07 
Cabom03g11440 (CYP52F1) 78.35 105.24 135.80 
Cabom03g15730 (CYP52N1) 763.27 340.23 261.92 
Total counts P450s 3042.12 4153.96 5447.34 
Cabom01g04810 (CPR) 304.66 326.10 387.95 
Ratio P450:CPR 9.99 12.74 14.04 
 
Chimeragenesis of a P450 and a CPR has been applied successfully. By making the P450 
self-sufficient, eukaryotic P450s can be expressed in prokaryotic expression and production 
systems. Furthermore, its catalytic properties like substrate affinity, product formation and 
electron transport can be altered or elevated401. Two hypothesis are tested concerning 
chimeric P450-CPR systems in S. bombicola. The first one is if an increased productivity for 
wild type sophorolipids is possible by the relatively high ratio of P450 (in this case CYP52M1) 
and CPR, a 1:1 ratio of CYP52M1 with its own CPR might result in higher electron transfer 
rates and subsequent P450 activity. As a result, this might push the sophorolipid pathway 
ending in higher productivity. The second postulate is researching if heterologously expressed 
class II P450s are active in S. bombicola and if their activity can be increased by coupling a 
reductase to their C-terminus. To test both assumptions, two different reductases were 
selected. The first CPR is from S. bombicola, this to maximize compatibility with CYP52M1 
and to investigate and validate the lack of production in certain experiments. The second one 
is BMR, the reductase and linker region of CYP102A1 from B. megaterium. This reductase is 
chosen since it has been investigated thoroughly the last few decades. Based on sequence 
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alignment and amino acid conservation, the start of the linker of CYP102A1 was deduced to 
start at amino acid 452 for CYP102A1.  
 
Figure 3.8: Sequence alignment with conserved regions highlighted of the CYP102A family. Amino acid 
conservation drops between positions 451 and start again at 482, suggesting the end of the P450 and the 
start of the reductase respectively406. 
 CYP52M1 from S. bombicola 
Production of sophorolipids is already very efficient in S. bombicola. Productivity values of up 
to 3.5 g/L.h are reported in literature for the wild type mixtures422. Engineered strains are also 
capable of exceeding 0.5 g/L.h174. Still, efforts in increasing these values are interesting since 
they result in shorter fermentation times or higher final yields. These advantages could be 
translated in lower costs of the final product. Furthermore, understanding genetic optimization 
of the production of wild type molecules can be translated to new types of molecules. In order 
to investigate the effect of chimeric constructs on the sophorolipid production, CYP52M1 was 
coupled to the reductase of CYP102A1 and its own S. bombicola CPR (SbCPR). For the 
enzyme with the SbCPR as reductase domain, the transmembrane helix was removed to 
ensure the SBCPR is not limited in its movability by this membrane anchor. The chimeric 
sequences were introduced at the cyp52m1 locus and the resulting strains were tested on oleic 
acid and sampled regularly to assess any differences in production efficiency.  
Unfortunately, no elevated production could be detected for the CYP52M1SbCPR and 
CYP52M1BMR strains (Figure 3.9). In the case of the BMR chimeric construct, a significant 
lower sophorolipid concentration was found at the end of the growth trial, but for the SbCPR 
chimer this drop is less clear. It is not known if both reductase domains are still contributing 
electrons to the P450 and if they have an influence on the activity of the uncoupled S. 
bombicola CPR or any interaction with other proteins it has to make. Coupling two enzymes 
can hinder their interaction if the linker hasn’t got the proper length or form. As such it may be 
that electron transfer in the chimeric enzymes is hampered or even that the P450 domain still 
receives its electrons from the membrane bound CPR, but that this is less efficient due to the 
coupled reductase blocking the way. Furthermore, the membrane anchor of SbCPR was 
removed, which might affect its structure and/or activity.  
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Figure 3.9: Sophorolipid concentrations for the growth trials with the wild type S. bombicola and the two 
different chimeric P450s strains. Error bars depict standard deviation. Sample size for each strain was 3. 
Since no clear difference could be detected for the wild type molecules with the 
CYP52M1SbCPR chimer, another strain was chosen whose productivity is lower. The recently 
developed bola-sophorolipid producing strain423 was a suitable candidate since production 
levels on fermentor scale are already at 0.5 g/L.h, but further improvement is necessary. If the 
chimeric CYP52M1SbCPR enzyme has a beneficial effect on the pathway by delivering more 
precursors, productivity might rise. When the CYP52M1SbCPR was introduced in a ura3 
negative bola-sophorolipid strain, production of these molecules was severally hampered. 
Though again the real reason is unknown, it might be that the earlier modification of the 
sophorolipid gene cluster (knock-out of the acetyltransferase) and the additional introduction 
of a less than optimal functioning chimeric P450 resulted in lower expression values of the 
cluster genes due to local disruption of the gene cluster and overall lowered production. 
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Figure 3.10: Production of bola-sophorolipids by the original strain and a strain carrying the chimeric 
CYP52M1SbCPR. Error bars depict standard deviation. Sample size for each strain was 3. 
 CYP52A4 from Candida maltosa 
Heterologous expression of the wild type CYP52A4 in S. bombicola resulted in no detectable 
activity of this P450 both for sophorolipid synthesis and in fatty acid hydroxylations424. However, 
enzyme tests in Saccharomyces cerevisiae W(R) were successful. Potentially, an 
incompatibility of the P450 and the S. bombicola CPR might be the reason for the lack of 
activity. Therefore, a chimeric construct of CYP52A4 with the reductase of CYP102A1 was 
constructed to see if by introducing an additional electron donor, transport can be established. 
A growth trial was performed using ethyl esters of lauric and myristic acid. Analysis of the 
sophorolipid samples was done by LC-MS. In Figure 3.11 and Figure 3.12, the resulting 
chromatograms are depicted. For the ethyl myristate growth trial, sophorolipids with m/z values 
of 623 m/z, 651 m/z, 679 m/z and 705 m/z are easily detected. They correspond to di-
acetylated acidic sophorolipids with fatty acid tails of 12, 14, 16 and 18 carbon atoms. The 
ethyl laureate growth trial resulted in C12 sophorolipids, but no other congeners were detected. 
However, a clear signal for dicarboxylic acids appeared around 18 minutes. 
One interesting observation is the wide range of fatty acids being incorporated in the 
sophorolipids while according to the research of Zimmer et al249 CYP52A4 (also known as Cm2)  
shows a clear preference towards chain lengths of 12 and 14 carbon atoms in vitro. Besides 
the potential different behaviour of the P450 in vivo compared to in vitro, a possible explanation 
is the interplay between the specificities of the glucosyltransferases of S. bombicola and the 
new chimeric CYP52A4 enzyme. Furthermore, it is known that coupling of a reductase can 
change the substrate preference and products formed by the P450 domain. If this is the case, 
CYP52A4BMR might be producing hydroxylated C16 and C18 fatty acids as well. Then, the 
specificities of the chimer and the transferase can be called opposites of each other, resulting 
in a relatively uniform product spectrum from C12 until C18 sophorolipids. 
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Figure 3.11: Total ion scans for the CYP52A4BMR growth trial on A.) ethyl laureate and B.) ethyl myristate. 
Prominent molecules are oleic acid (m/z = 281), myristic acid (m/z = 227), lauric acid (m/z = 199). Hydroxy 
lauric acid (m/z = 215) is visible at 25 minutes in chromatogram A.) while the dicarboxylic derivative elutes 
after 19 minutes (m/z = 229). Di-acetylated C14 sophorolipids (m/z = 651) are visible at 22 minutes in B.). 
 
Figure 3.12: Mass scans of the ethyl myristate growth trial with the CYP52A4BMR strain. (A): C12 acidic 
sophorolipids; (B): C14 acidic sophorolipids; (C): C16 acidic sophorolipids; (D): C18:1 acidic sophorolipids 
The first glucosyltransferase UGTA1 has a clear preference towards ω-1 hydroxylated oleic 
acid176. Preference for hydroxylated palmitic acid is only 29% of that for hydroxy oleic acid. For 
shorter chains like hydroxy lauric acid, no activity was detected. However, fermentation 
experiments using alcohols392 and ketones393 resulted in novel kinds of sophorolipids with 
yields up to 15 g/L after 10 days of fermentation. One may conclude that UGTA1 can 
glucosylate shorter chain lengths, but with significant lower activity. A remark has to be made 
that this still might depend on the substrates used. Alcohols and ketones differ from hydroxy 
fatty acids by the big carboxyl group at the other side of the chain (besides the differences 
between the hydroxy or keto group on those molecules). This dissimilarity can have an effect 
on the preference of the glucosyltransferase.  
When looking at UGTB1, the activity towards the glucolipid 17-O-glucopyranosyloctadecenoic 
acid compared with decylglucoside is very similar with a drop of only 17% for decylglucoside. 
This is interesting since decylglucoside lacks a carboxyl group and is significantly shorter than 
the C18 glucolipid. Potentially the carbohydrate group is necessary for catalytic activity instead 
of any other functional group or chain length. Both observations relating to the 
glucosyltransferases result in UGTA1 having a big influence on the fatty acids being 
incorporated. 
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The lack of other kinds of sophorolipids with ethyl laureate compared to ethyl myristate is 
another interesting observation. Besides sophorolipids, dicarboxylic acids were detected as 
well for both substrates with the highest amount in the culture with ethyl laureate. Relating 
back to the specificity of the glucosyltransferases, it might be that the pool of hydroxy laureate 
is more easily converted to the corresponding carboxylic acids than incorporated in 
sophorolipids. Though mostly untested, one of the other endogenous P450s of S. bombicola 
might be responsible for this conversion. In other organisms like Candida maltosa249,250 or 
Candida tropicalis425, P450s belonging to the CYP52 family can convert alkanes or terminal 
hydroxy fatty acids to the corresponding α,ω diacids. 
 CYP1 from Ustilago maydis 
Wild type CYP1 expressed in S. bombicola 
CYP1 from Ustilago maydis takes part in the cellobiose lipid synthesis (see I.4.1) by terminal 
hydroxylating palmitic acid (C16:0). Hence, it is one of the few identified P450s hydroxylating 
fatty acids and being involved in glycolipid synthesis. This features render it a promising 
candidate for creating sophorolipid with an altered fatty acid chain in S. bombicola.  
 
An initial growth trial was performed on palmitic acid (5 g/L) to investigate the activity of the 
unaltered CYP1 P450. A strain not capable of synthesizing sophorolipids by knocking out the 
P450 was used as a control. This way, even low amount of production can be detected by 
comparison against any background activity. Identification of the products was done by LC-
MS analysis. The spectrum showed a signal for the production of the sophorolipid with mass 
679 m/z (di-acetylated acidic sophorolipid with a C16 fatty acid chain). Peaks for the masses 
661 m/z (di-acetylated lactonized sophorolipid with a C16 fatty acid chain) and 663 m/z (mono-
acetylated acid sophorolipid with a mono-unsaturated C18 fatty acid chain) were detected as 
well (data not shown). The signal with a molecular weight of 679 m/z was clearly higher in the 
strain carrying the heterologously expressed CYP1 (Figure 3.13 and Figure 3.14) compared 
to the control. This shows that replacement of CYP52M1 by another unaltered P450 can result 
in altered sophorolipid production. It has to be noted that the amount of sophorolipids produced 
remained extremely low. After 8 days of production, signal was barely above the detection limit 
of the LC-MS. 
Several explanations can be found for this. First of all, U. maydis produces relatively low 
amounts of cellobiose lipids. Spoeckner et al.21 reported yields up to 30 g/L of a 
mannosylerythritol lipids and cellobiose lipids mixture of which 10% are the latter molecules. 
Similar values have been achieved by Saerens et al.381. This might be due to low activity of 
CYP1 in this pathway. When copying an enzyme with low overall activity, it shouldn’t be a 
surprise that this is also observed in a heterologous system. Another problem might be non-
optimal expression. Though the codon usage of CYP1 was compared to that of S. bombicola 
and deemed compatible, small problems might still exist upon translation of the RNA or folding 
of the amino acid sequence, resulting in suboptimal expression. Thirdly, one has to take into 
account that the P450 needs to interact with the cytochrome P450 reductase (CPR) for 
obtaining the required electrons. This is based on electrostatic interactions on the surface of 
both the P450 and CPR. When these surfaces are not compatible, inefficient electron transport 
can result from this and in the end, the catalytic turnover of the P450 will suffer. 
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Figure 3.13: LC-MS chromatogram of the CYP1 knock-in strain and the CYP52M1 knock-out strain. The 
strain expressing the heterologous P450 CYP1 shows a novel mass of 679 m/z (680 – 1) at 24.5 minutes. In 
the knock-out strain, this signal is masked by another mass of 723 m/z. 
 
Figure 3.14: A mass spectrum scan at 24.5 minutes shows the shift in ratios between the mass of 679 m/z 
and 723 m/z.  
Initial production analysis of the CYP1 chimeric P450 
CYP1 is a typical class II P450 (I.3.3.3) requiring assistance of a CPR for delivery of electrons. 
Introduction of a chimeric CYP1BMR in S. bombicola in order to improve the activity and create 
higher yields of sophorolipids with a modified fatty acid tail was performed. The sophorolipid 
production on palmitic acid was investigated and increased amounts of C16 sophorolipids were 
detected for the strain with the CYP1BMR fusion compared to the CYP1 strain, but still much 
lower than regular wild type sophorolipid production. LC-MS analysis revealed that other 
congeners were present as well, mostly non- and mono-acetylated variant of the C16 
sophorolipids. Small amounts of sophorolipids with an oleic acid (C18:1) tail were detected as 
well. They comprise roughly 5% of the total sophorolipid mixture produced. This small fraction 
can be explained by the fact that C18:1 is shorter than C18:0, more closely mimicking the 
natural substrate C16:0. 
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Figure 3.15: HPLC-ELSD chromatogram of the sophorolipid production of the CYP1BMR strain grown on 
palmitic acid after 8 days in the stationary phase. Products detected are di-acetylated acidic sophorolipids 
(22.2 minutes), di-acetylated lactonic sophorolipids (27.5 minutes) and the substrate palmitic acid (39.2 
minutes). Both types of sophorolipids contain a C16 fatty acid tail. 
Several interesting conclusions can be drawn from this growth experiment. First of all, it is 
possible to use the reductase of a self-sufficient P450 and couple it to a P450 of interest to 
produce more uniform kinds of molecules. In the case of the CYP1BMR fusion protein, only 
two different kinds of sophorolipids are observed in relatively high quantities, namely the acidic 
and lactonic di-acetylated C16 sophorolipids. Still, the total amount of sophorolipids in the 
culture broth remained below 100 mg/L. 
 Substrate and fermentation optimization of CYP1BMR 
Further optimization of the process was carried out by testing different substrates like fatty acid 
ethyl esters. Substrate accessibility can be a bottleneck during production for most fatty acids 
as they are solid at 30 °C. Adding an emulsifier like Tween-20 can improve accessibility, but 
poses different problems during downstream processing. Ethyl esters of fatty acids are liquid 
at room temperature and have been used in the past for efficient production of sophorolipids426. 
Therefore, a comparison between palmitic acid and ethyl palmitate was conducted.  
It was found that ethyl palmitate further enhanced productivity at least fiftyfold when comparing 
the amounts of the different sophorolipids produced (Figure 3.16). After 11 days in the 
stationary phase, a final concentration of 1.56 g/L was measured. The higher productivity can 
be explained by the fact that ethyl palmitate is liquid at 30°C while palmitic acid is not. The 
ethyl ester will easily disperse in the broth to form small droplets ensuring a high contact 
surface. The yeast will be able to use this higher contact area, and resulting higher substrate 
availability, for elevated production. Using ethyl palmitate did not have an effect on cell viability, 
both during the exponential as the stationary phase. During the optimization, several substrate 
concentrations were used between 5 and 25 g/L. Increasing the amount of ethyl ester did not 
further improve production of C16 sophorolipids. Therefore, in future Erlenmeyer experiments 
a concentration of 5 g/L was used. 
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Figure 3.16: Productivity of C16 sophorolipids on palmitic acid (A) and ethyl palmitate (B). The acidic di-
acetylated C16 sophorolipids elute at 15.5 minutes, the lactonic at 15.8 minutes. The substrate ethyl 
palmitate can be seen at 25.1 minutes while palmitic acid eluates at 27.5. It has to be noted that these elution 
times differ from the ones used elsewhere in this manuscript due to the usage of an experimental shorter 
HPLC-ELSD analysis protocol. 
Validation of the CYP1BMR strains 
During the previous experiments it was proven that by coupling a suitable electron donor to 
CYP1 it is feasible to have higher activity of this enzyme. Still, in order to fully confirm these 
conclusions, several validations need to occur. First of all, coupling CYP1 to the S. bombicola 
CPR should result in almost no production since it was proven that simple heterologous 
expression of CYP1 didn’t result in efficient production. Secondly, mutating the BMR at certain 
essential residues rendering it less efficient in transporting the electrons to the P450 should 
again result in lower production levels, proving that the BMR domain is responsible for electron 
donation.  
Essential residues in the FMN domain are the glycine at position 570, the tryptophan at 574 
and the tyrosine at 536 in CYP102A1. Mutating these residues separately to aspartate resulted 
in a BM3 reductase domain with 30% of the original activity towards cytochrome c427. In the 
validation strategy, the glycine at position 570 will be altered. In the chimeric protein CYP1BMR 
this corresponds to the glycine at position 785. Similar to the FMN domain, several residues 
exist in the NADPH binding domain that have an effect on electron transfer and NADPH/NADP+ 
binding and stability. One of these is the cysteine at position 999 (position 1216 in the chimeric 
enzyme). Mutating it to an alanine results in lowered performance due to higher affinity for 
NADP+, thereby blocking the site for exchange with a new NADPH404,405. A 5-fold decrease for 
the reduction of cytochrome c was measured with the C999A mutant. The mutations will be 
tested on their own as well in a double mutant. It is expected that almost no sophorolipid 
production will be observed with this double mutation strain if the fused BMR is responsible for 
the electron delivery to the CYP1. 
The growth trial was conducted using 5 g/L ethyl palmitate as a substrate with both single 
mutants, the double mutant and the non-mutated CYP1BMR strain and lasted until the glucose 
levels dropped below 10 g/L. Ethanol extraction of the sophorolipids and subsequent 
quantification resulted in the data presented in Figure 3.17. As can be seen, the mutation in 
the NADPH domain did not result in a drop in sophorolipid production. The mutation in the 
FMN domain resulted in a 5-fold drop while the double mutant has a 16-fold reduction 
compared to the non-mutated chimeric CYP1BMR. Though it was expected that both single 
mutations would result in a reduction of production, the results clearly show this is not the case.  
Chapter III  Engineering of the P450 pool of S. bombicola 
  
 
99 
 
 
Figure 3.17: C16 sophorolipid production by the different CYP1BMR mutants and the non-mutated 
chimeric protein. Error bars depict standard deviation. Sample size for each strain was 3. 
A potential explanation for this might be the difference between in vitro assays performed in 
the original papers and the in vivo experiments conducted in this research. Optimisation of an 
enzyme essay can result in reaction conditions differing significantly from in vivo conditions 
resulting in influenced enzyme performance. Nevertheless, the double mutation showed an 
additional effect of the mutated NADPH domain together with the FMN mutation. Another 
explanation might be that the mutation in the NADPH binding motif does not have an effect on 
its own, but combined with the one in the FMN domain, the BMR might be sufficiently disturbed 
to see an effect on activity. 
This data, combined with the enhanced productivity of CYP1BMR compared with the wild type 
non-chimeric P450, clearly show that the BMR domain of CYP102A1 is responsible for the 
donation of electrons to the P450. 
Scale up of C16 sophorolipid production by the CYP1BMR chimeric strain 
Scale up of production of C16 sophorolipids was further done in a 3 L and 30 L bioreactor. In 
the 3 L bioreactor, 2 mL ethyl palmitate was added manually every day while aeration was kept 
at 1 vvm and stirring rate at 600 rpm. During this fermentation, heavy foaming occurred which 
was problematic. It was observed that this foaming was reduced each time ethyl palmitate was 
added to the fermentor. Therefore, the addition of hydrophobic substrate was split up in two 
portions of 1 mL a day. In Figure 3.18, glucose consumption and average optical density can 
be seen.  
Depending on the growth phase, a glucose consumption rate of 12.5 g/L.day and 8.9 g/L.day 
was calculated for the exponential and stationary phase, respectively. This is lower than the 
glucose consumption of a wild type S. bombicola, which can easily reach 20 g/L.day during 
production. A likely explanation for this is the significant lower productivity of this new strain 
since biomass is on par with the wild type S. bombicola. The entire fermentation lasted 411.4 
hours with a total yield of 9.9 ± 0.1 g of C16 sophorolipids. This results in a productivity of 24 
± 0.2 mg/L.h, roughly 40 fold lower than reported by Roelants et al.174 for other engineered 
strains. Analysis by HPLC and LC-MS showed that the major products being produced are the 
lactonic di-acetylated C16 sophorolipids (Figure 3.19).  
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Figure 3.18: Glucose consumption and optical density for the 3 L fermentation with S. bombicola CYP1BMR 
 
Figure 3.19: Sophorolipids produced in a 3 L fermentor using ethyl palmitate. At 18.9 minutes, non-
acetylated C16:0 molecules can be seen. Di-acetylated congeners are present around 22.4 and 26.6 minutes, 
corresponding to acidic and lactonic sophorolipids respectively. At 37.4 palmitic acid can be seen while a 
small amount of C18:1 di-acetylated acidic sophorolipids are visible. 
Foam formation became even more troublesome on a 30 L scale compared to 3 L. A first 30 L 
fermentation (fermentation A) was run using the same feeding and stirring strategy as the 3 L 
fermentor. However due to the excessive foam formation, aeration was reduced to 
approximately 0.1 vvm. A second 30 L fermentation (fermentation B) used a different feeding 
strategy.  
Conventional anti-foam methods like overpressure or higher stirring speeds seemed 
inappropriate to combat the foaming during previous fermentations and usage of a silicon 
based antifoam was not opted due to the separation problems during downstream processing 
of these molecules from the sophorolipids. An interesting observation is that when a small 
amount of ethyl palmitate is added to the reactor, foam will disappear for 1 hour after which it 
will slowly start to accumulate. By using the substrate as an antifoam by adding it every 20 
minutes in short bursts of 2 seconds (equalling 200 µL of ethyl palmitate), a relatively foam 
free fermentation process was possible. Achieving this required an automatic feeding system.  
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However, care had to be taken as ethyl palmitate has a melting point of 24-26 °C. Also, not 
every kind of tubing is resistant to ethyl palmitate or similar hydrophobic substrates. The 
regularly used Norprene® tubing (formulation A-60-G, Saint-Gobain) leaked this compound 
and even disintegrated. Eventually, Tygon® tubing (formulation F-4040-A, Saint-Gobain) was 
used. This type of tubing, however, is tougher and was not compatible with the peristaltic pump 
of the bioreactor control unit, so a very small diameter section had to be used for the part going 
through the pump. The ethyl palmitate feed bottle was kept on a heating plate with magnetic 
stirring at a temperature of 60 °C. This allowed in an overall higher aeration rate in fermentation 
B compared to A. The parameters can be found in Table 3.8. As can be seen, due to the new 
feeding and anti-foam strategy, aeration could be increased up to 0.3 vvm in fermentation B. 
Fermentation B resulted in a higher total amount of sophorolipids in a shorter time frame than 
fermentation A. 
Table 3.8: Parameters for 30 L fermentations A and B. The average optical density was calculated for the 
stationary phase. 
 Fermentation A (manual feed) Fermentation B (automatic feed) 
Aeration ± 1.2 L/ min (approx. 0.1 vvm) ± 5 L/min (approx. 0.3 vvm) 
Stirring rate 600 rpm 600 rpm  
Total glucose consumption 3492 g 2577 g 
Total ethyl palmitate 54.85 g 162 g 
Duration 448 h 359 h 
Average optical density 131.9 ±16.7 120.9 ±13.6 
Total amount of sophorolipids 9.0 ± 0.2 g 12.1 ± 0.2 g 
 
At the end of both 30 L fermentations, the broth was harvested and stored at 4 °C for further 
downstream processing. After 48 hours, a brown precipitation could be observed. Analysis on 
HPLC revealed that these were C16 sophorolipids. When comparing the different 
fermentations, a striking difference can be seen. The ratio of the acidic and lactonic C16 
sophorolipids (Figure 3.20) differs drastically between both fermentations. Fermentation A has 
a lower amount of lactonic sophorolipids compared to fermentation B. In literature, an effect of 
low aeration has been described430–433 resulting in changes in saturation degree of the fatty 
acids incorporated and different levels of lactonic sophorolipids being produced.  
Interestingly, Fermentation B already has a very low aeration compared to the 3 L, but still 
overall the product mixture remains the same. It has been reported that only at very low 
aeration rates the composition of the sophorolipids can change, but that from a certain 
threshold value their composition does not change that much431–433. The lower product titer for 
fermentation A might be explained by this as well, lower expression levels of the enzymes 
caused by lower oxygen levels and its inhibitory effect on cell growth and maintenance. 
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Figure 3.20: Difference between acidic (22.4 minutes) and lactonic (26.6 minutes) di-acetylated C16 
sophorolipids. 
Substrate specificity of CYP1BMR 
From the chromatograms is it clear that CYP1BMR has a high preference towards palmitic 
acid, yet the true substrate specificity of CYP1 has never been experimentally proven. There 
are some strong indications that palmitic acid is the main substrate, for example due to the 
incorporation of this molecule in both cellobiose lipids and the C16 sophorolipids. In S. 
bombicola CYP1BMR some small amounts of stearic and oleic acid sophorolipids are detected 
as well, suggesting that the substrate specificity is not as strict as initially thought. In U. maydis, 
no cellobiose lipids with other chain lengths than 16 carbon atoms are detected. 
Chimeragenesis can alter substrate specificity, but when examining the products formed it is 
clear that the amounts of non-C16 sophorolipids are low. Glucosyltransferase UGTA1 has a 
clear preference towards longer chain lengths compared with highest activity for 17-S-hydroxy 
oleic acid. The final sophorolipid products of S. bombicola will be a result of the specificities of 
the chimeric CYP1BMR and both glucosyltransferases. For the U. maydis UGT1, substrate 
specificity has never been researched (IV.3.4.1). 
To investigate the CYP1 and CYP1BMR specificity, an overexpression system in S. cerevisiae 
W(R) was used. To ensure that the enzymes would be isolated, both cytosolic and microsomal 
fractions are tested. The reason for this is the N-terminal region of CYP1 itself. All class II P450 
are anchored to the ER membrane, but when CYP1 is analysed for this, no clear anchor could 
be found in the beginning of the protein sequence. A potential transmembrane helix is situated 
between residues 148 and 167, much further when compared to the CYP52M1 anchor (Figure 
3.21). This might give problems to anchor the P450 to the ER membrane in S. cerevisiae. 
Since CYP1BMR has its own reductase domain, it can be active in the cytosol and convert 
fatty acids when available.  
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Figure 3.21: Prediction of the transmembrane helices of CYP52M1 and CYP1. Blue represents the part of 
the enzyme inside the ER, red the transmembrane helix and pink the cytosolic part. Prediction was made 
using the TMHMM Server v2.0 from the Centre for Biological Sequence Analysis situated at the Technical 
University of Denmark. 
Another possibility lies in the quality of the sequence itself. The coding sequence used in this 
research was taken from the sequenced genome from the Broad institute database. This is a 
technical annotated genome of U. maydis 521402. Since no further data is available, gene 
prediction software was used. Potentially, the predicted coding sequence of CYP1 might have 
been faulty. When looking at the sequence, two introns were predicted in the genomic 
sequence, one of 193 nucleotides and one of 41 nucleotides. Both of them are positioned in 
the beginning of the genomic sequence. When taking the start of the transmembrane helix 
(position 148) and moving back towards the start of the protein sequence, a methionine is 
found at position 105, 43 amino acids before the anchor (Figure 3.22). If the methionine at 
position 105 would be the correct starting point of the P450, its overall size would be 564 amino 
acids, a bit longer than the CYP1 enzyme belonging to Pseudozyma flocculosa434, which has 
a length of 534 amino acids.  
 
Figure 3.22: Structure of the genomic sequence of U. maydis 521 CYP1. Red depicts the exons, blue the 
introns. M is the first methionine before the transmembrane helix (TMH). 
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In Figure 3.23, an LC-MS chromatogram can be seen for palmitic acid. From all the tested 
substrates (fatty acids with chain lengths of 12 to 20 carbon atoms), only palmitic acid resulted 
in detectable product formation for only the microsome fraction of the chimeric CYP1BMR. 
Though during the growth trials oleic acids were incorporated as well, this was only in very low 
amounts. No products could be seen for all the other different fatty acids tested, for the 
cytosolic fractions and for the wild type CYP1. Again very low activity of CYP1BMR is 
measured. While these results are obtained using S. cerevisiae W(R) instead of S. bombicola 
and relied on in vitro experiments, it is clear that the P450 chimera is not very active. Even 
though only palmitic acid was converted to the corresponding hydroxy fatty acid, other 
substrates might be accepted as well, but at much lower rates. As already mentioned before, 
the low productivity of sophorolipids in the CYP1BMR strain could easily be explained by low 
activity of the chimeric enzyme. When taking into account that UGTA1 still has 29% activity 
towards palmitic acid compared to oleic acid, it is most likely that CYP1BMR is the main cause 
for the low productivity of the C16 sophorolipids. 
 
Figure 3.23: LC-MS chromatogram of the CYP1BMR microsome test. The value of 271 m/z corresponds to 
juniperic acid, the terminally hydroxylated variant of palmitic acid. Palmitic acid has a m/z value of 255, 
oleic acid corresponds to 281 m/z. A.) A total chromatogram for the microsome enzyme test. B.)  Mass scan 
for m/z 271 C.) Standard of juniperic (16-hydroxy palmitic acid; m/z = 271). 
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Introducing a novel P450 in S. bombicola to alter the fatty acid tail of the molecules produced 
is a valuable tool in creating tailor-made glycolipids. Depending on the P450, a shift towards 
shorter chains of either 16 or 14 carbon atoms can be attained. In the first part of Chapter III, 
three different class VIII enzymes were investigated in their capability of contributing to novel 
kinds of sophorolipids. Since these P450s are self-sufficient, they can operate without the need 
of additional reaction partners. All three have activity towards shorter fatty acid chains. The 
conducted growth trials did show some minor activity, but the incorporated fatty acids all 
corresponded to the longer variants with C16 and C18 fatty acid tails. Further enzyme tests 
proved their activity, even towards shorter fatty acid chains.  
It is clear that these enzymes are active in S. bombicola, but do not produce the right kind of 
hydroxy fatty acids. According to literature, replacing the phenylalanine at position 87 in 
CYP102A1 and related enzymes would enable the production of terminal hydroxy fatty acids. 
Still, other reports indicate a shift towards more subterminal positions as well. The different 
alanine mutants of the self-sufficient P450s were tested as well. Both in vivo and in vitro cell 
lysate experiments showed no evidence for the claims that these mutants would be able to 
produce terminal hydroxylated fatty acids and the enzyme tests even showed a reduction of 
activity for the alanine mutants. Their overall lower activity compared to the wild type enzymes 
is a major drawback for their use as biocatalysts. Still, modelling and engineering of P450s is 
a valuable tool for understanding the catalytic activity and steering product formation towards 
more desirable molecules.  
In the second part of Chapter III, heterologous expression of class II P450s was attempted. In 
the case of CYP1 from U. maydis, low amounts of activity could be detected. To make sure 
sufficient electron transfer happened from the CPR to the P450, a strategy with the generation 
of chimeric P450s was attempted. The P450s CYP52A4 from C. maltosa and CYP1 from U. 
maydis were coupled to the reductase domain of CYP102A1. At the end, activity was detected 
for both chimeric proteins. Further validation that the BMR domain was responsible for enzyme 
activity was performed on the CYP1BMR. This further proved that coupling P450s to a 
reductase is an interesting strategy to increase activity of heterologous enzymes. In the case 
of CYP1BMR, further optimisation and scale-up of the production process resulted in a final 
amount of 30 grams of C16 sophorolipids. 
Increasing wild type sophorolipid production was attempted as well. By coupling CYP52M1 to 
the reductase of CYP102A1 and its own S. bombicola CPR, it was suspected that these new 
strains might have a higher productivity. Though it can only be verified on RNA level, more 
P450 transcripts are present compared to the CPR. By creating a fusion protein, each P450 
domain would have its own electron donor. However, this strategy proved to be incapable of 
increasing productivity. Though the exact reason is unknown, interference of the reductase 
domain with for example UGTA1 interactions might be a possible explanation. As it was proven 
in Chapter II, CYP52M1 and UGTA1 are colocalised. Even though the coupled reductase might 
enhance electron transfer rates, if the next step in the biocatalytic pathway is hindered by it 
overall lower productivity might be observed. 
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Glycolipids are compounds composed of a carbohydrate hydrophilic group coupled to a 
hydrophobic fatty acid or lipid derived structure. In nature, these compounds have very specific 
roles in cell signalling and recognition, membrane structure, bacterial motility and so on. 
Recent years, due to growing concerns about the production and environmental effects of 
petrochemical derived surfactants, interest in glycolipids produced by means of biotechnology 
has grown significantly. These molecules find applications in for example medicine435 and 
cosmetics436,437. 
Especially bacterial and fungal molecules are being investigated intensely. Well studied 
examples are the rhamnolipids produced by Pseudomonas and Burkholderia species and the 
sophorolipids produced by Starmerella bombicola.  
Both kinds of surfactants are already commercially available (see Chapter I Table 1.3). 
However, research to elevate production titers and enhance product uniformity is still 
continuing. In the case of S. bombicola, the sophorolipids are still a mixture of congeners 
differing in acetylation degree, integrated fatty acid tail and potential lactonisation of the 
molecules. Recent attempts to engineer this yeast to enhance product uniformity resulted in 
strains capable of producing either only lactonic or acidic sophorolipids174. Control over the 
fatty acid tail can be done by feeding special substrates392,393,404,438. As S. bombicola prefers to 
incorporate oleic acid using a substrate rich in these molecules can increase product uniformity. 
These strategies result in industrially interesting titers of the target molecules. 
Engineering S. bombicola for the production of other kinds of glycolipids than sophorolipids 
has been attempted as well. Glucolipids, intermediates in the sophorolipid pathway, are being 
produced as a final product in strains lacking the second glucosyltransferase UGTB1. However, 
compared to the wild type S. bombicola, production is severely impaired with yields of about 4 
g/L after 14 days of production317.  
Another engineering example are the cellobiose lipids, naturally produced by fungi like U. 
maydis and P. flocculosa. The hydrophilic head group of these molecules only differs from 
sophorose by how the two glucose molecules are coupled. In the case of cellobiose both 
glucose molecules are connected β-1,4 instead of β-1,2 for sophorose. Introduction of the 
glucosyltransferase of U. maydis resulted in a strain producing novel kinds of glycolipids in S. 
bombicola. However, again the titers remained below the 5 g/L mark and only 10% of the 
glycolipids produced were presumed to be cellobiose lipids318. 
In the following chapter, optimization of the productivity of the glucolipid and cellobiose lipid 
producing strains is described. First of all, the genetic background of the existing strains was 
evaluated. Starting from these results, new strains were developed to increase production 
titers, and finally the best performing strain was scaled-up to a 3L bioreactor. 
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Culture conditions can be found in II.2.1. Strains used for glucolipid and cellobiose lipid 
production are the ones created by Saerens et al.317 and Roelants et al.318. More details on 
their genetic background and genetic modifications are given in the Results and Discussion 
section. New strains were derived from the ura3 auxotrophic PT strain311. Protein expression 
for protein characterization was done in E. coli BL21 (Bioké; The Netherlands). 
 
 General techniques 
The general molecular techniques used are identical to the ones described in II.2.2. 
 Construction of integrative cassettes 
Cassettes targeting the ugtb1 locus 
A first strain (B11new) was constructed with the original knock-out cassette described by 
Saerens et al.317, but this time using S. bombicola PT36 as a background instead of the G9 
auxotrophic strain used in previous research310,317,318 (Figure 4.1 A). The other production 
cassettes are derived from an earlier constructed plasmid (BS_EC_0269_ADH_UGTB1_loc) 
for integration at the ugtb1 locus. The 5’ and 3’ homologous regions of this new plasmid 
correspond to parts of the alcohol dehydrogenase gene (adh) upstream of the sophorolipid 
cluster and of the sophorolipid transporter (mdr) situated downstream of the ugtb1 locus. The 
gene of interest can be integrated between the ugtb1 promotor (pUGTB1) and terminator 
(tUGTB1). As a marker the ura3 marker is used. It is inserted between the 5’ homologous 
region and the terminator of ugtb1. It is controlled by its endogenous promotor pURA3, but 
terminated by the bidirectional terminator t14190 (terminator of genes cabom01g14190 and 
cabom01g14200). This way, both the ura3 and adh transcripts will be terminated correctly. 
Removal of the ura3 marker from engineered S. bombicola strains is possible by amplification 
of a recovery cassette and subsequent transformation and selection on 5-fluoroorotic acid (5-
FOA). The cassette can be created from genomic wild type S. bombicola DNA with primers 
P337_3'ura3delUGT1Rev and P653b_FOR_vectorUgtUMKI_ura3_UGTB1locus_tUGTB1.  
A second strain created with this new plasmid has its ugtb1 coding sequence replaced with 
that of ugta1 (Figure 4.1 B) called BS_EC_0321_UGTA1_KI_UGTB1_KO. A third one was 
engineered by coupling the promotor and terminator of ugtb1 without a coding sequence 
between (Figure 4.1 C) with the name 
BS_EC_0380_pGEMT_PUGTB1_TUGTB1_Ura_CORRECT. The same plasmid for the ugbt1 
locus was used to express the U. maydis ugt1 at the ugtb1 locus as well (Figure 4.1 D) named 
BS_EC_0305_UGT1_Kol1. In Table 4.1, an overview is given of the primers used to create 
these different constructs. In Figure 4.2, a schematic representation of the sophorolipid gene 
cluster can be seen. The region where the different cassettes are integrated can be seen inside 
the red square. 
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Figure 4.1: Different knock-in and -out cassettes for the development of glucolipid (A, B and C) and a 
cellobiose lipid (D) producing strain. A.) Original knock-out cassette developed by Saerens et al.317. B.) New 
developed cassette for introduction of the ugta1 coding sequence at the ugtb1 locus. C.) Knock-out 
cassette for the ugtb1 locus derived from the new plasmid for recombination at the ugtb1 locus. D.) New 
ugt1 knock-in cassette. 
 
Figure 4.2: Schematic overview of the sophorolipid gene cluster. The location where the different 
cassettes are integrated is depicted within the red square. 
Table 4.1: Primers used for the creation of the different ugtb1 knock-out and the ugta1 knock-in cassettes. 
Non-binding regions are separated by a dash.  
Primer name Primer sequence  
P337_3'ura3delUGT1Rev ACCCAGTTCCTGGCACTATTG 
P350_CepBURA3F TCTGGCGAATAACAGCACTC 
P653b_FOR_vectorUgtUMKI_ura3_UGTB1locus_tUGTB1 CCTGGCTCTTTTTCTAGATATGTCTG 
P662_pJetMakeFor ATCTTTCTAGAAGATCTCCTACAATATTC 
P663_pJetMakeRev ATCTTGCTGAAAAACTCGAGCCATC 
P983_ADHMDRinfpJETFor CTTCCGGATGGCTCGAGTTTTTCAGCAAGAT-
ACCCAGTTCCTGGCACTAT 
P984_ADHMDRinfpJETRev GAGAATATTGTAGGAGATCTTCTAGAAA-
GATCCTCGCCACCACCTAGTT 
P987_tUGTB1Rev TTCTGCTCTCAACACCGAGTGTAG 
P988_tCabomInfADHFor GCCAAGTCCCTTTAA-ATTTGCTAGGCTGCAGTGCTTATA 
P989_pUraInftUGTB1Rev TTGAGAGCAGAAGTT-GAACCATGATGGCAGTGTTC 
P1426_PromGTIIandMDR_Rev AAGCCAAAATCAGAGAGTGGGACC 
P1596_ACP_check_out_fw_2 TATGCTGGTGCATCCAGTTG 
P1822_UGT1InfFor AGAAAAAGAGCCAGG-TCAAAAGAGGCGGACTTCTGC 
P1823_UGT1InfRev AATAAAGTCTCCTAT-ATGGCGACCGAACATATTCTTTTG 
P1861_UGTB1URAKO_lig_fw ATAGGAGACTTTATTGTTTTATGC 
P1862_UGTB1URAKO_lig_rv CCTGGCTCTTTTTCTAGATATGTC 
P1863_UGTB1URAKO_cass_fw AAAGCAGCATAGACACGAGCTGAC 
P1864_UGTB1URAKO_cass_rv TGCTTCCGGCTCGTATAATG 
P1894_UGTB1_KO_Cass_rv CCTCGCCACCACCTAGTTTGTC 
P2246_UGTB1KOCass_Karen_fw GAGAGTGGGACCTGATTC 
P2247_UGTB1KOCass_Karen_rv CTGCTCTCAACACCGAGTGTAG 
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Cassettes targeting the ura3 locus 
To circumvent potential negative regulation, the coding sequence of ugt1 was introduced at 
the ura3 locus under the control of the phosphoglycerate kinase promotor (pGKI)312. This way 
no need for extra engineering inside the cluster is necessary. Introduction of this construct was 
done in S. bombicola PT36 Δugta1. The expression cassette contains the nourseothricin 
acetyltransferase gene (NAT), necessary for nourseothricin resistance. Expression of the 
resistance gene is achieved by the glyceraldehyde 3'-phosphate dehydrogenase promotor 
(pGAPD). Both promotors show high expression during the exponential phase and no 
downregulation during the stationary phase368. The primers used for the construction of this 
expression cassette (BS_EC_0395_UmUGT1_OE_Uraloc_kol4) can be found in Table 4.2. 
The vector backbone was amplified from plasmid BS_EC_0291_pGAPD1555_nat1. 
Construction of the plasmid for UGT1 characterisation in E. coli BL21 
Expression of the ugt1 gene in E. coli BL21 was done using the commercial pET21a plasmid. 
Expression is achieved by induction with isopropyl β-D-1-thiogalactopyranoside (IPTG). The 
coding sequence of ugt1 was equipped with a 6xhis tag at its C-terminus. The primers needed 
for amplifying the vector backbone and ugt1 insert can be found in Table 4.2. The final 
expression plasmid is BS_EC_0392_pET21a_UmUGT1_kol1. 
Table 4.2: Primers used for the creation of the ura3 locus ugt1 overexpression cassette and the pET21a 
plasmid for expression in E. coli. Non-binding regions are separated by a dash. 
Primer name Primer sequence  
P1_FOR_URA3v AGAACAAGGCCGAGTATGTC 
P32_REV_cassette GTCAGATTAGCCTCCGACATAG 
P33_FOR_checkcassIN CCATACTCAAGCGCGAACAC 
P34_REV_checkcassIN_URA3 GATGTCGAATAGCCGGGCTGCTAC 
P35_REV_checkcassIN_DOWN GAGCTCAAGACGCGTTTACTCAATGC 
P306_trypcastestrev ACTAGCCGAGATCGTTGC 
P1600_GAPD_insert_check_rv GTCCCGATACTGGGATGTTG 
P2365_nat1_sequencing_1 ATCGAGGCACTGGATGGGTCCTTCAC 
P2483_UmUGT1GibpPKIFor GTAAACTACCCAAGGTCCTCCAAACCAGAAAAA-ATGGCGACCGAACATATT 
P2484_UmUGT1GibtTKRev CCGTGTTTCAGTTAGCCTCCCCCATCTCCC-CTAAAAGAGGCGGACTTC 
P2482_pGKIRev TTTTTCTGGTTTGGAGGACCTT 
P2475_pET21promrev CCCGTATATCTCCTTCTTAAAG 
P2476_pET21termfor GATCCGGCTGCTAACAAAGC 
P2477_UmUGT1GibpETpromFor CTTTAAGAAGGAGATATACGGG-ATGGCGACCGAACATATTCTTTTGGTCTGCT 
P2479_UmUGT1hisGebpETtermRev CCTTTCGGGCTTTGTTAGCAGCCGGATCTCA-
GTGATGGTGATGGTGATGAAAGAGGCGGACTTCTGC 
P2388_tTK_For GGGAGATGGGGGAGGCTAAC 
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 E. coli BL21 ugt1 expression 
Protein expression 
One colony of the desired E. coli BL21 strain was inoculated in 5 mL of LB medium with 100 
µg/mL ampicillin and incubated overnight. This preculture was used for inoculation of 250 mL 
LB medium containing 100 µg/L ampicillin. The Erlenmeyer flasks were incubated at 37 °C at 
200 rpm. When the optical density of the culture reached 0.6, 250 µL of an 1M IPTG stock was 
added and further incubated at 16 °C at 200 rpm overnight. The cells are harvested by 
centrifugation at 9000 rpm for 30 minutes at 4 °C. The cell pellets were stored for at least 1 
hour at -20 °C before lysis and purification. 
Lysis of E. coli BL21 
The pellet originating from 250 mL broth were suspended in 8 mL lysing buffer (300 mM NaCl, 
50 mM NaPO4, pH 8, 1 mg/mL Lysozyme) and placed on ice for 30 minutes. After incubation 
on ice, the cell suspension was sonicated twice with a duty cycle of 50 % and an output control 
of 3. All sonication steps were performed on ice. Afterwards, the cell debris was removed by 
centrifugation at 10.000 rpm at 4 °C during 30 minutes. The supernatant was filter sterilized 
through a sterile 0.22 µm sterile filter. 
6xHis tag protein purification 
The His-tag purification columns were packed before the purifications. This was done by 
suspending the Ni-NTA agarose in its original buffer and container by agitation and 
subsequently pouring 1.5 mL of the agarose resin suspension into a 10 mL purification column 
and allowing the resin to settle by gravity. The supernatant remaining on top of the resin was 
removed and the resin was rinsed with 6 mL of sterile distilled water. The resin was settled by 
gravity. Afterwards, the supernatant was removed and the resin was rinsed a second time, 
with 6 mL of equilibrium buffer (10 mM imidazole in 50 mM NaPO4, 300 mM NaCl; pH 8). After 
settling and removing the supernatant, this rinsing step was repeated twice. 
A volume of 8 mL of the cell lysate was loaded on the prepared Ni-NTA column. The column 
was incubated for 60 minutes at 4 °C and gentle agitation was applied to keep the resin 
suspended in the lysate. After the hour, the resin was settled by gravity, the supernatant was 
recovered and stored at 4° for SDS-PAGE analysis. The resin was washed with 8 mL wash 
buffer (30 mM imidazole in 50 mM NaPO4, 300 mM NaCl; pH 8) and again allowed to settle by 
gravity. The supernatant was removed and stored for further analysis by SDS-PAGE. This step 
was repeated three more times. Each time a sample of the flow-through was kept for SDS-
PAGE analysis afterwards. Finally, the His-labeled proteins were eluted with 2x 4 mL elution 
buffer (250 mM ididazole in in 50 mM NaPO4, 300 mM NaCl; pH 8).  
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SDS-PAGE 
An SDS-PAGE was performed on all the collected fractions to assess any losses of the His-
tag purified enzyme. The composition of both the stacking and resolving gels can be found in 
Table 4.3. First the resolving gel was made and allowed to settle for 30 minutes. On top of the 
mixture a layer of isopropanol was added to straighten to top layer of the gel. Next the stacking 
gel was poured. 
Table 4.3: Composition of the stacking and resolving gels used for SDS-PAGE. 
Components Stacking gel (5%) Resolving gel (10%) 
Distilled water (mL) 2.85 4.1 
30% Acrylamide/Bis (mL) 0.85 3.3 
1.5 M Tris-HCl pH 8.8 (mL) / 2.5 
0.5 M Tris-HCl pH 8.8 (mL) 0.25 / 
10 % SDS (µL) 50 100 
10 % Ammonium Persulfate (µL) 50 50 
TEMED (µL) 5 5 
Total (mL) 5 10 
 
A volume of 10 µL of sample was added to 20 μL of sample buffer (Table 4.4). The purified 
samples have a standard concentration of 1 mg/mL. For crude cell extracts and the initial flow-
through of the extract through the purification column, only 5 μL of sample was taken diluted 
in sample buffer. The insoluble fraction after cell lysis was diluted in 50 mL of distilled water 
and 10 µL was added to the sample buffer. The samples were incubated at 95 °C for 5 minutes. 
10 µL of the prepared sample was loaded on the gel and the gel was run at 200 V for 60 
minutes. 
After the gel was run, excess SDS was rinsed from the gel with distilled water and the gel was 
fixed with fixation buffer (40% Ethanol and 10% acetic acid in mQ) for 15 minutes. The fixed 
gel was washed with distilled water twice for 2 minutes. Staining of the gel was done with 
staining solution (34% (v/v) MeOH, 3% (w/v) H3PO4, 17% (w/v) (NH4)2SO4 and 0.2% (w/v) CCB-
G-250) overnight at room temperature. An orbital shaker was used for efficient mixing of the 
staining solution and assuring full coverage of the gel. After incubation, the gel was destained 
using distilled water and incubated again using an orbital shaker. 
Table 4.4: Composition of the sample buffer required for loading the samples on the SDS-Page gel. 
Components Volumes  
Distilled water (mL) 3.55 
0.5 M Tris-HCl pH 6.8 (mL) 1.25 
Glycerol (mL) 2.5 
10 % (w/v) SDS (mL) 2.0 
0.5 % (w/v) Bromophenol blue (µL) 200 
Total (mL) 10 
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Buffer exchange 
A buffer exchange was needed before enzyme tests were performed. To exchange the buffer, 
Millipore Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-30 membrane were used. A 
volume of 4 mL of the enzyme solution was applied on the filter and centrifuged at 4 °C and 
4500 rpm for 9 minutes or until a volume of 0.5 mL remained on the filter unit. The filter units 
were washed with the washing buffer four times. To prevent clogging of the filter, the remaining 
liquid was disturbed by pipetting with the washing buffer before each washing step. Store the 
enzyme at -20 °C. 
Enzyme tests 
The enzyme tests were performed as described by Saerens et al.176 As glycosyl donor UDP-
glucose was tested. Glycosyl acceptors were juniperic acid and hydroxy fatty acids derived 
from sophorolipids by acidic hydrolysis16.  
The enzyme mixtures were sampled after 3 hours of incubation at 30 °C. Extraction of the 
glycolipids was done by adding 440 µL ethyl acetate and 10 µL acetic acid to the reaction 
mixture. After vigorous mixing, the samples were centrifuged at maximum speed for 5 minutes. 
The supernatant was then analysed on LC-MS for glycolipids with a scan range from 400 to 
800 m/z as described in II.2.4.2. 
 S. bombicola enzyme tests 
Cell lysates of the ugt1 overexpression strain were created and subsequently tested as 
described in Saerens et al.176 Sampling and analysis were equal as for the E. coli BL21 enzyme 
tests described in IV.2.3.1. 
 
Sampling and analysis of glucose, optical density and glycolipids is performed as described in 
II.2.4.1 
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Production of novel glycolipids in S. bombicola has been achieved the recent years by genetic 
engineering of a ura3 auxotrophic strain. In this strain, either the second glucosyltransferase 
ugtb1 was knocked-out for glucolipid (Figure 4.3 A) production or replaced by ugt1 from U. 
maydis for cellobiose lipid (Figure 4.3 B) production. Still, the amounts produced by both strains 
were not at the same level as those of the wild type sophorolipids318. Several hypotheses can 
be made on the cause of this drop in product titers. First of all, altering the structure of the 
sophorolipid gene cluster might have an effect on the regulation of its genes. This effect can 
be due to deletion of essential regulatory sequences embedded in the promotors, terminators 
or even the coding sequences themselves. Deletion of these regulatory regions can influence 
the association of transcription factors or other DNA binding proteins necessary for gene 
expression. Another possibility related to regulation is chromatin structure. In fungi, regulation 
of many secondary metabolite gene clusters is due to epigenetic marking of the histones 
involved in DNA packaging and thereby accessibility of the DNA for other proteins439,440.  
A third reason for the lowered production can be transporter specificity. Though the MDR 
transporter of S. bombicola is classified as a multi-drug resistant ATP-binding cassette 
transporter39, its specificity has never been tested. If this transporter is specific towards the 
sophorose head group, different carbohydrate structures might impair the transport of non-
sophorolipid glycolipids across the plasma membrane. 
A fourth possibility is the strain used for engineering. In the past, two ura3 auxotrophic strains 
were developed. S. bombicola G9310 was the first ura3 negative strain developed for further 
engineering. It was selected as a spontaneous mutant when the wild type yeast was grown on 
medium containing 0.1% 5-fluoroorotic acid (5-FOA). Though this strain is effectively ura3 
negative, using a spontaneous mutant can have an influence on other factors as well since 
mutations in other regions or even altered epigenetic regulation can occur. Therefore, a second 
ura3 negative strain was developed by deleting the ura3 coding sequence through targeted 
engineering methods, only leaving the promotor and terminator at the original locus. This strain 
is called PT36. 
In the following experiments, these two strains will be evaluated for the production of different 
glycolipids. Thereby, a better understanding of their production can be achieved. 
 
Figure 4.3: Molecular structures of A.) glucolipids and B.) cellobiose lipids produced by S. bombicola. The 
R-group on the 6’ carbon atom of each glucose molecule can be either an hydroxy or acetyl group. 
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As a difference in production between the two ura3 auxotrophic strains, the G9 strain and the 
PT36 strain, can explain some details about the fitness of both strains, a production experiment 
was conducted with both strains on production medium described by Lang et al.370 
complemented with uracil (0.3 g/L) and uridine (0.5 g/L). At the start of the secondary phase, 
37.5 g/L rapeseed oil was added. In Figure 4.4, optical density and sophorolipid production are 
plotted. A striking difference between the G9 and PT36 can be seen for both parameters 
evaluated.  
 
Figure 4.4: Optical density and sophorolipid production for the ura3 negative S. bombicola strains G9 and 
PT36. G9 is a spontaneous ura3 negative strain while the PT36 is an engineered deletion strain. Error bars 
depict standard deviation. Sample size for each strain was 3. 
One easy can see that for biomass, the G9 only reaches a value of 40 while the wild type easily 
reaches 80, a two-fold difference. For the sophorolipids, titers of 25 g/L can be achieved for 
the PT36, rivalling the wild type production levels. The G9 hardly rises above 1 g/L. This clearly 
shows that the engineered ura3 negative PT36 is superior compared to the G9 strain, both in 
fitness and sophorolipid production. The true nature of this difference is not known, but possibly 
additional mutations are present in the G9 genome influencing the fitness and production 
capacity of this strain.  
 
 Characterization of glucolipid producing strains 
Based on the striking superiority of the PT36 strain over the G9 strain it was decided to develop 
new glucolipid producing strains (see also Figure 4.1). A first one was made using the same 
expression cassette as used for the already existing G9 glucolipid strain (B11)317, but this time 
in a PT36 background. This strain is referred to as B11new. Other cassettes were designed 
and introduced as well, in an attempt to circumvent potential negative influence of the old 
construct on production since parts of the ugtb1 coding sequence are still present in the original 
recombination cassette. They might have a negative influence on for example cluster 
regulation, preventing the efficient expression of the remaining sophorolipid genes. One new 
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strain is again a knock-out of the ugtb1 gene, but this knock-out was made by fusing the 
promotor and terminator (strain UGTB1_PT). Finally, the ugtb1 coding sequence was replaced 
by the one of ugta1, effectively doubling the copy number of the gene producing the glucolipids 
(strain A²). 
Characterisation of the novel strains was done in a production experiment using rapeseed oil. 
As a control, the original glucolipid producing strain B11 was taken along. Besides glucolipid 
production, consumption of glucose and optical density were analysed. During the production 
trial, a clear visual difference was noticed between the new strain A², carrying two copies of 
ugta1, and the G9 derived B11 (Figure 4.5). The original glucolipid strain B11 shows a stronger 
yellow colour compared to the new strains. A similar observation was made for the B11new 
and UGTB1_PT strain. Besides the colour, a brown sediment could be detected in the 
Erlenmeyer flasks of the new glucolipid strains, strongly resembling non-soluble glycolipids. 
 
Figure 4.5: Colour difference between the original B11 glucolipid strains and the strain carrying the first 
glucosyltransferase twice (A²-strain). 
When looking at the optical densities and glucose consumption of the different strains, it is 
clear that the wild type S. bombicola reaches a high optical density faster than the glucolipid 
strains (Figure 4.6). Though the difference becomes negligible at the end of the experiment for 
the A², B11new and UGTB1_PT strains, for the original B11 strain the discrepancy increases 
during the production trial. For glucose consumption, a similar observation can be made. The 
wild type, A², B11new and UGTB1_PT strains consume the glucose within 8 days after 
inoculation while in the culture of B11 still 15 g/L remains at this time point. This comes down 
to an average daily consumption of 9.3 g/L.day for the B11 compared to 15 g/L.day for the 
other strains.  
Analysis of the glucolipids production by the different strains was done by TLC during the 
growth trial and by UPLC and LC-MS afterwards (see II.2.4.2). To be able to compare the 
different strains, only ethanol samples were used (II.2.4.2). UPLC analysis shows that the B11 
strain is capable of producing glucolipids, but only in low amounts compared to the other 
glucolipid producing strains (Figure 4.7). Analysis of the molecules on LC-MS proved that the 
produced glucolipid mixture of all strains is similar in profile. Molecular masses of 504, 502 and 
500 are easily detected and correspond to acetylated glucolipids with respectively stearic, oleic 
and linoleic acid incorporated. Other masses corresponding to non-acetylated glucolipids were 
detected as well with a mass of 460 Dalton (Figure 4.8).  
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Figure 4.6: Optical density and glucose consumption for the wild type S. bombicola and the B11, B11new, 
UGTB1_PT and A² strains. Error bars depict standard deviation. Sample size for each strain was 3. 
Lab-scale purification of the glycolipids was performed by solvent extraction using methyl tert-
butyl ether (MTBE), hexane and water. It appeared necessary to wash the glycolipids first with 
hexane to remove any fatty acids and oils left from the growth trial. This step is essential to be 
able to extract the glucolipids. Total production in shake flask for the A² strain amounted to 
31.52 g/L, 27.17 g/L for the B11new strain and 31.03 g/L for the UGTB1_PT. These 
concentrations are similar to sophorolipid production values found in literature for other 
engineered strains174. A significant difference is the glucolipid concentration obtained with the 
original B11 strain, which amounts to 3.55 g/L. No significant difference could be found 
between the new strains. 
 
Figure 4.7: Concentration of glucolipids 10 days after inoculation produced by the old B11 strain and the 
new developed A², B11new and UGTB1_PT strains. Error bars depict standard deviation. Sample size for 
each strain was 3. 
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Figure 4.8: UPLC chromatogram of the glycolipids produced by the S. bombicola strain carrying two copies 
of the ugta1 gene. The main glucolipids present are C18:1 non- and mono-acetylated ones (mw 460 and 502 
Dalton). 
Curiously, several masses corresponding to molecules with two glucose moieties coupled to 
the same fatty acids were present among the glucolipids (Figure 4.9). These are for example 
705 m/z corresponding to a di-acetylated molecule with an oleic acid tail. Other masses like 
661 m/z and 663 m/z are also significantly present, representing molecules with one acetyl-
group and respectively a stearic or oleic acid tail. Interestingly, no masses corresponding to 
lactonized molecules could be detected, suggesting that glucolipids as well as the higher mass 
molecules are not substrates of the lactone esterase. If lactonized molecules would be present, 
they would elute from the column between 27 and 33 minutes, but no such signals could be 
detected. 
 
Figure 4.9: Mass scan for glycolipids produced by the A² glucolipid strain containing an oleic acid tail. A = 
459 m/z (non-acetylated C18:1 glucolipid); B = 621 m/z (non-acetylated C18:1 bola-glucolipid); C = m/z 705 
(di-acetylated C18:1 bola-glucolipid); D = 687 m/z (lactonized di-acetylated C18:1 glycolipid). Lactonized 
molecules elute at 30 minutes. As can be clearly seen, no such signal is present. 
The promiscuity of UGTA1 might clarify the presence of several molecules with higher masses. 
These molecules do not correspond to disaccharides coupled to fatty acids like sophorolipids 
or cellobiose lipids, but might be a novel class of glucolipids with one glucose unit coupled to 
both the hydroxyl and carboxyl group. A visual representation of the proposed structure of 
these molecules can be found in Figure 4.10. The readiness of UGTA1 to glucosylate the 
carboxyl group of fatty acids is observed as well in S. bombicola strains producing bola-type 
sophorolipids423. Though bola-amphiphilic sophorolipids are only produced at high amounts 
when the acetyltransferase and lactone esterase both are knocked out, bola glucolipids readily 
appear in the new strains without these modifications.  
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One explanation might be that the molecules reside longer in the cytosol, giving UGTA1 more 
time to glucosylate the carboxylic group. This longer presence can be triggered due to slower 
transport of the molecules across the membrane. When looking at the new glucolipid strains, 
production levels are on par with the wild type as well, making the hypothesis about slower 
transport a difficult one to maintain. Still, the exact reason for this “bolafication” of glycolipids a 
mystery. 
 
Figure 4.10: Proposed structure of a non-acetylated bola-glucolipid with an oleic acid linker.  
 3 L Bioreactor for A²-strain  
Upscaling in a 3L bioreactor was performed for the A²-strain. In the beginning, a start volume 
of 1.2 L was present. A late exponential culture of 200 mL was used as inoculum. Oleic acid 
was added as a substrate every day in shots of 18 mL. When glucose levels dropped below 
30 g/L, a 60 % glucose solution was added until a final concentration of 100 g/L was obtained. 
The fermentation time between each glucose addition will be referred to as a phase (not to be 
confused with a cyclic fermentation). Acidity of the broth was kept at pH 3.5 by adding aliquots 
of 5 M NaOH. This level was reached after 23.8 hours, another indication besides production 
that the cells were transitioning from exponential growth to stationary production. At the end of 
the fermentation, a final volume of 1.55 L was attained due to the different additions of glucose 
and oleic acid. 
Consumption of glucose appeared normal during the fermentation compared to other strains 
tested in this PhD and literature174 (Figure 4.11). During the first phase including the non-
productive exponential phase, 25.5 g/L.day was consumed. When looking only at the 
stationary phase, this value rises to 30.3 g/L.day. The second phase showed a lower 
consumption of glucose with only 16.9 g/L.day while the third uncompleted phase this value 
dropped to 8 g/L.day. First signs of production were detected on TLC after 23.8 hours. 
Microscopic analysis of the broth revealed large globules devoid of any cells. After 
centrifugation, a distinct layer could be observed resting above the cells. When heated to 60 °C, 
this layer rapidly melted into a brown oily substance. Purification of the molecules was 
performed by the Bio Base Europe - Pilot Plant because of the large volume of both broth and 
molecules produced. 
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HPLC analysis of the different glycolipid samples from the fermentation shows a total 
production of 206.6 grams of glycolipids. At the first refeeding of glucose, the concentration of 
glycolipids amounted for 60.35 g/L. When looking at the productivity this results in 0.61 g/L.h 
during the entire phase. When excluding the non-productive exponential phase, this value rises 
to 0.81 g/L.h. For the second phase productivity seems similar to the first phase, but no exact 
figure could be calculated due to a missing data point before the second glucose refeeding. 
For the part of the third phase sampled, a value of 0.67 g/L.h was obtained, again not differing 
much from the first one. 
 
Figure 4.11: Evolution of glucose and glycolipid concentration during the fermentation of the novel A² 
strain. 
 
During previous research it has been shown that modification of the carbohydrate moiety from 
a sophorose to either a glucose or a cellobiose (4-O-β-D-glucopyranosyl-β-D-glucopyranose) 
is possible318. However, production remained limited for both molecules. Moreover, the 
cellobiose lipid producing, G9 derived S. bombicola Δugtb1::ugt1 described by Saerens et 
al.318 produces a glycolipid mixture consisting of maximum 25% cellobiose lipids, the remaining 
fraction being glucolipids. The large remainder of glucolipids in the produced glycolipid mixture 
makes it difficult to isolate the cellobiose lipids. In order to enhance product uniformity, the 
Δugtb1::ugt1 cassette described by Saerens et al. carrying the ugt1 gene from the cellobiose 
lipid producer U. maydis was introduced in strain A113, an earlier created, G9 derived S. 
bombicola strain lacking the first glucosyltransferase ugta1175. Indeed, in U. maydis and P. 
flocculosa only one glucosyltransferase is present in the cellobiose lipid gene cluster, 
suggesting a dual catalytic function for this transferase, both glucosylation reactions of the 
hydroxy fatty acid and subsequent of the glucolipid intermediate. The characterisation of the 
both strains is described in IV.3.4.1. An overview of their engineered cluster is given in Figure 
4.12. 
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Figure 4.12: Differences between the original cellobiose strain (A.) and the novel strain wherein the ugta1 
coding sequence was deleted (B.). Both strains are derived from the G9 ura3 auxotrophic S. bombicola. 
In a next step it was envisaged to increase production. In IV.3.3 it has been shown that it is 
possible to enhance glucolipid productivity by using a different strain background (PT36 strain 
obtained by targeted engineering compared to S. bombicola G9, a spontaneous ura3 
auxotrophic strain). The improvement was obtained combining several new knock-in and -out 
cassettes in the defined genetic background. For the production of cellobiose lipids, a similar 
strategy was followed: a new designed cassette for the ugtb1 locus was constructed and 
introduced in S. bombicola PT36, thereby resulting in a strain similar to the original cellobiose 
lipid strain described by Saerens et al. (Figure 4. D.). 
 Characterisation of G9 cellobiose lipids strains 
In a first growth trial, the G9 background strains were incubated in Lang medium with rapeseed 
oil as a hydrophobic substrate. After seven days, the cultures were analysed for their cellobiose 
lipid production. In Figure 4.13, chromatograms of S. bombicola Δugtb1::ugt1 (Figure 4.12 A.) 
and S. bombicola Δugtb1::ugt1 Δugta1 (Figure 4.12 B.) can be seen. A clear difference is 
visible between the original cellobiose lipid strain and the strain lacking both ugtA1 and ugtB1, 
i.e. the strain only expressing the U. maydis ugt1. S. bombicola Δugtb1::ugt1 clearly produces 
more glycolipids than S. bombicola Δugtb1::ugt1 Δugta1. 
In the chromatogram of the original S. bombicola Δugtb1::ugt1, the signals at 21.5 and 22.9 
correspond to non-acetylated glucolipids with respectively oleic and stearic fatty acid tails. 
Acetylated variants are also detected after 25 minutes. Interestingly, also molecules with two 
glucose units are present, which elute at 23.9 and 24.4 minutes. Possibly these are di-
acetylated cellobiose lipid molecules. When analysing the products of S. bombicola 
Δugtb1::ugt1 Δugta1, it becomes clear that the strain produces less glycolipids in general. The 
signal at 22.3 minutes corresponds to a molecule with a mass of 724. Though no glycolipids 
are known with this molecular weight, analyses of the mass spectrum of this peak reveals a 
molecule with a molecular weight of 664 Dalton. This corresponds to a mono-acetylated 
disaccharide, presumably cellobiose, with an oleic acid tail. It is known that the acetate in the 
eluents can form adducts with glycolipids. Another possibility is the modification of the fatty 
acid tail. Since the mass of the unknown compound only differs by 16 Dalton from the known 
di-acetylated C18:0 cellobiose lipid, two potential explanations can be found. 
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Figure 4.13: Comparison of S. bombicola Δugtb1::ugt1 (1 and 3) and S. bombicola Δugtb1::ugt1 Δugta1 (2 
and 4). Cross-analysis of the samples on LC-MS resulted in identification of the different signals. Non-
acetylated glucolipids with an oleic acid tail elute at 21.5 while acetylated ones elute at 24.4. Glucolipids 
with a stearic acid tail elute at 22.9. The signal at 22.3 minutes has a molecular mass of 724.  
A first one might be the activity of an enzyme such as a P450 on the stearic acid tail adding a 
second oxygen atom somewhere in the fatty acid tail. Several other P450s are present in the 
genome of S. bombicola, but only few have been characterised254 , hence such a reaction 
could be facilitated (see III.4). Another explanation could the activity of an enzyme such as a 
hydratase on the double bond of oleic acid. Several enzymes have been described that 
effectively hydrate the double bond441,442. This way, a product with a molecular mass of 724 is 
also reached. The higher hydrophilicity of the molecule by the addition of an extra oxygen also 
explains the earlier elution of the compound. Still, further structural analysis of the molecules 
needs to be done before any further conclusions on its structure can be made. 
The difference in the amount of glycolipids being produced can be attributed to several 
bottlenecks. It is possible that the glucolipids produced by UGTA1 in the original cellobiose 
lipid strain are a substrate for UGT1. Another possibility might be lower production of hydroxy 
fatty acids in the ugta1 knock-out strain. Since the ugta1 coding sequence is positioned 
upstream of the bidirectional promotor of both the ugta1 and cyp52m1, removal or alterations 
in the sequence might have an impact on cyp52m1 gene expression. Yet another possibility is 
that the masses detected in the original cellobiose lipid strain are not all cellobiose lipids, but 
the earlier described bola glucolipids. To test the latter hypothesis, alkaline hydrolysis of the 
glycolipid mixture was performed. Hereby, the glucose molecules attached to the carboxylic 
group will be removed, resulting in a disappearance or reduction of the presumably produced 
cellobiose lipids. If all the molecules however are cellobiose lipids, only deacetylation will occur.  
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In Figure 4.14 analysis by LC-MS of the glycolipids can be seen after hydrolysis for the S. 
bombicola Δugtb1::ugt1. Clearly visible is the cellobiose lipid signal. Further analysis on UPLC-
ELSD for both alkaline hydrolysis proves that the amount of cellobiose lipid molecules is much 
lower than previously reported. It is estimated that the total amount of cellobiose lipids in the 
sample is only 14,31% of the total glycolipid pool. For the strain only carrying the ugt1 gene, 
deacetylated molecules can be seen with a mass of 622 Dalton (621 m/z), corresponding to a 
disaccharide with an oleic acid tail.  
 
Figure 4.14: LC-MS analysis of the glycolipid mixture produced by the original cellobiose lipid strain after 
alkaline hydrolysis. The majority of the molecules correspond to glucolipids with either an oleic (m/z 459 
and 501) or stearic (m/z 503) fatty acid tail. The molecule with m/z 621 corresponds to a disaccharide 
coupled to an oleic acid. 
Though the reason for the low production of cellobiose lipids is unknown, several possibilities 
exist. First of all, expression of the transferase might be impaired due to problems arising 
during transcription or translation. Secondly, activity of the enzyme itself might be impaired due 
to incompatible or even absent post-translational modifications. Thirdly, the enzyme might be 
not that active compared to the S. bombicola UGTA1 and UGTB1 to start with.  
A second growth trial was performed comparing the original G9 S. bombicola Δugtb1::ugt1 
strain and a PT36 derived Δugtb1::ugt1. As can be seen in Figure 4.15, in the original G9 strain 
a small remainder of the ugtb1 coding sequence is still present as part of the homologous 
regions. In the new cassette transformed in PT36 (see Figure 4.1 D), the entire coding 
sequence is replaced by the one from ugt1. However, after the growth trial only the G9 derived 
strain showed production of glycolipids.   
 
Figure 4.15: Expression cassette developed by Saerens et al.381 for the production of cellobiose lipids in S. 
bombicola G9. ORF-2’ is part of the sophorolipid transporter. UGTB1 P and T are the original promotor and 
terminator of the ugtb1 gene. 
  
Chapter IV  Enhancing glycolipid production in S. bombicola 
  
 
126 
 
 Overexpression of ugt1 at ura3 locus 
To counter potential low production due to expression problems caused by altering or 
downregulation of the sophorolipid gene cluster, a ugt1 overexpression strain with ugt1 
integrated at the ura3 locus was created in a ugta1 negative strain of S. bombicola with PT36 
background. The reason for the ura3 locus is to evade potential negative influence of or on the 
ugt1 coding sequence if it would be integrated in the sophorolipid gene cluster. The choice for 
a ugta1 negative strain is because UGTA1 still produced high amounts of glucolipids, a 
molecule that might not at all be a substrate for UGT1. This way, all the hydroxy fatty acids 
produced by S. bombicola will be available for UGT1 to potentially convert them to cellobiose 
lipids. The choice for PT36 background was made since it became clear that strains developed 
from the spontaneous ura3 auxotrophic G9 are heavily impaired in their glycolipid production. 
To ensure high product uniformity, oleic acid was used as a substrate instead of rapeseed oil. 
As can be seen in Figure 4.16, a mixture of different cellobiose lipid molecules is being 
produced. The most prevalent molecules are variants carrying a C18:1 fatty acid tail. The 
differing masses correspond to varying acetylation patterns such as non-acetylated (m/z 621), 
mono-acetylated (m/z 663) and di-acetylated (m/z 705). Interestingly, no lactonic molecules 
with m/z values such as 645 and 687 for respectively mono- and di-acetylated lactonic 
molecules can be detected for oleic acid derived molecules. This suggests that the lactone 
esterase, which is responsible for sophorolipid ring-closure, is not capable of performing the 
same reaction on the slightly different cellobiose head group. A similar observation was made 
when looking at the glucolipids produced in the different strains described in IV.3.3. Though 
the exact mechanism of lactonisation is unknown, the presence of a sophorose group and a 
sufficiently long fatty acid are apparently both necessary.  
Two other signals are present between the cellobiose lipids (21 to 26 minutes) and the fatty 
acids linoleic and oleic acid (36 and 41 minutes). These signals correspond to masses 
belonging to hydroxylated variants of oleic (m/297) and stearic acid (m/z 299). The presence 
of such molecules is likely due to CYP52M1 producing more hydroxy fatty acids than UGT1 
can convert in cellobiose lipids or that can be degraded by the cell own fatty acid metabolism. 
 
Figure 4.16: Detailed view of the cellobiose lipids produced on oleic acid by the ugt1 overexpression strain. 
Non-acetylated cellobiose lipid = m/z 621; mono-acetylated cellobiose lipid = m/z 663 and di-acetylated 
cellobiose lipid = m/z 705. The substrate oleic acid can be seen with an m/z value of 281. Cell own linoleic 
acid = m/z 279. Hydroxy fatty acids derived from oleic and stearic acid have m/z values of respectively 297 
and 299. 
Chapter IV  Enhancing glycolipid production in S. bombicola 
  
 
127 
 
The overall production of the strains remained below 100 mg/L, a level far lower than the titers 
achieved with U. maydis21 and the reported cellobiose lipid strain already available at the lab318. 
The relatively low levels of production can be attributed to several reasons. First of all, as 
described above, activity of the enzyme itself might be impaired due to incompatible or even 
absent post-translational modifications or the enzyme might be not that active compared to the 
S. bombicola UGTA1 and UGTB1 to start with. Second, it might be that the transferase is not 
that active towards longer hydroxy fatty acid chains. In U. maydis, the only fatty acid being 
incorporated is palmitic acid. Though oleic acid is shorter than stearic acid, it still might be too 
long for efficient incorporation. Also in Cryptococcus humicola, only a small portion of the 
cellobiose lipids have a C18 fatty acid tail443.  
Another problem arises from the hydroxylation profile of CYP52M1. Most of the products 
formed are ω-1 hydroxy fatty acids. In U. maydis, the same position is hydroxylated as well, 
but the glucosylation reaction always occurs on the terminal group. Knocking out CYP1, 
hydroxylating the terminal position, in U. maydis results in abolishment of the cellobiose lipid 
production while knocking out CYP2, hydroxylating the ω-1 position, only has an effect on the 
ω-1 hydroxylation327. This suggests that UGT1 has very low or even no activity towards ω-1 
hydroxy fatty acids as a substrate. It has to be noted that chirality also plays a role since in S. 
bombicola, only S-configured ω-1 hydroxy fatty acids are formed by CYP52M1. CYP2 reaction 
products have never been subjected to detailed analysis on the absolute configuration of the 
hydroxy group incorporated. Hence it is unknown if UGT1 can accept either R- or S-hydroxy 
fatty acids. So, it might be that the ω-1 hydroxy palmitic acids produced in U. maydis by this 
enzyme are unsuitable as a glucose acceptor for UGT1 due to the stereochemistry of the 
hydroxy group.  
A second production trial was performed using different substrates. This time oleic acid, ethyl 
palmitate and juniperic acid (16-OH palmitic acid) were fed to the ugt1 overexpression strain. 
No palmitic acid was used since this substrate tends to be less available for the yeast to use 
as a substrate since it is not liquid at 30 °C. In Figure 4.17, a detailed LC-MS chromatogram 
of the final ethyl acetate extractions can be seen. Using the different substrates, no clear 
difference can be seen regarding the mixture of produced cellobiose lipid molecules. All 
cellobiose lipids have either a stearic, oleic or palmitic acid tail, most likely due to de novo 
synthesis of C18 fatty acids. No molecules with masses for the lactonized variants are detected, 
again pointing towards the cellobiose lipids being an unsuitable substrate for the lactone 
esterase. Analysis of the total extracted cellobiose lipid content of the broth revealed that ethyl 
palmitate and juniperic acid both raised the production of cellobiose lipids at least 2-fold 
compared to oleic acid. This is most likely due to the higher preference of UGT1 towards 
hydroxylated palmitic acid. Furthermore, the products and titers don’t differ when adding 
juniperic acid or ethyl palmitate. The low activity of UGT1 might result in CYP52M1 being able 
to provide enough hydroxylated palmitic acid from ethyl palmitate to mask the bypassing of 
this step when feeding juniperic acid. As can be concluded, the use of a C16 substrate results 
in more efficient production of cellobiose lipids.  
An interesting observation is again the molecule with an m/z value of 723 observed in the 
production trial with oleic acid. Though also present in the molecules produced on the other 
two substrates, it is masked by the di-acetylated C16 cellobiose lipids (m/z 679). If the signal 
corresponds to a C18 cellobiose lipid with a modified fatty acid tail, other acetylation variants 
should be present as well. A non-acetylated variant would have an m/z value of 639. Such a 
value is indeed visible at 20.5 minutes. The mono-acetylated variant is not visible in the total 
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mass scan, but when performing a single ion scan, a signal can be detected (Figure 4.18). 
However, further molecular characterisation such as NMR is needed before final conclusions 
can be made on the new detected masses. 
Table 4.5: Overview of the different cellobiose lipids produced by the S. bombicola ugt1 overexpression 
strain. In Appendix F, an overview is given of several types of glycolipids, fatty acids and derivatives and 
their corresponding mass. 
Fatty acid tail Non-acetylated (m/z) Mono-acetylated (m/z) Di-acetylated (m/z) 
Palmitic acid (C16:0) 595 637 679 
Stearic acid (C18:0) 621 663 705 
Oleic acid (C18:1) 623 665 707 
  
A direct comparison between the different cellobiose lipid strains tested in the production trails 
is biased due to the different genetic backgrounds of the auxotrophic strains used. Still, 
overexpression of UGT1 in a Δugta1 S. bombicola strain is an interesting strategy for the 
production of cellobiose lipids.  Total production remained below 100 mg/L, but the product 
uniformity is clearly better than the G9 derived Δugtb1::ugt1. The presence of hydroxy fatty 
acids in the supernatant points towards sufficient supply of substrate for the 
glucosyltransferase. Still, as already mentioned, several uncertainties remain about the 
reasons for the low production levels. Therefore, a characterisation of the transferase is 
attempted. 
 
Figure 4.17: Detailed view of the molecules produced on A.) juniperic acid (m/z 271); B.) ethyl palmitate (m/z 
255 for palmitic acid) and C.) oleic acid (m/z 281) by the S. bombicola PT36 Δugta1 ugt1 overexpression 
strain. 
Chapter IV  Enhancing glycolipid production in S. bombicola 
  
 
129 
 
 
Figure 4.18: Single ion scan of the potential mono-acetylated C18 cellobiose lipid with an extra oxygen 
atom incorporated. 
 UGT1 enzyme characterization  
In order to fully understand the glucosylation capacity of UGT1, an in vitro enzyme 
characterization was performed. Initially, his-tag purification of the UGT1 enzyme was 
attempted to eliminate any background activity from other transferases present in E. coli BL21. 
However, after several attempts it became clear that his-tag purification is not feasible for this 
enzyme: SDS-PAGE analysis provided proof that the enzyme is not retained on the columns. 
Though no models are existing for this enzyme, it might be that the C-terminal 6xhis-tag is not 
freely available, thus hindering interaction of the tag with the Ni-NTA resin. Further tests were 
done using cell lysate from the ugt1 expressing E. coli strain as well as a BL21 strain carrying 
an empty expression plasmid as a control for background activity. Juniperic acid (16-OH 
palmitic acid) and a mixture of C18 ω-1 hydroxy fatty acids (mostly C18:1), derived from 
sophorolipids by Bio Base Europe Pilot Plant, were incubated for three hours at 30°C.  
As can be seen in Figure 4.19, there was activity on the terminal hydroxylated palmitic acid 
(m/z 595). No activity could be detected on the longer C18 variants (Appendix E Figure A.1). 
The latter can be due to the fairly low amounts of ω-hydroxy fatty acids in the substrate 
combined with lower activity towards longer chain lengths. As discussed above (IV.3.4.2), it 
seems that UGT1 is not active towards subterminal hydroxy groups, though R/S chirality 
incompatibility cannot be excluded. Interestingly, glucolipids were also produced with juniperic 
acid as a substrate (m/z 433). This indicates that UGT1 can perform the sequential addition of 
glucose molecules, but that some loss of the glucolipid intermediate occurs. The reason for 
this is unknown, but potentially this might be due to the enzyme being expressed in E. coli, 
resulting in different (suboptimal) conditions compared to expression in S. bombicola or U. 
maydis. These might for example result in a less stable binding of the glucolipid intermediate. 
As it became apparent that the enzyme was active, characterisation of the S. bombicola 
overexpression strain was performed as well. When the cells were in the stationary phase for 
three days, they were harvested and lysed. The cell lysate was again incubated with 
hydroxylated C16 and C18 fatty acids as well as 12-OH lauric acid and primary alcohols 
ranging from 10 to 20 carbon atoms in length. This was done to see if similar activity could be 
detected for these molecules as for the fatty acids. That way they could be used as a proxy for 
activity towards other hydroxy fatty acids that are not commercially available like 14-OH 
myristic acid. The substrates were incubated for 24 hours and analysed on LC-MS. In Figure 
4.20, an ethyl acetate extraction can be seen with juniperic acid as a substrate. Though the 
strain used was overexpressing the ugt1 gene product, only marginal activity was detected 
Non-acetylated cellobiose lipids were detected in low amounts (m/z 595). 
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Figure 4.19: Detailed LC-MS chromatogram from enzyme tests on the cell lysate from E. coli BL21 
expressing the ugt1 gene. The chromatograms showed are the tests with juniperic acid as a substrate (m/z 
= 271) with A.) total ion scan with glucolipids visible at 23 minutes. The m/z value of 433 corresponds to 
non-acetylated C16 glucolipids and B.) mass scan for m/z 595 corresponding with a palmitic acid coupled 
to a presumed cellobiose head group. 
 
Figure 4.20: Detailed LC-MS chromatogram of enzyme tests on raw cell lysate of the mutant S. bombicola 
overexpressing the UGT1 enzyme. A.) Total ion scan showing the substrate juniperic acid (m/z = 271) and; 
B.) Mass scan for m/z 595, a non-acetylated cellobiose lipid. 
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Production of glycolipids with a carbohydrate head group different from sophorose is possible 
when several precautions are taken into account. Firstly, it is necessary to start from strains 
thoroughly tested for their fitness. Mutant strains that are severely impaired in growth or other 
biological functions compared to the wild type S. bombicola will result in bad producing strains, 
as illustrated by the glucolipids production with the G9 background strains. Secondly, it is of 
great importance to be able to differentiate the newly produced molecules from naturally 
produced ones and to eliminate substrate loss in side reactions performed by native enzymes, 
while simultaneously improving product uniformity. It is therefore necessary to specifically 
engineer S. bombicola in this way that unwanted side reactions are eliminated. This was clearly 
essential in the case of the cellobiose lipid production, where the new molecules co-occurred 
with other glycolipids if the native UGTA1 was still active.  
In the case of the glucolipids, several new strains were created that are capable of producing 
significantly higher amounts compared to the original strain. Concentrations above 25 g/L in 
Erlenmeyer flasks and up to 130 g/L in a bioreactor were easily achieved. Productivity of the 
A² strain was on par with other engineered strains of S. bombicola174. Still, the molecules 
produced remain a mixture. Different fatty acid tails and acetylation patterns are observed. A 
knock-out of the acetyltransferase or an overexpression of it can already help to achieve a 
more uniform product177. Purification of the molecules was achieved using solvents during the 
initial tests, but solvent-free methods could be developed as well. For sophorolipids, 
purification of acidic and lactonic molecules has been described using neutral polymeric 
sorbents444. Using a similar approach for the glucolipids, a more uniform pure product could 
be achieved in a more cost-effective way. 
For the cellobiose lipids, the low production titers are probably not solely caused by an 
excessive burden of previous manipulations of S. bombicola or by substrate loss in side 
reactions. Major causes of the lower productivity might be related to suboptimal transport of 
the cellobiose lipids out of the cell, to non-optimal/non-fine-tuned activity of the UGT1 enzyme 
in the constructed strains or to problems with the localisation of UGT1 (since UGTA1 is 
localised near the CYP52M1 enzyme).  The in vitro experiments indicate towards a main 
contributor to the low productivity being the UGT1 enzyme itself. The results of the enzyme 
tests performed with E. coli cell lysates support the hypothesis that UGT1 is solely responsible 
for the glucosylation of hydroxy fatty acids to cellobiose lipids and that these glucosylations 
are performed sequentially. Indeed, strong indications were present due to it being the only 
transferase in the U. maydis cellobiose lipid gene cluster327, but no characterisation has been 
done before.  
Besides optimisation of the resulting production strain, for example through optimising the 
expression and activity of the UGT1 enzyme, and besides fermentation optimisation, detailed 
structural analysis of the produced molecules is essential. Ideally nuclear magnetic resonance 
should be performed, but given the tendency of molecules being produced as a mixture instead 
of a uniform product this is not always feasible. Still, other possibilities exist to investigate the 
molecular structure even without state-of-the-art methods. For example, hydrolysis of the 
molecules, either alkaline or acidic, will show the composition for the hydrophobic part as well 
as the location of the carbohydrates on the fatty acid, either on a hydroxy group or the carboxyl 
group. 
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Chapter V – Production of rhamnolipids in S. 
bombicola 
 
Glycolipid biosurfactants are produced by several microorganisms like Pseudomonas 
aeruginosa, Starmerella bombicola, Ustilago maydis and many others. They find applications 
in medicine, pharmacy and nanoindustry. Rhamnolipids, a well-studied glycolipid, is produced 
by several species from the Pseudomonas and Burkholderia genera. The top producer is P. 
aeruginosa PAO119, an opportunistic pathogen, with titers up to 120 g/L. Other species are 
less productive. Rhamnolipid synthesis required precursor input from two pathways. Firstly, 
activated dTDP-L-rhamnose is generated from glucose-1-phosphate. Thymidylation and 
subsequent (de)hydrogenase and epimerase activity results in the rhamnose precursor for the 
hydrophilic moiety. Secondly, the hydrophobic part originates from the bacterial fatty acid 
synthesis. Since this synthesis uses a dissociated enzyme system445, the intermediates 
produced are easily accessible for other enzymes to divert them towards production molecules 
different from fatty acids. One group of these intermediates are the β-hydroxy fatty acids. The 
first rhamnosyltransferase RhlA is able to couple two of these molecules into a dimer called a 
3-(3-hydroxyalkanoyloxy) alkanoic acids (HAA). In P. aeruginosa, this enzyme has a high 
preference towards chain lengths varying from 8 to 12 carbon atoms with the highest activity 
for 10 carbon atoms. In Burkholdera species, longer congeners with 14 carbon atoms are 
produced. Though a dimer is the most common variant, monomers and trimers occur as well44. 
Finally, transferases RhlB and RhlC will utilize dTDP-L-rhamnose as a donor to rhamnosylate 
the HAA group.  
Sophorolipids, another well-studied kind of glycolipid, is produced by the yeast S. bombicola446. 
It is a secondary metabolite composed out of a hydroxy fatty acid and two sugar moieties. The 
glucosylation of the hydroxy fatty acid is achieved by a glucosyltransferase named UGTA1175 
while the second transferase UGTB1 couples a second glucose to the first one by a β-1,2 
glycosidic bond. High production titers have been achieved in optimized production setups370 
with productivities up to 3.5 g/L.h422. To achieve these high levels, an efficient flux of 
metabolites has to exist inside the cell. UDP-glucose is generated from glucose-1-phosphate 
and UTP. Two sources of glucose-1-phosphate are present in the central metabolism of many 
organisms. A first one is gluconeogenesis. In this pathway, glucose-1-phosphate is generated 
in a mechanism similar to reversed glycolysis. It is proven in C. apicola that some percentage 
of glucose-1-phosphate is indeed created this way447. A second route is catalysed by 
phosphoglucomutase (PGM). It interconverts glucose-6-phosphate to glucose-1-phosphate448. 
Though it is not known for S. bombicola, it has been proven that the route via PGM to UDP-
glucose can be engineered for higher fluxes through the Leloir pathway449,450. 
Harnessing the capability of S. bombicola to glucosylate fatty acids in an efficient manner 
opens up possibilities for production of other kinds of glycolipids. As was demonstrated in 
Chapter IV, changes to the carbohydrate head group are possible. During this research, 
heterologous production of rhamnolipids was attempted. The precursor pathways for both 
activated rhamnose and HAA molecules were introduced and tested for their activity. 
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General cultivation conditions for S. bombicola and E. coli can be found in II.2.1. For the 
quercetin glycosylation experiments with S. bombicola, 1 g/L of quercetin dissolved in DMSO 
was added to the cultures. Pseudomonas aeruginosa PAO1 LMG24986 was obtained from 
the Belgian Co-Ordinated Collections of Micro-organisms and cultured in the same medium as 
E. coli Dh5α. 
 
  General techniques 
General molecular techniques are identical as described in II.2.2. 
 Plasmid development 
Creation of a UDP-rhamnose strain 
The plasmid developed in II.2.3.2 was used for efficient recombination at the cyp52m1 locus. 
The vector backbone was amplified with primers P52_REV_upCYP and P69_FOR_RegulUP 
(Table 5.2) (6539bp). The coding sequence of Rhm2/Mum4 (GenBank: AEE32949.1) was 
codon optimized by backtranslation from the protein sequence and ordered as a gBlock at 
Integrated DNA technologies (Leuven) (Appendix D). The gBlock was used as a template for 
amplification with primers P1052_Rhm2GibCypFor and P1781_Rhm2GibCypRev (2073bp). 
Assembly was performed with Gibson assembly and correct plasmids are screened with 
primers P945_Rhm2SeqFor and P79_REV_tCYP_extBamHI (1870bp). After sequencing, the 
expression cassette is amplified with primers P847_Cm2ExCasLongFor and 
P887_Cm2ExCasRev (5516bp) from BS_EC_0285_Cyplocus_Rhm2 and transformed in S. 
bombicola PT36. The mutants are finally screened with primers P946_Cm2checkRev and 
P79_REV_tCYPextBamHI for the 5’-region and P38_For_qPCRURA3 combined with 
P952_A21TotRev for the 3’-region. All the necessary primers can be found in Table 5.2. 
Development of a dTDP-L-rhamnose strain 
Creation of the dTDP-L-rhamnose strain involved the introduction of three genes at the three 
final loci of the sophorolipid biosynthetic cluster. The original bacterial pathway was shortened 
by one enzyme by using the Arabidopsis thaliana AtNRS/ER to perform the final two steps. 
The coding sequence was ordered as a gBlock (GenBank: AEE34035.1) at IDT (Appendix D) 
and subsequently amplified and assembled into the final expression vector. The vector 
backbone used was amplified from the earlier developed cyp52m1 locus plasmid developed 
in II.2.3.2. All other sequences were amplified from genomic material from P. aeruginosa PAO1 
and S. bombicola (Table 5.2). If necessary, intermediate fragments were generated by fusion 
PCR with Primestar and subsequently stored in a pJET vector. The final assembly 
(BS_EC_0102_pGEMTRhamnose 1) was performed by Gibson assembly and is shown in 
Figure 5.1.  
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The final expression cassette was created by primers P508_MDRendFor and 
P887_CM2ExCasREV (8117bp). Mutants were screened with P264_MDRseq4 and 
P940_ugtA1_start (2886bp) and P953_URA3outendFor combined with P952_A21totRev 
(1172bp). 
Table 5.1: Sequences needed for the construction of a dTDP-L-rhamnose S. bombicola strain. 
Sequence name Length (base pairs) Homology 5’-region Homology 3’-region 
5’ homologues region 951 pJET vector backbone Atnrs/er 
Atnrs/er 906 Atnrs/er Terminator UGTA1 
Terminator UGTA1 262 Terminator UGTA1 rmlB 
rmlB 1059 Terminator UGTA1 Promotor UGTA1 
Promotor UGTA1 550 rmlB rmlA 
rmlA 882 Promotor UGTA1 3’ homologues region 
3’ homologues region  3499 rmlA pJET vector backbone 
 
 
Figure 5.1: Visual representation of the plasmid carrying the expression cassette for the production of 
dTDP-L-rhamnose in S. bombicola (BS_EC_0102_pGEMTRhamnose 1). 
Recovery of the NDP-rhamnose strains. 
The strains that are able of synthesizing NDP-rhamnose all have the ura3 marker in their 
genome. To perform additional modifications, this marker needs to be removed. This can be 
done by using a recovery cassette for transformation and plating out the cells on selective 
medium containing 5-FOA. The recovery cassette can be amplified from genomic DNA of wild 
type S. bombicola ATTC22214 with primers P69_FOR_RegulUP and P887_Cm2ExCasRev 
(930bp). After several days, the emerging colonies are screened with P69_FOR_RegulUP and 
P206_PfCYP1Rev (Table 5.2). Correct mutants produce a PCR product of 1060bp.  
NDP-rhamnose validation plasmid 
Validation of the abovementioned strains is done by glycosylation of quercetin by the A. 
thaliana AT78D1451 glycosyltransferase. A previous constructed plasmid for the ura3 locus 
(BS_EC_0395_UmUGT1_OE_Uraloc_kol4) was reused for construction of the expression 
cassette BS_EC_0393_AT78D1_OE_Uraloc kol 2. The coding sequence of the transferase 
was ordered as a gBlock (GenBank: AEE31240.1) at IDT (Appendix D) and ligated by Gibson 
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assembly in the linearized vector. The cassette was transformed in strains containing the 
previously constructed UDP- and dTDP-L-rhamnose pathways as well in a S. bombicola strain 
lacking the ugta1 gene. Selection was performed on nourseothricin. The gene at78d1 is 
controlled by the strong constitutive promotor from phosphoglycerate kinase. Amplification of 
the expression cassette is performed from this final plasmid. A second validation cassette 
containing the second rhamnosyltransferase rhlB was designed as well. The RhlB enzyme will 
also be expressed ura3 locus using nourseothricin as marker (pCARBO425 
pGEMT_pGKIRhlB_Nourseo). All the primers used can be found in Table 5.2. 
Table 5.2: Primers used for the construction of the different expression cassettes for nucleotide sugars 
and glycosylated quercetin. Binding and non-binding domains of the primers are separated by ligature. 
Primer name Primer sequence 
P1_FOR_URA3v AGAACAAGGCCGAGTATGTC 
P32_REV_cassette GTCAGATTAGCCTCCGACATAG 
P33_FOR_checkcassIN CCATACTCAAGCGCGAACAC 
P35_REV_checkcassIN_DOWN GAGCTCAAGACGCGTTTACTCAATGC 
P38_FOR_qPCRURA3 AGGTGGAGTGTTTAAGA 
P52_REV_upCYP ATATGTACTTTTCAATATGATAAACGGAGAAATAACG 
P69_FOR_RegulUP GTTTCTTAGCCTCCCATGGAAG 
P79_REV_tCYP_extBamHI CAGGATCC-GTCGGTTAAACGCACTCCTTC 
P377_MegaHit8For CTCCCTCCGTTGGCAATCAAACTG 
P554_MDRpAT5homGibFOR TTCCGGATGGCTCGAGTTTTTCAGCAAGAT-TGGTCTGGCCCTGAGTCTGAAG 
P555_MDRpAT5homoverREV TGCGTCTGCAACCAT-TGAATTCTAGAATGTGAGGTGGAATGAGGCAAGG 
P556_NRSERoverFOR ACATTCTAGAATTCA-ATGGTTGCAGACGCAAACG 
P557_NRSERoverREV ATGAATTTAGTTTAC-TCAAGCTTTAACTTCAGTCTTCTTGT 
P558_tAToverFor GAAGTTAAAGCTTGA-GTAAACTAAATTCATGACAGCCTTT 
P559_tATgibRev CGCGAGTGGGTGGGTAAGCAGTACGCATGA-AATCGTACGATCAAATCAGAT 
P560_RmlBcasGibFor TCTTCCCTGATCTGATTTGATCGTACGATT-TCATGCGTACTGCTTACCCACCCACT 
P561_RmlBcasoverrev CTTTCAGGCCATATA-ATGACGATTCTCGTGACCGGCAGCGCCGGCTT 
P562_pUGTAoverfor CACGAGAATCGTCAT-TATATGGCCTGAAAGAGG 
P563_pUGTAoverrev GCCCTTGCGTTTCAT-ATATGTACTTTTCAATATGATAAAC 
P564_RmlAcasoverfor TTGAAAAGTACATAT-ATGAAACGCAAGGGCATCATCC 
P565_RmlAcasGibrev GAACGTTTCTTCCATGGGAGGCTAAGAAAC-TCAGTACACGGTCTCGGTCAG 
P566_DOWNCYPFOR AAGCGCCTGCTGACCGAGACCGTGTACTGAGTTTCTTAGCCTCCCATGGAAG 
P567_DOWNCYPREV AGAATATTGTAGGAGATCTTCTAGAAAGATAAGCGTGAAGCTCCTCTGACAATC 
P568_pJETrhamnGibfor AGTTTTGATTGTCAGAGGAGCTTCACGCTT-ATCTTTCTAGAAGATCTCCTACAAT 
P569_pJETrhamnGibrev CTGCGTTACTTCAGACTCAGGGCCAGACCA-ATCTTGCTGAAAAACTCGAGCCATC 
P840_MDRSeq3 TGATTGGCGGCATAGTTACTGG 
P841_MDRSeq4 TGGTCTGGCCCTGAGTCTGAAG 
P847_Cm2ExCasLongFor CGTTGTCAAGTCCTAAGGTAT 
P887_Cm2ExCasRev AAGCGTGAAGCTCCTCTGACAATC 
P940_ugtA1_start CACAATGAGCCCTTCATCACAC 
P945_Rhm2SeqFor TGGCACTCATGTGCTCTTGG 
P946_Cm2checkRev CAACAGTACGAACATTTCCGTTAGAG 
P952_A21TotRev GCTCTTGTTCGGTACTCTTATT 
P953_ura3outendfor TAAAGAAACGAAGGGCCCAGCAGTC 
P1052_Rhm2GibCypFor CGTTATTTCTCCGTTTATCATATTGAAAAGTACATAT-ATGGATGATACAACATACAA 
P1344_REV_MDR CGAGAAACGCACTGCCGAGCATAC 
P1580_AOX2_sequencing_3 CGCTGAGACTCACTCACTTG 
P1596_ACP_check_out_fw_2 TATGCTGGTGCATCCAGTTG 
P1600_GAPD_insert_check_rv GTCCCGATACTGGGATGTTG 
P1772_nat1_check_rv TCATGTAGAGCGCCTGCTCG 
P1781_Rhm2GibCypRev GGGAACGTTTCTTCCATGGGAGGCTAAGAAAC-
TTAGGTTCGCTTATTGGGTTCGAAAAC 
P1814_tATrev AATCGTACGATCAAATCAGATC 
P2312_tGALFor ATATACACTAGATGCTATCGATAATATCG 
P2391_At78D1GibpGKIFor CTCCAAACCAGAAAAA-ATGACCAAATTCTCCGAGCCAA 
P2392_At78D1GibtTKRev CCGTGTTTCAGTTAGCCTCCCCCATCTCCCCTA-AACTTTCACAATTTCGTCCAACAA 
P2482_pGKIRev TTTTTCTGGTTTGGAGGACCTT 
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ACP and PPTase expression cassette at ura3 locus 
Construction of the first expression cassette carrying the acyl carrier protein (ACP) and the 
phosphopantheteine transferase (PPTase) was done using the pJET vector backbone for 
cloning in E. coli. All the different parts of the expression cassette can be found in Table 5.3 in 
their order of assembly. The pJET vector was chosen as a vector backbone to construct the 
expression cassette. The sequences of the ACP and PPTase were amplified from isolated 
genomic DNA from P. aeruginosa PAO1. The primer used for amplification of the ACP 
contained a 6xHis tag. All other sequences were picked up from S. bombicola ATCC22244 
genomic DNA except for the vector backbone. Primers were ordered at Integrated DNA 
Technology (IDT, Leuven, Belgium). The final expression plasmid is 
BS_EC_0130_pJETACPPPTase 1 (Figure 5.2). The expression cassette for integration in the 
genome of S. bombicola PT36 Δcyp52m1 is created by using primers 
P49_FOR_URA3upextNheI and P1013_GAPDAT_FusionF (Table 5.4). Screening of the 
mutants after incubation on SD medium was performed by colony-PCR with primers 
P1_FOR_URA3v and P690_ACPhisGibpCypFor (2330bp) for the 5’ region and 
P843_A21knockhygroCasFor combined with P35_REV_checkcassIN_DOWN (1897bp) for 
the 3’ region. 
Table 5.3: Fragments used for the ACP-PPTase expression cassette 
Sequence name Length (base pairs) Homology 5’-region Homology 3’-region 
5’ homologues region 1849 pJET vector backbone Terminator AT 
Terminator AT 330 5’ homologues region  acp 
acp 229 Terminator AT Promotor UGTA1 
Promotor UGTA1 590 acp pptase 
pptase 774 Promotor UGTA1 3’ homologues region  
3’ homologues region  1062 pptase pJET vector backbone 
 
 
Figure 5.2: Overview of the ACP-PPTase expression cassette (BS_EC_0130_pJETACPPPTase 1). 
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Table 5.4: Primers used for the ACP-PPTase expression cassette. 
Primer name Primer sequence 
P1_FOR_URA3v AGAACAAGGCCGAGTATGTC 
P35_REV_checkcassIN_DOWN GAGCTCAAGACGCGTTTACTCAATGC 
P49_FOR_URA3upextNheI CGCTAGCCATGCTGAAGACAGCACCGCTGCTATC 
P685_5-regionURA3GibpJETFor CCGCCAGATCTTCCGGATGGCTCGAGTTTTTCAGCAAGAT-AACAAGGCCGAGTATGTC 
P686_5-regionURA3GibtAtRev CTGTCATGAATTTAGTTTAC-TCATCTTGACTGAACTTTTCT 
P687_tATGib5-regionFor GAAAAGTTCAGTCAAGATGA-GTAAACTAAATTCATGACAGCCTTTTC 
P688_tATGibACPRev CATCATCACCATCACCACTAA-AATCGTACGATCAAATCAGATCA 
P689_ACPhisGibtAtRev GATCTGATTTGATCGTACGATT-
TTAGTGGTGATGGTGATGATGTTGCTGGTGAGCAACGATGTAG 
P690_ACPhisGibpCypFor CTTGCCTCTTTCAGGCCATATA-ATGAGCACCATCGAAGAACG 
P691_pUGTAGibACPFor CGTTCTTCGATGGTGCTCATTAT-ATGGCCTGAAAGAGGCAAG 
P692_pUGTAGibPPTaseRev CGGTCGTTCATGGCGCGCAT-ATATGTACTTTTCAATATGATAAACGGAGAAAT 
P693_PPTaseGibpUGTAFor GTTTATCATATTGAAAAGTACATAT-ATGCGCGCCATGAACGACCGTCTCCC 
P694_PPTaseGibp3-regionRev GAAGGAACTGTTTGAGAAAA-TCAGGCGCCGACCGCCACCAGGCT 
P695_3-regionGibPPTaseFor CTGGTGGCGGTCGGCGCCTGA-TTTTCTCAAACAGTTCCTTCAATGCAACTT 
P696_3-regionGibpJetRev CATGGCAGCTGAGAATATTGTAGGAGATCTTCTAGAAAGAT-
GAAGCAGGCGAGTCGGAGCA 
P843_A21knockhygroCasFor GAGTCGGGCGTTATTTCTCC 
P1013_GAPDAT FusionF GCCTCGTCAACCATCTTATC 
 
ACP, PPTase, FabD and FabY expression cassette at ura3 locus 
Introduction of the fabD and fabY genes in plasmid BS_EC_0130_pJETACPPPTase was done 
by linearising the vector with primers P697_5-regionGibtCabom03g16530Rev and P706_3-
regionGibFabYFor (Table 5.6) and ligating the different fragments in the order found in Table 
5.5 by Gibson assembly. The final plasmid is BS_EC_0403_ACP_FabDY_final (Figure 5.3). 
Table 5.5: Fragments used for the ACP-PPTase-FabD-FabY expression cassette. 
Sequence name Length (base pairs) Homology 5’-region Homology 3’-region 
tCabom03g16530 202 Vector backbone FabD 
fabD 982 tCabom03g16530 Promotor UGTB1 
Promotor UGTB1 527 FabD FabY 
fabY 1970 Promotor UGTB1 Vector backbone 
 
Table 5.6: Primers used for the ACP-PPTase-FabD-FabY expression cassette. Non-binding regions are 
separated by a dash. 
Primer name Primer sequence 
P697_5-regionGibtCabom03g16530Rev GAAATAAATTATTATAAGCACTGCAGCCTAGCAAAT-
TCAGGCGCCGACCGCCACCAGGC 
P698_tCabom03g16530Gib5-regionFor CTGGTGGCGGTCGGCGCCTGA-ATTTGCTAGGCTGCAGTGCTTATAATAATTTATTTC 
P699_tCabom03g16530GibFabDRev CGCGCGCCGCCCTGGCCTGA-TTTGGTTTCGCAGTGTCGAATTG 
P700_FabDGibUGTB1For CCACTCTCTGATTTTGGCTT-ATGTCTGCATCCCTCGCATTCGTCTTCCCTGG 
P701_FabDGibtCabom03g16530Rev CAATTCGACACTGCGAAACCAAA-TCAGGCCAGGGCGGCGCGCGT 
P702_pUGTB1GibFabDFor GAATGCGAGGGATGCAGACAT-AAGCCAAAATCAGAGAGTGG 
P703_pUGTB1GibFabYRev CAATGACCGGTAGTCGAGACATA-TAGGAGACTTTATTGTTTTATGC 
P704_FabYGibpUGTBFor CATAAAACAATAAAGTCTCCTAT-ATGTCTCGACTACCGGTCATTGTTG 
P705_FabYGibp3-regionRev GTATTCATGTGCAAGTTGCATTGAAGGAACTGTTTGAGAAAA-
TCAGTCGAGCATGTCGCTGAAA 
P706_3-regionGibFabYFor TTCAGCGACATGCTCGACTGA-TTTTCTCAAACAGTTCCTTCAATGCAACTT 
P1057_FabYSeqFor CTGGTCAAGGCCGAAGGCGGCCGCTA 
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Figure 5.3: Overview of the ACP-PPTase-FabD-FabY expression cassette (BS_EC_0403_ACP_FabDY_final). 
FabV, FabZ, FabF1 and FabG expression cassette for the lactone 
esterase locus 
The second expression cassette for the introduction of the bacterial fatty acid synthesis was 
designed for the lactone esterase locus. A similar strategy was followed as for the previous 
mentioned expression cassettes for the ura3 locus. In Table 5.7 the different fragments and 
their properties are mentioned. The final expression cassette can be amplified with primers 
P1666_lactcasrev and P297_kolip2flankrev (Table 5.8) from the plasmid 
BS_EC_0345_FabVZ1 (9043bp). Screening of the mutants is done by PCR with primers 
P940_ugtA1start, P1664_lactcheckcasfor, P551_ura3endrev and P1665_lactcheckcasrev 
resulting of fragments of 2321bp and 2408bp for the 5’ and 3’-region. Alternatively, a second 
cassette with hygromycine selection was created as well. This was to encounter potential ura3 
recovery problems. The final plasmid with hygromycine resistance is 
BS_EC_0404_FabGFZV_hygromycine kol 1. 
Table 5.7: Fragments used for the FabF1-FabV-FabG-FabZ expression cassette 
Sequence name Length (base pairs) Homology 5’-region Homology 3’-region 
5’ region 1000 Vector backbone FabF1 
fabF1 1245 5’ region Promotor UGTA1 
Promotor UGTA1 550 FabF1 FabV 
fabV 1197 Promotor UGTA1 Terminator At 
Terminator At 262 FabV FabG 
fFabG 744 Terminator At Promotor UGTB1 
Promotor UGTB1 484 FabG FabZ 
fabZ 441 Promotor UGTB1 Terminator 01g4190 
Terminator 01g4190 816 FabZ URA3-marker 
ura3 marker 
hygromycine marker 
1412 
1814 
Terminator 01g4190 
Terminator 01g4190 
3’ region 
3’ region 
3’region 1000 URA3-marker Vector backbone 
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Figure 5.4: Overview of the FabF1-FabV-FabG-FabZ expression cassette with ura3 selection 
(BS_EC_0345_FabVZ1) 
Table 5.8: Primers used for the FabV-FabZ-FabF1-FabG expression cassette 
Primer name Primer sequence 
P297_kolip2flankrev TACTGCTCTGCCGATCGTTG 
P551_ura3endrev TCATCTTGACTGAACTTTTCTCAGATA 
P940_ugtA1start CACAATGAGCCCTTCATCACAC 
P955_lacton5GibpjetFor CAGATCTTCCGGATGGCTCGAGTTTTTCAGCAAGAT-AACCAAGGGGTGATCTCTCG 
P956_Lacton5GibfabF1Rev CGCAGGTTCGCCGACTGA-TTTGAGACCATTTGAATCCC 
P957_fabF1Gib5regionRev GATTCAAATGGTCTCAAA-TCAGTCGGCGAACCTGCGGA 
P958_fabF1GibpCypFor CCTCTTTCAGGCCATATA-ATGTCGCGTAGACGCGTCGTCA 
P959_pCYPGibfabF1For CGACGCGTCTACGCGACAT-TATATGGCCTGAAAGAGGCA 
P960_pCypGibfabVRev GCGCGGTTTGATGATCAT-ATATGTACTTTTCAATATGATAAACGGAGAA 
P961_fabVGibpCYPFor CATATTGAAAAGTACATAT-ATGATCATCAAACCGCGCGTG 
P962_fabVGibtATRev GTCATGAATTTAGTTTAC-TCAGGCCTGGATCAGGTTGG 
P963_tATGibfabVFor CAACCTGATCCAGGCCTGA-GTAAACTAAATTCATGACAGCCTTT 
P964_tATGibfabGRev GGGATGTACATGAGCTGA-AATCGTACGATCAAATCAGA 
P965_fabGGibtAtRev GATTTGATCGTACGATT-TCAGCTCATGTACATCCC 
P966_fabGGibpMDRFor CACTCTCTGATTTTGGCTT-ATGAGTCTGCAAGGTAAGG 
P967_pMDRGibfabGFor CTTACCTTGCAGACTCAT-AAGCCAAAATCAGAGAGTG 
P968_pMDRGibfabZRev CTCGTTGATGTCCATCAT-ATAGGAGACTTTATTGTTTTATGC 
P969_fabZGibpMDRFor CATAAAACAATAAAGTCTCCTAT-ATGATGGACATCAACGAGATTC 
P970_fabZGibtcabomRev CACTGCAGCCTAGCAAAT-TCATAGTTTGCGTTCCGC 
P974_pUraGibLacton3For CATGTAGTCGCACCCGCCCC-GTTGAACCATGATGGCAGTGTT 
P975_lacton3GibUraFor CTGCCATCATGGTTCAAC-GGGGCGGGTGCGACTACATG 
P976_lacton3GibpJetRev CAGCTGAGAATATTGTAGGAGATCTTCTAGAAAGAT-
GATCGCAGTAAGGCCCCTCGT 
P1660_FabZGibTermRev TCATAGTTTGCGTTCCGCACAGATGATTTCAGCC 
P1661_Term41904200GibFabZFor CATCTGTGCGGAACGCAAACTATGA-GCACACACGAAGAGTGCC 
P1662_Term41904200GibURA3Rev CATATCTGAGAAAAGTTCAGTCAAGATGA-GTCTCATTCTATCAAAAGCCAGTACTA 
P1664_lactcheckcasfor ACCAAGGGGTGATCTCTCGAGATGG 
P1665_lactcheckcasrev GCAGTAAGGCCCCTCGTTACCC 
P1666_lactcasrev TGCTCGTCTGAGACGGCTTGGG 
P2293_HygroGibUGTB1locFor ACTAGTACTGGCTTTTGATAGAATGAGAC-TCAGTTAGCCTCCCCCATCTCCCGATCC 
P2294_HygroGibUGTB1locRev CAAGAACTACACTCGGTGTTGAGAGCAGAACCAATGGCAGTGGCTTAC 
P2295_LactonasebbFor GGGGCGGGTGCGACTACATGAACATC 
P2296_HygroGibLaclocRev GAGCGATGTTCATGTAGTCGCACCCGCCCC-CCAATGGCAGTGGCTTAC 
Chapter V  Production of rhamnolipids in S. bombicola 
 
 
143 
 
HAA production cassette 
Expression of the P. aeruginosa rhlA was obtained by creating an expression vector designed 
for the cyp52m1 locus (see II.2.3.2). The coding sequence of rhlA was amplified from genomic 
material DNA from P. aeruginosa PAO1 isolated using the GenElute Bacterial Genomic DNA 
Kit (SigmaAldrich; USA). The vector was linearized and both fragments were assembled with 
the In-Fusion® HD Cloning Kit (Takara; Japan). After transformation in S. bombicola ΔPT36, 
the mutants were screened with primers P954_Cm2checkFor and 938_ura3outbeginrev for 
the 5’ region (Table 5.9). The 3’ region was screened with P946_Cm2checkRev and 
P952_A21TotRev. Again both ura3 and nourseothricin (respectively BS_EC_0403 and 
BS_EC_0404) selection constructs were designed. The expression cassette was also 
introduced in in a S. bombicola strain carrying the cassettes. 
Table 5.9: Primers used for the creation of the rhlA expression cassette designed for the cyp52m1 locus of 
S. bombicola. 
Primer name Primer sequence 
P52_REV_upCYP ATATGTACTTTTCAATATGATAAACGGAGAAATAACG 
P69_FOR_RegulUP GTTTCTTAGCCTCCCATGGAAG 
P163_RhlainfFor ATTGAAAAGTACATAATGCGGCGCGAAAGTCTGTTGG 
P164_RhlainfRev AACGCTAGCTTGGCGTCAGGCGTAGCCGATGGCCATCTC 
P938_ura3outbeginrev ACTGCCATCATGGTTCAACCTCAC 
P946_Cm2checkRev CAACAGTACGAACATTTCCGTTAGAG 
P952_A21TotRev GCTCTTGTTCGGTACTCTTATT 
P954_Cm2checkFor TCATAGCGAGTTTCTTTGCATGTG 
 
 
Extraction of proteins from S. bombicola strains is described in III.2.5. 
 
 Native PAGE 
For the native separation of basic and neutral proteins (pI < 7.0), a basic gel can be applied 
for separation. The composition of both the stacking and running gel can be found in Table 
5.10. The gels are both let to polymerize for 1 hour. The total amount of protein to be loaded 
depends on the application, but may vary from 0.5 to 5 µg. The samples are loaded with a 5 x 
concentrated sample buffer (50 % glycerol 50 %, 27 % mQ, 22.9 % Tris-HCl pH 6.8, 0.1 % w/v 
Bromophenol Blue). The gels run at 250 V in a cooled buffer (0.05 M Tris, 0.38 M glycine in 
distilled water).  
 
Table 5.10: Composition of a basic native polyacrylamide gel. 
Components Stacking Gel Resolving Gel 15% 
Tris-HCl 1.5M pH 8.9 (mL) - 1.3 
Tris-HCl 0.5M pH 6.8 (mL) 1.25 - 
30% Acryl-Bis 500 µL 2.63 mL 
Distilled water (mL) 3.2 1.17 
TEMED (µL) 5 11.5 
10% APS (µL) 50 20 
Total 5.005 5.1315 
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 Native Western Blotting 
The proteins are transferred from the native PAGE to a nitrocellulose membrane. The 
membrane, Watmann-paper, spunch and native gel are put in CAPS buffer (0.1 M CAPS, pH 
11) and stacked according to the order seen in Figure 5.5. The transfer is at 100 V for 60 
minutes.  
 
Figure 5.5: Composition and order of the transfer stack for native Western blotting. 
After transfer, the membrane is blocked for 1 hour in phosphate buffer solution (PBS) (0.1 M 
NaCl, 0.083 M Na2HPO4 and 0.017 M NaH2PO4 at pH 7.2) containing 1% casein and incubated 
at room temperature on an orbital shaker overnight. Afterwards, the membrane is washed 
thrice with PBS containing 0.2 % Triton X100. Blotting of the membrane is done by applying 
the first antibody (anti-His from mouse, Sigma) in a 1/2700 diluted solution in 20ml PBS 
containing 1 % casein and 0.2 % Triton X100. Incubate for 2h on an orbital shaker. Wash the 
membrane thrice with PBS containing 0.2 % Triton X100. Blot with the second antibody (anti-
mouse from goat with alkaline phosphatase conjugate, Sigma) in a 1/6700 diluted solution in 
20ml PBS containing 1 % casein and 0.2 % Triton and incubate for 1 hour on an orbital shaker. 
Wash the membrane again three times with PBS. Develop the blotted membrane by 
phosphatase conjugation. Add 50µl NBT/BCIP stock solution (Sigma) to 10ml 10mM Tris pH 
9.5 containing 100mM NaCl and 50mM MgCl2. Incubate the membrane during 30min at 37°C 
in the dark. 
 
5’-Uridinediphospho glucose disodium salt hydrate (UDP-glucose) and 2'-Deoxy-Thymidine 
diphosphate rhamnose (dTDP-rhamnose) were obtained from Carbosynth. Quercetin and 2'-
Deoxy-Thymidine diphosphate glucose (dTDP-glucose) was ordered at SigmaAldrich. 
Substrate solutions were prepared freshly in 50 mM KH2PO4, pH 7.7 except for quercetin, 
which was dissolved in DMSO. Enzyme assays contained 2 mM of all the substrates used and 
200 µl fresh protein solution (III.2.5) in a total volume of 250 µl. For the blank reactions 
phosphate buffer replaced either the donor, the acceptor or the protein solution. All enzyme 
reactions were incubated at 30°C for 3, 6 and 24h. Reactions were stopped by addition of 200 
µl HCl (2N) and analysed by LC-MS and TLC. 
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 Analysis of NDP-sugars and monosaccharides 
Nucleotide activated sugars were analyzed on HPLC and LC-MS with a method described by 
Räbinä et al.452. The column used was a Grace™ Alltech™ Prevail™ C18 250mm column. The 
HPLC system was a Varian Prostar HPLC system coupled to a Varian dual wavelength 
detector. The LC-MS consisted of an Intertek ASG (Manchester, UK) with a Micromass Quattro 
Ultima LIMS 1107 (Waters). Two types of detection were used.  When negative ion mode was 
applied, the scanning range was set between 550 and 700 m/z. With single ion mode, the 
masses below (Table 5.11) were used for detection.  The same column and LC conditions as 
for the HPLC analysis were used. 
Table 5.11: Masses of the different nucleotide sugars used in single ion mode. 
Nucleotide sugar Mass (Dalton; m/Z + 1) 
UDP-Galacturonic acid / Glucuronic acid 580 
UDP-D-Galactose / Glucose 566 
UDP-N-Acetylgalactosamine / glucosamine 607 
UDP-L-Rhamnose 550 
GDP-D-Mannose 605 
dTDP-L-Rhamnose 548 
dTDP-L-Glucose 564 
dTDP-4-dehydro-6-deoxy -L-mannose/D-glucose 546 
  
Monosaccharides were analysed on the LC-MS using the X-Bridge Amide column made by 
Waters. Both single ions (163, 179) as a range (100-350 m/z) were used for detection. Elution 
of the sugar molecules from the column was done isocratic with 75% acetonitrile and 25% mQ 
and 0.15% trimethylamine. The flow rate was 1 mL/minute while the column was kept at 35 °C. 
Standard series of rhamnose were used to determine the concentration in the samples. 
 Analysis of quercetin glycosides 
Quercetin glycosides from culture broth or enzymatic reactions were analyzed by TLC on Silica 
gel 60 F254 (Merck, Germany). Separation of quercetin and the different quercetin derivatives 
was done by using ethyl acetate:acetic acid:formic acid:water (100:11:11:27) as a mobile 
phase. Compounds were visualized either by staining with 10 % H2SO4 and subsequent 
charring or by UV-detection at 254 nm. 
LC-MS analyses was done using the method described in Pandey et al453. 
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 Sampling of glycolipids and HAA molecules 
Sampling of glycolipids and HAA molecules was done as described in II.2.4.2. LC-MS analysis 
was conducted to identify the different congeners possible. In Table 5.12 the different masses 
of the most likely HAA molecules can be found. 
Table 5.12: Table of the different HAA molecules that can be produced. Though shorter and longer chains 
can be incorporated, only the most likely molecules are searched for. 
HAA molecule Molecular weight 
C8-C8 302 
C8-C10 / C10-C8 330 
C8-C12 / C12-C8 356 
C10-C10 358 
C10-C12 / C12-C10 386 
C12-C12 414 
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Engineering of S. bombicola for the production of activated rhamnose is undertaken by 
following two strategies. The first one tries to import the bacterial dTDP-L-rhamnose pathway 
using glucose-1-phosphate as a substrate. In nature, this pathway uses four distinct steps to 
generate the activated rhamnose. However, in Arabidopsis thaliana, a 3,5-epimerase/4-keto 
reductase called AtNRS/ER (AT1G63000) was discovered that shows activity towards dTDP-
4-keto-6-deoxy-glucose454 and produces dTDP-L-rhamnose. A second strategy is based on 
the plant based system for the generation of UDP-rhamnose from UDP-glucose. This is 
catalysed by one single enzyme called RHM2/MUM4 (AT1G53500)455. One benefit of this 
strategy is that the enzyme can directly use the already available pool of UDP-glucose, which 
is efficiently generated in S. bombicola. Both kinds of activated rhamnose pathways will be 
introduced in S. bombicola and their products will be measured.  
Isolation of nucleotide sugars and their subsequent detection is possible, but one needs to 
keep in mind that they are intracellular metabolites. Breaking open the cells and isolate them 
can result in relatively large variations so that real quantification can be tricky. A more robust 
way of analysis is using the available pool for further modifications like rhamnosylations. The 
presence of NDP-sugars can be proven and furthermore demonstrated to be accessible and 
usable for other enzymes. As a proof of concept, this pool will be used as a substrate for 
rhamnosylation of quercetin. For this, another gene from A. thaliana will be expressed in S. 
bombicola. The enzyme ATUGT78D1 (AT1G30530) is a flavonol-3-O-rhamnosyltransferase 
capable of using UDP-D-glucose, UDP-L-rhamnose and dTDP-L-rhamnose for in vivo 
glycosylations451,456. An overview of all the different steps in the creation of a flavonoid 
glycosylation platform can be seen in Figure 5.6. The different chemical structures of quercetin 
and its glycosides can be seen in Figure 5.7. 
 
Figure 5.6: Overview of the steps required to produce UDP-L-rhamnose and dTDP-L-rhamnose from 
glucose-1-phosphate. Utilizing these pools for the glycosylation of quercetin is done by ATUGT78D1. 
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Figure 5.7: Chemical structures of quercetin and the glycosides that are produced by ATUGT78D1. 
Quercetin glucoside can be seen in the middle named isoquercetin while the rhamnoside can be seen as 
quercitrin. 
 Engineering and evaluation of NDP-L-rhamnose strains 
A first production trial was conducted with the dTDP-L-rhamnose and UDP-L-rhamnose strains 
in comparison with the wild type and cyp52m1 knock-out S. bombicola strains (for strain 
construction see Chapter V.2.2.2). Both NDP-L-rhamnose strains contain the genes necessary 
for production of activated rhamnose. The coding sequences are knocked-in at the cyp52m1 
locus for the UDP-L-rhamnose strain and at the loci of the acetyltransferase, ugta1 and 
cyp52m1 all situated inside the sophorolipid gene cluster. Regulatory sequences such as 
promotors and terminators were recycled for their respective locus. The cyp52m1 knock-out 
was taken along since it does not produce sophorolipids, a product that might interfere with 
both the availability of UDP-glucose and further analysis. Both the supernatant and the cells 
were collected and processed. Nucleotide sugars ware purified and concentrated as described 
in materials and methods. Initially, the methods described by Räbinä et al.452 was tested both 
for purification as analysis. Separation of the different nucleotide sugars was feasible using a 
Grace Alltech Prevail C18 HPLC Column as can be seen in Figure 5.8. Purification of cell 
lysate remained troublesome. The method developed by Räbinä et al.452 appeared not suitable. 
A different method designed by Behmüller et al.457 was tested as well, but the results remained 
inconclusive. Though the purification of a stock solution of UDP-glucose was possible, using 
the same technique for purification of nucleotide sugars from yeast cells remained inconclusive. 
 
Figure 5.8: Standard of different nucleotide sugars used to optimise separation on a Grace Alltech Prevail 
C18 HPLC Column 
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Though nucleotide sugars can be isolated efficiently from cells according to several papers, 
no success was achieved with the various different methods tested. However, these molecules 
tend to be instable during longer periods of time by hydrolysis in the corresponding 
monosaccharide by enzymes belonging to the Nudix hydrolase superfamily. It is known that S. 
bombicola is not capable of utilizing rhamnose458 for growth so any hydrolysis will result in a 
small accumulation of rhamnose over time. Therefore, detection of the monosaccharide 
rhamnose would in parallel prove the existence of the activated rhamnose inside and 
potentially outside the cell.  
The same strains as mentioned above were grown on standard production medium without 
the addition of any hydrophobic substrate. After 8 days, the cells were collected by 
centrifugation and both the remaining broth and the cells were analysed for rhamnose 
production. In Figure 5.9, a direct comparison can be found between the different strains tested. 
Rhamnose has an elution time of approximately 14.5 minutes. When looking at the wild type 
and the cyp52m1 knock-out strains, no signal can be detected at this time point. When 
comparing the NDP-rhamnose strains, one can see in comparison a new signal at 14.5 minutes. 
Though this is indicative of a novel molecule being formed in the rhamnose strains, it still shows 
a slightly different position compared to the standard. This might be explained by the more 
complex matrix in which the samples are dissolved. Standard addition of rhamnose was 
performed as well and confirmed the position of the new signal to be likely rhamnose. Though 
it is not a direct measurement of the nucleotide sugar, the origin of the rhamnose can only be 
derived from this activated molecule since it cannot be found in the control strains.   
 
Figure 5.9: LC-MS chromatograms of the analysed supernatant for the different strains tested. (A) rhamnose 
standard, (B) wild type S. bombicola, (C) Δcyp52m1 S. bombicola, (D) dTDP-L-rhamnose strain, (E) UDP-L-
rhamnose strain. The elution time of rhamnose is 14.5 minutes and is marked by the yellow line. 
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 Glycosylation of interesting biomolecules 
Growth trial with quercetin 
To assess the availability of the different NDP-rhamnose pools in the engineered S. bombicola 
strains, the A. thaliana ugt78d1 gene was introduced in the NDP-L-rhamnose producing strains 
developed in V.2.2.2 as well in a Δugta1 strain of S. bombicola. The latter one was chosen as 
a control since it doesn’t produce any activated rhamnose so the A. thaliana transferase would 
only be able to produce quercetin glucosides. The NDP-L-rhamnose strain would be capable 
of producing both the rhamnoside and the glucoside. The three different mutant strains were 
inoculated and grown until the stationary phase at 48 hours. At this time point, quercetin 
dissolved in DMSO was added in a concentration of 1 g/L. After 8 days the cultures were 
harvested and both the supernatant and the intracellular matrix were analysed by TLC and LC-
MS. 
TLC already showed a clear difference between the dTDP-L-rhamnose strains and the two 
other strains. In Figure 5.10, a TLC is visible from an ethyl acetate extraction from the culture 
broth of all the strains tested. Though the amount of quercetin rhamnoside produced remains 
low, it is clearly visible for sample 2, the extraction corresponding to the dTDP-L-rhamnose 
strain. Interestingly, no quercetin glucosides are detected for all the strains tested. This is 
unexpected since the AT78D1 transferase is capable of utilizing UDP-glucose for the 
glucosylation of flavonoids.  
 
Figure 5.10: TLC of the ethyl acetate extraction from the growth trial with the different at78d1 carrying 
strains. Standards are visible in the first 3 lanes. Q = Quercetin, QR = Quercitrin, QG = Isoquercetin. Lane 1 
corresponds to the strain only carrying the at78d1 gene while lanes 2 and 3 are respectively the dTDP- and 
UDP-rhamnose strains carrying the at78d1 gene. 
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Enzyme tests on crude cell lysate 
Since the production levels were low, enzyme assays were conducted in parallel to test the 
production of glycosylated quercetin molecules using the activated rhamnose molecules. The 
3 strains carrying the at78d1 gene were inoculated in production medium and protein isolation 
was performed after 3 days in the stationary phase. For the UDP-rhamnose strain, only UDP-
glucose and quercetin were added as substrates since biosynthesis of UDP-rhamnose starts 
from UDP-glucose. For the dTDP-rhamnose strain, dTDP-rhamnose and dTDP-glucose were 
tested. As a control, the enzyme test was also performed on the Δugta1 cell lysate carrying 
the same at78d1 gene. The enzyme assay was sampled at 3, 6 and 24 hours and analysed 
on both TLC and LC-MS. Interestingly, no activity could be detected for these experiments. 
This stands in contrast to the samples from the growth experiment were the quercetin 
rhamnoside was detected for the dTDP-rhamnose strain.  
Though the exact nature for the lack of activity is unknown, several explanations can be found. 
First of all, quercetin is almost insoluble in water. This can lead to low substrate availability 
resulting in no or very low amounts of product formation. Secondly, the enzyme assays were 
conducted following the protocol also used for assaying the glucosyltransferases involved in 
the sophorolipid production175. It might be that the assay is not suitable for AT78D1, again 
resulting in no detectable activity.   
 
As in all living organisms, fatty acids can be synthesised de novo by the fatty acid synthase 
complex. In bacteria, this system is constituted out of different enzymes that are not associated 
with each other (see I.2.2). The growing acyl chain is transported between the different catalytic 
steps by the so-called acyl carrier protein (ACP), which buries the hydrophobic acyl chain 
inside the protein body shielding it from the watery cytosolic environment. In eukaryotes, the 
same types of catalytic steps are utilized for production of fatty acids. However, one big 
difference is the arrangement of the synthase complex. Instead of utilizing different enzymes, 
only two big proteins called α and β carry all the necessary domains459. These two enzymes 
form a multizyme consisting out of several α and β proteins and resembles a cage with the 
ACP protein (or better domain) trapped inside. This has as an advantage that locally high 
concentrations of fatty acid intermediates are present, pushing the equilibrium of the reactions 
towards the next step. However, this has as a consequence that the growing acyl chain is not 
available for the synthesis of other molecules.  
To ensure that the precursors needed for rhamnolipid production are present, it was opted to 
introduce all the genes necessary for cytosolic, dissociated fatty acid syntheses. To 
accomplish this, eight different genes need to be introduced in S. bombicola. Though more 
enzymes can catalyse a specific step in the pathway, a selection was made to limit the amount 
of genes required to be knocked-in and to ensure an as high as possible productivity and 
product uniformity or that might be interesting enzyme engineering targets for further 
optimization. An overview is given in Figure 5.11.  
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Figure 5.11: Proposed pathway for the production of HAA molecules in S. bombicola. The general 
precursor is Acetyl-CoA, originating from either glycolysis or β-oxidation of fatty acids.  
As a proof of concept, HAA molecules will be produced. One limiting factor for the engineering 
of this bacterial fatty acid synthase complex in S. bombicola is the limited amount of defined 
promotors and terminators. Therefore, the promotors and terminators of the sophorolipid 
biosynthetic cluster will be used. These promotors are all active during the stationary phase. 
Another benefit is the bidirectional nature for the ugtb1 and ugta1 promotors, saving space in 
the expression cassettes. Though it is unknown if essential regulatory regions are present in 
the coding sequences of the sophorolipid biosynthetic genes upstream of these promotors, 
activity has been measured for the cyp52m1 promotor368. 
 Expression of rhlA in S. bombicola Δcyp52m1. 
As already mentioned previously, RhlA required β-hydroxy fatty acids coupled to an ACP. 
Though highly unlikely, an initial experiment is performed by expressing RhlA in S. bombicola 
without the entire bacterial fatty acid synthase complex. The only β-hydroxy fatty acids coupled 
to an ACP are present in the fungal synthase complex and not freely accessible. Still it can’t 
be ruled out 100% that RhlA cannot access them. To ensure no interference can occur from 
the native sophorolipid production, a cyp52m1 knock-out strain39 was used as a parent strain. 
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The analysis of the final samples was done using LC-MS and HPLC-ELSD. The masses of the 
expected congeners are described in V.2.6.3. As can be seen in Figure 5.12, no difference 
can be seen between the strain expressing the rhlA gene and the cyp52m1 knock-out strain. 
Analysis on LC-MS did not reveal any masses corresponding with the HAA molecules. 
Therefore, the strategy of the implementation of a bacterial fatty acid synthase in an eukaryotic 
host was chosen as the next step.  
 
Figure 5.12: HPLC-ELSD chromatogram of A.) the rhla strain and B.) cyp52m1 knock-out strain. The 
expected molecules for the RhlA strain would elute from the column between 25 and 35 minutes. 
 Introduction of a bacterial fatty acid synthase in S. bombicola 
The different cassettes carrying the genes required for the FAS II pathway were created as 
described in V.2.2.2. Initially, after every transformation, the ura3 marker would be removed 
by a recovery cassette. Though due to difficulties with this process, antibiotic resistance genes 
were used as an alternative. The coding sequence of the acp gene was equipped with a 6xHis 
tag for purification and detection by Western blotting. Due to the changing confirmation of the 
ACP during the elongation of the coupled acyl chain, a native polyacrylamide gel 
electrophorese allows the separation of different intermediate acyl-ACP congeners81. Both 
purification and detection of the ACP appeared difficult since no consistent results could be 
obtained. 
The final strain carrying all the genes necessary was compared in a growth trial to the 
Δcyp52m1 S. bombicola as the constructed HAA strain is not capable of producing 
sophorolipids. When analysing the chromatograms, it became clear that there was no 
detection of HAA molecules. The most likely explanation is a problem in the synthesis of these 
molecules, as the pathway relies on the correct expression of 9 genes and their correct 
interaction, it cannot be ruled out that the metabolism of S. bombicola interferes with production. 
HAA molecules are two or more β-hydroxy fatty acids coupled together. Growth trials 
performed by Roelants et al.368 show that metabolism of rhamnolipids is possible, but only after 
prolonged incubation times and when glucose has been depleted. This was confirmed by the 
presence of rhamnose and monorhamnolipids in the culture broth, molecules not present in 
the substrate.  
Analysis of the samples for this specific product was performed on LC-MS (Figure 5.13). When 
scanning for the masses corresponding to those formulated in V.2.6.3, no product could be 
identified. It has to be concluded that either one or several steps for the production of HAA 
molecules is not functioning or that the produced amounts are too low to compete with 
degradation or to be detected by the standard analytical methods at the lab. 
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Figure 5.13: LC-MS chromatogram for the growth trial with the strain carrying the FAS II synthase complex 
and the first rhamnosyltransferase RhlA. A.) Total chromatogram; B.) Mass scan of the most common HAA 
congener consisting out of two β-hydroxy decanoic acid molecules (m/z 357). 
 
Since no strain was created that could produce rhamnolipids in vivo, but only the necessary 
precursor strains, it was opted to test the in vivo and in vitro capabilities of the strains. Both 
NDP-rhamnose strains were equipped with the rhlB coding sequence, necessary for 
rhamnosylation of HAA molecules. During an initial production trial, both NDP-rhamnose 
strains were co-cultured with the HAA strain. After eight days, the broth was sampled and 
analysed on LC-MS. No molecules with masses similar to rhamnolipids could be detected. 
During a second experiment, crude cell lysates were generated from both NDP-rhamnose 
strains as well as from the HAA strain. Both crude lysates were combined and incubated at 
30 °C. Samples were taken after 24 hours. The lysate was extracted with an equal volume of 
ethyl acetate. This fraction was dried and the remaining pellet was dissolved. Analysis of the 
extract on LC-MS clearly showed that no new molecules are present when compared to the 
blanc. As can be concluded, the cell lysates of the precursor strains were not able to generate 
either HAA molecules or rhamnolipid like molecules. 
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Production of molecules structurally different from sophorolipids is possible with S. 
bombicola318. Still, often these molecules are derived from precursors that are easily 
accessible inside the cell. In the case of polyhydroxyalkanoate (PHA) production, the PHA 
synthase was targeted towards the peroxisome where the acyl-CoA precursors are readily 
available thanks to the β-oxidation. In the case of rhamnolipids production, the necessary 
precursors are not available or accessible for the different rhamnosyltransferases. Therefore, 
introduction of the bacterial derived pathways was needed.  For the production of 
monorhamnolipids, the variant with only one rhamnose molecule attached, 11 genes need to 
be introduced when using UDP-rhamnose as the carbohydrate donor.  
To assess the availability of the activated rhamnose, rhamnosyltransferase ATUGT78D1 from 
A. thaliana was introduced in the new strains. After an initial growth trial, quercitrin was 
detected on TLC for the dTDP-l-rhamnose strain. Though the acquired levels of quercitrin are 
low, together with the detection of rhamnose in the culture broth it proves the existence of an 
activated rhamnose molecule. 
No limitations are present when looking at the regions where these genes can be introduced 
in S. bombicola, but the limited knowledge and availability regarding promotors, terminators 
and their activity strongly hamper the engineering. The different expression cassettes created 
in this chapter, all contain promotors belonged to the sophorolipid synthesis cluster. This 
choice was made in the beginning to save space in the expression cassettes, as two out of 
three of them are bidirectional, and they are active during the stationary phase. This way, a 
lower burden would be introduced on the yeast cells compared to expression during the 
stationary phase. Furthermore, due to a lack of a promotor library, it seemed the only possible 
strategy to follow. 
During the engineering and testing of the novel strains, several problems turned up. First of all, 
in the case of the activated rhamnose, low product titers are present, even after prolonged 
incubation of the different production strains. This could be due to the presence of heterologous 
sequences inside the sophorolipid gene cluster. In Chapter II, several problems were 
encountered as well with different configurations of UGTA1-RFP constructs. Potentially, as 
stated previously, knocking in genes inside the sophorolipid gene cluster might have an 
influence on the activity of the promotors and subsequently the genes regulated by them.  
For the ACP-coupled β-hydroxy fatty acids and derived HAA-molecules, no activity could be 
detected. Production of these molecules required introducing 9 genes at 3 different loci. 
Problematic expression of just one of those genes can already result in no products being 
formed. One reason might be that the genes introduced originate from a Gram-negative 
bacterium with a differing codon usage. In general, S. bombicola has an AT ratio of 
approximately 50 % while P. aeruginosa can reach values of 34 %. For the genes introduced, 
similar ratios were found. Though there might be no regulatory effect on the promotors, the 
differing codon usage can still influence the expression of all those genes. To test whether 
expression is the reason for no production, qPCR or MRM experiments could be conducted. 
They don’t provide information of the confirmation of the enzymes being produced, it might 
learn something more about the bottlenecks in the research. 
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Traditional (bio)surfactants have many applications in for example personal care, oil recovery, 
cosmetics and agriculture (Figure 6.1). They promote solubilisation, emulsification and 
dispersion of other molecules. Globally, the market for surfactants is one of the largest when 
looking at the different industrial chemicals available. Their market share encompasses over 
€34 billion in 2016 and projected to grow each year with 5.6%. This translates in production 
volumes exceeding 15 million MT. Due to rising ecological awareness, a shift towards biobased 
surfactants can be seen. While the traditional surfactants are based on petrochemical 
resources, these biosurfactants are produced by renewable means. The first generation of 
biosurfactants are produced from oleochemicals like coconut and palm oil. It has to be noted 
that this is still a chemical process with often only the hydrophobic substrate being renewable. 
Second generation biosurfactants involve microbial produced molecules like sophorolipids 
(SLs), rhamnolipids (RLs) and mannosylerythritol lipids (MELs). Several multinationals show 
particular interest in these biosurfactants. MELs are mainly produced by Toyobo (Japan) while 
RLs mostly by Jeneil (USA) and Urumqi Unite Bio-Technology Co., Ltd. (China). SLs have a 
more international profile with producers, distributers and applicants such as Soliance (France), 
Ecover (Belgium), Evonik (Germany), Wheatoleo (France), Saraya (Japan), MG Intobio 
(Korea), SyntheZyme (USA) and multinationals such as Henkel. As already mentioned, these 
biosurfactants have their use in cosmetics, food, feed and drug formulation. When surveying 
the IP-landscape, multiple patents can be found for these applications. Still, a limited structural 
variety and high production costs hamper market penetration. Engineering of wild type or 
platform organisms can solve this problem. Since all commercial biosurfactants belong to the 
glycolipid class, expanding the diversity of the glyco- and lipo- part seem logical approaches 
to tackle the structural diversification. Lowering production cost can be done by optimization 
of the biosynthetic pathways and producer strains and state-of-the-art downstream processing. 
 
Figure 6.1: Biosurfactant market volume share by application in 2013460 
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In essence, molecular diversification can be achieved relatively easy when analysing the 
diversity already available in nature. When only glucose is considered, numerous 
disaccharides can be produced depending on the glycosidic bond between both monomers. 
However, certain carbohydrate moieties will be preferred over others because of their ease to 
be synthesised or other properties such as biological activity. From a practical point of view, 
the expansion of carbohydrate diversity can be reduced by searching for molecules with added 
biological benefits and by varying the degree of polymerisation. Depending on the hydrophobic 
group used, new physico-chemical properties will become available.  
When looking at the commercialised glycolipids, several different carbohydrate and lipidic 
groups are available. The most studied glycolipids are composed of for example sophorose, 
rhamnose, mannosylerythritol and trehalose as carbohydrate group. Variation of the lipidic 
group includes different kinds of hydroxy fatty acids, either as is or modified and/or polymerised. 
To further expand this variety, several strategies can be utilized. Genetic engineering has been 
proven to be a valid way to either increase product uniformity or to obtain novel kinds of 
molecules. Cellobiose lipids without the subterminal hydroxyl group on the palmitic acid tail are 
obtained by deleting the gene coding for the second P450 involved in the biosynthesis. In the 
case of sophorolipids, either knocking-out or overexpressing certain enzymes such as the 
second glycosyltransferase UGTB1, the acetyltransferase or the lactone esterase gives rise to 
either glucolipids, sophorolipids enriched in for example acidic or lactonic variants and even 
bola-sophorolipids. Though these example all involve direct interference into the biosynthetic 
pathway, other metabolic processes can have an impact as well. A deletion strain of S. 
bombicola lacking the MFE-2 enzyme essential to the β-oxidation was able to produce higher 
amounts of novel kinds of sophorolipids than the wild type strain with no adverse effects on 
cell viability314. Process engineering can also help to further expand and control the structural 
variability. In essence, the test with the mfe-2 knock-out is a good example of both kinds of 
engineering for enhanced sophorolipid production. 
S. bombicola has the potential to be a platform organism for the production of glycolipids or 
other molecules. Still, decent strain development is only possible when a solid foundation of 
molecular tools is available. Turning S. bombicola in the organism of choice will require further 
expanding the fundamental knowledge and ways to steer the metabolism. In Chapter II, both 
expanding the molecular tools and understanding sophorolipid synthesis are described. 
Transformation and selection has been developed by Van Bogaert et al.310 and further 
expanded to see the upper limits of the recombination system in S. bombicola. As became 
apparent, no clear limit can be detected up to 13.8 kb. During the research in Chapter II, it 
became clear that the stepwise lengthening and subsequent integration of cassettes for the 
cyp52m1 locus were not hampered in integration efficiency up to 11 kb. This opened the door 
for a proof-of-concept integration cassette with the potential of having a beneficial effect on the 
production of sophorolipids. Therefore, an additional copy of the sophorolipid biosynthetic 
cluster was integrated at the ura3 locus. The final integration cassette encompassed 14 kb in 
length and harboured five genes and a selection marker. The general idea was that an 
additional copy of each gene, except the lactone esterase, would help to enhance the flux 
throughout the pathway. Furthermore, it would enable future research on the regulation of the 
sophorolipid gene cluster. Unfortunately, no big gains in productivity could be measured and 
qPCR and MRM follow-up experiments provided opposite results and RNA and protein levels 
inside the cell. Still, the different experiments on integration length prove that it is possible to 
introduce entire pathways in one single transformation event at one specific location in the 
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genome. For the moment, only the ura3 locus has been tested for cassettes of 14 kb in length. 
However, there is no reason to believe this is a feature unique to this locus since throughout 
the research, several different loci were targeted for engineering and often integration 
cassettes larger than 8 kb were introduced. The lactone esterase locus was engineered in 
Chapter V by an integration cassette of 9 kb carrying four genes and a marker. 
One has to keep in mind that there’re several limiting factors for this technique. First of all, the 
recombination cassettes are dependent on large homologues regions both at the 5’ and 3’ part. 
Smaller sequences can be used, but this will have an impact on efficiency. During the research, 
no severe problems were encountered with low transformation efficiencies. Second drawback 
is the lack of suitable markers to use. Though the ura3 gene is already extensively used for 
engineering and counter selection is possible by 5-FOA, it slows down the speed at which new 
strains can be designed. Throughout this thesis, two antibiotic markers were used as well to 
circumvent problems with ura3 removal. Still, expanding the number of auxotrophic markers is 
necessary for complex metabolic engineering of S. bombicola. In the case of S. cerevisiae, up 
to 12 auxotrophic markers are available461. The lack of markers combined with relative efficient 
recombination events became problematic in Chapter II where during the screening for a 
functional ARS sequence in S. bombicola, (il)legitimate recombination of the screening vector 
resulted in many mutants being created of which none had a functional plasmid. Targeting of 
the plasmid towards either the ura3 locus (due to the promotor of the ura3 gene), the 
cabom03g11120 locus (source of the terminator for the ura3 marker in the screening vector) 
or even other locations in the genome (due to the screened DNA sequences) made it possible 
for S. bombicola to integrate the marker. Interestingly, when the same screening vectors were 
transformed in S. cerevisiae, it became apparent that the S. bombicola ura3 promotor was 
active in this yeast, allowing growth without integration of the plasmid. A potential solution to 
the integration problems might be using the ura3 promotor of for example S. cerevisiae in S. 
bombicola for expression of the ura3 marker. This way, homology is reduced. 
Essential to homologues recombination is the double-stranded break (DSB) of the DNA at the 
location where recombination is wanted. Several strategies are available to enhance the 
efficiency of homologues recombination by deliberately introducing these DSB. A powerful 
technique is using nucleases. Nucleases such as zinc finger nucleases (ZFN)462 or 
transcription activator-like effector nucleases (TALEN)463 can be targeted towards specific 
location in the genome and introduce double stranded DNA breaks. Both techniques rely on 
combining DNA interacting domains with the non-specific nuclease FokI. Engineering of the 
DNA interacting domain results in identification of specific sequences unique for the targeted 
locus or genomic region. Still, a major drawback for both techniques is the nuclease used. FokI 
needs to be a dimer before genome cutting can be performed. Therefore, an upstream and 
downstream ZFN or TALEN needs to be designed. This not only complicates the design of 
both classes, it also leads to the risk of homodimers being formed resulting in potential 
cleavage of genomic regions not targeted for engineering. Another strategy is using 
meganucleases464,465, DNA cleaving enzymes that recognize DNA sequences of 15 to 40 bp. 
Engineering of these enzymes is more complicated since the recognition and cleavage regions 
of the enzyme are grouped into a single domain. Still, several examples of successful 
engineering in plants, animals466 or even human cells467 can be found for all the techniques 
mentioned. 
One more drawback for the nuclease derived techniques is their locus dependency. The DNA 
interacting domains are all specific for one locus. If extensive engineering is required at multiple 
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locations several ZFNs, TALENs or meganucleases will have to be designed and introduced 
in the cells. A locus independent technique such as clustered regularly interspaced short 
palindromic repeat RNA-guided Cas9 nucleases (better known as CRISPR/Cas9) has already 
been used for yeast engineering. In S. cerevisiae, the technique has been used successfully 
for multigene knock-outs with efficiencies up to 87 %468. Using CRISPR/Cas9 in S. bombicola 
would require some engineering before the tool can be used. In other organisms, the coding 
sequences for the proteins can be delivered by a transient plasmid, but this is not possible for 
S. bombicola. The genes required would have to introduced in the genome first, preferably 
under the control of an inducible promotor to have full control over the activity of the system. 
Another essential part of the genetic engineering is the availability of standardised sequences. 
In the case of S. bombicola, only a couple of promotors have been characterised throughout 
the years. Reusing promotors with known properties was attempted in Chapter V to circumvent 
this problem, but ideally a promotor library is available for optimal balancing of the engineered 
pathways. This balancing is crucial for achieving optimum strain fitness and production. An 
imbalance in gene expression or enzyme activity can lead to stress responses due to 
excessive protein build-up, precursor depletion and accumulation of intermediates, which can 
inhibit enzymes or even can become cytotoxic. An example for this is the production of dTDP-
L-rhamnose. When intracellular levels of this molecule become too high, it effectively inhibits 
RmlA, the first step of its own biocatalytic pathway. Ideally these molecules are further used 
such as rhamnosylation of biomolecules as attempted in Chapter V. Creation of such a library 
can be done using the fluorescent proteins of Chapter II.  
Bidirectional promotors are of special interest since they can express two genes while often 
using the same amount of base pairs as a monodirectional promotor. This way, more genes 
can be introduced into an expression cassette with limited length. This was proven to be a 
valid strategy in the case of activated rhamnose production in Chapter V. For the production 
of dTDP-L-rhamnose, three genes were introduced at the loci of the acetyltransferase at, 
glucosyltransferase ugta1 and P450 cyp52m1 in the sophorolipid biosynthetic cluster. The 
detected production of rhamnose proved the activity of the (bidirectional) promotor pUGTA1-
pCYP52M1. 
Still, some caution is necessary as it became apparent in Chapters II and IV where suboptimal 
expression and production was achieved with certain configurations of genes and promotors. 
In the case of the RFP-coupled UGTA1, the N-terminal coupled RFP resulted in almost no 
production and fluorescence. Potentially one has to take into account the local DNA structure 
or regulatory sequences encoded in the coding sequences of the originally upstream of a 
promotor. Though no information is available on the regulation of sophorolipid synthesis, in 
other organisms the genes encoding secondary metabolites are often clustered in 
subtelomeric regions. Several ways of gene regulation are possible. In the case of cellobiose 
lipids, rua1 encodes a transcription factor necessary for the expression of the entire 
biosynthetic cluster. For S. bombicola, no such element can be found either inside the cluster 
or outside. The data obtained from RNA sequencing also did not yield potential candidates 
since no transcription factor or transcription related genes seem to behave the same or 
opposite of the sophorolipid biosynthetic genes. Another way of gene regulation is by global 
regulators that integrate environmental changes. Sophorolipid synthesis is initiated at high 
carbon/nitrogen ratios. Potentially, such a global regulator might be involved. A third kind of 
regulation is epigenetic. Certain modifications of histones can result in either dense chromatin 
called heterochromatin and the more open euchromatin. The latter one is more accessible for 
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enzymes acting on the DNA such as polymerases. Local disruptions of the DNA can have an 
influence on the state of the chromatin and subsequently the expression of the genes in that 
area. An interesting experiment to investigate the potential regulation can be done using the 
double cluster strain developed in Chapter II. Though the results obtained do not support any 
kind of conclusion, the technique itself could be used. Development of a strain lacking the 
entire cluster at its original location, but having a copy at the ura3 locus might result in a loss 
of regulation due to the different genomic location. 
Another interesting strategy to circumvent the potential negative influences of regulation on 
the production of novel molecules would be using characterised promotors and terminators. 
However, multi-step pathways require each gene to be suited with its own promotor and 
terminator, quickly resulting in large expression cassettes. Until recently, polycistronic 
expression of pathways was a quality exclusively given to bacteria. Several techniques are 
developed to allow multiple proteins to be translated from a single mRNA molecule in 
eukaryotes. A first example is the introduction of Internal ribosome entry sites (IRES)469 (Figure 
6.2 A). These IRES allow the ribosomes to initiate protein synthesis at any place on the mRNA. 
Eukaryotic mRNA translation starts by binding of the cap-binding complex eukaryotic initiation 
factors (eIF) 4F to the mRNA 5’-m7G cap-structure. This complex acts as a scaffold for several 
initiation factors as well as ATP-dependent RNA helicase eIF4A, which dissolves the 
secondary structure of the 5’-untranslated region (5’-UTR). Furthermore, the 40S ribosomal 
unit will be recruited and positioned with several other enzymes at the first encountered start 
codon. Final recruitment of the 60S ribosomal unit forms the elongation-competent 80S 
ribosome470. When no cap structure is present, initiation of translation can still occur when 
certain secondary and tertiary mRNA structures are present in de 5-UTR. Several types of 
IRES sequences have been identified and have been grouped depending on the amount of 
canonical eIFs and IRES trans-activating factors are needed471. The higher the group number, 
the more the IRES initiation complex starts to resemble the cap-dependent system. 
However, problems with expression levels of proteins encoded in front or behind the IRES472 
required the development of different systems. Several viruses employ so-called 2A peptides 
to create polycistronic expression473. The coding sequences of these peptides are situated 
between the open reading frames (ORFs) of the genes that need to be expressed. At the end 
of the 2A amino acid sequence, several highly conserved residues introduce a ribosomal skip, 
successfully preventing the subsequent condensation of the next amino acid to the already 
formed peptide chain and thereby releasing smaller individual proteins instead of one big 
protein (Figure 6.2 B). This technique has been used in several eukaryotes like Pichia 
pastoris474, Arabidopsis thaliana475 and even mammalian cells originating from human476, 
zebrafisch476 or mice477 tissue. All 2A peptides have a conserved GDVE(E/S)NPGP motif at 
the end of their amino acid sequence. In front of this motif, some sequence conservation can 
be seen for several residues, but their exact role remains unclear. 
Caution is necessary as several drawbacks exist for this technique. The major one is that this 
has never been attempted in S. bombicola so it is uncertain that it will work. Secondly, in the 
case of the 2A peptides, there exists a high degree of homology between the different types. 
Bicistronic expression is not bothered by this, but polycistronic expression might have to deal 
with illegitimate recombination and thereby a loss of function. The 2A tool can also help in the 
development of an episomal vector for S. bombicola. When looking at for example the 2µ 
plasmid, four genes are involved. These are rep1, rep2, rep3 and flp. Introduction of these 
genes in the S. bombicola genome might result in a strain able to use the 2µ plasmid. 
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Figure 6.2: The mechanism behind IRES (a) and 2A peptides (b).  
Still, it is possible to locally change the DNA sequence and not influence expression of 
neighbouring genes. This is clear from several experiments conducted in chapters II, III and 
IV. Substituting or altering coding sequences still resulted in good activity for several mutant 
strains. This clearly points towards the possibility of generating new kinds of precursors for 
glycolipid production and further on utilizing either the sophorolipid biosynthetic genes or 
heterologous ones.  
In Chapter III, P450 engineering is proven as a way to provide shorter hydroxy fatty acids to 
the glucosyltransferases. Several P450s with interesting properties were either introduced 
without any modifications, as a part of a fusion protein or mutated at an essential amino acid 
for their regiospecificity. In the case of unmodified P450s, CYP1 from U. maydis, CYP52A4 
from C. maltosa, CYP102A1 from B. megaterium, CYP102A7 from B. licheniformis and 
P450Foxy from F. oxysporum were used. Though activity was detected for all except CYP52A4, 
production of specific molecules remained difficult. For the self-sufficient CYP102A1, 
CYP102A7 and P450Foxy, mixtures of sophorolipids with palmitic, oleic and stearic acid were 
detected. For CYP1, the produced molecules were more uniform with mostly palmitic acid 
being incorporated. Still, only marginal activity was detected for CYP1. The reason for this is 
unknown, but the most likely is CPR incompatibility. P450s of class II require electrons to be 
donated from a second reaction partner (see I.3.3). The interaction between P450 and CPR is 
electrostatically and small changes on the surface of either enzyme can have a big impact on 
electron delivery478. Therefore, the creation of fusion proteins, so called chimeric P450s was 
attempted. By coupling a reductase domain to the P450, a more efficient electron transfer 
could be obtained. In the case of CYP1 and CYP52A4, activity could be detected when the 
P450 was coupled to the reductase domain of CYP102A1 called BMR. Even though the 
productivity was low, it was a successful proof of concept for P450 engineering. For CYP1, 
further optimisation of the production process resulted in the production of highly uniform C16 
sophorolipids using a strain carrying the CYP1BMR chimeric P450. This proves that 
introducing novel P450s in S. bombicola is a valid strategy to alter the fatty acid tail of the 
glycolipid produced.  
Still, several strategies remain to improve the production of novel kinds of sophorolipids. For 
the already created chimeric strains, further engineering attempts could be made. A first one 
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is the overexpressing of these P450 chimeras. Though more protein not necessarily translates 
to higher production values, it is a first simple strategy to investigate. A second one focusses 
on the coding sequence and structure of the P450 itself. As already mentioned in III.3.2.4, 
several remarks can be made on the quality of the coding sequence used for CYP1. If the 
starting methionine is indeed the one from position 105, a new chimeric CYP1 can be made 
with a shorter region of the protein inside the ER. A third solution lays in the resistance of S. 
bombicola towards shorter fatty acid chains. If the stress caused by shorter chains impairs 
productivity, adaptive evolution of these strains towards higher resistance might help to reach 
higher product titers of short- and medium-chain sophorolipids.  
A more fundamental and extensive solution requires exploring the linker between the 
reductase and P450. For the moment the natural CYP102A1 linker is used for all the different 
chimeric P450s, but numerous literature reports have proven the importance of the linker in 
P450 chimeragenesis479–482 since the mobility of both domains relative to each other plays an 
important role for efficient electron transport. CYP102A1 might function as a dimer in vivo with 
the BMR domain donating electrons to the P450 domain of the second enzyme481. If the BMR 
is less-than-optional positioned, this can severely interfere with electron transport. In the case 
of chimeragenesis of P450s, the rigidity of the linker will have a serious influence on the degree 
of freedom of the reductase domain towards its own or other P450s. On the other hand, if the 
electron transfer happens within the chimeric P450, linker length will have a role as well. If any 
improvement could be made at all for the P450 system in S. bombicola through 
chimeragenesis, different linkers should be investigated. Molecular tools are available to 
construct libraries of P450 chimeras with different linker lengths and structures, for example P-
Link483 and DuaLinX484. Related to the linker is the reductase used for creating the chimeric 
enzyme. As could be seen for CYP52M1, production was impaired by the coupling of the 
reductase while it enabled production for CYP52A4 and CYP1. Combinatorial design of the 
chimera using different reductases and linkers can further enhance the knowledge on creating 
these proteins.  
Though all these strategies tested are based on introducing heterologous P450s with 
interesting characteristics, S. bombicola has some other potential candidates as well. A first 
candidate is cyp52m1. A structural study of might result in identification of the essential amino 
acid residues responsible for either substrate, regio- and stereospecificity and potentially 
altering them. Besides cyp52m1, the coding sequences of 7 other P450s belonging to the 
CYP52 family are present in S. bombicola. In Table 6.1, an overview is given and their 
sequence identities and similarities. Recently, two were tested by in vitro experiments. Both 
CYP52N1 and CYP52E3 showed activity towards shorter fatty acids like myristic acid254. High 
amino acid sequence similarities exist between the members of the same subfamily, but they 
still might be sufficiently different to allow different products to be formed. Characterisation of 
these enzymes might lead to the discovery of P450s active towards longer or shorter fatty 
acids. Still, modification of the lipidic part is no guarantee for the efficient production of novel 
sophorolipids due to the specificity of the glucosyltransferases. UGTA1 is known to have 
already lower activity towards hydroxy palmitic acid and almost no activity towards hydroxy 
lauric acid. Identification of the residues responsible for this restricted specificity can lead to 
engineered mutant enzymes with a tailor-made substrate and product profile. Another benefit 
of utilizing S. bombicola P450 is the compatibility of the P450s with the CPR of this yeast. In 
the same light P450s from closely related species like C. apicola or C. batistae could be used 
as well. 
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Table 6.1: Overview of all the CYP52 family P450s present in S. bombicola. Sequence identities are given 
above the diagonal while sequence similarities are given below the diagonal. All percentages are calculated 
using the ORCAE blast tool. 
P450\P450 CYP52E3 CYP52E4 CYP52E5 CYP52E6 CYP52M1 CYP52N1 CYP52N2 CYP52N3 
CYP52E3  85% 85% 84% 47% 42% 43% 43% 
CYP52E4 92%  99% 85% 46% 42% 42% 42% 
CYP52E5 82% 100%  85% 46% 42% 41% 42% 
CYP52E6 93% 92% 92%  45% 42% 42% 43% 
CYP52M1 62% 62% 62% 62%  46% 45% 45% 
CYP52N1 59% 59% 59% 60% 64%  87% 86% 
CYP52N2 58% 58% 57% 58% 63% 95%  95% 
CYP52N3 58% 58% 58% 59% 63% 94% 97%  
 
Modification of the carbohydrate part is possible as well. Though this has been done in the 
past by Saerens et al.317 and Roelants et al.318 for the production of glucolipids and cellobiose 
lipids, productivity remained low compared to other engineered strains described174,423. 
Interestingly, all the strains altered in their carbohydrate biosynthesis are derived from S. 
bombicola G9, a spontaneous ura3 mutant. Other, better producing strains are either derived 
from the wild type S. bombicola ATCC22214 or the derived PT36 strain. This PT36 strain is a 
specifically engineered S. bombicola strain where the coding sequence of the ura3 marker has 
been removed by an engineered recombination cassette. A comparing production trial 
between both auxotrophic strains clearly showed the difference in production capacity. While 
the PT36 easily reaches titers up to 25 g/L, comparable to wild type production levels in shake 
flask experiments, the G9 hardly achieved 1 g/L. Though these results do not explain the low 
productivity of the glucolipid and cellobiose lipid strains, it is a good indication that the 
spontaneous mutant is not a suitable starting strain for engineering. 
Introduction of several knock-out and knock-in cassettes in the PT36 strain resulted in 
production of glucolipids comparable to wild type sophorolipid levels for all the strategies tested. 
For the original glucolipid producing strain, the most likely explanation according to Saerens 
et al.317 was transporter incompatibility. Though the S. bombicola sophorolipid has never been 
characterised, selectivity towards certain molecules can occur. This is for example observed 
for MELs where 2’ and 3’ acylations are necessary for export328. The growth trial and 
subsequent upscaling however do not support this hypothesis since production can be 
improved dramatically by only changing the starting strain.  
Further carbohydrate modifications were obtained by introduction of the U. maydis ugt1 gene 
involved in cellobiose lipid production. The original G9 derived cellobiose lipid strain produced 
a mixture of glucolipids and cellobiose lipids in low amounts. Higher product uniformity was 
obtained by utilizing a S. bombicola strain deficient in the ugta1 gene. This way, no glucolipids 
could be produced. Further enzyme characterisation of UGT1 proved that this enzyme is 
indeed the sole transferase responsible for the sequential double glucosylation of 16-OH 
palmitic acid. The experiments on the cell lysate of an S. bombicola UGT1 overexpression 
strain further indicated that low amounts of activity are present. The real cause of this low 
activity is unknown, but several explanations can be made. It might be that UGT1 is not that 
active resulting in low productivity in an in vivo system. Another explanation is the potential 
localisation of the enzyme. As was proven in Chapter II, UGTA1 and CYP52M1 are colocalised 
inside the cell. The reason for this colocalization is unknown, but potentially electrostatic 
interactions might play a role. Since ugt1 comes from a non-related fungus, interaction 
between UGT1 and CYP52M1 might be non-existent resulting in the enzyme not efficiently 
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receiving the hydroxy fatty acids required for cellobiose lipid production. Furthermore, as 
already mentioned in Chapter 4, the hydroxy fatty acids produced by CYP52M1 might not have 
the correct regio- and stereospecificity. In U. maydis, only terminal hydroxy fatty acids are 
incorporated in the cellobiose lipids. It is still unknown whether UGT1 can accept subterminal 
hydroxylated fatty acids and if so, which stereochemistry they must have. Still, by introducing 
heterologous transferases carbohydrate modifications can be made possible. Though only 
cellobiose lipids are being produced for the moment, other types of glycolipids are possible as 
well. Finding suitable enzymes by screening transferases for their capability of using hydroxy 
fatty acids or intermediate glycolipids can be done relatively fast in vitro or in silico. However, 
this does not ensure optimal production of the desired molecules when using them in S. 
bombicola, it can give an idea on the possibilities for the in vivo glycorandomasation 
possibilities. Large data sets are available for carbohydrate-processing enzymes thanks to 
glycoarrays.  
The substrate pool used for glucolipids and cellobiose lipids is UDP-glucose (Chapter IV), also 
efficiently used for the sophorolipid biosynthesis. Other kinds of glycolipids, for example 
rhamnolipids or xylolipids, require non-existing or suboptimal precursor pools. However, as 
can be seen in Figure 6.3, several interesting nucleotide sugars can be produced starting from 
existing pools. An interesting strategy is using the already available UDP-glucose pool as a 
start and by introducing suitable NDP-sugar modifying enzymes, new precursor pools can be 
created. It is for example possible to convert UDP-glucose to UDP-rhamnose455 and UDP-
galactose485 using only one catalytic step. Creating these carbohydrate donors and combining 
them with capable transferases can lead to new-to-nature glycolipids with altered properties 
originating from the altered hydrophilic moiety. In Chapter V it is shown that is indeed possible 
to utilize the UDP-glucose and glucose-1-phosphate pool for the creation of activated 
rhamnose.     
 
Figure 6.3: Potential production of several nucleotide sugars starting from readily available pools inside S. 
bombicola. Glc = glucose; Frc = fructose; Fuc = fucose; Man = mannose; Gal= galactose; GlcN = 
glucosamine; GlcNAc = N-acetyl-glucosamine; Rha = rhamnose.   
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As can be seen throughout this work, S. bombicola can be turned into a platform organism for 
not only different kinds of sophorolipids, but also other kinds of glycolipids. Several obstacles 
still need to be tackled. A first hurdle to be taken is the limited fundamental knowledge on 
promotors, the position effect of the targeted locus and the regulation of sophorolipid synthesis. 
Though the latter one can be evaded by integrating pathways at other locations than the 
sophorolipid gene cluster, production of glycolipids related to sophorolipids might benefit from 
a better understanding on how the sophorolipid gene cluster is actually regulated. Expanding 
the molecular toolkit with for example a stable plasmid or the above mentioned polycistronic 
expression methods can further enhance the speed of engineering resulting in both more 
knowledge and the generation of new production strains.  
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Biosurfactants, surfactant molecules originating from microbial synthesis and/or renewable 
resources, have been proven to be a valuable alternative to the (petro)chemical based variants 
widely used today. Due to the structural variability of these molecules, a wide variety of 
(potential) applications ranging from household usage to pharmaceuticals have been identified. 
Thanks to their biological degradability and production using renewable resources combined 
with their (biological) activity even at low concentrations, the focus of surfactant production is 
slowly turning towards these molecules. Still, widespread usage of these fascinating molecules 
remains low mostly due to the higher production cost and limited structural variability of the 
commercialised compounds. When looking at glycolipids, carbohydrate or lipid variety is often 
limited to just a handful of different types of groups with minor modifications. In the case of 
sophorolipids, the fatty acid tail is most often limited to a C18 fatty acid, either with its carboxylic 
group free or condensed to the sophorose moiety. Longer or shorter congeners are possible, 
but only in low amounts or as a part of a more complex mixture of molecules.  
When taking productivities into account, only a few microorganisms are capable of producing 
enough biosurfactant in a short amount of time to reduce the cost of making them. 
Unfortunately, one has to take into account certain drawbacks like potential pathogenicity of 
the producer strain. Using robust producer strains for the production of wild type, modified or 
new-to-nature molecules has been proven to be an interesting technique to enhance the 
production of these molecules. Both on a genetic and process level optimisation has been 
done with varying degrees of success.  
During this thesis, S. bombicola was turned into a robust strain for the production of different 
kinds of molecules. Both genetic engineering and better understanding the production 
parameters allowed to gain deeper insights in how S. bombicola produces biosurfactants and 
how to steer the production towards novel kinds of molecules. 
In the second chapter, the main focus was creating new molecular tools for easier modification 
and/or screening of novel strains. A first tool was the development of an episomal vector for S. 
bombicola. Though many yeast species have one or several plasmids, no such thing is known 
for S. bombicola. By using in silico characterisation techniques and using heterologous and 
homologous sequences in a suitable screenings vector, the aim was to identify ARS 
sequences. Unfortunately, no active sequence could be found. The second tool is the 
maximum size of the integration cassettes used for knock-in and -out strategies. As it became 
clear that no clear upper limit could be found up until 11600 base pairs, a more practical was 
followed to double the genetic cluster of sophorolipid production. Though the idea was that 
more expression would result in more production, the results were not straight forward pointing 
towards higher transcription, translation and final productivity. Still, it proved that large 
constructs can be designed and transformed efficiently in S. bombicola, opening the possibility 
of introducing complex multistep pathways in a few steps. The final tool can be seen as multiple 
smaller tools together. Firstly, new kinds of fluorescent proteins were tested successfully in S. 
bombicola besides the already available GFP. Secondly, it was shown that coupling multiple 
domains does not necessarily impair protein function. This opens the possibility of creating 
larger chimeric enzymes where the catalytic domains are coupled for enhanced turnover. 
Summary 
  
198 
 
Thirdly, using the sophorolipid biosynthetic enzymes for the coupling resulted in their cellular 
localisation and provided a tool for comparing productivity with expression levels of the 
enzymes involved. When integrating this knowledge with qPCR data, better fine tuning of gene 
expression levels can be achieved. 
Chapter three and four both focus on modifying either the carbohydrate or the lipidic group. In 
chapter three, is was proven that introducing novel P450s in S. bombicola can be an interesting 
strategy to alter the fatty acids being incorporated. Several self-sufficient P450 were introduced 
in S. bombicola for the production of new kinds of sophorolipids. Their activity could be 
measured, but no new molecules were produced. Engineering of the self-sufficient P450s by 
altering the critical phenylalanine at position 87 did not result in more favourable intermediates 
being produced. Still, they can be used as a starting point for other strategies. One of those 
was explored in depth by creating self-sufficient chimeric variants of CYP52A4 and CYP1. 
Though the production levels remained low, a high product uniformity was achieved for the 
CYP1BMR strain. Further optimisation including the substrate used resulted the production of 
C16 sophorolipids, both acidic and lactonic.  
In chapter four, the main concept was modification of the carbohydrate group. The production 
levels of glucolipids and cellobiose lipids produced by previously designed strains remained 
low. Redesigning the original constructs as well as using optimized engineering strains 
resulted in the production of glucolipids up to 130 g/L. Interestingly, new molecules were 
observed as well in the produced mixture. It was already known that the UGTA1 transferase is 
capable of coupling a glucose moiety to both hydroxyl and carboxyl groups, the observation of 
bola glucolipids remained elusive until the first growth trials with the newly engineered 
glucolipid strains. For the cellobiose lipids, higher product uniformity was achieved by only 
expressing the ugt1 gene from U. maydis in S. bombicola. This not only resulted in losing the 
contaminating glucolipid fraction from the older strains, it also showed that UGT1 is solely 
responsible for the sequential glucosylation of the hydroxy palmitic acid. Further optimisation 
of the production strains is necessary to produce these molecules in bigger volumes, but for 
the first time relatively uniform cellobiose lipids have been produced in a non-wild type 
producer. 
Chapter five was about turning S. bombicola into a producer of molecules that are unknown to 
this yeast. Rhamnolipids are molecules that originate from a bacterial producer and are 
structurally not similar to sophorolipids or cellobiose lipids. Production of these molecules 
involved integrating several bacterial pathways for the production of the necessary precursors. 
To obtain the hydrophobic part, the genes necessary for the bacterial FAS II system were 
introduced at two different locations in the genome. As a proof-of-concept, the production of 
HAA molecules was attempted. After several growth trials, it became clear to no activity could 
be measured. For the production of activated rhamnose, two different pathways were designed 
resulting in dTDP-L-rhamnose or UDP-L-rhamnose. To assess the availability of these 
rhamnose donors, a proof-of-concept was designed around the rhamnosylation of quercetin 
by the transferase At78D1 from Arabidopsis thaliana. After a growth trial, it became clear that 
only the strain producing dTDP-L-rhamnose was capable of producing a rhamnosylated 
product. A final experiment was carried out by combining cell lysates of both the NDP-strains 
equipped with the second rhamnosyltransferase RhlB and the HAA-strain. No production of 
rhamnolipids or related molecules could be observed. 
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In conclusion, utilizing the robustness of S. bombicola for creating a platform for biosurfactant 
production is a valuable strategy. Though several obstacles remain concerning the 
fundamental knowledge of the organism, it is already possible to engineer strains that are 
capable of producing novel molecules on scales relevant for industrial production. The results 
in this work show that S. bombicola is a relevant player in the field of glycolipid production. 
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Biosurfactanten, surfactant moleculen geproduceerd door micro-organismen of vanuit 
hernieuwbare grondstoffen, zijn een evenwaardig alternatief voor de tegenwoordig 
veelgebruikte (petro)chemische surfactanten. Een veelvoud aan potentiele toepassingen zijn 
reeds bekend gaande van huishoudelijke tot farmaceutische applicaties zijn al reeds bekend. 
Andere aspecten zoals hun biodegradeerbaarheid, hernieuwbare productie en potentiele 
biologische activiteit hebben ervoor gezorgd dat de interesse naar deze moleculen gevoelig 
gestegen is. Ondanks deze voordelen zijn nog enkele grote nadelen verbonden aan deze 
verbindingen. Zo is de productiekost nog steeds significant hoger en is de structurele variatie 
van de reeds gecommercialiseerde moleculen beperkt.  
Een interessante deelklasse van de biosurfactanten, namelijk de glycolipiden, werden reeds 
uitvoerig bestudeerd. Men dient echter in gedachten te houden dat deze klasse van moleculen 
slechts een handvol variaties kent voor zowel het koolhydraat als het vetgedeelte van de 
glycolipide. Een specifiek voorbeeld zijn de sophorolipiden. Alle moleculen van deze subklasse 
zijn samengesteld uit een sophorose en een C18 vetzuur. Eventuele verzadiging van de C18 
staart of de locatie van de hydroxylatie kunnen variëteit veroorzaken maar ketens met langere 
of kortere varianten zijn quasi onbestaande. De enige uitzondering hiervoor zijn de moleculen 
van R. bogoriensis die standaard een C22 vetzuurketen hebben. Het is echter niet onmogelijk 
afwijkende vetzuren of analoge moleculen te incorporeren maar vaak leidt dit tot een meer 
complex mengel moleculen of tot lagere productieniveaus. Verder is het belangrijk de 
productiecapaciteit van bepaalde organismen niet te vergeten. Slechts enkele zijn in staat tot 
hoge en snelle productie van biosurfactanten zoals P. aerugiosa of S. bombicola. Nadelen 
zoals potentiele pathogeniciteit kunnen echter een grote rol spelen in de kostprijs en 
applicaties van bepaalde moleculen.  
Het gebruik maken van robuuste micro-organismen voor de productie van eigen wild-type, 
gemodificeerde wild-type of nieuwe types van moleculen kan een interessante strategie zijn 
om enerzijds de kostprijs van biosurfactanten te laten dalen en anderzijds om de moleculaire 
diversiteit te vergroten. Dit is in het verleden als reeds enkele malen toegepast op kleine schaal. 
Gedurende dit eindwerk werd getracht S. bombicola om te vormen tot een robuuste producent 
van verscheidene moleculen. Nieuwe inzichten op het vlak van genetische modificaties alsook 
op procesniveau zorgden voor een diepere kennis betreffende de productie van deze 
moleculen. 
In hoofdstuk twee werden verscheidene nieuwe technieken getest voor het modificeren en 
opvolgen van S. bombicola. Een eerste techniek bestond uit het ontwikkelen van een plasmide 
voor S. bombicola. Hoewel verscheidene micro-organismen een of meerdere types van 
plasmide hebben is er tot op heden geen bekend voor S. bombicola. Door gebruik te maken 
van in silico screeningstechnieken alsook het uittesten van enkele homologe en heterologe 
sequenties werd getracht een gelijkaardig systeem te ontwikkelen maar tot op heden zonder 
succes. De tweede techniek betreft de grootte van de recombinatie cassettes. Hoewel slechts 
enkele groottes getest zijn werd snel duidelijk dat voor het gros van de modificaties geen reële 
limiet bestaat. Vanuit een meer praktisch oogpunt werd besloten om de gencluster van de 
sophorolipiden synthese te verdubbelen. Hoewel initieel verwacht werd dat het hogere kopij 
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aantal van de genen tot verhoogde transcriptie, translatie en productie zou leiden, werd snel 
duidelijk dat dit niet het geval was. Desalniettemin was het duidelijk dat grote cassettes 
gebruikt kunnen worden voor het efficiënt introduceren van grote en/of complexe metabolische 
netwerken in een beperkt aantal tussenstappen. De laatste tool bestond uit het introduceren 
van fluorescente eiwitten en kan beschouwd worden als meerdere kleine tools tezamen. 
Allereerst werden twee nieuwe fluorescente eiwitten correct tot expressie gebracht in S. 
bombicola. Dit opent mogelijkheden met meerdere promotoren of localisatiesignalen 
tegelijkertijd te testen. Ten tweede werd aangetoond dat het koppelen van extra domeinen aan 
bepaalde enzymen niet zorgt voor een daling in activiteit. Dit kan in de toekomst verder benut 
worden door het koppelen van andere katalytische elementen tot grote chimere eiwitten met 
een verhoogd omzettingsvermogen. Tot slot zorgde het koppelen van de fluorescente eiwitten 
aan deze enzymen van de sophorolipiden synthese voor enerzijds het lokaliseren van deze 
moleculen binnenin de cel en anderzijds voor een visuele tool om expressieniveaus te kunnen 
meten en tegelijkertijd te koppelen aan productiviteit. Wanneer deze data gekoppeld wordt met 
qPCR data kan een beter begrip van de eiwitexpressie bekomen worden en kan deze beter 
afgesteld worden om een zo min mogelijke impact te hebben op celvitaliteit. 
Hoofdstukken drie en vier focusten beide op de modificatie van een bepaald deelaspect van 
de structuur van glycolipiden. Hoofdstuk drie draait om het veranderen van de vetzuurketen 
door middel van expressie van P450s enzymen. Het vervangen van het celeigen CYP52M1 
door andere, eventueel zelfvoorzienende, P450s bleek een interessante doch niet succesvolle 
manier te zijn om nieuwe compatibele hydroxy vetzuren te produceren en incorporeren in 
glycolipiden. Hun activiteit was echter eenvoudig meetbaar wat bevestigde dat heterologe 
expressie van P450s functioneel kan zijn. Het muteren van enkele zelfvoorzienende P450s 
zorgde eveneens niet voor de gehoopte productie. De reden hiervoor kan echter gezocht 
worden in enerzijds een lagere activiteit van de mutant en anderzijds de productie van minder 
compatibele intermediairen. Het tweede deel van hoofdstuk drie was gericht op het creëren 
van zogenaamde chimere, zelfvoorzienende P450s. Enkele varianten zoals deze met 
CYP52A4 en CYP1 bleken interessante eigenschappen te hebben voor de productie van 
nieuwe types sophorolipiden. Voor het CYP1BMR eiwit bleek het mogelijk specifiek C16 
sophorolipiden te produceren. Verdere optimalisatie resulteerde in hogere productiviteit van 
deze moleculen. 
In hoofdstuk 4 lag de focus op het modificeren van de koolhydraatgroep. Productie van 
glucolipiden en cellobiose lipiden was al reeds mogelijk dankzij eerder geconstrueerde 
stammen maar de behaalde opbrengsten waren laag in vergelijking met de productie van 
sophorolipiden. Verder was de productuniformiteit niet optimaal. Het opnieuw ontwerpen van 
de originele recombinatiecassettes zorgde in het geval van de glucolipiden in een significant 
hogere productie. Hoewel deze stijging grotendeels te danken was aan het gebruiken van een 
specifiek ontworpen ura3 auxotrofe stam van S. bombicola bleek er een groot verschil te zijn 
in de verschillende cassettes en hun effect op de productie. Een andere interessante 
waarneming waren de bolaglucolipiden. Het was al reeds bekend dat UGTA1 in staat is om 
zowel hydroxyl als carboxylgroepen te glucosyleren in vivo. Voor de productie van cellobiose 
lipiden werd een hogere product uniformiteit behaald door enkel het ugt1 gen van U. maydis 
te expresseren in een ugta1 knock-out strain van S. bombicola. Hierdoor werden er geen 
glucolipiden meer geproduceerd en kon definitief aangetoond worden dat enkel het UGT1 
verantwoordelijk is voor de dubbele glucosylering van het hydroxy palmitinezuur. Verdere 
optimalisatie van de productiestammen is echter nodig voor het behalen van hogere titers.       
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Het laatste hoofdstuk gaat over het aanwenden van S. bombicola voor het produceren van 
rhamnolipiden. Rhamnolipiden zijn moleculen die structureel niet verwant zijn aan de 
sophorolipiden en hun synthese verloopt verschillend dan deze van de sophorolipiden. Om 
productie te bekomen was het noodzakelijk om bacteriële metabolische processen te 
integreren in S. bombicola aangezien de celeigen eukaryote netwerken niet flexibel genoeg of 
toereikend waren. De integratie van een type II vetzuursynthese werd ondernomen door de 
vereiste genen te integreren op twee verschillende locaties in het genoom. Als proof-of-
concept molecule werd getracht om dimeren van β-hydroxy vetzuren te bekomen. Na enkele 
groeiproeven werd duidelijk dat er geen activiteit gemeten kan worden. Voor de geactiveerde 
rhamnose werden twee pathways in parallel getest, één specifiek voor UDP-L-rhamnose, de 
andere voor dTDP-L-rhamnose. Om te beschikbaarheid van het geactiveerde rhamnose te 
testen werd een poging ondernomen voor het rhamnosyleren van quercetine door het 
transferase At78D1 van Arabidopsis thaliana. Een groefproef wees uit dat de stam uitgerust 
met de pathway voor dTDP-L-rhamnose productie in staat was om een gerhamnosyleerd 
product te vormen. Een finaal experiment waarbij cellysaten van beide precursorstammen 
gecombineerd werden leidde uiteindelijk niet tot de productie van rhamnolipiden of andere 
verwante moleculen. 
Als conclusie kan met stellen dat S. bombicola de nodige robuustheid bezit om te dienen als 
productieplatform voor verscheidenen types biosurfactanten. Hoewel enkele obstakels nog 
aanwezig zijn, zowel op een fundamenteel als een meer procesmatige niveau, is gebleken dat 
het reeds mogelijk is om industrieel relevante giststammen te ontwikkelen. De resultaten van 
dit werk vertellen duidelijk dat S. bombicola een relevant organisme is voor 
glycolipidenproductie. 
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Codon usage tables used for codon optimization of synthetic sequences. 
10 Genes Stationary Genes 
AAA 0.62% GAA 0.71% AAA 1.42% GAA 1.71% 
AAC 4.14% GAC 3.19% AAC 1.33% GAC 1.17% 
AAG 4.14% GAG 4.04% AAG 1.84% GAG 2.14% 
AAT 0.62% GAT 1.57% AAT 1.48% GAT 1.67% 
ACA 0.57% GCA 0.38% ACA 1.68% GCA 1.60% 
ACC 1.95% GCC 1.81% ACC 1.25% GCC 1.61% 
ACG 0.24% GCG 0.24% ACG 1.15% GCG 1.28% 
ACT 2.00% GCT 2.28% ACT 1.54% GCT 2.03% 
AGA 0.29% GGA 0.71% AGA 1.78% GGA 1.53% 
AGC 0.86% GGC 2.05% AGC 1.90% GGC 1.61% 
AGG 0.24% GGG 0.10% AGG 1.57% GGG 1.06% 
AGT 0.29% GGT 1.90% AGT 1.24% GGT 1.33% 
ATA 0.10% GTA 0.24% ATA 1.03% GTA 0.73% 
ATC 2.85% GTC 2.47% ATC 1.69% GTC 1.23% 
ATG 4.76% GTG 0.43% ATG 2.00% GTG 1.59% 
ATT 1.81% GTT 1.62% ATT 1.73% GTT 1.59% 
CAA 0.76% TAA 4.19% CAA 2.16% TAA 0.67% 
CAC 3.85% TAC 4.04% CAC 1.33% TAC 1.16% 
CAG 4.00% TAG 0.62% CAG 2.05% TAG 0.61% 
CAT 0.90% TAT 0.71% CAT 1.49% TAT 1.27% 
CCA 0.48% TCA 0.29% CCA 1.74% TCA 2.38% 
CCC 1.86% TCC 1.47% CCC 1.30% TCC 1.26% 
CCG 0.62% TCG 0.52% CCG 1.24% TCG 1.59% 
CCT 1.86% TCT 1.28% CCT 1.47% TCT 2.01% 
CGA 0.29% TGA 0.00% CGA 1.58% TGA 2.02% 
CGC 1.14% TGC 3.47% CGC 1.35% TGC 1.90% 
CGG 0.05% TGG 4.76% CGG 1.14% TGG 2.36% 
CGT 2.85% TGT 1.28% CGT 1.05% TGT 1.43% 
CTA 0.14% TTA 0.10% CTA 1.06% TTA 1.10% 
CTC 2.19% TTC 3.95% CTC 1.98% TTC 2.14% 
CTG 0.57% TTG 0.38% CTG 2.31% TTG 2.42% 
CTT 1.38% TTT 0.81% CTT 2.05% TTT 1.88% 
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Optimized coding sequences of gfpco10genes, bfpcostat and rfpco10stat. 
gfpco10genes 
ATGTCGAAAGGAGAGGAGCTGTTCACTGGCGTCGTCCCAATCCTGGTCGAACTTGATGGCGACG
TTAACGGTCACAAGTTTAGCGTGAGCGGTGAAGGTGAGGGTGATGCTACCTACGGCAAGCTGAC
TCTTAAGTTCATCTGCACCACTGGCAAGCTTCCAGTTCCATGGCCCACACTCGTTACAACCTTCG
GCTATGGCGTTCAGTGCTTTGCCCGTTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCG
GCCATGCCTGAGGGCTATGTTCAGGAACGTACTATCTTCTTCAAGGACGACGGCAACTACAAAAC
TCGTGCTGAAGTCAAGTTTGAGGGCGATACTTTGGTAAACCGTATCGAGCTCAAGGGCATTGACT
TCAAGGAGGACGGTAACATTCTTGGTCATAAGCTTGAGTATAATTACAACTCTCACAACGTCTACA
TTATGGCTGACAAGCAGAAGAATGGAATTAAAGTCAACTTCAAGATTCGCCATAACATCGAGGAC
GGCAGCGTACAGCTCGCTGACCACTACCAACAGAACACTCCCATTGGCGACGGCCCTGTTCTTC
TCCCTGACAACCACTATCTATCTACCCAGTCCGCCTTGTCCAAAGACCCCAACGAGAAGCGCGAC
CACATGGTTCTTTTGGAGTTCGTTACTGCCGCTGGCATCACGCACGGAATGGACGAGCTGTACAA
ATAA 
bfpcostat 
ATGTCGAAAGGAGAGGAGCTGTTCACTGGCGTCGTCCCAATCCTGGTCGAACTTGATGGCGACG
TTAACGGTCACAAGTTTAGCGTGAGCGGTGAAGGTGAGGGTGATGCTACCTACGGCAAGCTGAC
TCTTAAGTTCATCTGCACCACTGGCAAGCTTCCAGTTCCATGGCCCACACTCGTTACAACCTTCA
GCCACGGCGTTCAGTGCTTTAGCCGTTACCCCGACCACATGAAGCGGCACGACTTCTTCAAGTC
GGCCATGCCTGAGGGCTATGTTCAGGAACGTACTATCTCCTTCAAGGACGACGGCAACTACAAAA
CTCGTGCTGAAGTCAAGTTTGAGGGCGATACTTTGGTAAACCGTATCGAGCTCAAGGGCATTGAC
TTCAAGGAGGACGGTAACATTCTTGGTCATAAGCTTGAGTATAATTACAACTCTCACAACGTCTAC
ATTACGGCTGACAAGCAGAAGAATGGAATTAAAGCAAACTTCAAGATTCGCCATAACATCGAGGA
CGGCAGCGTACAGCTCGCTGACCACTACCAACAGAACACTCCCATTGGCGACGGCCCTGTTCTT
CTCCCTGACAACCACTATCTATCTACCCAGTCCGCCTTGTCCAAAGACCCCAACGAGAAGCGCGA
CCACATGGTTCTTTTGGAGTTCGTTACTGCCGCTGGCATCACGCACGGAATGGACGAGCTGTACA
AATAA 
rfpco10stat 
ATGAGGTCTTCCAAGAACGTTATCAAGGAATTTATGCGCTTCAAGGTCCGCATGGAAGGTACTGT
TAACGGTCACGAGTTCGAGATTGAGGGAGAGGGTGAGGGTCGTCCCTACGAGGGCCACAACAC
TGTCAAGCTCAAGGTTACCAAGGGTGGTCCTCTTCCATTCGCATGGGACATTCTTTCCCCTCAGT
TCCAGTATGGCTCCAAGGTCTACGTCAAGCACCCCGCAGACATCCCCGATTACAAGAAACTTTCC
TTCCCTGAAGGCTTCAAGTGGGAGCGTGTGATGAACTTCGAGGACGGGGGCGTCGTTACAGTTA
CGCAGGATAGCTCTCTCCAAGACGGTTGCTTCATCTATAAGGTCAAGTTCATCGGTGTCAACTTC
CCCTCAGACGGTCCCGTCATGCAAAAGAAGACGATGGGTTGGGAAGCCAGCACAGAGCGCCTTT
ACCCCCGTGACGGTGTCCTTAAGGGTGAAATTCACAAGGCACTCAAGCTGAAGGATGGAGGCCA
CTACCTCGTCGAGTTCAAGTCGATTTATATGGCTAAGAAGCCTGTTCAGCTCCCTGGTTACTACTA
CGTCGACTCGAAGCTGGACATCACATCGCACAATGAGGATTACACGATCGTTGAGCAGTACGAA
CGTACCGAGGGCCGTCACCACCTCTTCCTCTAG 
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Ordered gBlock for cyp1bmr validation. Mutated codons are in bold font and underlined. 
TGCTGATGAAGTAAAAGGCGTTCGCTACTCCGTATTTGATTGCGGCGATAAAAACTGGG
CTACTACGTATCAAAAAGTGCCTGCTTTTATCGATGAAACGCTTGCCGCTAAAGGGGCA
GAAAACATCGCTGACCGCGGTGAAGCAGATGCAAGCGACGACTTTGAAGGCACATATG
AAGAATGGCGTGAACATATGTGGAGTGACGTAGCAGCCTACTTTAACCTCGACATTGAA
AACAGTGAAGATAATAAATCTACTCTTTCACTTCAATTTGTCGACAGCGCCGCGGATATG
CCGCTTGCGAAAATGCACGGTGCGTTTTCAACGAACGTCGTAGCAAGCAAAGAACTTCA
ACAGCCAGGCAGTGCACGAAGCACGCGACATCTTGAAATTGAACTTCCAAAAGAAGCTT
CTTATCAAGAAGGAGATCATTTAGGTGTTATTCCTCGCAACTATGAAGGAATAGTAAACC
GTGTAACAGCAAGGTTCGGCCTAGATGCATCACAGCAAATCCGTCTGGAAGCAGAAGA
AGAAAAATTAGCTCATTTGCCACTCGCTAAAACAGTATCCGTAGAAGAGCTTCTGCAATA
CGTGGAGCTTCAAGATCCTGTTACGCGCACGCAGCTTCGCGCAATGGCTGCTAAAACG
GTCTGCCCGCCGCATAAAGTAGAGCTTGAAGCCTTGCTTGAAAAGCAAGCCTACAAAGA
ACAAGTGCTGGCAAAACGTTTAACAATGCTTGAACTGCTTGAAAAATACCCGGCGTGTG
AAATGAAATTCAGCGAATTTATCGCCCTTCTGCCAAGCATACGCCCGCGCTATTACTCG
ATTTCTTCATCACCTCGTGTCGATGAAAAACAAGCAAGCATCACGGTCAGCGTTGTCTCA
GGAGAAGCGTGGAGCGGATATGGAGAATATAAAGGAATTGCGTCGAACTATCTTGCCG
AGCTGCAAGAAGGAGATACGATTACGTGCTTTATTTCCACACCGCAGTCAGAATTTACG
CTGCCAAAAGACCCTGAAACGCCGCTTATCATGGTCGGACCGGGAACAGGCGTCGCGC
CGTTTAGAGGCTTTGTGCAGGCGCGCAAACAGCTAAAAGAACAAGGACAGTCACTTGG
AGAAGCACATTTATACTTCGGCTGCCGTTCACCTCATGAAGACTATCTGTATCAAGAAGA
GCTTGAAAACGCCCAAAGCGAAGGCATCATTACGCTTCATACCGCTTTTTCTCGCATGC
CAAATCAGCCGAAAACATACGTTCAGCACGTAATGGAACAAGACGGCAAGAAATTGATT
GAACTTCTTGATCAAGGAGCGCACTTCTATATTGCCGGAGACGGAAGCCAAATGGCACC
TGCCGTTGAAGCAACG 
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Ordered gBlocks with coding sequence of the A. thaliana atnrs/er. Due to the big size of the 
coding sequence and the limit of IDT for a gBlock at the time, two separate gBlocks were 
ordered. At the 5’ of gBlock 1 and 3’ of gBlock 2 homologous regions are present for assembly 
in a pJET vector (underlined). Both gBlocks also carry homologues regions for each other to 
enable easy assembling (bold). 
gBlock 1 
GTTTTTCAGCAAGATATGGTTGCAGACGCAAACGGTTCATCATCAAGCTCATTTAACTTC
CTAATCTACGGTAAAACCGGATGGATCGGTGGTTTACTCGGTAAACTCTGCGAAGCTCA
AGGAATCACTTACACTTACGGCTCCGGTCGTCTTCAAGATCGTCAATCGATCGTCGCCG
ACATCGAATCCGTGAAACCTAGCCACGTGTTCAACGCTGCTGGAGTCACCGGTCGTCCT
AATGTTGATTGGTGCGAATCTCACAAAGTTGAGACGATTCGTACTAATGTCGCCGGAAC
CCTAACTCTCGCTGACATTTGCAGAGAGAAAGGACTTGTTCTGATCAATTACGCTACGG
GTTGTATATTTGAGTATGATTCGGGTCATCCTCTCGGGTCGGGTATTGGATTCAAGGAG
GAGGATACTCCTAATTTCACCGGATCTTTCTACTCTAAAACCAAAGCTATGGTGGA 
gBlock 2 
CAAAGCTATGGTGGAGGAGCTGCTCAAGAACTATGAAAATGTATGCACGCTAAGAGTG
CGAATGCCGATTTCATCGGATCTAACAAACCCGAGAAACTTCATCACGAAGATTGCTCG
GTATGAGAAAGTTGTGGACATCCCAAACTCGATGACAATCCTCGATGAGCTTCTCCCGA
TATCAATCGAAATGGCGAAGAGGAACTTAACCGGGATCTACAATTTCACTAACCCGGGT
GTTGTGAGCCACAACGAGATCTTGGAGATGTACAGAGACTACATTGACCCGAGTTTTAC
TTGGAAGAACTTCACATTGGAGGAACAAGCTAAAGTGATTGTGGCGCCAAGGAGTAACA
ATGAGCTTGATGCAACTAAGTTGAAGACTGAGTTCCCTGAGTTGATGTCTATCAAAGAGT
CTCTGATCAAGTTCGTGTTTGAGCCCAACAAGAAGACTGAAGTTAAAGCTTGAATCTTTC
TAGAAGAT 
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Ordered gBlocks with coding sequence of the A. thaliana rhm2/mum4. Due to the big size of 
the coding sequence and the limit of IDT for a gBlock at the time, two separate gBlocks were 
ordered. At the 5’ of gBlock 1 and 3’ of gBlock 2 homologous regions are present for assembly 
in the expression vector for the cyp51m1 locus (underlined). Both gBlocks also carry 
homologues regions for each other to enable easy assembling (bold). 
gBlock 1 
CGTTATTTCTCCGTTTATCATATTGAAAAGTACATATATGGATGATACTACGTATAAGCCA
AAGAACATTCTCATTACTGGAGCTGCTGGATTTATTGCTTCTCATGTTGCCAACAGATTA
ATCCGTAACTATCCTGATTACAAGATCGTTGTTCTTGACAAGCTTGATTACTGTTCAGAT
CTGAAGAATCTTGATCCTTCTTTTTCTTCACCAAATTTCAAGTTTGTCAAAGGAGATATCG
CGAGTGATGATCTCGTTAACTACCTTCTCATCACTGAAAACATTGATACGATAATGCATT
TTGCTGCTCAAACTCATGTTGATAACTCTTTTGGTAATAGCTTTGAGTTTACCAAGAACAA
TATTTATGGTACTCATGTTCTTTTGGAAGCCTGTAAAGTTACAGGACAGATCAGGAGGTT
TATCCATGTGAGTACCGATGAAGTCTATGGAGAAACCGATGAGGATGCTGCTGTAGGAA
ACCATGAAGCTTCTCAGCTGTTACCGACGAATCCTTACTCTGCAACTAAGGCTGGTGCT
GAGATGCTTGTGATGGCTTATGGTAGATCATATGGATTGCCTGTTATTACGACTCGCGG
GAACAATGTTTATGGGCCTAACCAGTTTCCTGAAAAAATGATTCCTAAGTTCATCTTGTT
GGCTATGAGTGGGAAGCCGCTTCCCATCCATGGAGATGGATCTAATGTCCGGAGTTACT
TGTACTGCGAAGACGTTGCTGAGGCTTTTGAGGTTGTTCTTCACAAAGGAGAAATCGGT
CATGTCTACAATGTCGGCACAAAAAGAGAAAGGAGAGTGATCGATGTGGCTAGAGACAT
CTGCAAACTTTTCGGGAAAGACCCTGAGTCAAGCATTCAGTTTGTGGAGAACCGGCCCT
TTAATGATCAAAGGTACTTCCTTGATGATCAGAAGCTGAAGAAATTGGGGTGGCAAGAG
CGAACAAATTGGGAAGATGGATTGAAGAAGACAATGGACTGGTACACTCAGAATCCTGA
GTGGTGGGGTGATGTTTCTGGAGCTTTGCTTCCTCATCCGAG 
gBlock 2 
GGGGTGATGTTTCTGGAGCTTTGCTTCCTCATCCGAGAATGCTTATGATGCCCGGTGG
AAGACTTTCTGATGGATCTAGTGAGAAGAAAGACGTTTCAAGCAACACGGTCCAGACAT
TTACGGTTGTAACACCTAAGAATGGTGATTCTGGTGACAAAGCTTCGTTGAAGTTTTTGA
TCTATGGTAAGACTGGTTGGCTTGGTGGTCTTCTAGGGAAACTATGTGAGAAGCAAGGG
ATTACATATGAGTATGGGAAAGGACGTCTGGAGGATAGAGCTTCTCTTGTGGCGGATAT
TCGTAGCATCAAACCTACTCATGTGTTTAATGCTGCTGGTTTAACTGGCAGACCCAACGT
TGACTGGTGTGAATCTCACAAACCAGAGACCATTCGTGTAAATGTCGCAGGTACTTTGA
CTCTAGCTGATGTTTGCAGAGAGAATGATCTCTTGATGATGAACTTCGCCACCGGTTGC
ATCTTTGAGTATGACGCTACACATCCTGAGGGTTCGGGTATAGGTTTCAAGGAAGAAGA
CAAGCCAAATTTCTTTGGTTCTTTCTACTCGAAAACCAAAGCCATGGTTGAGGAGCTCTT
GAGAGAATTTGACAATGTATGTACCTTGAGAGTCCGGATGCCAATCTCCTCAGACCTAA
ACAACCCGAGAAACTTCATCACGAAGATCTCGCGCTACAACAAAGTGGTGGACATCCCG
AACAGCATGACCGTACTAGACGAGCTTCTCCCAATCTCTATCGAGATGGCGAAGAGAAA
CCTAAGAGGCATATGGAATTTCACCAACCCAGGGGTGGTGAGCCACAACGAGATATTG
GAGATGTACAAGAATTACATCGAGCCAGGTTTTAAATGGTCCAACTTCACAGTGGAAGA
ACAAGCAAAGGTCATTGTTGCTGCTCGAAGCAACAACGAAATGGATGGATCTAAACTAA
GCAAGGAGTTCCCAGAGATGCTCTCCATCAAAGAGTCACTGCTCAAATACGTCTTTGAA
CCAAACAAGAGAACCTAAGTTTCTTAGCCTCCCATGGAAGAAACGTTCCCTCCTTA 
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Ordered gBlock with coding sequence of A. thaliana atugt78d1. At the 5’ and 3’ side of the 
gBlock homologous regions are present for assembly in the expression vector for the ugtb1 
locus (underlined). 
AATAAAGTCTCCTATATGACCAAATTCTCCGAGCCAATCAGAGACTCCCACGTGGCAGT
TCTCGCGTTTTTCCCCGTTGGCGCTCATGCCGGTCCTCTCTTAGCCGTCACTCGCCGTC
TCGCCGCCGCTTCTCCCTCCACCATCTTTTCTTTCTTCAACACCGCAAGATCAAACGCGT
CGTTGTTCTCCTCTGATCATCCCGAGAACATCAAGGTCCACGACGTCTCTGACGGTGTT
CCGGAGGGAACCATGCTCGGGAATCCACTGGAGATGGTCGAGCTGTTTCTCGAAGCGG
CTCCACGTATTTTCCGGAGCGAAATCGCGGCGGCAGAGATAGAAGTTGGAAAGAAAGT
GACATGCATGCTAACAGATGCCTTCTTCTGGTTCGCAGCGGACATAGCGGCTGAGCTG
AACGCGACTTGGGTTGCCTTCTGGGCCGGCGGAGCAAACTCACTCTGTGCTCATCTCT
ACACTGATCTCATCAGAGAAACCATCGGTCTCAAAGATGTGAGTATGGAAGAGACATTA
GGGTTTATACCAGGAATGGAGAATTACAGAGTTAAAGATATACCAGAGGAAGTTGTATTT
GAAGATTTGGACTCTGTTTTCCCAAAGGCTTTATACCAAATGAGTCTTGCTTTACCTCGT
GCCTCTGCTGTTTTCATCAGTTCCTTTGAAGAGTTAGAACCTACATTGAACTATAACCTA
AGATCCAAACTTAAACGTTTCTTGAACATCGCCCCTCTCACGTTATTATCTTCTACATCG
GAGAAAGAGATGCGTGATCCTCATGGCTGCTTTGCTTGGATGGGGAAGAGATCAGCTG
CTTCTGTAGCGTACATTAGCTTCGGCACCGTCATGGAACCTCCTCCTGAAGAGCTTGTG
GCGATAGCACAAGGGTTGGAATCAAGCAAAGTGCCGTTTGTTTGGTCGCTGAAGGAGA
AGAACATGGTTCATCTACCAAAAGGGTTTTTGGATCGGACAAGAGAGCAAGGGATAGTG
GTTCCTTGGGCTCCACAAGTGGAACTGCTGAAACACGAGGCAATGGGTGTGAATGTGA
CACATTGTGGATGGAACTCAGTGTTGGAGAGTGTGTCGGCAGGTGTACCGATGATCGG
CAGACCGATTTTGGCGGATAATAGGCTCAACGGAAGAGCAGTGGAGGTTGTGTGGAAG
GTTGGAGTGATGATGGATAATGGAGTCTTCACGAAAGAAGGATTTGAGAAGTGTTTGAA
TGATGTTTTTGTTCATGATGATGGTAAGACGATGAAGGCTAATGCCAAGAAGCTTAAAGA
AAAACTCCAAGAAGATTTCTCCATGAAAGGAAGCTCTTTAGAGAACTTCAAGATCTTGTT
GGACGAAATTGTGAAAGTTTAGCCTGGCTCTTTTTCT 
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Molecular masses of several common types of fatty acids, fatty acid derivatives and glycolipids. 
The molecular mass for the saccharide monomers used in the calculations was 180 Dalton. 
OH-FA = hydroxy fatty acid; gl = glycolipid with one saccharide; gl-gl = glycolipid with a 
disaccharide carbohydrate moiety; ac = acetylation; lac = lactonisation 
Fatty acids Mass OH-FA ω-al FA Dicarboxylic acid gl ac-gl 
C22:0 340 356 354 370 518 560 
C20:0 312 328 326 342 490 532 
C18:0 284 300 298 314 462 504 
C18:1 282 298 296 312 460 502 
C18:2 280 296 294 310 458 500 
C18:3 278 294 292 308 456 498 
C16:0 256 272 270 286 434 476 
C14:0 228 244 242 258 406 448 
C12:0 200 216 214 230 378 420 
C10:0 172 188 186 202 350 392 
C8:0 144 160 158 174 322 364 
 
Fatty acids Mass gl-gl ac-gl-gl lac-ac-gl-gl ac-ac-gl-gl lac-ac-ac-gl-gl 
C22:0 340 680 722 704 764 746 
C20:0 312 652 694 676 736 718 
C18:0 284 624 666 648 708 690 
C18:1 282 622 664 646 706 688 
C18:2 280 620 662 644 704 686 
C18:3 278 618 660 642 702 684 
C16:0 256 596 638 620 680 662 
C14:0 228 568 610 592 652 634 
C12:0 200 540 582 564 624 606 
C10:0 172 512 554 536 596 578 
C8:0 144 484 526 508 568 550 
 
